data_6mk7_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6mk7 _Structure_validation_residue.Date_analyzed 2019-02-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.481 0.181 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.39 134.76 65.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.5 t -122.08 126.69 74.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.816 0.341 . . . . 0.0 110.827 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 94.2 t -109.05 115.3 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -84.79 135.75 33.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.446 0.641 . . . . 0.0 110.047 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.2 mt -107.51 157.89 7.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.327 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? . . . . . 0 CA--C 1.514 -0.416 0 O-C-N 123.632 0.583 . . . . 0.0 110.229 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.6 tptt . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 120.973 0.416 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.6 t -70.41 -38.57 74.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.908 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.78 -44.17 96.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.216 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.47 -39.75 92.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.528 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.3 p -67.84 -36.35 80.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.398 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.92 -17.82 54.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.99 -35.76 20.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.063 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -87.32 6.93 31.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.574 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.5 mtt -50.98 -20.18 1.27 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 77.95 -53.63 0.51 Allowed 'General case' 0 C--N 1.345 0.373 0 O-C-N 123.86 0.725 . . . . 0.0 110.323 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.4 m -85.12 13.48 6.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.312 0.577 . . . . 0.0 110.576 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 p -98.41 147.71 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.985 0.422 . . . . 0.0 110.732 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -102.75 -42.88 5.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.348 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.6 t -159.9 146.61 16.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.59 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.79 126.31 64.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.7 m -124.37 128.78 49.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 110.439 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -86.7 116.89 25.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.086 0.469 . . . . 0.0 110.705 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 t -105.67 114.0 27.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.95 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.6 p -64.59 162.08 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.097 0.475 . . . . 0.0 110.799 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.4 pttt . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.759 -179.333 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.862 0.363 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.92 144.28 53.37 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.332 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.22 144.87 50.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.07 0.462 . . . . 0.0 110.684 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.431 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 1.6 m-85 -118.81 106.34 12.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.36 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -80.24 110.77 16.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.099 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.3 t -114.55 134.12 58.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.263 0.554 . . . . 0.0 110.821 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -100.79 107.48 19.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.656 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.64 147.2 52.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -58.11 -39.47 78.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.725 0.298 . . . . 0.0 110.291 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -137.06 160.22 66.9 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.452 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.78 -24.13 78.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.787 2.325 . . . . 0.0 112.118 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -88.12 -6.17 58.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.486 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -93.41 -19.28 21.45 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 120.631 0.253 . . . . 0.0 110.353 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.0 m -57.22 -29.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.254 0.549 . . . . 0.0 109.548 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.11 -37.88 57.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.974 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.475 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 95.9 m -72.02 -36.42 69.7 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 121.567 0.699 . . . . 0.0 110.055 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.2 mm -68.2 -39.8 81.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.364 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.93 -39.25 83.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.374 0.607 . . . . 0.0 111.318 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 149' ' ' THR . 1.3 pp20? -71.23 -26.01 62.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.635 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.54 -38.58 23.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.397 0.617 . . . . 0.0 109.774 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.96 -22.56 62.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.63 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -65.74 -17.16 64.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.46 7.12 22.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.9 mt -87.21 127.78 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.664 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 36.01 -129.12 0.12 Allowed 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.421 1.075 . . . . 0.0 111.043 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -107.13 67.49 0.23 Allowed Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.36 107.42 4.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.055 0.455 . . . . 0.0 110.122 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 t -61.13 -44.62 97.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.788 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -169.46 159.32 8.47 Favored 'General case' 0 C--O 1.202 -1.441 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.846 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 68.2 t -128.71 133.4 66.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 120.719 0.295 . . . . 0.0 110.263 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -119.88 124.27 45.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.921 0.391 . . . . 0.0 110.74 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -90.11 115.81 27.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.736 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 . . . . . 0 C--O 1.227 -0.099 0 CA-C-O 120.866 0.365 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.1 t -144.41 144.88 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.237 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.4 t -120.71 127.4 75.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.807 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.2 t -108.82 117.07 53.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -83.97 138.78 32.95 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.765 0.793 . . . . 0.0 110.54 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.31 161.24 5.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.704 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.214 0 O-C-N 123.661 0.601 . . . . 0.0 110.454 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 tptt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.75 -39.27 77.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.881 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -64.82 -41.16 95.98 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.553 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -66.91 -39.57 87.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.339 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.6 m -65.55 -42.12 92.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.172 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.02 -39.27 66.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.015 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -37.67 84.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.018 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -95.56 6.47 48.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.683 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.2 ttm -63.31 -19.26 64.45 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.612 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 t 72.47 160.71 0.23 Allowed 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.3 m 72.21 2.16 4.21 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 124.111 0.882 . . . . 0.0 110.925 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.3 m -112.23 139.49 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 110.543 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -40.71 28.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.537 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 85.4 p -164.81 162.0 20.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 96.0 t -133.59 131.81 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.146 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.1 m -125.76 136.74 53.49 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 121.012 0.434 . . . . 0.0 110.973 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -87.37 124.67 33.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.188 0.518 . . . . 0.0 110.137 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.7 p -116.75 108.98 16.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.953 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.6 m -61.38 165.65 4.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.445 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.995 0.426 . . . . 0.0 110.143 -179.462 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.75 143.59 57.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.224 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.01 137.68 44.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.007 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -101.99 113.33 26.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.5 mt -88.7 109.9 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.14 148.39 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.175 0.512 . . . . 0.0 109.815 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -105.84 107.12 17.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.217 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.4 58.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.824 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -52.89 -26.52 15.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.296 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -161.38 165.77 16.13 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-O 121.262 0.553 . . . . 0.0 110.75 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.69 -30.33 83.52 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.747 2.298 . . . . 0.0 111.715 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -84.09 -7.49 59.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -96.99 -20.06 18.33 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.617 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.0 m -56.12 -31.12 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.233 0.539 . . . . 0.0 110.034 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -33.93 48.83 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.045 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.8 m -71.1 -39.51 72.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.335 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.3 mm -67.72 -40.39 83.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.392 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.87 -41.55 97.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.366 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.5 -38.91 81.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.821 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.18 -35.99 74.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.533 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.8 81.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.503 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -65.25 -17.08 64.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.091 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -98.69 7.77 45.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.99 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.0 mm -65.02 -86.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -165.37 -79.03 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.808 0.337 . . . . 0.0 110.549 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -93.78 34.66 4.52 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.79 94.68 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.476 0.655 . . . . 0.0 110.723 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.0 t -63.95 -45.41 89.31 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.27 165.13 37.62 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.914 0.387 . . . . 0.0 110.375 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.14 138.26 30.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.788 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -140.31 138.16 34.72 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.644 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -80.61 178.39 8.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.897 0.38 . . . . 0.0 110.686 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.619 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.373 0.606 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.34 140.36 48.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.1 t -120.25 126.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.534 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.7 t -111.04 124.76 68.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.184 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -91.9 136.23 33.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.13 0.49 . . . . 0.0 110.114 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.15 143.94 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.528 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.404 179.682 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.04 0.448 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.79 -35.77 75.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -64.92 -41.33 95.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.434 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.54 -39.59 77.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.647 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.4 p -68.01 -40.18 83.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.879 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.7 mt -74.6 -39.91 61.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.019 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -37.69 75.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.666 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -95.89 6.74 48.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.059 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.424 ' O ' ' CB ' ' A' ' 98' ' ' SER . 9.1 ttm -56.79 -17.27 8.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 119.258 -0.401 . . . . 0.0 111.031 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 97' ' ' MET . 0.9 OUTLIER 84.79 -61.35 0.08 Allowed 'General case' 0 C--N 1.353 0.738 0 O-C-N 123.952 0.783 . . . . 0.0 110.762 -179.552 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 31.9 m -68.13 -7.41 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.029 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.0 t -96.52 118.84 43.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.883 0.373 . . . . 0.0 110.788 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -69.76 -43.58 71.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.81 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -155.4 159.04 39.57 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.323 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.6 t -133.52 129.88 56.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.601 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.4 m -123.13 124.13 42.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -86.81 113.71 22.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.025 0.44 . . . . 0.0 110.542 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.2 t -100.4 105.47 16.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.78 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.2 p -65.11 163.6 14.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.936 0.398 . . . . 0.0 110.098 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.14 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.862 0.363 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -58.36 140.75 53.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.939 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.67 143.3 50.34 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.522 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.06 108.22 15.47 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.1 mt -89.06 110.59 21.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.9 m -119.4 150.49 21.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.134 0.493 . . . . 0.0 110.09 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -102.86 106.89 17.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.167 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.72 144.95 47.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 4.9 m-80 -69.32 83.57 0.38 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.765 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 142' ' ' ASN . . . 90.52 157.43 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 O-C-N 124.281 0.988 . . . . 0.0 110.56 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.89 -24.26 75.48 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.842 2.361 . . . . 0.0 112.582 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -80.1 -10.07 59.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.263 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -97.59 -19.96 17.98 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 120.586 0.231 . . . . 0.0 111.127 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.0 m -53.63 -31.83 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -76.47 -32.93 58.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.853 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 87.0 m -72.95 -37.88 66.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.516 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.8 mm -71.25 -40.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.319 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.28 -40.36 81.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 149' ' ' THR . 2.3 pp20? -75.12 -31.25 61.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.73 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -78.14 -37.27 46.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.386 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.12 82.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.968 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -62.55 -15.58 51.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.757 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -96.85 5.94 49.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.089 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.06 129.86 42.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.675 0.274 . . . . 0.0 110.614 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 44.05 -121.03 0.76 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.251 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.56 54.76 0.76 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -45.14 146.42 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.5 p -97.02 -35.37 10.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.422 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -170.07 158.91 7.28 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.412 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.05 143.69 39.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.673 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -140.29 132.19 27.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.522 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.66 124.96 48.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.581 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.575 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.808 0.337 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -129.44 137.43 56.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.39 126.04 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 0.0 110.654 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 90.5 t -110.33 118.97 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.386 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -86.17 133.54 33.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.165 0.507 . . . . 0.0 109.715 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.6 mt -100.62 149.75 5.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.916 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.706 179.644 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 121.146 0.498 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.0 t -67.12 -38.44 81.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.796 179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -63.39 -43.77 96.6 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.04 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.65 -40.13 96.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.652 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.3 t -70.25 -39.52 74.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.239 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.42 -20.77 56.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.049 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.59 -33.15 16.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -89.68 7.27 37.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -17.63 6.77 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.155 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 77.12 -68.35 0.18 Allowed 'General case' 0 C--N 1.35 0.591 0 O-C-N 123.39 0.431 . . . . 0.0 110.776 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.7 m -58.02 -19.26 29.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.037 0.446 . . . . 0.0 110.531 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.41 133.72 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.137 0.494 . . . . 0.0 110.798 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -82.13 -43.27 18.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.178 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.2 p -160.01 159.27 31.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.237 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 91.1 t -132.83 128.72 57.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.141 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.0 m -121.07 125.24 46.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.842 0.353 . . . . 0.0 110.243 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -85.66 115.66 23.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.832 0.349 . . . . 0.0 110.112 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.4 t -105.05 108.66 20.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.258 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -59.85 159.95 8.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.431 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.438 . . . . 0.0 110.058 -179.425 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.77 144.7 56.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.087 0.47 . . . . 0.0 110.132 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.67 145.73 50.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.605 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 1.2 m-85 -117.53 106.97 13.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.763 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.5 mt -92.07 111.13 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.3 m -116.45 150.21 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.204 0.525 . . . . 0.0 110.133 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -107.55 107.86 18.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.1 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.28 142.21 58.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.614 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -54.59 -34.61 62.25 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.941 0.4 . . . . 0.0 110.119 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -141.74 159.27 60.45 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 121.124 0.488 . . . . 0.0 110.859 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -56.79 -26.39 66.15 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.652 2.235 . . . . 0.0 111.911 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -88.06 -7.57 56.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.759 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -92.28 -20.31 21.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.286 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.0 m -55.98 -33.28 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.312 0.577 . . . . 0.0 109.652 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -33.33 57.61 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.534 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 95.6 m -71.73 -39.34 70.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.393 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 23.5 mm -67.85 -40.63 83.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.928 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.37 97.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.932 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.84 -38.95 87.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.584 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.95 -37.59 81.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.264 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.31 73.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.768 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -62.56 -23.12 66.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.262 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -92.02 -7.93 47.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.984 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.4 mm -55.65 -23.06 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.031 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 73.84 131.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.166 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.01 82.99 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.4 t -79.14 119.94 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 O-C-N 122.659 -0.318 . . . . 0.0 110.541 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.2 t -62.89 -48.02 80.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -168.5 152.64 5.88 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 99.2 t -121.15 135.41 61.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.804 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -124.9 126.25 45.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.783 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.6 115.7 27.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.386 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.656 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.689 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.982 0.42 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -125.43 139.82 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.884 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.19 124.28 72.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.939 0.399 . . . . 0.0 110.924 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -114.35 107.76 23.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.724 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -82.22 146.19 29.64 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.056 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.2 mt -113.94 146.2 18.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.728 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 121.419 0.628 . . . . 0.0 111.32 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 tptp . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.086 0.47 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.63 -35.38 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.249 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -67.8 -41.03 83.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.125 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.39 -40.44 95.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.438 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.6 m -66.04 -40.37 90.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.26 -13.89 59.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.696 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -95.74 -32.68 12.61 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.972 0.415 . . . . 0.0 111.531 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -91.59 4.77 51.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.923 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.5 mtt -52.16 -19.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.449 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t 77.15 -65.6 0.28 Allowed 'General case' 0 C--N 1.345 0.403 0 O-C-N 123.331 0.395 . . . . 0.0 110.078 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.7 m -62.81 -19.07 63.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.483 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.96 146.21 11.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.137 0.494 . . . . 0.0 111.496 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -98.57 -44.81 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.648 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -161.19 159.05 28.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.075 0.464 . . . . 0.0 110.472 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.9 t -134.83 129.29 51.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.602 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 96.3 m -122.18 132.95 54.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.223 0.535 . . . . 0.0 110.653 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -86.14 124.45 32.56 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.488 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.83 89.94 3.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.063 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -51.65 145.43 9.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.345 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.7 pttt . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.538 -179.469 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 119.932 -0.08 . . . . 0.0 111.159 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.561 ' O ' ' O ' ' A' ' 136' ' ' ALA . 66.9 m-20 72.73 -48.05 0.68 Allowed 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.138 0.899 . . . . 0.0 112.456 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . 41.44 124.32 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.695 0 O-C-N 124.36 1.037 . . . . 0.0 112.36 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.2 106.44 14.37 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.471 -0.768 . . . . 0.0 110.113 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 57.6 mt -84.25 108.1 16.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 79.8 t -108.95 137.4 41.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.076 0.465 . . . . 0.0 110.753 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -107.33 111.28 23.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.427 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.6 146.21 46.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.665 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.1 -34.04 54.91 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.225 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -141.44 160.02 58.52 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 120.755 0.312 . . . . 0.0 110.45 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.47 -20.2 65.84 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.644 2.229 . . . . 0.0 112.197 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.86 -4.3 58.87 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -103.34 -8.62 20.12 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.722 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.1 m -62.31 -27.49 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 109.757 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -33.4 31.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.992 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 m -72.85 -39.08 66.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.415 0.626 . . . . 0.0 110.525 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 19.1 mm -69.68 -39.93 78.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.287 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.32 -40.53 97.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.576 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -72.1 -29.46 64.11 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.494 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -76.89 -35.87 57.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.561 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.67 -34.57 78.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.649 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.35 -14.11 46.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.81 -1.06 57.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.054 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -91.15 131.28 38.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.332 0.587 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -64.57 141.08 58.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.321 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.87 -14.46 64.68 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.44 127.26 36.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.519 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -94.6 -49.88 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.849 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.88 142.92 24.01 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.85 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.08 132.39 67.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.784 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -136.05 148.6 48.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.221 0.534 . . . . 0.0 110.474 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 58.4 p-10 -87.05 -172.13 3.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.901 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.755 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.697 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 tpp85 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.3 t -128.89 132.24 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.9 t -119.52 121.51 66.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.6 t -108.52 118.31 55.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -86.13 132.27 34.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 mt -91.38 150.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.119 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 . . . . . 0 C--O 1.236 0.365 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.254 179.707 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.9 t -69.1 -38.32 77.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.701 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -62.0 -44.86 95.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.653 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.99 -39.69 95.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.38 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.8 p -67.15 -38.44 85.5 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.414 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.2 mt -69.27 -39.38 78.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.755 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -68.39 -36.37 79.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.558 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -99.76 7.97 44.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.763 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.1 ttm -62.25 -18.89 62.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.262 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 t 74.32 158.76 0.21 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.3 m 69.48 4.93 4.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.877 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.29 153.37 14.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 CA-C-O 120.953 0.406 . . . . 0.0 110.298 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -101.28 -37.19 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.786 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.6 t -162.39 152.19 16.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.953 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.97 128.95 63.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.492 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.9 m -123.91 129.37 50.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.635 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -87.35 119.0 27.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.137 0.494 . . . . 0.0 109.928 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.6 t -106.67 116.61 32.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.788 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -63.96 155.68 30.18 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.45 . . . . 0.0 110.084 -179.647 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.918 0.389 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -61.85 150.23 37.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.72 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.56 145.88 45.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.612 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -117.39 114.58 23.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.7 mt -89.79 113.95 26.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.5 t -116.71 136.48 53.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.634 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -100.38 108.74 20.83 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.069 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 145.98 50.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.772 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -59.28 -41.09 88.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.278 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.16 159.57 71.6 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.577 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.42 -22.98 71.51 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.592 2.195 . . . . 0.0 112.223 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -89.53 -5.06 57.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.212 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.405 ' O ' HG12 ' A' ' 150' ' ' ILE . 96.7 m-20 -97.57 -16.37 20.09 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.35 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.6 m -55.0 -34.03 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.549 0.69 . . . . 0.0 109.322 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -73.73 -33.26 64.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.933 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.5 m -71.14 -38.77 72.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.456 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 146' ' ' ASP . 43.7 mm -66.59 -40.92 87.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.962 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.43 94.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.742 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.47 -33.69 71.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.62 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -71.45 -39.31 71.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.974 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.08 79.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.277 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -61.88 -25.93 67.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.708 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -105.88 -4.62 20.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.565 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mt -60.66 -51.56 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.384 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -151.76 -97.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.02 80.66 0.22 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.1 m -92.7 134.14 31.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.1 p -69.28 -34.38 74.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.161 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -172.41 163.9 5.63 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.645 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.97 138.17 50.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -130.07 133.12 46.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.16 135.25 41.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.995 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 179.853 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.5 t -126.65 140.23 49.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -119.58 124.86 73.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.12 0.486 . . . . 0.0 110.604 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 59.5 t -114.0 110.01 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -78.48 144.23 35.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.116 0.484 . . . . 0.0 110.316 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.3 mt -111.64 137.0 46.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.837 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.619 -179.662 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 121.057 0.456 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.78 -39.37 84.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.177 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.1 -43.6 98.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.635 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.82 -39.01 90.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.504 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.2 m -66.59 -42.29 87.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.406 0.622 . . . . 0.0 110.52 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.0 mt -72.58 -33.8 67.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.704 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -80.89 -27.37 36.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.846 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -93.95 -3.58 51.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.117 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.79 -19.02 2.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.977 -0.535 . . . . 0.0 111.025 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.24 -54.51 0.43 Allowed 'General case' 0 C--N 1.346 0.431 0 O-C-N 123.992 0.808 . . . . 0.0 110.543 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 31.6 m -72.21 -5.17 33.88 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.767 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.8 t -91.0 123.97 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.948 0.404 . . . . 0.0 111.2 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.99 -43.53 64.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.868 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.0 t -161.74 157.54 24.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.109 0.48 . . . . 0.0 110.53 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.6 t -131.35 127.66 60.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.214 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 98.8 m -120.92 129.22 53.38 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 120.968 0.413 . . . . 0.0 110.027 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -90.97 109.68 20.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.167 0.508 . . . . 0.0 110.779 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.1 t -96.07 114.27 25.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.305 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.6 p -67.96 162.62 23.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.929 0.395 . . . . 0.0 110.534 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 121.033 0.444 . . . . 0.0 109.98 -179.761 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.889 0.376 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -65.92 141.1 58.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.54 144.75 50.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.465 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 1.4 m-85 -112.23 108.74 18.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.023 0.44 . . . . 0.0 110.551 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 59.6 mt -86.34 104.37 13.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.5 t -110.79 137.61 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.167 0.508 . . . . 0.0 111.074 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -101.36 105.53 16.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.112 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.41 144.81 51.42 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.833 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.511 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 14.0 t-20 -69.36 84.57 0.39 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.04 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 142' ' ' ASN . . . 92.24 149.67 0.05 OUTLIER Pre-proline 0 N--CA 1.451 -0.396 0 O-C-N 124.301 1.001 . . . . 0.0 110.553 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.97 -21.25 48.85 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.629 2.22 . . . . 0.0 112.709 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -82.7 -6.31 59.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.244 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -104.36 -13.49 16.09 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.925 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.4 m -58.89 -30.89 43.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -75.71 -33.24 60.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.721 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.1 m -72.56 -40.18 66.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.678 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 47.5 mm -68.57 -40.02 81.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.753 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.97 -39.68 94.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.682 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -70.16 -38.53 75.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.053 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.08 -36.92 72.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.42 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.805 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -65.62 -16.59 63.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.62 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -91.56 -1.43 57.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.47 134.76 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.038 0.447 . . . . 0.0 110.535 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.02 143.47 57.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.623 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 90.55 -10.09 75.62 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.48 137.09 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 120.88 0.371 . . . . 0.0 110.637 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t -108.36 -51.43 2.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -154.42 141.08 18.98 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.06 135.58 63.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.775 0.322 . . . . 0.0 110.793 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -138.29 144.81 40.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.988 0.423 . . . . 0.0 110.288 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -110.03 155.3 22.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.733 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.613 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.864 0.364 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.38 127.06 68.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.3 t -115.36 118.76 59.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.7 t -105.91 119.18 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 110.424 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -88.1 129.1 35.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.12 143.54 12.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.965 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 121.142 0.496 . . . . 0.0 110.985 179.589 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm . . . . . 0 N--CA 1.446 -0.644 0 CA-C-O 121.188 0.518 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.1 t -66.33 -38.59 82.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.099 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -61.46 -43.2 99.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.542 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -65.34 -40.37 93.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.235 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.7 m -66.03 -40.8 91.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.508 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -76.72 -21.1 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.946 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -89.92 -25.81 20.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.152 0.501 . . . . 0.0 111.253 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -94.02 9.54 37.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.281 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 67.8 mmm -56.84 -18.14 11.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.024 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 82.02 -49.52 0.22 Allowed 'General case' 0 C--N 1.349 0.557 0 O-C-N 123.531 0.519 . . . . 0.0 110.956 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.8 m -81.28 -13.97 57.89 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.757 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.8 t -82.78 141.96 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.915 0.388 . . . . 0.0 111.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -98.33 -43.51 6.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.042 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.6 t -153.74 149.81 27.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.093 0.473 . . . . 0.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.4 t -131.11 129.93 63.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.973 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.1 m -122.66 127.43 49.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.233 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -83.96 120.59 26.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.918 0.39 . . . . 0.0 110.325 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.1 t -108.01 107.06 17.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.892 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.0 m -61.62 159.64 12.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.189 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.259 0.552 . . . . 0.0 110.147 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.74 0.305 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -68.51 150.16 48.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.482 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -128.96 150.0 50.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.347 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.98 110.86 14.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.3 mt -88.71 109.79 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.0 t -109.82 137.68 40.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.265 0.555 . . . . 0.0 111.152 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -100.95 107.81 19.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.798 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.49 150.3 43.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.34 -40.98 79.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.891 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -136.97 159.99 67.92 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.676 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.04 -23.34 68.29 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.694 2.263 . . . . 0.0 112.168 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -91.32 -4.53 55.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.378 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -99.04 -12.71 20.32 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.3 m -61.91 -32.66 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -74.25 -35.33 63.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.934 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.4 m -71.61 -40.04 70.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.487 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.2 mm -67.43 -39.54 82.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.495 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.97 95.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.968 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.52 -38.76 90.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.725 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -69.91 -37.27 75.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.656 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.71 77.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.465 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.92 -16.94 61.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.728 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -97.61 6.25 48.3 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.993 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.3 mt -98.41 129.01 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 40.48 -117.64 0.3 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.624 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.33 77.89 0.39 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.3 t -78.47 122.09 32.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.9 p -68.17 -40.85 82.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.155 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -174.87 152.69 1.58 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.917 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.5 t -124.91 133.83 68.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.948 0.404 . . . . 0.0 110.784 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -122.54 129.86 52.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.845 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -104.35 128.56 52.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.655 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.693 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.5 140.12 49.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.862 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.6 t -117.46 115.35 48.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.337 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -99.1 109.51 24.44 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -80.0 139.19 37.08 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.068 0.461 . . . . 0.0 110.848 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.2 mt -111.22 159.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.69 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 . . . . . 0 N--CA 1.463 0.211 0 O-C-N 123.558 0.536 . . . . 0.0 110.541 179.674 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.088 0.47 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.98 -40.66 81.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.345 0.593 . . . . 0.0 109.853 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -63.06 -44.81 94.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.501 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.36 -40.58 96.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.644 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.2 m -66.12 -38.64 88.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.253 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.65 -11.85 59.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.82 -39.53 16.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.812 0.339 . . . . 0.0 111.681 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -85.69 7.17 24.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -52.04 -19.8 2.08 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.295 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 77.02 -62.22 0.41 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.497 0.319 . . . . 0.0 110.759 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.2 m -65.48 -11.87 47.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.53 139.49 18.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.636 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -95.71 -43.47 7.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.289 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.3 p -158.55 154.24 26.32 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.389 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -135.22 127.95 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.751 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.1 m -127.32 134.25 50.01 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.007 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -79.29 121.77 25.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.214 0.531 . . . . 0.0 109.901 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.7 t -115.64 122.99 47.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.151 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.3 t -67.98 163.15 22.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.37 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 pttt . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.711 -179.655 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.104 0 N-CA-C 110.421 -0.215 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.91 140.43 19.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.91 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.48 151.36 41.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.729 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -98.98 120.46 39.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.388 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 58.0 mt -82.6 100.23 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.6 t -101.41 131.14 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.597 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -99.5 107.78 20.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.989 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.98 146.28 54.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.439 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -57.87 -36.91 73.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.079 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -139.64 159.2 66.26 Favored Pre-proline 0 C--N 1.328 -0.326 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.859 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.91 -28.1 81.38 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.501 2.134 . . . . 0.0 112.033 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -86.16 -5.49 59.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.225 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -95.65 -14.67 23.28 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.399 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.68 -32.52 55.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -75.56 -37.85 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.075 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.1 m -69.72 -40.59 76.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.17 0.51 . . . . 0.0 110.456 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.6 mm -67.47 -39.58 82.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.464 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.7 98.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.152 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.26 -39.59 82.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.859 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.14 -38.05 75.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.001 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.37 -27.85 67.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.663 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -61.76 -20.95 64.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.806 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.64 -8.96 57.0 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.694 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 14.1 mm -74.46 130.36 36.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.098 0.475 . . . . 0.0 110.818 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -65.91 138.76 58.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.273 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 94.9 -14.14 65.87 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.484 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.26 127.35 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 122.339 -0.507 . . . . 0.0 110.91 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.8 p -95.15 -32.48 13.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.015 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -170.84 160.39 6.78 Favored 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.186 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 19.5 t -133.97 134.56 55.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.318 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -131.96 124.18 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.743 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -79.11 178.4 8.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 0.0 110.761 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.608 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.175 0 CA-C-O 121.029 0.442 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.3 t -128.11 140.69 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.048 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.9 t -120.12 126.54 75.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.9 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.1 t -114.33 112.21 39.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -79.52 139.17 37.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.21 0.529 . . . . 0.0 110.091 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.9 mm -96.86 156.78 3.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.041 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.433 179.203 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.123 0.487 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.0 t -70.3 -39.72 77.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.017 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -63.12 -44.62 95.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.517 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.23 -39.91 94.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.806 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.8 m -68.93 -40.15 79.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.345 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.56 -30.34 67.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.653 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -34.61 66.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -84.57 6.36 24.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 7.7 mmm -57.53 -19.18 23.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 119.634 -0.222 . . . . 0.0 110.884 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 75.34 -68.22 0.21 Allowed 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.4 0.438 . . . . 0.0 110.687 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.7 m -60.83 -14.79 24.11 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.806 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -73.22 145.62 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.129 0.49 . . . . 0.0 111.304 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.35 -43.46 5.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.583 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.2 t -159.23 149.02 18.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.275 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.04 130.45 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.232 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.0 m -125.24 131.04 53.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.311 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -87.69 113.75 23.66 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.927 0.394 . . . . 0.0 110.543 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.1 t -97.16 106.54 18.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.726 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -64.09 156.02 29.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.151 0.501 . . . . 0.0 110.364 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.418 -179.71 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.099 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -79.84 167.89 19.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.674 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.23 149.4 41.3 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.785 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -118.05 105.48 11.9 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.7 mt -80.73 103.35 7.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.8 t -106.69 137.3 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.099 0.476 . . . . 0.0 111.261 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -102.18 108.01 19.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.295 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.5 142.93 53.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.721 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.92 -32.73 34.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.631 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -149.91 163.16 25.71 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-O 121.235 0.541 . . . . 0.0 111.307 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.17 -28.64 84.7 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.591 2.194 . . . . 0.0 112.004 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -86.52 -5.41 59.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.232 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.55 -16.99 19.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.1 m -58.12 -34.08 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -33.99 63.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.885 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.4 m -71.35 -39.35 71.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.654 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 22.9 mm -66.37 -40.66 87.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.622 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.17 96.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.468 0.651 . . . . 0.0 110.523 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -68.8 -39.43 80.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.847 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -71.06 -36.28 72.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.12 -35.46 78.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.329 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -61.44 -18.7 60.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.16 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.43 -14.7 39.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.679 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 mm -57.86 -100.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.757 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 171.17 138.43 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 78.78 13.75 82.79 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.644 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.1 t -81.84 127.21 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.618 -0.342 . . . . 0.0 110.335 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.8 p -96.58 -34.88 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.481 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.32 157.95 6.42 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.917 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.25 142.28 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.091 0.472 . . . . 0.0 110.389 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -142.11 119.89 11.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.854 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -82.12 173.26 12.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.784 0.326 . . . . 0.0 110.874 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.694 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.933 0.397 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.24 137.16 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.964 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.03 122.81 70.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -112.32 105.0 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -74.36 146.34 43.09 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.9 mt -120.07 135.12 61.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.732 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.644 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.603 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 12.4 tptp . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.994 0.426 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.7 t -65.21 -42.99 95.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.207 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -66.95 -42.45 85.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.66 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.74 -38.69 83.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.449 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 t -68.17 -42.77 79.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.487 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.29 -26.02 62.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.915 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -91.64 -30.53 16.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.699 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -99.88 2.87 44.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.446 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -15.93 61.72 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 72.7 158.54 0.2 Allowed 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 123.643 0.589 . . . . 0.0 109.711 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.5 m 72.66 5.6 5.26 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.908 0.755 . . . . 0.0 110.818 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.39 121.13 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -61.86 -44.95 95.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.0 p -163.39 163.72 24.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.22 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.2 t -134.69 129.27 51.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.266 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.1 m -121.92 132.38 54.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.981 0.419 . . . . 0.0 110.719 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 84.4 t80 -88.79 106.95 18.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.439 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.2 t -95.67 118.5 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.004 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.2 p -70.82 160.81 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.379 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.6 pttm . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 121.075 0.464 . . . . 0.0 110.571 179.684 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.522 -0.122 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.436 ' HB3' ' CE1' ' A' ' 105' ' ' PHE . 93.7 m-20 -74.5 131.96 41.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.659 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.86 137.32 54.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.072 0.463 . . . . 0.0 111.361 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -95.48 120.3 35.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 51.4 mt -92.63 104.4 15.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.0 t -105.65 132.74 51.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.4 . . . . 0.0 110.355 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -98.99 107.09 19.44 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.484 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.44 142.92 57.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.954 0.407 . . . . 0.0 110.684 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -59.44 -40.22 86.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.208 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -136.84 160.7 65.31 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 121.15 0.5 . . . . 0.0 110.91 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.94 -15.22 46.17 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.701 2.267 . . . . 0.0 111.87 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -96.81 -5.66 37.88 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.406 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -98.19 -24.15 15.4 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 120.71 0.29 . . . . 0.0 110.581 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -36.57 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.19 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -71.54 -35.71 70.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.926 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.9 m -73.05 -39.7 65.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.454 0.645 . . . . 0.0 110.58 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 25.5 mm -69.31 -38.99 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.39 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.23 -40.05 95.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.238 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -66.08 -40.03 90.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.57 -37.39 73.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.865 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.01 72.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.774 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -72.66 -13.07 61.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.081 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -107.57 9.99 29.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.859 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.5 mm -55.08 -88.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.51 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -151.93 -84.56 0.08 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.631 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.89 35.66 4.71 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.49 143.84 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.993 0.425 . . . . 0.0 109.952 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.7 t -97.34 -51.33 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -166.46 145.89 5.8 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.001 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 95.1 t -117.99 129.26 74.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.023 0.439 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -128.25 128.27 44.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.762 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -77.61 168.97 19.11 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.424 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.5 131.61 57.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 87.8 t -121.07 124.01 71.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.74 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 80.0 t -111.38 114.71 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.136 0.494 . . . . 0.0 111.463 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -79.31 134.77 36.62 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.121 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 54.5 mt -117.5 139.33 45.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.734 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.589 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.5 tptp . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.357 0.598 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.0 t -69.23 -38.83 78.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.631 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -60.37 -45.85 92.04 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.017 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.54 -39.91 92.28 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.585 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 t -65.9 -42.25 90.47 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.409 0.623 . . . . 0.0 110.425 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 91.6 mt -73.19 -36.23 66.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -37.37 68.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.023 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -91.57 6.91 43.83 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.805 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.38 -19.88 0.95 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.539 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t 67.77 67.55 0.36 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 167.21 -23.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.809 0.693 . . . . 0.0 110.257 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.2 m -85.78 149.27 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.113 0.482 . . . . 0.0 111.413 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -91.62 -43.17 9.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.016 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.9 p -154.22 152.75 30.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.082 0.468 . . . . 0.0 110.491 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.3 t -132.56 128.64 58.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.766 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.5 m -124.68 131.34 53.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.781 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -92.58 122.2 34.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.548 0.689 . . . . 0.0 110.108 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.17 106.95 18.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.702 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.0 m -66.43 145.33 55.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 110.88 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.9 pttt . . . . . 0 CA--C 1.514 -0.42 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.928 179.621 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.986 0.422 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.73 -169.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.73 127.78 3.7 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -105.96 106.38 16.85 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.4 mt -82.9 110.58 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.3 t -115.41 137.02 50.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.048 0.451 . . . . 0.0 110.47 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -101.34 109.33 21.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.041 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.65 147.39 49.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.587 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -57.53 -40.0 77.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.041 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -135.2 159.95 69.98 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.638 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.07 -19.34 62.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.379 2.053 . . . . 0.0 112.215 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -91.52 -5.49 54.07 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.234 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -98.92 -16.12 18.91 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.241 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.3 m -60.0 -33.17 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 121.18 0.514 . . . . 0.0 109.736 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -38.25 63.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.454 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.8 m -68.73 -40.35 79.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.3 0.571 . . . . 0.0 110.797 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.43 -41.27 91.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.494 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.31 98.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.314 0.578 . . . . 0.0 109.965 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.42 -40.21 89.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.745 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.06 -37.47 78.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.765 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.94 73.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.382 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -61.72 -19.93 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.102 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -92.86 6.59 47.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.998 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 17.3 mm -88.14 120.98 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 41.91 -97.06 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.464 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -159.95 52.16 0.36 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.1 m -46.7 163.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-O 120.723 0.297 . . . . 0.0 110.362 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.4 t -83.93 -50.36 8.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.165 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -169.48 148.76 3.84 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.706 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.22 148.56 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.253 0.549 . . . . 0.0 110.484 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -142.01 148.82 39.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.652 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.46 135.48 51.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.451 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.766 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.101 0.476 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.84 137.48 53.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.983 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.41 123.8 72.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.856 0.36 . . . . 0.0 110.47 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.52 116.13 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.24 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -85.35 134.58 34.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.61 147.8 6.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.743 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.721 179.631 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 tptt . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.868 0.366 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.4 t -66.68 -40.28 85.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.782 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -66.71 -41.71 87.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.489 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -65.01 -40.56 95.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.385 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.6 m -68.24 -37.32 80.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.124 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.3 mt -79.14 -11.48 59.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.018 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -94.81 -32.87 13.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.866 0.365 . . . . 0.0 111.407 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -89.55 8.52 30.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.185 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 77.5 mmm -53.46 -20.16 4.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.841 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.35 -48.22 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.613 0.571 . . . . 0.0 110.74 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.9 m -88.17 17.76 4.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 0.0 110.83 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.3 p -107.25 138.55 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.12 0.486 . . . . 0.0 111.262 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -95.54 -42.24 8.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.795 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.6 t -157.98 150.1 22.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.585 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.58 128.84 61.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.736 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.3 m -125.42 132.47 52.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.546 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -86.9 118.77 26.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.006 0.431 . . . . 0.0 110.599 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.2 t -105.83 118.01 35.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.403 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.1 m -69.14 150.34 47.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.088 0.471 . . . . 0.0 110.601 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.6 pttt . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.787 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.796 0.331 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.59 140.39 51.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.11 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.57 151.14 49.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.197 0.523 . . . . 0.0 110.696 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.08 110.48 16.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.159 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 51.6 mt -83.43 108.25 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.4 t -113.28 137.19 47.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.17 0.509 . . . . 0.0 110.979 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -99.21 106.9 19.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.18 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.87 146.51 39.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.893 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 17.9 m-80 -75.32 88.79 2.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.604 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 142' ' ' ASN . . . 87.95 156.66 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 O-C-N 123.945 0.778 . . . . 0.0 110.716 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.74 -24.84 77.2 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.584 2.189 . . . . 0.0 112.468 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -78.35 -13.62 59.77 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.513 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 142' ' ' ASN . 82.5 m-20 -97.73 -17.08 19.61 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 120.651 0.262 . . . . 0.0 111.309 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.6 m -61.17 -32.97 54.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -75.83 -34.24 60.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.62 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.7 m -70.98 -40.03 72.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.42 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.4 mm -65.69 -41.1 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.297 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.23 95.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.321 0.581 . . . . 0.0 110.166 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -66.85 -40.48 87.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.719 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.47 -32.77 66.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.265 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.04 69.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.771 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.2 -18.05 59.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.323 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.64 8.27 45.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.73 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 17.6 mm -84.59 117.87 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.682 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 38.49 -115.31 0.15 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.09 0.869 . . . . 0.0 111.519 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -120.7 40.57 2.12 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 p -42.96 146.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.0 p -92.74 -47.44 7.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.222 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -165.39 154.12 11.91 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.819 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.02 140.96 47.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.774 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -143.28 137.36 28.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -90.2 179.11 5.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.713 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.661 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.808 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.915 0.388 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.23 141.19 38.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.388 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.6 t -116.19 125.04 73.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.16 116.63 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.182 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -84.35 138.65 32.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.11 153.28 5.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.122 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 . . . . . 0 C--O 1.236 0.382 0 CA-C-O 121.728 0.775 . . . . 0.0 110.831 179.469 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 tttp . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.153 0.502 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.8 -37.52 69.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.441 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -64.48 -43.54 93.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.914 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.34 -37.62 74.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.422 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -64.92 -42.13 94.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.4 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.1 mt -69.32 -39.77 78.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.834 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -68.82 -24.3 64.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.076 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -90.56 4.53 50.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.477 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.8 mmt -59.83 -23.37 63.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.653 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.32 -62.22 0.45 Allowed 'General case' 0 C--N 1.349 0.585 0 O-C-N 123.466 0.479 . . . . 0.0 111.196 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.7 m -59.39 -17.25 28.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.114 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.3 m -86.38 149.89 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.773 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -90.83 -42.36 10.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.916 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.5 p -157.57 156.47 32.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.528 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.7 t -134.84 129.89 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.913 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.2 m -125.76 131.76 52.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.003 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -87.03 116.26 24.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.064 0.459 . . . . 0.0 110.379 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.4 t -104.74 119.89 40.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.607 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.3 t -62.41 160.4 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.028 0.442 . . . . 0.0 110.207 -179.853 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.796 0.332 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.87 154.26 22.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.46 151.28 41.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.871 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -123.06 112.19 17.47 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.209 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.3 mt -86.85 111.24 21.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.4 t -114.8 138.27 45.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.366 0.603 . . . . 0.0 110.82 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -104.85 108.31 19.74 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.25 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.58 145.95 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 0.0 110.947 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -57.45 -39.3 76.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.796 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -137.39 161.33 61.39 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.813 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -59.64 -19.94 55.45 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.848 2.365 . . . . 0.0 112.062 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -95.16 -4.79 45.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.641 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -97.61 -22.11 16.68 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 120.762 0.315 . . . . 0.0 110.574 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.6 p -57.8 -35.07 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.004 0.43 . . . . 0.0 109.961 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -71.88 -34.99 69.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.813 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 59.7 m -73.25 -38.75 65.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.98 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.4 mm -69.06 -40.46 80.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.37 95.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.635 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.87 -24.46 52.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.129 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -85.1 -34.85 22.12 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.253 0.549 . . . . 0.0 110.547 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.49 -30.02 67.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.866 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -67.84 -12.18 60.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 110.998 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -105.65 9.12 33.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.078 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.0 mm -53.78 -78.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.77 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -145.44 -80.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.135 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.04 62.11 0.52 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.72 156.66 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 110.28 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.4 t -109.81 -42.77 4.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.322 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -166.63 153.62 9.14 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.614 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.75 135.5 60.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.5 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -137.8 133.56 34.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -78.23 178.43 7.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.833 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.829 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 . . . . . 0 N--CA 1.448 -0.531 0 CA-C-O 121.091 0.472 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.5 t -125.42 133.43 69.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.646 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.9 t -115.5 122.46 69.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.47 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.1 t -106.74 108.71 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.108 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -81.18 145.61 30.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.998 0.427 . . . . 0.0 110.026 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.3 mt -111.82 157.75 12.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.853 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.569 179.02 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.02 -38.99 79.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.121 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -61.01 -41.79 97.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.418 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -36.81 73.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.41 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.6 m -67.05 -41.98 85.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.351 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.9 mt -71.71 -39.55 70.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.975 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -66.85 -31.56 72.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.274 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -82.56 5.23 21.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.1 mmt -55.81 -24.63 37.31 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.865 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 76.47 -56.18 0.57 Allowed 'General case' 0 C--N 1.343 0.322 0 O-C-N 123.365 0.416 . . . . 0.0 110.469 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.6 m -71.07 -10.95 60.64 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.454 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.28 137.93 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 120.891 0.377 . . . . 0.0 110.96 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -86.34 -43.22 13.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.494 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.4 t -156.35 151.24 26.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.434 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.7 t -130.25 128.79 64.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.983 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.6 m -119.02 130.42 55.64 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 110.578 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -90.76 113.67 25.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.077 0.465 . . . . 0.0 110.66 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.7 t -94.02 107.54 19.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.058 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.1 t -57.72 142.42 45.34 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.319 0.58 . . . . 0.0 110.862 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.015 -179.742 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.649 0.261 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.86 149.62 24.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.68 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -131.4 141.62 49.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.04 115.71 29.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.816 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.7 mt -93.88 111.38 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.7 m -115.49 150.83 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.054 0.454 . . . . 0.0 110.312 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -108.74 107.7 18.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.42 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.83 139.11 58.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -58.32 -39.15 78.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -134.95 162.14 59.49 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-O 121.16 0.505 . . . . 0.0 110.711 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.42 -15.08 46.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.76 2.307 . . . . 0.0 111.385 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.73 -5.21 31.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.711 0.291 . . . . 0.0 110.301 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -92.38 -25.81 18.34 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 120.706 0.289 . . . . 0.0 110.731 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -49.65 -35.22 9.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.816 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -33.03 60.66 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.685 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 84.3 m -72.1 -39.87 68.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.406 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.1 mm -69.88 -40.51 78.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.513 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.91 -41.76 86.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -73.59 -33.85 64.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.558 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -71.65 -35.76 70.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.559 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.07 73.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.345 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -61.13 -20.46 62.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -3.67 58.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.62 120.4 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.472 0.653 . . . . 0.0 110.477 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -58.28 147.48 30.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.646 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 91.58 -9.49 76.97 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.5 129.73 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 120.988 0.423 . . . . 0.0 110.266 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 62.1 p -100.65 -42.77 6.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.467 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -167.81 145.61 4.46 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.16 133.92 67.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.441 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -139.62 136.81 34.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.391 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -88.82 179.7 6.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.8 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.765 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.601 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 120.921 0.391 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.06 139.73 51.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.86 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 63.7 t -117.25 122.97 71.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.829 0.347 . . . . 0.0 110.742 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 91.3 t -103.58 115.67 45.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.118 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -79.7 132.02 36.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.996 0.426 . . . . 0.0 110.121 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 64.4 mt -109.82 135.16 49.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.883 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.807 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.869 0.366 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.03 -35.65 75.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.794 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -64.6 -40.17 95.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.898 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -67.94 -40.18 83.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.704 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.9 m -67.03 -40.24 87.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.476 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.6 mt -70.96 -37.71 72.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.73 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -65.99 -30.5 71.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.268 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -87.23 4.25 43.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.3 mmt -56.49 -23.61 40.53 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.81 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.79 -47.45 0.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.335 0.397 . . . . 0.0 110.38 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -88.53 18.77 4.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.278 0.561 . . . . 0.0 110.676 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -104.04 141.37 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.152 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -101.06 -40.87 7.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.228 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.5 t -160.27 148.84 16.92 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.453 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.24 126.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.548 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.53 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 99.9 m -117.68 126.03 51.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.18 0.514 . . . . 0.0 110.571 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 43.4 t80 -92.59 119.16 31.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.677 ' O ' ' O ' ' A' ' 135' ' ' ASP . 7.4 t -110.94 87.68 2.6 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.07 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 106' ' ' SER . 30.9 t -39.72 139.52 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.942 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.8 pttt . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.931 -178.597 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 . . . . . 0 C--O 1.225 -0.22 0 CA-C-O 120.949 0.404 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.677 ' O ' ' O ' ' A' ' 106' ' ' SER . 96.8 m-20 -58.31 -30.3 66.57 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.868 0.842 . . . . 0.0 110.856 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.565 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . 51.98 125.6 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.629 0.728 . . . . 0.0 111.392 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -112.65 103.65 11.7 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.628 -0.67 . . . . 0.0 109.588 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 1.4 mp -79.27 108.58 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.828 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.6 t -111.18 135.49 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.407 0.622 . . . . 0.0 111.313 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -96.34 106.36 18.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.327 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.68 147.2 50.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.647 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -52.34 -35.33 50.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.222 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.75 164.03 23.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.744 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.73 -29.4 85.57 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.936 2.424 . . . . 0.0 112.071 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -83.64 -3.82 58.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.71 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -98.73 -10.69 22.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.6 m -62.44 -29.03 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.32 -34.16 36.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.02 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 97.5 m -72.34 -40.0 67.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.172 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.9 mm -66.71 -40.86 87.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.287 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.24 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.16 -39.11 82.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.708 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -72.3 -34.98 68.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.624 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.07 82.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.43 -17.88 60.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.861 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -93.9 8.07 42.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 18.2 mm -92.32 119.94 40.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 44.58 -98.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.683 0.615 . . . . 0.0 111.025 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -159.16 48.77 0.41 Allowed Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.3 m -50.5 143.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.355 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.0 t -61.8 -48.38 80.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.942 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -174.39 154.56 2.15 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.552 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.96 131.94 66.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.47 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -127.7 127.14 43.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -78.1 174.18 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.575 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.7 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.832 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.366 0.603 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.21 137.04 58.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.989 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.7 t -116.82 122.98 71.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.569 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.98 117.12 53.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -83.91 139.02 32.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.022 0.439 . . . . 0.0 110.282 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.8 mt -100.78 148.64 6.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.472 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? . . . . . 0 C--N 1.332 -0.184 0 CA-C-O 121.336 0.589 . . . . 0.0 111.017 179.947 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.964 0.411 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.17 -36.76 78.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -62.09 -40.99 97.7 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.089 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -68.56 -39.88 80.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.52 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.6 t -66.99 -42.01 85.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.441 0.639 . . . . 0.0 110.316 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.1 mt -73.51 -39.57 64.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.261 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -68.47 -39.56 81.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.572 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -92.77 6.35 47.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.427 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.4 ttm -61.62 -17.46 55.35 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.739 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.53 157.38 0.19 Allowed 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 123.879 0.737 . . . . 0.0 109.457 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.0 m 70.5 5.31 5.32 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.895 0.747 . . . . 0.0 110.896 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.7 m -112.79 124.86 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.163 0.506 . . . . 0.0 110.488 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -66.82 -44.21 81.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.159 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.8 p -163.28 162.37 25.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.303 0.573 . . . . 0.0 110.355 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.7 129.19 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.69 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.3 m -119.65 128.93 54.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 0.0 110.072 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -87.31 120.69 28.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.295 0.569 . . . . 0.0 110.634 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.4 t -105.3 116.94 32.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.452 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.5 t -65.43 146.95 54.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.758 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.283 -179.754 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.807 0.337 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.89 147.33 43.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.47 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -130.92 145.22 51.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -115.59 114.07 24.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.127 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.8 mt -89.01 106.53 16.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.8 t -110.74 136.91 45.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.97 0.414 . . . . 0.0 110.751 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -98.72 106.87 19.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.696 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.83 150.83 39.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.855 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 34.0 t-20 -80.91 91.23 5.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.849 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 142' ' ' ASN . . . 92.76 149.74 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 O-C-N 124.564 1.165 . . . . 0.0 110.47 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.15 -19.84 58.68 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.862 2.375 . . . . 0.0 112.58 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -86.72 -5.34 59.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.63 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -101.19 -17.85 16.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.784 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.9 m -58.94 -33.51 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.091 0.472 . . . . 0.0 109.756 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -38.36 65.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.15 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.3 m -68.76 -39.18 80.38 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.524 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.43 -40.3 86.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.403 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.66 -40.43 95.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.472 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.52 -39.39 85.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.723 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -73.3 -35.02 66.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.622 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.86 78.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.517 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.82 -15.14 61.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.023 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -101.39 8.74 42.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.6 mm -59.45 -69.6 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.18 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 171.87 -77.6 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 123.73 0.643 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -93.23 31.03 6.6 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.4 p -82.43 131.84 32.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.0 t -96.34 -53.97 3.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.929 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -152.93 153.77 33.67 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.62 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 98.3 t -122.78 134.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -118.52 115.57 24.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.472 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.32 114.06 21.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.956 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.545 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.737 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.317 0 CA-C-O 121.307 0.575 . . . . 0.0 111.17 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.9 t -148.52 147.3 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.403 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.7 126.01 74.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.208 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.65 115.35 49.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 CA-C-O 120.946 0.403 . . . . 0.0 110.041 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -85.67 141.13 29.98 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.286 0.565 . . . . 0.0 109.92 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.7 mt -115.45 144.7 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.931 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 CA--C 1.516 -0.35 0 CA-C-O 118.824 -0.608 . . . . 0.0 109.374 179.476 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.77 -39.29 77.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.032 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.55 -43.96 97.52 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.181 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.98 -40.87 97.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.599 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -67.98 -41.69 81.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.256 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.3 mt -70.73 -25.69 63.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.654 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -28.7 25.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.042 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -103.51 3.71 35.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.339 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.8 ptm -60.75 -17.21 47.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.953 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.31 152.03 0.13 Allowed 'General case' 0 C--N 1.341 0.231 0 O-C-N 123.869 0.731 . . . . 0.0 109.542 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.1 m 73.59 5.91 4.97 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.841 0.713 . . . . 0.0 110.7 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -108.05 133.1 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-O 121.201 0.524 . . . . 0.0 110.795 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -85.87 -51.75 6.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.975 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -149.04 155.02 40.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.3 t -133.56 128.7 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.237 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.8 m -124.98 132.38 53.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.584 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -90.92 116.98 29.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 109.978 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.7 t -108.11 128.25 54.52 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.087 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 82.9 p -66.02 159.49 25.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.126 0.489 . . . . 0.0 110.86 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.287 -179.515 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 121.059 0.457 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.01 147.96 52.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.589 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -130.01 146.5 51.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.702 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -113.34 108.98 17.97 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.2 mt -86.5 111.32 21.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.4 149.8 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-O 121.115 0.483 . . . . 0.0 109.904 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -105.76 107.52 18.55 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.909 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.09 149.3 43.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.53 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 47.7 t-20 -79.61 87.86 5.15 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.95 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 142' ' ' ASN . . . 95.96 153.36 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 125.104 1.502 . . . . 0.0 109.662 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.76 -15.45 48.95 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.135 1.89 . . . . 0.0 112.206 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -88.33 -10.21 50.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.304 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -96.16 -15.48 22.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.338 0.113 . . . . 0.0 111.012 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.3 m -56.92 -31.96 37.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.47 62.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.246 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.7 m -69.95 -40.15 75.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.194 0.521 . . . . 0.0 110.357 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 21.5 mm -66.07 -41.33 89.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.255 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.89 92.09 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.521 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -67.13 -40.54 86.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.585 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -70.06 -39.97 75.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.426 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.99 74.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.734 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -62.13 -20.29 63.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.797 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -86.64 -2.77 58.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.7 mm -83.46 129.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 120.917 0.389 . . . . 0.0 110.119 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.54 140.03 58.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.163 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 91.48 -6.99 80.52 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.2 p -66.26 131.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 117.295 0.548 . . . . 0.0 110.131 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.7 t -105.62 -48.75 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.475 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -161.66 147.49 13.74 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.725 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.06 141.71 45.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.196 0.522 . . . . 0.0 111.207 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -138.49 135.88 35.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.55 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -90.28 156.32 18.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.909 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.586 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.774 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -129.39 134.42 63.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.812 0.339 . . . . 0.0 110.424 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.36 122.58 68.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.93 116.42 52.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -86.98 137.54 32.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.794 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.6 mt -105.37 146.53 12.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.495 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.823 179.191 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 120.829 0.347 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.7 t -66.82 -36.47 77.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.418 0.628 . . . . 0.0 109.401 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -65.61 -41.05 93.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.431 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -63.55 -40.77 97.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.523 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.0 p -65.66 -36.28 83.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.509 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.9 mt -80.34 -16.85 53.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.712 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -33.28 14.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.912 0.386 . . . . 0.0 111.567 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -93.91 6.55 48.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.866 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -19.43 2.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.439 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 80.04 -50.64 0.36 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 123.322 0.389 . . . . 0.0 110.935 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.2 m -83.81 22.46 1.12 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.936 0.398 . . . . 0.0 111.348 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.7 m -118.99 150.23 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.082 0.467 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -106.5 -32.77 7.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.492 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.0 t -164.2 148.53 9.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.61 128.13 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.386 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.7 m -120.89 124.38 44.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.92 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -85.07 115.6 22.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.949 0.404 . . . . 0.0 109.933 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.4 t -101.28 113.12 25.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.587 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 85.7 p -66.86 160.87 25.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.88 0.372 . . . . 0.0 110.491 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.9 pttt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.305 -179.62 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.226 -0.169 0 CA-C-O 120.83 0.347 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.92 143.76 57.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.775 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.93 148.11 51.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.132 0.491 . . . . 0.0 110.309 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -121.24 111.87 17.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.418 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.61 109.96 21.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.68 139.73 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.94 0.4 . . . . 0.0 111.008 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -100.3 105.7 17.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.805 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.91 151.61 38.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 53.6 t-20 -78.52 89.83 4.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.142 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 142' ' ' ASN . . . 93.44 152.18 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.265 0 O-C-N 124.613 1.196 . . . . 0.0 110.176 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.59 -19.95 62.41 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.43 2.087 . . . . 0.0 112.356 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -86.01 -6.9 58.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.512 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -101.19 -15.66 17.27 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.959 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 24.3 m -57.96 -35.28 51.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.135 0.493 . . . . 0.0 110.073 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -74.66 -32.61 62.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.995 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.2 m -71.46 -39.52 70.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.551 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 36.8 mm -65.04 -41.35 91.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.4 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.13 98.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.232 0.539 . . . . 0.0 110.282 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.9 -38.46 79.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -69.77 -37.45 76.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.608 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.14 80.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.607 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -62.85 -18.05 62.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.709 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -101.67 7.46 42.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.357 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.9 mt -79.23 -64.78 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.749 0.309 . . . . 0.0 111.46 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -143.07 -89.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.934 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -141.11 78.5 0.29 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 89.2 t -81.39 109.32 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.12 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.2 p -65.19 -39.9 93.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -150.76 155.96 40.31 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.67 123.72 16.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.994 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.43 127.92 49.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.656 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.99 102.92 12.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.453 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.877 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.702 0.287 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.46 126.33 75.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.3 t -114.02 119.96 62.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.205 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.95 113.53 44.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -86.18 134.17 33.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.434 HG22 HD13 ' A' ' 64' ' ' ILE . 93.9 mt -110.16 140.82 27.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.751 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.199 179.914 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HG3' ' H ' ' A' ' 90' ' ' VAL . 14.4 ptmt . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.043 0.449 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.41 ' H ' ' HG3' ' A' ' 89' ' ' LYS . 99.1 t -71.48 -37.77 65.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.489 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -64.95 -40.01 94.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.869 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -66.04 -41.25 91.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.432 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.5 m -66.79 -42.2 86.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.336 0.588 . . . . 0.0 110.217 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.5 mt -69.36 -22.68 63.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.457 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -86.79 -31.31 20.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.934 0.397 . . . . 0.0 111.525 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -88.89 -5.14 58.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.999 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.3 ttm -50.71 -19.88 1.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 78.57 -49.45 0.46 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.671 0.388 . . . . 0.0 111.127 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 m -82.18 12.22 4.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.951 0.405 . . . . 0.0 111.214 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.7 141.43 15.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.349 0.595 . . . . 0.0 111.294 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -103.92 -40.02 6.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.579 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.3 t -161.18 148.26 15.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.523 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.9 t -127.77 126.23 66.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.131 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.457 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 85.1 m -116.28 131.17 57.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.103 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -89.02 124.69 34.52 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -113.81 90.42 3.34 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.316 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.1 t -47.8 142.49 4.73 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 120.874 0.369 . . . . 0.0 110.766 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.655 -179.311 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ASP . . . . . 0.565 ' O ' ' O ' ' A' ' 136' ' ' ALA . 89.9 m-20 -55.09 -23.34 20.03 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.181 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . 0.565 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . 42.02 124.67 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.699 0 O-C-N 124.795 1.309 . . . . 0.0 112.357 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.27 106.94 12.39 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.66 -0.65 . . . . 0.0 109.7 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 32.0 mt -86.89 108.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.4 t -105.8 139.06 28.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.991 0.424 . . . . 0.0 110.666 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -103.05 110.61 22.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.057 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.28 148.69 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.171 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -57.69 -40.09 78.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.04 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.52 158.18 76.35 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.884 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.09 -12.17 28.57 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.721 2.281 . . . . 0.0 112.043 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -99.5 -3.97 32.33 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.975 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -96.68 -15.69 21.33 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 122.513 0.325 . . . . 0.0 111.11 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -34.76 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -71.88 -34.71 69.41 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.746 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 64.9 m -73.56 -38.76 65.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.572 0.701 . . . . 0.0 110.557 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.04 -41.64 87.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.452 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.94 -39.56 93.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -70.75 -30.12 66.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.476 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -74.87 -38.68 61.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.756 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.09 -26.28 64.84 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.906 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -62.63 -23.06 66.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -105.83 7.21 32.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.603 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.2 132.9 30.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.707 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 33.69 -129.43 0.06 Allowed 'General case' 0 CA--C 1.543 0.703 0 O-C-N 124.218 0.949 . . . . 0.0 111.463 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.14 41.6 2.17 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.3 p -43.13 135.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 110.77 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 41.1 t -77.11 -45.96 25.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.977 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -168.39 148.44 4.65 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.035 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.1 t -120.41 128.88 76.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.143 0.497 . . . . 0.0 110.698 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -116.27 119.23 35.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.38 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.64 155.64 16.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.918 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.689 0.28 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -122.22 49.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.544 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -83.97 111.63 19.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.32 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.39 134.76 65.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.5 t -122.08 126.69 74.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.816 0.341 . . . . 0.0 110.827 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.431 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 94.2 t -109.05 115.3 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -84.79 135.75 33.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.446 0.641 . . . . 0.0 110.047 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.2 mt -107.51 157.89 7.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.327 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 66' ' ' LYS . 3.3 mpt_? -40.87 154.66 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 123.632 0.583 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 65' ' ' ARG . 46.7 mmtt -30.94 -88.91 0.0 OUTLIER 'General case' 0 C--N 1.342 0.28 0 O-C-N 124.286 0.991 . . . . 0.0 111.552 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.91 53.24 0.7 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.785 0.326 . . . . 0.0 110.568 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 6.7 p -60.32 -26.56 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.657 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 56.93 34.85 25.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.103 0.478 . . . . 0.0 110.649 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -54.71 -45.12 74.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.721 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -101.72 41.35 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.642 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -126.86 -126.16 0.23 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.804 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 179.62 139.7 0.12 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 57.89 109.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.059 0.457 . . . . 0.0 110.847 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.426 HG23 HD13 ' A' ' 75' ' ' ILE . 10.8 mm -106.52 134.52 47.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.794 0.331 . . . . 0.0 110.456 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -83.95 100.28 10.93 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.285 0.564 . . . . 0.0 110.267 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -163.29 145.92 10.16 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.694 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 67.48 -76.46 0.05 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 123.893 0.746 . . . . 0.0 110.901 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.47 84.02 0.3 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 60.73 -158.57 0.33 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.472 0.177 . . . . 0.0 110.758 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.0 p -79.67 131.55 35.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.145 0.498 . . . . 0.0 110.478 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.8 p -127.92 135.15 63.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.335 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -40.73 130.6 2.48 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.425 0.453 . . . . 0.0 111.003 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -84.26 111.48 19.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.715 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -71.79 -4.61 28.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.472 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.93 17.8 21.28 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.781 0.324 . . . . 0.0 110.397 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -60.87 115.17 3.49 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.74 -179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 58.72 16.86 4.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.54 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -69.64 -43.67 72.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.973 0.416 . . . . 0.0 110.586 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.6 t -70.41 -38.57 74.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.908 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.78 -44.17 96.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.216 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.47 -39.75 92.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.528 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.3 p -67.84 -36.35 80.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.398 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.92 -17.82 54.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.99 -35.76 20.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.063 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -87.32 6.93 31.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.574 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.5 mtt -50.98 -20.18 1.27 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 77.95 -53.63 0.51 Allowed 'General case' 0 C--N 1.345 0.373 0 O-C-N 123.86 0.725 . . . . 0.0 110.323 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.4 m -85.12 13.48 6.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.312 0.577 . . . . 0.0 110.576 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.5 p -98.41 147.71 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.985 0.422 . . . . 0.0 110.732 -179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -102.75 -42.88 5.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.348 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.6 t -159.9 146.61 16.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.59 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 54.8 t -128.79 126.31 64.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.7 m -124.37 128.78 49.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 110.439 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -86.7 116.89 25.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.086 0.469 . . . . 0.0 110.705 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 t -105.67 114.0 27.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.95 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.6 p -64.59 162.08 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.097 0.475 . . . . 0.0 110.799 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -65.12 -37.71 88.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.759 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 81.9 mm-40 -64.64 -39.55 93.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.464 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.23 -32.9 65.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.429 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -37.7 85.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.541 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.43 -41.89 88.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.286 0.565 . . . . 0.0 109.779 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.98 -38.91 83.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.349 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.0 mmmt -67.96 -39.15 83.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.194 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.04 -38.97 89.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.986 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 68.4 p -73.77 -28.73 61.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.284 0.564 . . . . 0.0 110.558 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -72.42 -35.62 68.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.805 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.5 pt -85.05 -26.6 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.671 -178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.1 tpp -111.58 -66.02 1.12 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.762 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 142.85 -165.19 26.96 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -98.29 24.04 7.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.003 0.43 . . . . 0.0 110.899 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -128.18 33.73 4.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.701 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -125.16 -19.93 5.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.429 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.53 152.27 30.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.419 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.4 tt -168.55 39.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 122.044 0.926 . . . . 0.0 110.535 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -76.27 -62.99 1.43 Allowed 'General case' 0 C--N 1.313 -1.011 0 O-C-N 121.581 -0.699 . . . . 0.0 110.671 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 174.48 179.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.795 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.13 128.79 42.63 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 55.74 31.47 17.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.843 0.354 . . . . 0.0 110.393 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.64 152.97 37.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -128.01 67.99 75.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.768 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.86 -26.92 15.12 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.961 2.441 . . . . 0.0 111.778 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 80.3 mt -110.75 154.04 24.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.388 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 -163.33 1.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.92 144.28 53.37 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.332 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.22 144.87 50.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.07 0.462 . . . . 0.0 110.684 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.431 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 1.6 m-85 -118.81 106.34 12.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.36 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -80.24 110.77 16.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.099 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 90.3 t -114.55 134.12 58.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.263 0.554 . . . . 0.0 110.821 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -100.79 107.48 19.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.656 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.64 147.2 52.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -58.11 -39.47 78.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.725 0.298 . . . . 0.0 110.291 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -137.06 160.22 66.9 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.452 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -60.78 -24.13 78.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.787 2.325 . . . . 0.0 112.118 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -88.12 -6.17 58.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.486 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -93.41 -19.28 21.45 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 120.631 0.253 . . . . 0.0 110.353 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.0 m -57.22 -29.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.254 0.549 . . . . 0.0 109.548 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.11 -37.88 57.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.974 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.475 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 95.9 m -72.02 -36.42 69.7 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 121.567 0.699 . . . . 0.0 110.055 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.2 mm -68.2 -39.8 81.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.364 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.93 -39.25 83.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.374 0.607 . . . . 0.0 111.318 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 149' ' ' THR . 1.3 pp20? -71.23 -26.01 62.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.635 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.54 -38.58 23.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.397 0.617 . . . . 0.0 109.774 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.96 -22.56 62.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.63 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -65.74 -17.16 64.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.46 7.12 22.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 39.9 mt -87.21 127.78 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.664 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 36.01 -129.12 0.12 Allowed 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.421 1.075 . . . . 0.0 111.043 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -107.13 67.49 0.23 Allowed Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 3.7 p -74.36 107.42 4.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.055 0.455 . . . . 0.0 110.122 178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 t -61.13 -44.62 97.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.788 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -169.46 159.32 8.47 Favored 'General case' 0 C--O 1.202 -1.441 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.846 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 68.2 t -128.71 133.4 66.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 120.719 0.295 . . . . 0.0 110.263 179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -119.88 124.27 45.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.921 0.391 . . . . 0.0 110.74 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -90.11 115.81 27.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.736 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.824 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 CA--C 1.523 -0.074 0 CA-C-O 120.791 0.329 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -177.89 170.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.998 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 71.28 141.44 0.05 Allowed 'General case' 0 C--O 1.227 -0.099 0 O-C-N 123.611 0.569 . . . . 0.0 111.135 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.1 t -144.41 144.88 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.237 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 57.4 t -120.71 127.4 75.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.807 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 63.2 t -108.82 117.07 53.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -83.97 138.78 32.95 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.765 0.793 . . . . 0.0 110.54 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 61.6 mt -106.31 161.24 5.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.704 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.49 161.04 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.661 0.601 . . . . 0.0 110.454 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.6 -50.56 1.61 Allowed 'General case' 0 C--N 1.332 -0.175 0 O-C-N 123.619 0.574 . . . . 0.0 111.29 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -168.04 91.46 0.32 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.438 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.16 7.67 6.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.833 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 62.83 146.32 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.069 0.461 . . . . 0.0 110.228 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -157.92 -74.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.114 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.73 -15.06 62.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -63.66 -120.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 O-C-N 123.249 0.343 . . . . 0.0 110.614 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 176.82 -29.97 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.1 p -136.19 158.68 43.84 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.586 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.9 mt -115.47 133.86 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -95.05 122.99 38.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.266 0.555 . . . . 0.0 110.944 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -132.77 119.89 20.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.402 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 48.11 41.39 15.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.655 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.69 25.99 72.63 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.73 115.38 21.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.013 0.435 . . . . 0.0 110.589 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.61 117.73 23.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.144 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.6 t -123.86 132.22 71.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.193 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 t -49.15 141.02 8.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.019 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -96.09 114.62 26.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -65.0 -29.09 69.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.885 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -91.73 18.12 8.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.79 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -59.53 125.61 24.33 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.078 0.466 . . . . 0.0 110.685 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.11 18.05 3.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.811 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -71.64 -45.07 63.15 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.774 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.1 t -69.75 -39.27 77.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.881 -179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -64.82 -41.16 95.98 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.553 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -66.91 -39.57 87.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.339 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.6 m -65.55 -42.12 92.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.172 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.02 -39.27 66.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.015 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -37.67 84.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.018 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -95.56 6.47 48.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.683 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.2 ttm -63.31 -19.26 64.45 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.612 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 t 72.47 160.71 0.23 Allowed 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.3 m 72.21 2.16 4.21 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 124.111 0.882 . . . . 0.0 110.925 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.3 m -112.23 139.49 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 110.543 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -40.71 28.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.537 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 85.4 p -164.81 162.0 20.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 96.0 t -133.59 131.81 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.146 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.1 m -125.76 136.74 53.49 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 121.012 0.434 . . . . 0.0 110.973 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -87.37 124.67 33.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.188 0.518 . . . . 0.0 110.137 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 18.7 p -116.75 108.98 16.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.953 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.6 m -61.38 165.65 4.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.445 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -62.65 -36.41 82.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.995 0.426 . . . . 0.0 110.143 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -68.68 -41.15 79.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.179 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -70.49 -38.28 74.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.32 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -65.54 -40.62 93.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.383 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -62.74 -42.43 99.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.344 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.7 -38.44 90.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.211 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.2 mmtp -70.48 -38.31 74.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.626 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -69.52 -39.18 77.69 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.201 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.9 t -73.21 -30.74 63.73 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.365 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.66 -38.71 77.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.791 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.5 pt -78.36 -28.89 14.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.19 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.26 -72.76 0.59 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.496 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.92 -172.52 45.54 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -74.95 119.23 18.85 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.501 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.7 t30 50.57 52.02 15.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.743 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -67.51 -26.59 66.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.818 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.89 -177.88 3.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.703 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.6 mm -112.34 128.56 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.52 48.26 1.15 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.859 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -93.38 123.74 36.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.89 -38.38 3.36 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 56.0 p-10 -166.07 165.96 17.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 110.526 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -93.94 -3.03 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.7 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -125.64 79.19 68.05 Favored Pre-proline 0 N--CA 1.455 -0.188 0 CA-C-O 120.729 0.299 . . . . 0.0 110.209 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.73 158.63 57.02 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.976 2.451 . . . . 0.0 111.704 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 38.6 mt 63.9 174.16 0.18 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.394 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.96 -161.95 1.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.354 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.75 143.59 57.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.224 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -134.01 137.68 44.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.007 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -101.99 113.33 26.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.5 mt -88.7 109.9 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.4 m -116.14 148.39 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.175 0.512 . . . . 0.0 109.815 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -105.84 107.12 17.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.217 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.42 141.4 58.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.824 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -52.89 -26.52 15.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.296 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -161.38 165.77 16.13 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-O 121.262 0.553 . . . . 0.0 110.75 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_exo -56.69 -30.33 83.52 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.747 2.298 . . . . 0.0 111.715 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -84.09 -7.49 59.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -96.99 -20.06 18.33 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.617 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 13.0 m -56.12 -31.12 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.233 0.539 . . . . 0.0 110.034 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.34 -33.93 48.83 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.045 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.8 m -71.1 -39.51 72.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.335 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.3 mm -67.72 -40.39 83.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.392 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.87 -41.55 97.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.366 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.5 -38.91 81.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.821 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.18 -35.99 74.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.533 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.8 81.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.503 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -65.25 -17.08 64.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.091 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -98.69 7.77 45.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.99 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 12.0 mm -65.02 -86.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.837 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -165.37 -79.03 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.808 0.337 . . . . 0.0 110.549 -179.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -93.78 34.66 4.52 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.79 94.68 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.476 0.655 . . . . 0.0 110.723 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.0 t -63.95 -45.41 89.31 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.27 165.13 37.62 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.914 0.387 . . . . 0.0 110.375 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.14 138.26 30.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.788 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -140.31 138.16 34.72 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.644 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -80.61 178.39 8.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.897 0.38 . . . . 0.0 110.686 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.619 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 CA--C 1.523 -0.078 0 N-CA-C 110.889 -0.041 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 73.44 -3.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 123.612 0.57 . . . . 0.0 111.29 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -91.15 132.32 36.14 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.373 0.606 . . . . 0.0 111.034 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.34 140.36 48.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.1 t -120.25 126.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.534 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.7 t -111.04 124.76 68.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.184 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -91.9 136.23 33.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.13 0.49 . . . . 0.0 110.114 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 96.6 mt -110.15 143.94 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.528 179.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -58.02 157.39 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.404 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.07 -32.06 25.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.22 -22.11 65.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.735 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.8 p -102.67 146.81 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.834 0.35 . . . . 0.0 110.804 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -56.14 178.08 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.532 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.13 85.62 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.944 0.402 . . . . 0.0 110.51 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 51.66 43.75 29.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.609 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -128.19 118.88 24.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.694 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -72.2 -13.47 61.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.765 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.1 t -147.28 147.96 30.93 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.886 0.374 . . . . 0.0 110.252 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.54 150.19 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.506 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.38 127.96 49.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.452 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -144.64 131.55 20.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.439 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 54.64 32.25 16.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.509 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.13 24.25 77.24 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -127.33 131.19 50.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.506 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.2 p -91.35 121.63 33.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.315 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.72 151.3 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.044 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -66.96 152.87 44.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.409 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -92.37 -166.72 1.6 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.454 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -138.61 152.99 48.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.62 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 96.4 m-20 47.74 41.86 14.63 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.775 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -46.31 147.64 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.337 0.398 . . . . 0.0 110.617 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 64.7 83.83 0.16 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.95 0.405 . . . . 0.0 110.812 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.422 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -123.38 -66.7 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.779 -179.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 90.2 t -64.79 -35.77 75.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -64.92 -41.33 95.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.434 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.54 -39.59 77.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.647 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.4 p -68.01 -40.18 83.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.879 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 97.7 mt -74.6 -39.91 61.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.019 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -37.69 75.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.666 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -95.89 6.74 48.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.059 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.424 ' O ' ' CB ' ' A' ' 98' ' ' SER . 9.1 ttm -56.79 -17.27 8.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 119.258 -0.401 . . . . 0.0 111.031 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 97' ' ' MET . 0.9 OUTLIER 84.79 -61.35 0.08 Allowed 'General case' 0 C--N 1.353 0.738 0 O-C-N 123.952 0.783 . . . . 0.0 110.762 -179.552 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 31.9 m -68.13 -7.41 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.029 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 94.0 t -96.52 118.84 43.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.883 0.373 . . . . 0.0 110.788 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -69.76 -43.58 71.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.81 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -155.4 159.04 39.57 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.323 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 89.6 t -133.52 129.88 56.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.601 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.4 m -123.13 124.13 42.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -86.81 113.71 22.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.025 0.44 . . . . 0.0 110.542 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.2 t -100.4 105.47 16.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.78 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.2 p -65.11 163.6 14.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.936 0.398 . . . . 0.0 110.098 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -32.58 73.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.14 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -67.57 -40.81 84.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.091 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -70.01 -39.64 75.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.46 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -67.31 -37.7 83.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.686 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -62.73 -40.79 98.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.768 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -65.91 -39.17 90.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.352 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -66.51 -38.02 86.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.541 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 mp -66.77 -37.47 84.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.714 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 75.7 p -69.71 -30.99 68.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.657 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.74 -38.72 73.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.832 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.0 pt -80.12 -33.16 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.556 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.66 -13.64 27.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.72 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.21 -167.32 54.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -86.89 70.3 10.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.735 0.303 . . . . 0.0 110.445 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -174.25 58.69 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.352 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -174.16 -18.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.19 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -44.64 120.46 2.28 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.034 0.445 . . . . 0.0 110.752 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.7 tp -138.79 140.3 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.23 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -103.63 -34.09 8.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.691 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 48.95 46.02 22.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.905 0.383 . . . . 0.0 110.757 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.72 -106.96 0.57 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -109.39 -64.95 1.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.871 0.367 . . . . 0.0 110.652 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -170.7 -179.36 2.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.518 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 57.05 62.37 5.92 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 121.294 0.569 . . . . 0.0 111.218 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.75 -21.93 8.08 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.501 2.134 . . . . 0.0 112.132 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 86.9 mt -96.19 167.08 11.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.877 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -107.94 156.72 18.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.951 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -58.36 140.75 53.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.939 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.67 143.3 50.34 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.522 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -117.06 108.22 15.47 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 38.1 mt -89.06 110.59 21.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 14.9 m -119.4 150.49 21.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.134 0.493 . . . . 0.0 110.09 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -102.86 106.89 17.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.167 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.72 144.95 47.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 4.9 m-80 -69.32 83.57 0.38 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.765 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 142' ' ' ASN . . . 90.52 157.43 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 O-C-N 124.281 0.988 . . . . 0.0 110.56 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.89 -24.26 75.48 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.842 2.361 . . . . 0.0 112.582 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -80.1 -10.07 59.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.263 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -97.59 -19.96 17.98 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 120.586 0.231 . . . . 0.0 111.127 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 11.0 m -53.63 -31.83 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -76.47 -32.93 58.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.853 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 87.0 m -72.95 -37.88 66.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.516 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 50.8 mm -71.25 -40.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.319 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.28 -40.36 81.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 149' ' ' THR . 2.3 pp20? -75.12 -31.25 61.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.73 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -78.14 -37.27 46.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.386 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -66.16 -36.12 82.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.968 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -62.55 -15.58 51.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.757 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -96.85 5.94 49.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.089 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 84.6 mt -93.06 129.86 42.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.675 0.274 . . . . 0.0 110.614 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 44.05 -121.03 0.76 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.251 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.56 54.76 0.76 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -45.14 146.42 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.5 p -97.02 -35.37 10.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.422 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -170.07 158.91 7.28 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.412 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.05 143.69 39.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.673 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -140.29 132.19 27.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.522 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.66 124.96 48.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.581 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.575 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.584 0.23 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.423 ' O ' ' CB ' ' A' ' 59' ' ' ARG . 85.8 t -53.63 103.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 58' ' ' VAL . 7.0 tpt180 155.86 111.04 0.0 OUTLIER 'General case' 0 C--N 1.349 0.574 0 O-C-N 125.156 1.535 . . . . 0.0 110.69 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -129.44 137.43 56.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.39 126.04 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 0.0 110.654 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.459 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 90.5 t -110.33 118.97 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.386 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -86.17 133.54 33.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.165 0.507 . . . . 0.0 109.715 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 2.6 mt -100.62 149.75 5.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.916 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -52.83 150.08 5.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.706 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -60.27 -28.24 67.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.753 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -92.92 11.0 28.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.713 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.2 t -132.54 126.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.88 0.371 . . . . 0.0 110.035 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 71' ' ' ASN . 97.9 mt-10 -120.73 -22.69 6.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 90' ' ' VAL . 4.5 t70 61.43 -78.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 O-C-N 123.883 0.74 . . . . 0.0 111.157 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 69' ' ' GLU . 49.7 t-20 -76.12 61.99 1.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.0 p -140.33 -141.18 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.236 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.81 -31.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t -156.66 151.3 25.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.721 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.2 pt -127.41 157.43 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.183 0.516 . . . . 0.0 109.908 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.77 118.07 24.22 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.615 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -133.09 131.27 40.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.719 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 47.15 28.49 0.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.7 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -50.1 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -71.81 175.74 5.51 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.509 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.3 p -116.1 129.06 56.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.133 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.3 m -118.82 141.47 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.281 0.562 . . . . 0.0 110.242 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.6 m -60.69 132.15 52.96 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.99 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -80.37 160.04 25.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.676 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 -104.04 171.47 7.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.445 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 54.06 47.09 24.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.555 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -67.67 123.29 20.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.58 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.57 20.32 6.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.172 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -76.96 -48.0 19.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.146 0.498 . . . . 0.0 110.831 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.414 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 78.0 t -67.12 -38.44 81.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.796 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -63.39 -43.77 96.6 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.04 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.65 -40.13 96.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.652 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.3 t -70.25 -39.52 74.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.239 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 79.4 mt -76.42 -20.77 56.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.049 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.59 -33.15 16.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -89.68 7.27 37.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -17.63 6.77 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.155 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 77.12 -68.35 0.18 Allowed 'General case' 0 C--N 1.35 0.591 0 O-C-N 123.39 0.431 . . . . 0.0 110.776 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.7 m -58.02 -19.26 29.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.037 0.446 . . . . 0.0 110.531 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.41 133.72 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.137 0.494 . . . . 0.0 110.798 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -82.13 -43.27 18.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.178 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.2 p -160.01 159.27 31.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.237 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 91.1 t -132.83 128.72 57.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.141 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.0 m -121.07 125.24 46.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.842 0.353 . . . . 0.0 110.243 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -85.66 115.66 23.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.832 0.349 . . . . 0.0 110.112 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.4 t -105.05 108.66 20.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.258 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -59.85 159.95 8.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.431 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -62.76 -35.42 79.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.438 . . . . 0.0 110.058 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -70.64 -39.72 73.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.131 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.19 -39.63 75.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.249 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -67.37 -39.1 85.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.345 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -64.33 -38.96 92.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.922 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.47 -38.59 90.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.162 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.94 -37.94 85.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.219 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -34.63 74.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.668 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 78.1 p -70.48 -33.01 70.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -69.74 -40.04 76.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.722 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.4 pt -76.61 -36.8 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.981 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 33.1 mmt -67.74 -39.62 84.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.061 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 144.85 -122.04 1.67 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -130.3 116.34 18.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 0.0 110.569 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 61.0 t30 53.2 42.45 32.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.393 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 28.2 p-90 -60.06 -29.3 68.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.045 0.45 . . . . 0.0 110.248 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.92 164.31 25.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.371 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.0 tt -143.2 14.71 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.631 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.61 -4.79 58.94 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.1 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 75.11 -8.95 1.46 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 123.741 0.65 . . . . 0.0 110.832 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.79 -164.97 19.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 56.87 35.54 26.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.806 0.336 . . . . 0.0 110.579 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -130.53 -44.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.451 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 48.24 67.84 4.1 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.727 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.55 -23.41 74.81 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.882 2.388 . . . . 0.0 112.315 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 69.8 mt -107.98 169.14 8.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.52 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.58 -158.52 0.86 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.549 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.77 144.7 56.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.087 0.47 . . . . 0.0 110.132 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.67 145.73 50.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.605 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 1.2 m-85 -117.53 106.97 13.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.763 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.5 mt -92.07 111.13 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.3 m -116.45 150.21 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.204 0.525 . . . . 0.0 110.133 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -107.55 107.86 18.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.1 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.28 142.21 58.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.614 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -54.59 -34.61 62.25 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.941 0.4 . . . . 0.0 110.119 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -141.74 159.27 60.45 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 121.124 0.488 . . . . 0.0 110.859 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -56.79 -26.39 66.15 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.652 2.235 . . . . 0.0 111.911 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -88.06 -7.57 56.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.759 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -92.28 -20.31 21.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.286 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.0 m -55.98 -33.28 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.312 0.577 . . . . 0.0 109.652 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -33.33 57.61 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.534 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 95.6 m -71.73 -39.34 70.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.393 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 23.5 mm -67.85 -40.63 83.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.928 -179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.37 97.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.932 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.84 -38.95 87.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.584 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.95 -37.59 81.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.264 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.31 73.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.768 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -62.56 -23.12 66.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.262 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -92.02 -7.93 47.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.984 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.4 mm -55.65 -23.06 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.031 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 73.84 131.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.166 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.01 82.99 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.4 t -79.14 119.94 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 O-C-N 122.659 -0.318 . . . . 0.0 110.541 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.2 t -62.89 -48.02 80.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -168.5 152.64 5.88 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 99.2 t -121.15 135.41 61.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.804 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -124.9 126.25 45.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.783 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.6 115.7 27.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.386 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.656 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.689 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 . . . . . 0 C--O 1.231 0.106 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 73.86 -11.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.446 0.467 . . . . 0.0 111.737 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -97.21 126.77 42.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.982 0.42 . . . . 0.0 110.717 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -125.43 139.82 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.884 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 89.9 t -120.19 124.28 72.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.939 0.399 . . . . 0.0 110.924 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.9 t -114.35 107.76 23.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.724 178.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -82.22 146.19 29.64 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.056 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 34.2 mt -113.94 146.2 18.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.728 -178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.98 141.08 1.78 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.419 0.628 . . . . 0.0 111.32 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -71.69 -19.99 61.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.481 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -87.51 5.16 40.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.989 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.1 m -138.89 152.4 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.368 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -106.45 -174.78 2.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -172.76 147.33 1.73 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.015 0.436 . . . . 0.0 110.153 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.28 24.53 2.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.471 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.7 m -135.81 -27.53 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.762 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 65.98 155.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.148 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 63.54 131.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.593 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.2 mt -125.47 137.02 59.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.645 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -86.32 114.98 23.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.261 0.553 . . . . 0.0 110.064 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -126.43 134.02 51.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.725 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 57.27 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.757 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -143.13 25.05 2.22 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -148.17 173.75 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.748 0.309 . . . . 0.0 110.34 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.8 p -114.81 133.86 55.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.384 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.2 m -121.62 147.82 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.217 0.532 . . . . 0.0 109.945 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.2 m -69.66 131.77 45.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.061 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -86.97 145.13 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.099 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.11 -14.3 24.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.909 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -110.75 42.73 1.54 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.639 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -58.2 -49.47 76.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.768 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -125.81 56.94 1.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.005 0.431 . . . . 0.0 110.728 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -103.96 -53.68 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.086 0.47 . . . . 0.0 110.518 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.63 -35.38 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.249 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -67.8 -41.03 83.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.125 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.39 -40.44 95.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.438 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.6 m -66.04 -40.37 90.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.26 -13.89 59.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.696 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -95.74 -32.68 12.61 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.972 0.415 . . . . 0.0 111.531 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -91.59 4.77 51.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.923 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.5 mtt -52.16 -19.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.449 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t 77.15 -65.6 0.28 Allowed 'General case' 0 C--N 1.345 0.403 0 O-C-N 123.331 0.395 . . . . 0.0 110.078 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.7 m -62.81 -19.07 63.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.483 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -71.96 146.21 11.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.137 0.494 . . . . 0.0 111.496 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -98.57 -44.81 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.648 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -161.19 159.05 28.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.075 0.464 . . . . 0.0 110.472 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 53.9 t -134.83 129.29 51.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.602 179.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 96.3 m -122.18 132.95 54.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.223 0.535 . . . . 0.0 110.653 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -86.14 124.45 32.56 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.488 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -110.83 89.94 3.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.063 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -51.65 145.43 9.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.345 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -59.84 -35.49 74.86 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.538 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -68.46 -41.25 80.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.34 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -70.54 -39.28 74.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.724 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -66.73 -39.04 87.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.275 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -62.17 -42.91 99.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.763 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -62.92 -40.74 98.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -67.23 -39.05 86.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.862 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.62 -35.78 81.02 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.717 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.7 p -70.45 -31.63 68.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.416 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.16 -38.99 79.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.395 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.7 pt -85.86 -32.91 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.701 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 39.1 mmt -92.34 -6.24 50.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.614 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.73 174.99 45.75 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -94.61 16.31 15.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.795 0.331 . . . . 0.0 110.447 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -106.84 -22.17 12.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -81.31 156.83 25.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.51 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -172.22 -70.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.8 mp 44.96 32.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 121.276 0.56 . . . . 0.0 110.933 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -154.12 64.59 0.7 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.551 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -55.99 142.27 36.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.53 -139.72 15.6 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -61.43 -37.68 84.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.538 0.209 . . . . 0.0 110.477 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 69.39 77.04 0.22 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -128.76 72.22 81.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.432 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.41 -43.29 47.43 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.524 2.149 . . . . 0.0 112.574 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -106.68 165.62 11.17 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.085 0.469 . . . . 0.0 110.121 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.54 104.81 4.45 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.159 -177.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.561 ' O ' ' O ' ' A' ' 136' ' ' ALA . 66.9 m-20 72.73 -48.05 0.68 Allowed 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.138 0.899 . . . . 0.0 112.456 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . 41.44 124.32 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.695 0 O-C-N 124.36 1.037 . . . . 0.0 112.36 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -114.2 106.44 14.37 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.471 -0.768 . . . . 0.0 110.113 178.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 57.6 mt -84.25 108.1 16.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 79.8 t -108.95 137.4 41.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.076 0.465 . . . . 0.0 110.753 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -107.33 111.28 23.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.427 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.6 146.21 46.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.665 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.1 -34.04 54.91 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.225 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -141.44 160.02 58.52 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 120.755 0.312 . . . . 0.0 110.45 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.47 -20.2 65.84 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.644 2.229 . . . . 0.0 112.197 179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.86 -4.3 58.87 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -103.34 -8.62 20.12 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.722 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.1 m -62.31 -27.49 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 109.757 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.63 -33.4 31.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.992 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 m -72.85 -39.08 66.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.415 0.626 . . . . 0.0 110.525 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 19.1 mm -69.68 -39.93 78.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.287 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.32 -40.53 97.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.576 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -72.1 -29.46 64.11 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.494 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -76.89 -35.87 57.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.561 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.67 -34.57 78.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.649 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.35 -14.11 46.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.81 -1.06 57.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.054 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -91.15 131.28 38.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.332 0.587 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -64.57 141.08 58.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.321 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 95.87 -14.46 64.68 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.44 127.26 36.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.519 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -94.6 -49.88 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.849 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.88 142.92 24.01 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.85 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.08 132.39 67.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.784 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -136.05 148.6 48.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.221 0.534 . . . . 0.0 110.474 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 58.4 p-10 -87.05 -172.13 3.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.901 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.755 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.697 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.051 0.453 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.86 153.62 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.414 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 tpp85 158.45 115.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.608 1.193 . . . . 0.0 110.2 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.3 t -128.89 132.24 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.9 t -119.52 121.51 66.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 75.6 t -108.52 118.31 55.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -86.13 132.27 34.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 4.4 mt -91.38 150.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.119 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -46.41 142.41 3.05 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.254 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -78.5 75.78 5.01 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.9 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.48 -10.14 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.068 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.3 p -123.91 129.49 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.39 -24.51 24.19 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.444 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.0 -64.14 0.34 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.753 0.658 . . . . 0.0 111.241 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -68.82 -9.32 50.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.957 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.6 p -92.15 133.68 35.56 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.48 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -73.1 -17.94 61.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.997 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.1 t -148.76 158.95 44.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.941 0.4 . . . . 0.0 110.57 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.31 155.42 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.617 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -87.73 108.25 19.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.793 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 78' ' ' GLU . 6.8 mttp -143.01 148.11 36.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.3 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 77' ' ' LYS . 1.6 mt-10 -25.22 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.832 1.333 . . . . 0.0 110.909 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.4 24.29 1.79 Allowed Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 75.19 -160.33 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.699 0.285 . . . . 0.0 110.711 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.5 p -73.58 120.87 19.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.064 0.459 . . . . 0.0 109.794 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.49 133.12 67.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.84 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.4 t -47.07 126.83 9.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.118 -179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -64.18 -35.67 81.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.697 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 66.85 16.86 10.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.394 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -140.03 37.33 1.94 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.184 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.8 121.14 13.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.628 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 21.9 m170 50.87 32.26 7.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.915 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -47.19 26.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.9 t -69.1 -38.32 77.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.701 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -62.0 -44.86 95.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.653 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.99 -39.69 95.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.38 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.8 p -67.15 -38.44 85.5 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.414 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.2 mt -69.27 -39.38 78.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.755 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -68.39 -36.37 79.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.558 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -99.76 7.97 44.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.763 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.1 ttm -62.25 -18.89 62.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.262 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 t 74.32 158.76 0.21 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 7.3 m 69.48 4.93 4.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.877 -178.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.29 153.37 14.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 CA-C-O 120.953 0.406 . . . . 0.0 110.298 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -101.28 -37.19 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.786 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.6 t -162.39 152.19 16.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.953 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 60.6 t -130.97 128.95 63.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.492 179.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.9 m -123.91 129.37 50.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.635 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -87.35 119.0 27.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.137 0.494 . . . . 0.0 109.928 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.6 t -106.67 116.61 32.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.788 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -63.96 155.68 30.18 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -61.72 -34.35 75.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.45 . . . . 0.0 110.084 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.31 -39.35 82.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.078 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -73.97 -36.33 64.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.59 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -64.37 -41.23 96.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.395 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -66.32 -41.49 89.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.276 179.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.32 -39.64 94.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.523 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -67.85 -37.68 82.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.678 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.25 -35.59 80.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 74.9 p -70.81 -34.39 71.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.506 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -68.09 -40.1 82.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.06 0.457 . . . . 0.0 110.284 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 31.9 pt -80.85 -35.09 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.214 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.5 mmt -77.0 -53.93 7.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.115 0.483 . . . . 0.0 110.803 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.46 -168.39 26.49 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 56.07 18.07 2.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.684 0.278 . . . . 0.0 110.938 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 53.12 48.32 22.52 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.74 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . 0.484 ' CG ' ' N ' ' A' ' 124' ' ' LYS . 1.0 OUTLIER -56.69 -165.83 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' CG ' ' A' ' 123' ' ' TRP . 6.5 ttmt -27.99 109.97 0.04 OUTLIER 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.12 0.485 . . . . 0.0 111.667 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.2 tt -67.37 173.82 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.401 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -46.99 -71.69 0.07 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.101 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.64 152.45 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.87 0.367 . . . . 0.0 110.412 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.45 -172.53 52.37 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.89 -50.69 71.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.249 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -132.56 -70.82 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.23 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -134.17 148.38 67.67 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.431 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.2 -23.58 11.76 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.997 2.465 . . . . 0.0 112.269 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 84.0 mt -99.0 168.09 10.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -121.85 -165.24 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.993 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -61.85 150.23 37.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.72 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.56 145.88 45.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.612 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -117.39 114.58 23.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.7 mt -89.79 113.95 26.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 74.5 t -116.71 136.48 53.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.634 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -100.38 108.74 20.83 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.069 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 145.98 50.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.772 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -59.28 -41.09 88.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.278 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.16 159.57 71.6 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.577 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -63.42 -22.98 71.51 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.592 2.195 . . . . 0.0 112.223 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -89.53 -5.06 57.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.212 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.405 ' O ' HG12 ' A' ' 150' ' ' ILE . 96.7 m-20 -97.57 -16.37 20.09 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.35 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 29.6 m -55.0 -34.03 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.549 0.69 . . . . 0.0 109.322 -179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -73.73 -33.26 64.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.933 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.5 m -71.14 -38.77 72.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.456 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 146' ' ' ASP . 43.7 mm -66.59 -40.92 87.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.962 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.28 -39.43 94.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.742 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.47 -33.69 71.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.62 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -71.45 -39.31 71.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.974 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.08 79.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.277 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.1 mttp -61.88 -25.93 67.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.708 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -105.88 -4.62 20.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.565 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 2.5 mt -60.66 -51.56 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.384 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.5 mm-40 -151.76 -97.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 -179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.02 80.66 0.22 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.1 m -92.7 134.14 31.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.1 p -69.28 -34.38 74.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.161 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -172.41 163.9 5.63 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.645 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.8 t -133.97 138.17 50.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -130.07 133.12 46.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.16 135.25 41.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.995 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 179.853 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 119.601 -0.238 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER 43.4 -158.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 73.55 118.33 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.735 0.647 . . . . 0.0 110.93 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.5 t -126.65 140.23 49.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -119.58 124.86 73.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.12 0.486 . . . . 0.0 110.604 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.414 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 59.5 t -114.0 110.01 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -78.48 144.23 35.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.116 0.484 . . . . 0.0 110.316 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 49.3 mt -111.64 137.0 46.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.837 -179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -48.83 154.16 0.75 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.619 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -76.55 -27.05 55.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.846 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.5 -13.2 61.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.621 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.15 137.89 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 120.876 0.37 . . . . 0.0 110.484 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -115.27 90.35 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.02 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -70.11 163.48 26.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.211 0.529 . . . . 0.0 110.88 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 49.78 41.19 21.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.973 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.2 t -140.4 123.4 16.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.422 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.6 mm-40 -68.63 120.72 15.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.161 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.4 p 60.36 154.03 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.466 0.479 . . . . 0.0 110.645 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 33.6 pt -132.92 158.64 43.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.318 0.58 . . . . 0.0 110.505 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -89.37 109.98 20.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.985 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -130.84 130.71 43.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.869 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 66.83 23.13 10.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.678 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.81 8.34 87.59 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -126.28 161.69 27.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.526 0.203 . . . . 0.0 110.664 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.9 m -100.56 123.75 45.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.736 0.303 . . . . 0.0 110.481 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.61 154.68 40.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.24 0.543 . . . . 0.0 110.458 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 54.8 m -62.54 132.99 54.27 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.495 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -95.68 126.29 40.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.73 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -64.21 -25.24 67.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.618 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.41 66.89 0.64 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.631 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -58.63 -47.77 83.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.069 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.33 47.41 0.75 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.132 0.491 . . . . 0.0 110.731 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -65.38 -38.82 91.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.78 -39.37 84.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.177 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.1 -43.6 98.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.635 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.82 -39.01 90.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.504 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.2 m -66.59 -42.29 87.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.406 0.622 . . . . 0.0 110.52 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.0 mt -72.58 -33.8 67.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.704 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -80.89 -27.37 36.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.846 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -93.95 -3.58 51.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.117 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.79 -19.02 2.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.977 -0.535 . . . . 0.0 111.025 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.24 -54.51 0.43 Allowed 'General case' 0 C--N 1.346 0.431 0 O-C-N 123.992 0.808 . . . . 0.0 110.543 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 31.6 m -72.21 -5.17 33.88 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.767 179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.8 t -91.0 123.97 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.948 0.404 . . . . 0.0 111.2 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.99 -43.53 64.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.868 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.0 t -161.74 157.54 24.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.109 0.48 . . . . 0.0 110.53 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 63.6 t -131.35 127.66 60.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.214 179.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.465 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 98.8 m -120.92 129.22 53.38 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 120.968 0.413 . . . . 0.0 110.027 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -90.97 109.68 20.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.167 0.508 . . . . 0.0 110.779 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.1 t -96.07 114.27 25.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.305 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.6 p -67.96 162.62 23.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.929 0.395 . . . . 0.0 110.534 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -62.5 -27.22 68.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.033 0.444 . . . . 0.0 109.98 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.97 -38.61 88.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.022 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.34 -40.84 85.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.883 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -64.83 -36.71 85.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.362 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -68.14 -37.46 81.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.77 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -61.11 -39.36 89.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.403 0.62 . . . . 0.0 110.134 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -67.54 -36.41 80.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.991 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -66.2 -37.7 86.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.828 179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.9 p -69.2 -34.34 74.73 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.387 0.43 . . . . 0.0 110.684 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.72 -38.71 87.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.226 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 40.3 pt -85.79 -25.39 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.797 -179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.6 mmt -87.66 71.62 9.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.459 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.04 -129.24 47.67 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -126.48 0.6 6.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.62 0.247 . . . . 0.0 110.719 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -168.99 131.25 1.25 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.342 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -169.5 145.94 3.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.292 179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -148.09 138.21 22.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.988 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.6 tt -141.06 -5.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.01 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.431 ' O ' ' CG ' ' A' ' 126' ' ' PHE . 1.4 p90 -138.75 132.39 30.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.085 0.945 . . . . 0.0 110.073 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -134.99 38.2 3.0 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.719 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -167.09 -158.32 11.34 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.86 -38.26 84.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.557 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.19 135.25 57.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -149.48 128.65 6.25 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.446 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.37 -39.35 81.81 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.598 2.199 . . . . 0.0 112.152 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 73.1 mt -110.03 164.86 12.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.583 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.28 -165.1 1.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.29 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -65.92 141.1 58.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.54 144.75 50.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.465 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.414 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 1.4 m-85 -112.23 108.74 18.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.023 0.44 . . . . 0.0 110.551 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.465 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 59.6 mt -86.34 104.37 13.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 92.5 t -110.79 137.61 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.167 0.508 . . . . 0.0 111.074 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -101.36 105.53 16.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.112 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.41 144.81 51.42 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.833 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.511 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 14.0 t-20 -69.36 84.57 0.39 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.04 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 142' ' ' ASN . . . 92.24 149.67 0.05 OUTLIER Pre-proline 0 N--CA 1.451 -0.396 0 O-C-N 124.301 1.001 . . . . 0.0 110.553 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_exo -57.97 -21.25 48.85 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.629 2.22 . . . . 0.0 112.709 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -82.7 -6.31 59.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.244 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -104.36 -13.49 16.09 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.925 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 10.4 m -58.89 -30.89 43.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -75.71 -33.24 60.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.721 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.1 m -72.56 -40.18 66.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.678 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 47.5 mm -68.57 -40.02 81.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.753 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.97 -39.68 94.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.682 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -70.16 -38.53 75.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.053 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.08 -36.92 72.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.42 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.805 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -65.62 -16.59 63.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.62 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -91.56 -1.43 57.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.47 134.76 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.038 0.447 . . . . 0.0 110.535 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.02 143.47 57.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.623 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 90.55 -10.09 75.62 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.48 137.09 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 120.88 0.371 . . . . 0.0 110.637 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t -108.36 -51.43 2.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -154.42 141.08 18.98 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 40.0 t -125.06 135.58 63.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.775 0.322 . . . . 0.0 110.793 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -138.29 144.81 40.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.988 0.423 . . . . 0.0 110.288 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -110.03 155.3 22.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.733 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.613 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.89 0.376 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 28.8 m -95.15 143.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 165.64 92.15 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.939 0.774 . . . . 0.0 111.239 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.38 127.06 68.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.3 t -115.36 118.76 59.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 96.7 t -105.91 119.18 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 110.424 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -88.1 129.1 35.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.9 mt -98.12 143.54 12.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.965 -179.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -49.4 146.33 4.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.142 0.496 . . . . 0.0 110.985 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -60.26 -26.65 66.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.46 14.39 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.8 t -126.94 128.34 70.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.396 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -126.79 85.68 2.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.651 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -81.91 30.43 0.38 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.496 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -147.46 10.56 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.44 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.7 t -127.28 129.75 48.3 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.526 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.433 ' HG2' ' CE2' ' A' ' 87' ' ' TYR . 22.7 mt-30 -63.64 -37.98 89.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.118 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.7 p -136.2 151.49 49.77 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.514 -0.475 . . . . 0.0 110.163 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.47 150.76 30.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.069 0.462 . . . . 0.0 110.552 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -87.95 112.59 22.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.358 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 78' ' ' GLU . 62.9 tttp -153.65 146.02 23.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.641 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 77' ' ' LYS . 0.6 OUTLIER -17.05 105.5 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.988 1.43 . . . . 0.0 110.996 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.34 24.08 4.58 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 73.61 -161.03 0.09 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-O 120.691 0.281 . . . . 0.0 110.592 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 60.4 p -76.19 127.47 32.98 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.144 0.497 . . . . 0.0 109.949 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 m -117.53 136.62 54.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.134 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.9 t -68.54 144.97 54.4 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.912 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -115.06 22.47 13.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.971 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 66.25 -143.91 0.18 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.44 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.436 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 98.6 m-20 -61.55 -10.86 8.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.824 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.436 ' CD2' ' O ' ' A' ' 86' ' ' ASP . 46.1 p90 41.63 25.78 0.04 OUTLIER 'General case' 0 C--N 1.35 0.596 0 CA-C-O 121.103 0.478 . . . . 0.0 110.956 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.27 27.87 2.1 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 121.83 -0.544 . . . . 0.0 110.692 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -63.5 -38.85 92.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.213 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.1 t -66.33 -38.59 82.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.099 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -61.46 -43.2 99.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.542 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -65.34 -40.37 93.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.235 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.7 m -66.03 -40.8 91.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.508 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -76.72 -21.1 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.946 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -89.92 -25.81 20.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.152 0.501 . . . . 0.0 111.253 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -94.02 9.54 37.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.281 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 67.8 mmm -56.84 -18.14 11.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.024 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 82.02 -49.52 0.22 Allowed 'General case' 0 C--N 1.349 0.557 0 O-C-N 123.531 0.519 . . . . 0.0 110.956 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 32.8 m -81.28 -13.97 57.89 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.757 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 37.8 t -82.78 141.96 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.915 0.388 . . . . 0.0 111.366 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -98.33 -43.51 6.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.042 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.6 t -153.74 149.81 27.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.093 0.473 . . . . 0.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 55.4 t -131.11 129.93 63.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.973 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.1 m -122.66 127.43 49.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.233 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -83.96 120.59 26.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.918 0.39 . . . . 0.0 110.325 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 29.1 t -108.01 107.06 17.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.892 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.0 m -61.62 159.64 12.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.189 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -29.6 68.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.259 0.552 . . . . 0.0 110.147 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.36 -34.64 41.87 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.163 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -68.54 -41.38 79.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 0.0 110.649 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -73.22 -33.35 65.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.132 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -64.8 -41.68 95.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.157 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -65.69 -38.57 89.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.208 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.8 mmmt -70.37 -39.54 74.53 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.746 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 75.6 mt -67.16 -38.51 85.58 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.25 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.9 t -73.44 -30.87 63.49 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.111 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -69.57 -38.84 77.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.7 pt -77.34 -27.05 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.918 -179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -51.51 6.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 110.801 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.57 -89.85 0.08 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.01 128.78 2.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 110.642 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 53.45 41.27 32.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.757 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.08 173.54 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.21 -167.85 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.58 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 7.8 tt -113.86 154.62 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -113.94 9.96 17.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.418 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -63.66 -29.77 70.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.757 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -74.03 67.26 1.76 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 54.09 36.3 24.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.749 0.309 . . . . 0.0 110.496 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 60.08 31.7 20.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.904 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -179.54 95.33 0.2 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.633 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.52 -23.65 57.29 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.395 2.063 . . . . 0.0 112.297 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 75.8 mt -101.07 -171.29 1.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.561 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.62 -160.34 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.345 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -68.51 150.16 48.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.482 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -128.96 150.0 50.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.347 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -125.98 110.86 14.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.3 mt -88.71 109.79 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 35.0 t -109.82 137.68 40.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.265 0.555 . . . . 0.0 111.152 -179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -100.95 107.81 19.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.798 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.49 150.3 43.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.34 -40.98 79.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.891 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -136.97 159.99 67.92 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.676 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.04 -23.34 68.29 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.694 2.263 . . . . 0.0 112.168 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -91.32 -4.53 55.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.378 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -99.04 -12.71 20.32 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.3 m -61.91 -32.66 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -74.25 -35.33 63.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.934 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.4 m -71.61 -40.04 70.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.487 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 30.2 mm -67.43 -39.54 82.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.495 -179.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -62.81 -39.97 95.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.968 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.52 -38.76 90.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.725 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -69.91 -37.27 75.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.656 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.09 -35.71 77.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.465 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.92 -16.94 61.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.728 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -97.61 6.25 48.3 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.993 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.3 mt -98.41 129.01 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 40.48 -117.64 0.3 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.624 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.33 77.89 0.39 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 43.3 t -78.47 122.09 32.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.9 p -68.17 -40.85 82.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.155 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -174.87 152.69 1.58 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.917 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 57.5 t -124.91 133.83 68.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.948 0.404 . . . . 0.0 110.784 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -122.54 129.86 52.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.845 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -104.35 128.56 52.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.655 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.693 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.902 0.382 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -105.21 -156.99 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.227 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? 77.37 116.22 0.06 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.54 0.525 . . . . 0.0 111.102 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.5 140.12 49.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.862 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.6 t -117.46 115.35 48.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.337 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -99.1 109.51 24.44 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -80.0 139.19 37.08 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.068 0.461 . . . . 0.0 110.848 -179.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 72.2 mt -111.22 159.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.69 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.9 mmt180 -40.95 156.32 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.558 0.536 . . . . 0.0 110.541 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -35.57 -38.79 0.12 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.747 0.654 . . . . 0.0 111.719 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -165.44 95.56 0.65 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.117 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.4 t -98.48 -24.79 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.435 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 64.72 37.64 7.4 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.349 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.79 -40.97 85.59 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.912 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -90.22 6.61 42.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.07 109.55 21.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.976 0.417 . . . . 0.0 110.405 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -32.21 67.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.988 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 47.5 p -137.47 161.31 36.71 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.324 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.6 pt -127.78 148.69 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.073 0.463 . . . . 0.0 110.215 179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -100.67 130.33 46.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.254 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -152.01 136.89 17.17 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.764 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 51.39 34.82 12.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.6 27.21 73.97 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -135.4 143.54 46.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.683 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.1 p -103.64 123.27 46.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.099 0.476 . . . . 0.0 110.446 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 p -134.15 144.71 34.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.511 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.4 t -49.9 148.33 3.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.607 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -90.96 167.39 12.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.002 0.429 . . . . 0.0 110.586 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -106.31 143.02 35.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.233 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 58.08 46.86 15.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.957 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -64.71 129.17 38.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.946 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.5 m170 56.9 23.08 7.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.317 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -72.16 -44.25 63.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.47 . . . . 0.0 110.708 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.98 -40.66 81.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.345 0.593 . . . . 0.0 109.853 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -63.06 -44.81 94.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.501 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.36 -40.58 96.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.644 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.2 m -66.12 -38.64 88.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.253 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.65 -11.85 59.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.82 -39.53 16.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.812 0.339 . . . . 0.0 111.681 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -85.69 7.17 24.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -52.04 -19.8 2.08 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.295 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 77.02 -62.22 0.41 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.497 0.319 . . . . 0.0 110.759 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 91.2 m -65.48 -11.87 47.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.1 p -79.53 139.49 18.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.636 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -95.71 -43.47 7.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.289 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.3 p -158.55 154.24 26.32 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.389 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 57.3 t -135.22 127.95 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.751 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.1 m -127.32 134.25 50.01 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.007 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -79.29 121.77 25.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.214 0.531 . . . . 0.0 109.901 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.7 t -115.64 122.99 47.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.151 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.3 t -67.98 163.15 22.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.37 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -64.91 -34.07 77.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.711 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.01 -39.21 93.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.82 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.29 -38.86 85.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.718 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -66.18 -38.51 88.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.693 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -64.55 -40.81 96.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.086 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.48 -39.74 88.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.285 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -66.73 -38.93 87.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.756 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.7 mt -64.81 -38.99 92.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.662 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 59.6 p -67.27 -35.56 79.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.634 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.76 -39.49 84.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.887 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.4 pt -84.1 -27.24 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.475 -178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.4 mmt -89.86 -69.44 0.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.702 0.287 . . . . 0.0 110.874 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.09 169.15 40.86 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -61.08 120.21 9.84 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.976 0.417 . . . . 0.0 110.525 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.2 t30 50.43 42.17 25.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.877 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -64.53 169.93 4.43 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.487 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 54.45 -162.12 0.13 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.961 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.8 tp -141.43 143.56 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 120.967 0.413 . . . . 0.0 110.193 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -117.88 22.9 12.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.781 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.14 -41.33 92.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.371 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.96 134.97 13.21 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 59.11 162.65 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.087 0.47 . . . . 0.0 110.694 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.07 -42.45 98.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.77 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -158.6 135.27 6.58 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.353 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.66 -178.58 3.51 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.421 2.081 . . . . 0.0 112.099 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 61.19 166.67 0.09 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.464 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -132.8 173.72 11.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.421 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -51.91 140.43 19.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.91 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.48 151.36 41.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.729 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -98.98 120.46 39.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.388 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 58.0 mt -82.6 100.23 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.6 t -101.41 131.14 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.597 -179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -99.5 107.78 20.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.989 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.98 146.28 54.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.439 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -57.87 -36.91 73.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.079 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -139.64 159.2 66.26 Favored Pre-proline 0 C--N 1.328 -0.326 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.859 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -57.91 -28.1 81.38 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.501 2.134 . . . . 0.0 112.033 179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -86.16 -5.49 59.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.225 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -95.65 -14.67 23.28 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.399 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.68 -32.52 55.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -75.56 -37.85 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.075 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.1 m -69.72 -40.59 76.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.17 0.51 . . . . 0.0 110.456 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.6 mm -67.47 -39.58 82.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.464 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.55 -41.7 98.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.152 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.26 -39.59 82.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.859 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.14 -38.05 75.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.001 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.37 -27.85 67.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.663 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -61.76 -20.95 64.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.806 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.64 -8.96 57.0 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.694 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 14.1 mm -74.46 130.36 36.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.098 0.475 . . . . 0.0 110.818 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -65.91 138.76 58.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.273 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 94.9 -14.14 65.87 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.484 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.26 127.35 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 122.339 -0.507 . . . . 0.0 110.91 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.8 p -95.15 -32.48 13.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.015 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -170.84 160.39 6.78 Favored 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.186 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 19.5 t -133.97 134.56 55.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.318 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -131.96 124.18 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.743 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -79.11 178.4 8.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 0.0 110.761 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.608 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.1 t30 . . . . . 0 C--O 1.227 -0.129 0 CA-C-O 120.926 0.393 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.402 ' O ' ' CB ' ' A' ' 59' ' ' ARG . 16.7 m -122.69 -156.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER 82.28 114.21 0.06 Allowed 'General case' 0 C--N 1.346 0.453 0 O-C-N 124.177 0.923 . . . . 0.0 110.885 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.3 t -128.11 140.69 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.048 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 91.9 t -120.12 126.54 75.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.9 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 65.1 t -114.33 112.21 39.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -79.52 139.17 37.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.21 0.529 . . . . 0.0 110.091 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 3.9 mm -96.86 156.78 3.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.041 -179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 -50.45 175.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.433 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -45.9 -41.51 11.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.301 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -115.67 -117.64 0.32 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER 41.81 48.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.515 0 CA-C-O 121.304 0.573 . . . . 0.0 110.664 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -53.81 -23.4 12.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.589 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.3 t70 67.16 -71.59 0.1 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.975 0.417 . . . . 0.0 111.267 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -63.47 -15.02 56.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.794 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.9 t -79.05 120.4 23.55 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.702 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -64.04 -36.7 84.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.595 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.2 p -135.13 148.04 49.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.459 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.7 pt -132.32 152.78 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 110.549 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -87.06 107.33 18.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.758 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -165.86 144.43 5.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.382 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 70.12 -72.02 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.89 0.744 . . . . 0.0 110.683 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.71 86.52 0.21 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 60.85 -157.07 0.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.555 0.217 . . . . 0.0 110.534 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 46.8 p -75.56 128.18 34.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.186 0.517 . . . . 0.0 110.216 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.64 146.35 31.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.136 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.3 p -55.93 136.86 51.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.595 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -80.99 129.65 34.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.597 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -68.15 -27.39 66.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.456 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -112.88 74.02 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -92.06 125.4 36.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.555 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.5 m170 58.02 18.37 5.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.55 -43.27 73.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.123 0.487 . . . . 0.0 110.824 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.0 t -70.3 -39.72 77.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.017 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 81.5 t80 -63.12 -44.62 95.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.517 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.23 -39.91 94.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.806 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.8 m -68.93 -40.15 79.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.345 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.56 -30.34 67.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.653 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -34.61 66.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -84.57 6.36 24.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 7.7 mmm -57.53 -19.18 23.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 119.634 -0.222 . . . . 0.0 110.884 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 75.34 -68.22 0.21 Allowed 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.4 0.438 . . . . 0.0 110.687 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 86.7 m -60.83 -14.79 24.11 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.806 179.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -73.22 145.62 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.129 0.49 . . . . 0.0 111.304 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.35 -43.46 5.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.583 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.2 t -159.23 149.02 18.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.275 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -136.04 130.45 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.232 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.0 m -125.24 131.04 53.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.311 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -87.69 113.75 23.66 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.927 0.394 . . . . 0.0 110.543 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.1 t -97.16 106.54 18.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.726 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -64.09 156.02 29.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.151 0.501 . . . . 0.0 110.364 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -63.2 -29.55 70.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.418 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.56 -38.7 91.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.836 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.07 -39.87 78.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.516 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -68.08 -36.17 79.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.767 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.413 ' HD2' ' O ' ' A' ' 112' ' ' TYR . 0.2 OUTLIER -67.45 -40.41 85.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.515 0.674 . . . . 0.0 109.771 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -61.96 -40.67 96.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.148 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -67.36 -39.18 85.69 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.522 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.31 -35.92 76.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.475 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.4 p -70.04 -34.46 73.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.435 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -68.06 -41.09 82.51 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.318 0.58 . . . . 0.0 110.543 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.1 pt -74.74 -27.27 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.125 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.27 0.48 32.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.566 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.2 12.29 84.49 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.02 174.18 0.15 Allowed 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 28.7 m120 61.67 26.75 16.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.525 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.6 p-90 -109.82 0.25 18.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.306 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -115.82 138.36 51.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.959 0.409 . . . . 0.0 110.705 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.9 tp -149.3 10.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.764 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -107.52 29.29 7.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.164 0.507 . . . . 0.0 110.299 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.99 130.71 47.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.78 84.33 0.59 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.1 t0 57.45 51.69 9.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.071 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -110.33 -85.43 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.261 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.8 m120 48.88 72.95 1.09 Allowed Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.556 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.69 -28.63 76.76 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.631 2.221 . . . . 0.0 111.761 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.53 173.93 7.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.409 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.83 -170.08 2.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.007 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -79.84 167.89 19.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.674 179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -141.23 149.4 41.3 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.785 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -118.05 105.48 11.9 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.7 mt -80.73 103.35 7.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 73.8 t -106.69 137.3 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.099 0.476 . . . . 0.0 111.261 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -102.18 108.01 19.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.295 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.5 142.93 53.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.721 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.92 -32.73 34.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.631 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -149.91 163.16 25.71 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-O 121.235 0.541 . . . . 0.0 111.307 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -58.17 -28.64 84.7 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.591 2.194 . . . . 0.0 112.004 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -86.52 -5.41 59.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.232 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.55 -16.99 19.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 20.1 m -58.12 -34.08 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -33.99 63.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.885 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.4 m -71.35 -39.35 71.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.654 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 22.9 mm -66.37 -40.66 87.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.622 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.17 96.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.468 0.651 . . . . 0.0 110.523 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -68.8 -39.43 80.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.847 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -71.06 -36.28 72.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.12 -35.46 78.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.329 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -61.44 -18.7 60.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.16 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.43 -14.7 39.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.679 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 9.9 mm -57.86 -100.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.757 -178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 171.17 138.43 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 78.78 13.75 82.79 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.644 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.1 t -81.84 127.21 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.618 -0.342 . . . . 0.0 110.335 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 77.8 p -96.58 -34.88 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.481 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.32 157.95 6.42 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.917 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.25 142.28 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.091 0.472 . . . . 0.0 110.389 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -142.11 119.89 11.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.854 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -82.12 173.26 12.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.784 0.326 . . . . 0.0 110.874 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.694 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.765 0.317 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -105.7 -151.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 73.84 120.76 0.04 OUTLIER 'General case' 0 C--N 1.347 0.477 0 O-C-N 123.686 0.616 . . . . 0.0 110.321 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.1 t -129.24 137.16 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.964 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.03 122.81 70.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 3.5 t -112.32 105.0 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -74.36 146.34 43.09 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 65.9 mt -120.07 135.12 61.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.732 -178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.95 159.26 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.603 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -71.41 -66.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.335 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -55.96 -21.64 22.0 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.958 0.786 . . . . 0.0 110.035 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 13.2 t -71.43 -48.0 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.484 178.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 51.61 176.75 0.02 OUTLIER 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.322 0.582 . . . . 0.0 110.932 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -175.92 -176.72 0.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 74.05 -54.97 0.67 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.154 0.909 . . . . 0.0 110.746 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.2 m -129.93 131.41 45.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.303 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -74.12 68.07 1.39 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.801 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.67 109.02 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.852 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.61 153.87 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.305 0.574 . . . . 0.0 110.403 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -94.65 121.56 36.34 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.696 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -127.9 144.18 51.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.384 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -37.57 110.04 0.11 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.656 1.223 . . . . 0.0 110.2 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.86 -47.38 1.02 Allowed Glycine 0 CA--C 1.532 1.136 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.43 -154.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.21 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.6 m -109.35 128.43 55.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.74 143.59 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.242 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.0 p -80.09 159.3 26.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.92 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -122.81 -177.46 3.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.329 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -122.62 172.32 8.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.095 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 47.78 24.99 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.758 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -69.4 -32.44 71.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.798 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 0.32 39.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.719 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -69.79 -36.85 76.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.527 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.7 t -65.21 -42.99 95.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.207 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -66.95 -42.45 85.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.66 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.74 -38.69 83.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.449 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 t -68.17 -42.77 79.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.487 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.29 -26.02 62.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.915 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -91.64 -30.53 16.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.699 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -99.88 2.87 44.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.446 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -15.93 61.72 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 72.7 158.54 0.2 Allowed 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 123.643 0.589 . . . . 0.0 109.711 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.5 m 72.66 5.6 5.26 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.908 0.755 . . . . 0.0 110.818 -178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.6 m -110.39 121.13 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -61.86 -44.95 95.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.0 p -163.39 163.72 24.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.22 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 49.2 t -134.69 129.27 51.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.266 179.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.1 m -121.92 132.38 54.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.981 0.419 . . . . 0.0 110.719 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 84.4 t80 -88.79 106.95 18.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.439 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.2 t -95.67 118.5 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.004 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.2 p -70.82 160.81 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.379 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -66.27 -31.84 72.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.075 0.464 . . . . 0.0 110.571 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.9 -36.98 78.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.32 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.56 -36.44 76.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.701 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -65.42 -38.31 89.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.574 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -67.19 -40.36 86.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.36 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -68.33 -35.92 78.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.794 0.807 . . . . 0.0 110.126 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -70.17 -37.08 75.08 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.494 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.1 mt -65.59 -39.08 91.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.221 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.6 t -73.39 -29.44 62.61 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.406 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -69.34 -36.87 77.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.991 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 50.2 pt -86.01 -27.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.941 -179.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 13.3 mmt -93.16 -63.35 1.22 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.95 0.405 . . . . 0.0 110.715 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.63 -176.95 54.16 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.7 t0 63.67 25.7 14.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.498 0.189 . . . . 0.0 110.649 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 63.8 t30 51.21 66.89 1.05 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.099 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -76.23 -1.59 27.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.369 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -53.96 -83.57 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.956 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 mp 41.29 62.71 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 CA-C-O 121.452 0.644 . . . . 0.0 111.183 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -158.0 5.3 0.12 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.053 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 58.51 167.65 0.05 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.167 0.508 . . . . 0.0 110.674 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -93.79 8.81 73.76 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -92.77 10.77 29.41 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.661 0.267 . . . . 0.0 110.686 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -137.26 152.76 50.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.916 0.389 . . . . 0.0 110.322 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -129.04 72.03 81.98 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.277 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.47 -19.62 68.05 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.867 2.378 . . . . 0.0 112.349 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.73 153.79 32.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.442 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.53 -171.19 2.4 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.436 ' HB3' ' CE1' ' A' ' 105' ' ' PHE . 93.7 m-20 -74.5 131.96 41.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.659 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.86 137.32 54.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.072 0.463 . . . . 0.0 111.361 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 8.4 m-85 -95.48 120.3 35.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 51.4 mt -92.63 104.4 15.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 85.0 t -105.65 132.74 51.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.4 . . . . 0.0 110.355 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -98.99 107.09 19.44 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.484 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.44 142.92 57.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.954 0.407 . . . . 0.0 110.684 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -59.44 -40.22 86.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.208 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -136.84 160.7 65.31 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 121.15 0.5 . . . . 0.0 110.91 -179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -62.94 -15.22 46.17 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.701 2.267 . . . . 0.0 111.87 179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -96.81 -5.66 37.88 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.406 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -98.19 -24.15 15.4 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 120.71 0.29 . . . . 0.0 110.581 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -36.57 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.19 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -71.54 -35.71 70.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.926 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.9 m -73.05 -39.7 65.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.454 0.645 . . . . 0.0 110.58 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 25.5 mm -69.31 -38.99 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.39 -179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.23 -40.05 95.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.238 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -66.08 -40.03 90.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.57 -37.39 73.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.865 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.01 72.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.774 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 60.5 mtpt -72.66 -13.07 61.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.081 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -107.57 9.99 29.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.859 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.5 mm -55.08 -88.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.51 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -151.93 -84.56 0.08 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.631 -179.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.89 35.66 4.71 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.49 143.84 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.993 0.425 . . . . 0.0 109.952 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.7 t -97.34 -51.33 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -166.46 145.89 5.8 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.001 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 95.1 t -117.99 129.26 74.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.023 0.439 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -128.25 128.27 44.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.762 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -77.61 168.97 19.11 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.424 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.726 0.298 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.9 m -71.6 138.22 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 162.03 115.0 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.129 0.893 . . . . 0.0 110.248 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.5 131.61 57.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 87.8 t -121.07 124.01 71.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.74 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.408 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 80.0 t -111.38 114.71 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.136 0.494 . . . . 0.0 111.463 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -79.31 134.77 36.62 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.121 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 54.5 mt -117.5 139.33 45.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.734 -179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.08 168.94 0.19 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.589 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt -88.63 -10.43 48.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.421 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -100.31 31.55 3.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.893 0.378 . . . . 0.0 110.805 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 10.0 p -168.6 38.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.602 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -55.27 98.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 110.266 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -63.19 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.561 -178.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -87.29 69.37 9.98 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.108 0.48 . . . . 0.0 110.137 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.2 p -140.27 -38.91 0.44 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.811 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 76.58 -45.86 0.51 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.724 0.64 . . . . 0.0 111.086 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.9 t -147.43 153.52 39.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.3 pt -125.44 151.92 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.26 0.552 . . . . 0.0 110.109 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -89.44 118.24 28.95 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.029 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -124.95 134.32 52.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.876 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -33.15 109.98 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.058 0.849 . . . . 0.0 111.037 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.49 -48.62 0.94 Allowed Glycine 0 CA--C 1.528 0.9 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.396 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -168.78 -157.06 0.18 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.58 -0.365 . . . . 0.0 111.171 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.6 p -116.08 133.05 56.44 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.16 134.26 62.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.323 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.4 m -60.72 133.49 56.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.609 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -82.97 155.71 23.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.756 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -94.25 168.31 10.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.419 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 54.01 44.53 29.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.871 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -64.67 125.79 25.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.512 . . . . 0.0 110.44 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 54.15 18.17 1.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.94 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -71.01 -43.8 67.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.357 0.598 . . . . 0.0 110.518 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.0 t -69.23 -38.83 78.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.631 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -60.37 -45.85 92.04 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.017 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.54 -39.91 92.28 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.585 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 t -65.9 -42.25 90.47 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.409 0.623 . . . . 0.0 110.425 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 91.6 mt -73.19 -36.23 66.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.883 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -37.37 68.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.023 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -91.57 6.91 43.83 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.805 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.38 -19.88 0.95 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.539 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t 67.77 67.55 0.36 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER 167.21 -23.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.809 0.693 . . . . 0.0 110.257 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.2 m -85.78 149.27 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.113 0.482 . . . . 0.0 111.413 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -91.62 -43.17 9.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.016 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.9 p -154.22 152.75 30.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.082 0.468 . . . . 0.0 110.491 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 77.3 t -132.56 128.64 58.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.766 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.5 m -124.68 131.34 53.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.781 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -92.58 122.2 34.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.548 0.689 . . . . 0.0 110.108 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.17 106.95 18.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.702 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.0 m -66.43 145.33 55.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 110.88 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -70.75 -26.36 63.33 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.928 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -64.65 -41.01 96.42 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.7 tm-20 -68.2 -40.77 82.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.251 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -65.16 -39.81 93.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.803 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -62.25 -41.61 98.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.062 179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.2 -38.88 90.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.086 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -65.65 -38.17 88.6 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.484 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.25 -34.75 76.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.93 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 79.0 p -70.22 -35.42 73.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.371 -179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -66.48 -42.92 86.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.728 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.1 pt -73.15 -28.43 26.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.768 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 14.2 mmt -81.05 -8.58 59.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.312 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.2 17.73 71.06 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.485 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.8 t0 60.31 36.38 20.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.514 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -142.85 50.93 1.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.701 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -141.67 3.6 1.68 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.785 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -82.38 103.12 11.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.92 0.39 . . . . 0.0 110.288 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.33 -22.82 4.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.552 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -89.74 13.47 14.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.899 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 61.95 160.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.62 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -75.06 -174.16 33.64 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 58.9 31.18 21.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.727 0.299 . . . . 0.0 110.232 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -116.29 -44.13 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.327 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.9 m120 49.01 62.26 12.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.591 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.53 -19.08 66.64 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.808 2.339 . . . . 0.0 112.373 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 48.5 mt -89.4 168.5 12.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.012 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -117.97 161.1 20.35 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.823 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.73 -169.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -161.73 127.78 3.7 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.408 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 0.2 OUTLIER -105.96 106.38 16.85 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.4 mt -82.9 110.58 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 84.3 t -115.41 137.02 50.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.048 0.451 . . . . 0.0 110.47 -178.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -101.34 109.33 21.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.041 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.65 147.39 49.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.587 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -57.53 -40.0 77.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.041 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -135.2 159.95 69.98 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.638 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -61.07 -19.34 62.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.379 2.053 . . . . 0.0 112.215 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -91.52 -5.49 54.07 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.234 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 83.3 m-20 -98.92 -16.12 18.91 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.241 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 28.3 m -60.0 -33.17 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 121.18 0.514 . . . . 0.0 109.736 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -38.25 63.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.454 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.8 m -68.73 -40.35 79.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.3 0.571 . . . . 0.0 110.797 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 31.2 mm -64.43 -41.27 91.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.494 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.31 98.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.314 0.578 . . . . 0.0 109.965 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.42 -40.21 89.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.745 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.06 -37.47 78.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.765 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.53 -32.94 73.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.382 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -61.72 -19.93 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.102 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -92.86 6.59 47.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.998 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 17.3 mm -88.14 120.98 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 41.91 -97.06 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.464 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -159.95 52.16 0.36 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.1 m -46.7 163.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-O 120.723 0.297 . . . . 0.0 110.362 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.4 t -83.93 -50.36 8.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.165 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -169.48 148.76 3.84 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.706 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 22.4 m -120.22 148.56 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.253 0.549 . . . . 0.0 110.484 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -142.01 148.82 39.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.652 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.46 135.48 51.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.451 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.766 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.797 0.332 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -99.97 50.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -98.52 122.16 41.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.58 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.84 137.48 53.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.983 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.41 123.8 72.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.856 0.36 . . . . 0.0 110.47 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 90.1 t -108.52 116.13 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.24 179.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -85.35 134.58 34.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 71.6 mt -98.61 147.8 6.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.743 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -45.61 164.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.721 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 7.3 tttm -88.26 139.2 30.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.115 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 66' ' ' LYS . 12.0 t0 82.89 25.98 0.13 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 124.037 0.836 . . . . 0.0 110.752 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 p -147.32 108.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.531 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -107.87 98.44 8.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.92 0.391 . . . . 0.0 110.676 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.02 -48.11 83.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.026 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -96.37 68.26 2.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.834 0.35 . . . . 0.0 111.007 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.6 p -146.98 -31.54 0.33 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.986 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 67.95 3.91 3.77 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.681 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -171.13 156.96 4.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 84.6 mt -114.86 133.1 62.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -106.51 142.24 36.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.895 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.468 ' O ' ' C ' ' A' ' 78' ' ' GLU . 60.7 tttp -151.44 141.8 22.44 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.058 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 77' ' ' LYS . 20.3 tt0 -17.98 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 O-C-N 124.551 1.157 . . . . 0.0 111.726 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 80' ' ' GLN . . . 48.18 90.37 0.01 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.463 ' CB ' ' O ' ' A' ' 79' ' ' GLY . 57.6 tp60 143.92 116.06 0.0 OUTLIER 'General case' 0 C--N 1.361 1.104 0 O-C-N 124.964 1.038 . . . . 0.0 110.371 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.3 p -121.27 133.81 55.15 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.0 m -133.12 165.12 33.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-O 121.166 0.508 . . . . 0.0 110.301 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.6 p -61.26 163.78 6.07 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.212 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -113.7 -171.23 1.85 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 110.797 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -135.05 153.59 52.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.368 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 53.06 46.26 27.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.634 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -55.51 -47.57 76.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -118.73 45.04 2.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.874 0.369 . . . . 0.0 110.645 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -101.67 -51.42 3.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.75 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.4 t -66.68 -40.28 85.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.782 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -66.71 -41.71 87.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.489 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -65.01 -40.56 95.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.385 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.6 m -68.24 -37.32 80.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.124 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.3 mt -79.14 -11.48 59.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.018 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -94.81 -32.87 13.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.866 0.365 . . . . 0.0 111.407 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -89.55 8.52 30.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.185 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 77.5 mmm -53.46 -20.16 4.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.841 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.35 -48.22 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.613 0.571 . . . . 0.0 110.74 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 3.9 m -88.17 17.76 4.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 0.0 110.83 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.3 p -107.25 138.55 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.12 0.486 . . . . 0.0 111.262 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -95.54 -42.24 8.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.795 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.6 t -157.98 150.1 22.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.585 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.58 128.84 61.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.736 179.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.3 m -125.42 132.47 52.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.546 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -86.9 118.77 26.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.006 0.431 . . . . 0.0 110.599 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.2 t -105.83 118.01 35.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.403 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.1 m -69.14 150.34 47.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.088 0.471 . . . . 0.0 110.601 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -64.52 -31.8 73.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -64.7 -39.75 94.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.509 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.07 -38.4 79.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.319 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -66.29 -38.56 88.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.445 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -63.68 -41.47 98.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.917 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.62 -39.17 93.23 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.249 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -66.63 -38.32 86.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.576 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.78 -37.79 85.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.646 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 74.0 p -69.13 -35.26 76.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.78 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.78 -39.71 87.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.773 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.0 pt -78.09 -28.11 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.88 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -19.12 34.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.464 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.5 -159.05 44.15 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -77.62 71.64 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 0.0 110.158 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.05 -166.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.342 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 66.35 126.98 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.855 0.36 . . . . 0.0 110.427 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.3 mttt 172.55 65.97 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.59 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.01 -46.14 97.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 0.0 110.619 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -112.74 68.56 0.67 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.9 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.78 161.24 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.664 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.88 -153.62 43.99 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -80.29 114.34 19.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.049 0.452 . . . . 0.0 110.521 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -169.23 -41.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.339 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 25.0 m120 53.23 82.6 0.24 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.765 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -48.18 -34.62 24.56 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.683 2.255 . . . . 0.0 111.847 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.5 mp -109.19 167.89 9.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.809 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.97 -165.5 1.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.449 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.59 140.39 51.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.11 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.57 151.14 49.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.197 0.523 . . . . 0.0 110.696 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -120.08 110.48 16.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.159 179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 51.6 mt -83.43 108.25 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 69.4 t -113.28 137.19 47.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.17 0.509 . . . . 0.0 110.979 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -99.21 106.9 19.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.18 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -75.87 146.51 39.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.893 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.448 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 17.9 m-80 -75.32 88.79 2.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.604 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.448 ' CB ' ' O ' ' A' ' 142' ' ' ASN . . . 87.95 156.66 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 O-C-N 123.945 0.778 . . . . 0.0 110.716 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -59.74 -24.84 77.2 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.584 2.189 . . . . 0.0 112.468 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -78.35 -13.62 59.77 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.513 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 142' ' ' ASN . 82.5 m-20 -97.73 -17.08 19.61 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 120.651 0.262 . . . . 0.0 111.309 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.6 m -61.17 -32.97 54.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -75.83 -34.24 60.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.62 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.7 m -70.98 -40.03 72.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.42 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.4 mm -65.69 -41.1 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.297 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.23 95.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.321 0.581 . . . . 0.0 110.166 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -66.85 -40.48 87.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.719 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.47 -32.77 66.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.265 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.04 69.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.771 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -62.2 -18.05 59.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.323 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.64 8.27 45.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.73 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 17.6 mm -84.59 117.87 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.682 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 38.49 -115.31 0.15 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.09 0.869 . . . . 0.0 111.519 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -120.7 40.57 2.12 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 11.5 p -42.96 146.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.0 p -92.74 -47.44 7.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.222 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -165.39 154.12 11.91 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.819 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.02 140.96 47.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.774 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -143.28 137.36 28.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -90.2 179.11 5.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.713 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.661 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.808 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 m120 . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.531 0.205 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -145.39 173.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 71.71 137.06 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 123.643 0.589 . . . . 0.0 110.363 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.23 141.19 38.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.388 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.6 t -116.19 125.04 73.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.16 116.63 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.182 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -84.35 138.65 32.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 1.5 mt -102.11 153.28 5.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.122 -179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -59.02 149.02 28.69 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.728 0.775 . . . . 0.0 110.831 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.79 135.56 54.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.024 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t0 69.15 26.07 5.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.902 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 9.1 p -73.23 -29.43 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.996 0.427 . . . . 0.0 110.451 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 54.66 32.81 17.98 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.932 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -59.83 -37.75 80.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.015 0.436 . . . . 0.0 110.511 -179.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.53 22.86 14.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.631 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.425 ' O ' ' CE2' ' A' ' 87' ' ' TYR . 5.3 t -85.97 -139.43 0.08 Allowed 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -164.95 -32.35 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.33 145.24 16.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.983 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.5 pt -130.41 152.23 37.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.244 0.545 . . . . 0.0 110.429 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -99.68 120.89 40.42 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.933 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -145.17 138.13 26.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.244 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 57.6 29.27 16.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.717 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.82 11.88 74.09 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -122.9 141.25 52.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.9 m -96.48 125.68 41.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.876 0.369 . . . . 0.0 110.147 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.71 155.94 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.293 0.568 . . . . 0.0 109.883 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.4 p -70.55 147.71 49.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.666 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.67 152.85 17.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.927 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.19 102.57 0.17 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.244 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 87' ' ' TYR . 23.8 m-20 45.42 72.18 0.23 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.627 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.461 ' C ' ' O ' ' A' ' 86' ' ' ASP . 1.2 t80 -32.44 128.28 0.24 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.48 1.113 . . . . 0.0 109.909 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 63.15 41.78 7.74 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 123.245 0.341 . . . . 0.0 110.996 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -71.96 -46.72 56.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.153 0.502 . . . . 0.0 110.309 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.8 -37.52 69.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.441 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -64.48 -43.54 93.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.914 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.34 -37.62 74.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.422 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -64.92 -42.13 94.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.4 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.1 mt -69.32 -39.77 78.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.834 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -68.82 -24.3 64.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.076 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -90.56 4.53 50.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.477 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.8 mmt -59.83 -23.37 63.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.653 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.32 -62.22 0.45 Allowed 'General case' 0 C--N 1.349 0.585 0 O-C-N 123.466 0.479 . . . . 0.0 111.196 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 53.7 m -59.39 -17.25 28.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.114 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.3 m -86.38 149.89 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.773 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -90.83 -42.36 10.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.916 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.5 p -157.57 156.47 32.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.528 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 59.7 t -134.84 129.89 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.913 179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.2 m -125.76 131.76 52.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.003 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -87.03 116.26 24.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.064 0.459 . . . . 0.0 110.379 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.4 t -104.74 119.89 40.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.607 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.3 t -62.41 160.4 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -62.61 -37.12 85.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.028 0.442 . . . . 0.0 110.207 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -69.19 -40.46 78.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.926 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -70.43 -38.58 74.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.493 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 10.9 tp-100 -66.65 -40.5 88.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.36 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -63.54 -43.92 95.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.646 179.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.78 -39.45 87.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -67.27 -39.75 86.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.95 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 70.7 mt -66.29 -38.09 86.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.893 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 76.6 p -69.08 -33.64 73.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.183 0.515 . . . . 0.0 110.664 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -68.3 -38.63 81.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.98 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 41.5 pt -80.43 -33.07 13.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.568 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.89 8.13 45.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.425 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.19 -149.21 47.93 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -75.46 150.34 38.28 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.286 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.42 ' C ' ' H ' ' A' ' 124' ' ' LYS . 8.2 t-20 75.18 -150.89 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 124.166 0.916 . . . . 0.0 110.048 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 75.93 -29.68 0.18 Allowed 'General case' 0 C--N 1.344 0.329 0 O-C-N 123.562 0.539 . . . . 0.0 110.778 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.42 ' H ' ' C ' ' A' ' 122' ' ' ASN . 1.6 mmtm -145.23 -83.09 0.14 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.3 mp 58.58 106.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.189 0.519 . . . . 0.0 110.003 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.6 t80 179.51 97.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.355 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -149.72 33.71 0.69 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.586 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -99.3 -19.02 22.28 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.52 -64.31 0.85 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.847 0.356 . . . . 0.0 110.763 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -151.15 165.49 33.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -59.33 132.14 87.89 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.134 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.02 -25.74 31.73 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.115 2.543 . . . . 0.0 112.405 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 58.2 mt -112.5 -176.57 2.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.853 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.92 -162.65 1.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.49 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.87 154.26 22.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.46 151.28 41.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.871 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -123.06 112.19 17.47 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.209 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.3 mt -86.85 111.24 21.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 78.4 t -114.8 138.27 45.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.366 0.603 . . . . 0.0 110.82 -179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -104.85 108.31 19.74 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.25 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.58 145.95 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 0.0 110.947 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -57.45 -39.3 76.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.796 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -137.39 161.33 61.39 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.813 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -59.64 -19.94 55.45 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.848 2.365 . . . . 0.0 112.062 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -95.16 -4.79 45.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.641 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -97.61 -22.11 16.68 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 120.762 0.315 . . . . 0.0 110.574 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 6.6 p -57.8 -35.07 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.004 0.43 . . . . 0.0 109.961 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -71.88 -34.99 69.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.813 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 59.7 m -73.25 -38.75 65.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.98 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 33.4 mm -69.06 -40.46 80.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.857 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.37 95.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.635 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -76.87 -24.46 52.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.129 -179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -85.1 -34.85 22.12 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.253 0.549 . . . . 0.0 110.547 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.49 -30.02 67.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.866 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -67.84 -12.18 60.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 110.998 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -105.65 9.12 33.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.078 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 7.0 mm -53.78 -78.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.77 -179.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.5 mm-40 -145.44 -80.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.135 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.04 62.11 0.52 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.72 156.66 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 110.28 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.4 t -109.81 -42.77 4.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.322 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -166.63 153.62 9.14 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.614 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.75 135.5 60.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.5 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -137.8 133.56 34.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -78.23 178.43 7.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.833 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.829 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -177.52 -22.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.088 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -90.53 135.35 33.76 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.091 0.472 . . . . 0.0 110.246 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.5 t -125.42 133.43 69.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.646 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.9 t -115.5 122.46 69.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.47 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.1 t -106.74 108.71 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.108 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 82.4 m-85 -81.18 145.61 30.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.998 0.427 . . . . 0.0 110.026 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 78.3 mt -111.82 157.75 12.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.853 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -50.2 173.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.569 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -59.33 -117.07 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.367 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -84.94 55.26 3.4 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.641 -0.662 . . . . 0.0 110.318 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.1 p -84.81 -11.13 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.593 178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 68.21 131.9 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.222 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -149.17 -91.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.291 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -89.37 65.11 7.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.476 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.6 m -128.89 -125.64 0.22 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.796 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 180.0 -39.0 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.1 p -140.99 147.89 39.44 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.506 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.8 pt -129.87 148.79 33.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.553 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -97.7 122.7 41.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.372 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.78 134.88 24.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.886 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 55.39 31.48 16.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.425 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.87 21.99 76.84 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -131.04 137.2 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.749 0.309 . . . . 0.0 110.445 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.1 m -93.08 122.44 35.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.491 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.6 m -128.38 155.7 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.22 0.533 . . . . 0.0 110.099 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.8 p -73.03 153.16 41.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.585 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -82.05 -176.34 6.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -130.24 -34.44 1.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.768 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -97.95 56.75 1.26 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.206 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 89' ' ' LYS . 15.6 t80 -56.08 123.08 13.22 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.593 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.487 ' O ' ' CG ' ' A' ' 88' ' ' HIS . 2.0 p80 26.46 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 125.372 1.67 . . . . 0.0 111.11 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 87' ' ' TYR . 85.7 tttt -66.58 -40.36 88.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.61 -0.682 . . . . 0.0 110.466 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.02 -38.99 79.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.121 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -61.01 -41.79 97.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.418 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -36.81 73.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.41 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.6 m -67.05 -41.98 85.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.351 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.9 mt -71.71 -39.55 70.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.975 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -66.85 -31.56 72.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.274 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -82.56 5.23 21.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 3.1 mmt -55.81 -24.63 37.31 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.865 -179.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 76.47 -56.18 0.57 Allowed 'General case' 0 C--N 1.343 0.322 0 O-C-N 123.365 0.416 . . . . 0.0 110.469 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 92.6 m -71.07 -10.95 60.64 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.454 179.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.28 137.93 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 120.891 0.377 . . . . 0.0 110.96 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -86.34 -43.22 13.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.494 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.4 t -156.35 151.24 26.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.434 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 95.7 t -130.25 128.79 64.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.983 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.6 m -119.02 130.42 55.64 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 110.578 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -90.76 113.67 25.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.077 0.465 . . . . 0.0 110.66 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.7 t -94.02 107.54 19.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.058 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.1 t -57.72 142.42 45.34 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.319 0.58 . . . . 0.0 110.862 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -58.35 -32.23 68.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.015 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -63.51 -30.94 71.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -71.16 -38.34 72.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.818 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -67.31 -39.29 85.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.275 -178.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -65.12 -40.02 93.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.337 179.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.78 -38.11 89.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.966 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -64.99 -38.76 92.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.215 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 92.1 mt -64.84 -38.78 92.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.426 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 80.7 p -69.46 -30.83 68.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.518 0.675 . . . . 0.0 110.51 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -69.91 -36.64 75.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.716 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 46.1 pt -87.42 -29.71 5.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.582 -178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -113.09 22.9 13.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.97 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.57 -167.44 10.37 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -104.31 20.18 18.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.894 0.378 . . . . 0.0 110.779 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -101.26 -13.0 18.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.934 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -91.64 0.33 57.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.374 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -60.29 137.52 58.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.723 0.297 . . . . 0.0 110.663 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.3 tp -148.96 145.61 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.338 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 59.45 77.86 0.29 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.547 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -83.85 12.09 6.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.706 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -84.63 32.5 3.39 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.3 t0 64.88 17.63 11.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.609 0.242 . . . . 0.0 110.597 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.57 -41.67 99.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.358 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 48.12 80.92 0.27 Allowed Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.412 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.75 -39.0 47.82 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.654 2.236 . . . . 0.0 111.762 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -79.09 174.09 11.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.66 179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.74 -171.62 2.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.693 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.86 149.62 24.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.68 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -131.4 141.62 49.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 -179.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -99.04 115.71 29.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.816 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.7 mt -93.88 111.38 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 4.7 m -115.49 150.83 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.054 0.454 . . . . 0.0 110.312 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -108.74 107.7 18.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.42 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.83 139.11 58.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -58.32 -39.15 78.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -134.95 162.14 59.49 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-O 121.16 0.505 . . . . 0.0 110.711 -179.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.42 -15.08 46.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.76 2.307 . . . . 0.0 111.385 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.73 -5.21 31.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.711 0.291 . . . . 0.0 110.301 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -92.38 -25.81 18.34 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 120.706 0.289 . . . . 0.0 110.731 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -49.65 -35.22 9.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.816 179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -33.03 60.66 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.685 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 84.3 m -72.1 -39.87 68.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.406 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 40.1 mm -69.88 -40.51 78.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.513 -179.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.91 -41.76 86.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -73.59 -33.85 64.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.558 -179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -71.65 -35.76 70.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.559 179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.07 73.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.345 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -61.13 -20.46 62.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -3.67 58.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.62 120.4 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.472 0.653 . . . . 0.0 110.477 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -58.28 147.48 30.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.646 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 91.58 -9.49 76.97 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.5 129.73 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 120.988 0.423 . . . . 0.0 110.266 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 62.1 p -100.65 -42.77 6.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.467 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -167.81 145.61 4.46 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.16 133.92 67.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.441 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -139.62 136.81 34.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.391 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -88.82 179.7 6.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.8 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.765 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.601 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 72.94 -9.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 123.365 0.415 . . . . 0.0 111.162 -179.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -105.79 129.29 54.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.921 0.391 . . . . 0.0 110.859 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -128.06 139.73 51.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.86 179.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 63.7 t -117.25 122.97 71.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.829 0.347 . . . . 0.0 110.742 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.422 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 91.3 t -103.58 115.67 45.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.118 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -79.7 132.02 36.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.996 0.426 . . . . 0.0 110.121 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 64.4 mt -109.82 135.16 49.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.883 -179.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.01 169.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.75 157.31 21.07 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.15 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.64 -6.46 1.62 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.45 0.469 . . . . 0.0 110.917 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.8 t -66.21 -45.11 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 120.841 0.353 . . . . 0.0 110.776 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 48.86 42.91 21.01 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.47 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -56.43 -45.18 80.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.806 -179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -120.34 10.04 11.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.788 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -98.45 103.01 14.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -52.67 141.75 20.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.398 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.3 p 59.12 161.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.755 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.3 mt -125.35 135.16 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.115 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.47 120.15 40.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.474 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -131.88 129.18 40.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.696 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 56.99 -87.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.339 0.399 . . . . 0.0 110.707 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.69 25.79 1.33 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -134.54 148.05 50.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.71 133.8 55.6 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.082 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.46 167.76 19.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.304 0.573 . . . . 0.0 110.128 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.2 m -75.01 131.74 40.84 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.188 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -90.8 101.5 14.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.047 0.451 . . . . 0.0 110.54 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -74.61 -4.74 38.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -103.47 12.41 35.21 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.51 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.45 133.75 55.47 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.01 0.433 . . . . 0.0 110.382 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.16 63.36 1.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.453 0.644 . . . . 0.0 111.138 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -113.63 -57.86 2.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.637 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.03 -35.65 75.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.794 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -64.6 -40.17 95.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.898 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -67.94 -40.18 83.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.704 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 65.9 m -67.03 -40.24 87.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.476 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 75.6 mt -70.96 -37.71 72.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.73 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -65.99 -30.5 71.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.268 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -87.23 4.25 43.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.3 mmt -56.49 -23.61 40.53 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.81 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.79 -47.45 0.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.335 0.397 . . . . 0.0 110.38 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 16.9 m -88.53 18.77 4.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.278 0.561 . . . . 0.0 110.676 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -104.04 141.37 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.152 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -101.06 -40.87 7.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.228 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.5 t -160.27 148.84 16.92 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.453 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.24 126.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.548 179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.53 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 99.9 m -117.68 126.03 51.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.18 0.514 . . . . 0.0 110.571 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 43.4 t80 -92.59 119.16 31.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.677 ' O ' ' O ' ' A' ' 135' ' ' ASP . 7.4 t -110.94 87.68 2.6 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.07 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 106' ' ' SER . 30.9 t -39.72 139.52 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.942 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -50.79 -35.52 32.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.931 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -68.65 -38.98 80.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.288 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.07 -35.68 66.71 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.627 0.727 . . . . 0.0 110.685 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -74.24 -33.61 63.39 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.482 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -67.42 -42.04 83.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.339 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -68.98 -35.29 76.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.444 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -69.71 -38.17 76.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.66 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.52 -35.86 79.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.581 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.2 p -69.99 -32.69 71.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.1 0.476 . . . . 0.0 110.573 -179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -68.99 -37.99 79.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.853 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.3 pt -82.01 -30.49 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.505 -178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.36 7.36 38.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.773 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.71 -173.82 43.66 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -95.78 29.09 2.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.953 0.406 . . . . 0.0 110.585 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -125.71 42.9 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.114 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -141.67 -26.57 0.68 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.637 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -59.14 138.08 57.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.211 0.529 . . . . 0.0 110.753 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.401 ' C ' ' CG ' ' A' ' 126' ' ' PHE . 5.5 tp -139.82 -23.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.348 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . 0.401 ' CG ' ' C ' ' A' ' 125' ' ' ILE . 11.2 p90 34.27 56.3 0.64 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.957 0.786 . . . . 0.0 110.665 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.6 tm-20 -114.8 128.53 56.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.835 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.24 -107.81 3.36 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -59.89 -27.52 66.78 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.585 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 77.3 -14.24 0.86 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.792 0.683 . . . . 0.0 110.674 -179.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -132.44 71.74 78.86 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-O 120.736 0.303 . . . . 0.0 110.256 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.37 -31.82 59.04 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.674 2.25 . . . . 0.0 111.637 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -100.82 153.58 19.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -116.49 -175.14 2.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.034 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.677 ' O ' ' O ' ' A' ' 106' ' ' SER . 96.8 m-20 -58.31 -30.3 66.57 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.868 0.842 . . . . 0.0 110.856 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.565 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . 51.98 125.6 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.629 0.728 . . . . 0.0 111.392 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 0.1 OUTLIER -112.65 103.65 11.7 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.628 -0.67 . . . . 0.0 109.588 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.53 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 1.4 mp -79.27 108.58 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.828 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 99.6 t -111.18 135.49 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.407 0.622 . . . . 0.0 111.313 -179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -96.34 106.36 18.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.327 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -69.68 147.2 50.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.647 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -52.34 -35.33 50.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.222 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -148.75 164.03 23.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.744 179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -57.73 -29.4 85.57 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.936 2.424 . . . . 0.0 112.071 179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -83.64 -3.82 58.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.71 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -98.73 -10.69 22.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 8.6 m -62.44 -29.03 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -80.32 -34.16 36.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.02 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 97.5 m -72.34 -40.0 67.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.172 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 28.9 mm -66.71 -40.86 87.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.287 -179.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.24 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.16 -39.11 82.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.708 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -72.3 -34.98 68.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.624 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.07 82.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.43 -17.88 60.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.861 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -93.9 8.07 42.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 18.2 mm -92.32 119.94 40.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 44.58 -98.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.683 0.615 . . . . 0.0 111.025 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -159.16 48.77 0.41 Allowed Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.3 m -50.5 143.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.355 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.0 t -61.8 -48.38 80.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.942 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -174.39 154.56 2.15 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.552 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 45.1 t -115.96 131.94 66.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.47 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -127.7 127.14 43.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -78.1 174.18 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.575 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.7 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.832 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.3 m120 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.508 0.194 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 46.77 35.63 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.076 0.465 . . . . 0.0 111.016 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -101.1 133.63 45.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.82 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.21 137.04 58.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.989 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.7 t -116.82 122.98 71.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.569 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.5 t -109.98 117.12 53.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -83.91 139.02 32.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.022 0.439 . . . . 0.0 110.282 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.8 mt -100.78 148.64 6.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.472 -179.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -46.71 154.95 0.28 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.336 0.589 . . . . 0.0 111.017 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.93 -36.76 85.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.637 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.97 70.75 1.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.489 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.5 p 176.67 126.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.117 179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -122.03 89.94 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.031 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.12 -87.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.79 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -93.9 58.14 2.57 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.063 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 m -107.97 -30.02 8.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 71.6 95.87 0.07 Allowed 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.859 0.724 . . . . 0.0 110.157 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 71.25 144.94 0.06 Allowed 'General case' 0 C--O 1.232 0.182 0 O-C-N 123.567 0.542 . . . . 0.0 110.334 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.6 pt -119.35 151.74 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.247 0.546 . . . . 0.0 109.786 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -119.35 138.05 53.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.797 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -143.52 135.58 26.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.451 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 58.17 -86.25 0.02 OUTLIER 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.684 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.92 30.64 0.81 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -137.11 148.26 46.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.874 0.368 . . . . 0.0 110.869 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.9 m -112.39 129.16 56.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.094 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.3 t -127.37 135.28 63.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.528 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.7 151.64 20.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.548 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -97.48 172.81 7.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 0.0 110.791 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -122.4 -20.2 6.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.016 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -108.35 53.67 0.68 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.044 0.45 . . . . 0.0 110.686 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -60.25 -48.18 82.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.867 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -126.94 99.21 5.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.531 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -140.21 -64.0 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.21 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.17 -36.76 78.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -62.09 -40.99 97.7 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.089 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -68.56 -39.88 80.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.52 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.6 t -66.99 -42.01 85.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.441 0.639 . . . . 0.0 110.316 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 78.1 mt -73.51 -39.57 64.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.261 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -68.47 -39.56 81.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.572 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -92.77 6.35 47.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.427 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.4 ttm -61.62 -17.46 55.35 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.739 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.53 157.38 0.19 Allowed 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 123.879 0.737 . . . . 0.0 109.457 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 22.0 m 70.5 5.31 5.32 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.895 0.747 . . . . 0.0 110.896 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.7 m -112.79 124.86 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.163 0.506 . . . . 0.0 110.488 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -66.82 -44.21 81.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.159 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.8 p -163.28 162.37 25.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.303 0.573 . . . . 0.0 110.355 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 42.5 t -132.7 129.19 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.69 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.3 m -119.65 128.93 54.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 0.0 110.072 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -87.31 120.69 28.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.295 0.569 . . . . 0.0 110.634 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.4 t -105.3 116.94 32.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.452 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.5 t -65.43 146.95 54.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.758 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -65.61 -34.62 78.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.283 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -65.87 -40.25 91.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.942 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -69.86 -37.75 76.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.056 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -65.66 -40.27 92.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.097 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -68.8 -38.66 80.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.673 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.26 -37.1 85.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.148 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.404 ' O ' HG12 ' A' ' 118' ' ' ILE . 70.0 mmtt -70.5 -39.25 74.26 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.086 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 14.8 mt -65.78 -39.67 91.21 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 123.471 0.482 . . . . 0.0 111.667 -179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 t -71.66 -33.91 69.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.635 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -69.32 -39.05 78.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.052 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.404 HG12 ' O ' ' A' ' 114' ' ' LYS . 39.1 pt -80.76 -33.15 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.362 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 21.7 mmt -80.87 -20.75 41.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.94 102.97 1.4 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.55 -173.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -70.05 77.91 0.5 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.916 0.389 . . . . 0.0 110.324 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -62.05 -32.38 72.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.986 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -102.88 147.25 27.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.656 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.4 mm -101.5 116.31 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.215 0.531 . . . . 0.0 110.658 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.22 26.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -53.95 118.02 3.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.219 0.533 . . . . 0.0 110.792 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 154.09 -157.23 27.34 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -89.33 4.48 48.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.695 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -111.4 149.74 30.79 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -121.58 152.63 58.71 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.582 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.18 -27.9 34.71 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.91 2.406 . . . . 0.0 112.297 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.91 177.56 6.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.915 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.98 -169.9 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.555 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -60.89 147.33 43.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.47 179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -130.92 145.22 51.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -115.59 114.07 24.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.127 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.8 mt -89.01 106.53 16.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 71.8 t -110.74 136.91 45.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.97 0.414 . . . . 0.0 110.751 -179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -98.72 106.87 19.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.696 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.83 150.83 39.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.855 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.481 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 34.0 t-20 -80.91 91.23 5.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.849 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.481 ' CB ' ' O ' ' A' ' 142' ' ' ASN . . . 92.76 149.74 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 O-C-N 124.564 1.165 . . . . 0.0 110.47 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -60.15 -19.84 58.68 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.862 2.375 . . . . 0.0 112.58 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -86.72 -5.34 59.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.63 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -101.19 -17.85 16.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.784 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.9 m -58.94 -33.51 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.091 0.472 . . . . 0.0 109.756 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -38.36 65.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.15 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.3 m -68.76 -39.18 80.38 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.524 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.43 -40.3 86.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.403 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.66 -40.43 95.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.472 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.52 -39.39 85.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.723 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -73.3 -35.02 66.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.622 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.86 78.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.517 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -64.82 -15.14 61.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.023 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -101.39 8.74 42.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 8.6 mm -59.45 -69.6 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.18 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 171.87 -77.6 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 123.73 0.643 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -93.23 31.03 6.6 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.4 p -82.43 131.84 32.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.0 t -96.34 -53.97 3.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.929 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -152.93 153.77 33.67 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.62 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 98.3 t -122.78 134.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -118.52 115.57 24.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.472 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.32 114.06 21.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.956 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.545 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.737 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.9 m120 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 110.548 -0.167 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER 56.38 176.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 71.57 144.42 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.307 0.575 . . . . 0.0 111.17 179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.9 t -148.52 147.3 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.403 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.2 t -121.7 126.01 74.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.208 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.65 115.35 49.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 CA-C-O 120.946 0.403 . . . . 0.0 110.041 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -85.67 141.13 29.98 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.286 0.565 . . . . 0.0 109.92 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 80.7 mt -115.45 144.7 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.931 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.496 ' O ' ' C ' ' A' ' 66' ' ' LYS . 1.6 mpt_? -44.98 139.17 3.26 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 118.824 -0.608 . . . . 0.0 109.374 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 65' ' ' ARG . 17.5 mttm -5.48 -90.21 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 O-C-N 125.326 1.641 . . . . 0.0 111.466 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.8 p30 -140.14 50.59 1.71 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.9 p -49.77 -51.71 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.547 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 174.64 25.22 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.167 0.292 . . . . 0.0 110.239 178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 32.6 p-10 -62.68 -150.69 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.449 -178.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -78.4 60.82 2.68 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.287 0.565 . . . . 0.0 110.089 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.2 t -129.87 92.54 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.547 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -56.84 120.24 7.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 m 61.4 122.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.277 0.56 . . . . 0.0 111.041 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.5 pt -124.1 155.51 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.273 0.559 . . . . 0.0 110.126 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -87.23 111.69 21.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.999 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 78' ' ' GLU . 2.5 mttt -144.18 148.97 35.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.219 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -27.1 102.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.803 1.314 . . . . 0.0 111.076 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.17 22.4 2.9 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 78.12 -159.86 0.03 OUTLIER 'General case' 0 C--N 1.345 0.396 0 O-C-N 123.827 0.369 . . . . 0.0 110.442 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 82.3 p -70.44 120.4 16.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.088 0.47 . . . . 0.0 109.938 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.2 t -118.82 132.17 69.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.153 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.9 p -66.75 151.02 48.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.552 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -92.42 174.57 7.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.957 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -124.37 -4.4 7.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.233 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -128.89 54.63 1.78 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.955 0.407 . . . . 0.0 109.922 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -57.68 -49.42 76.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.841 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -122.95 26.73 8.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.721 0.296 . . . . 0.0 110.673 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -69.55 -45.77 67.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 86.3 t -69.77 -39.29 77.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.032 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.55 -43.96 97.52 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.181 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.98 -40.87 97.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.599 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -67.98 -41.69 81.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.256 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.3 mt -70.73 -25.69 63.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.654 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -28.7 25.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.042 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -103.51 3.71 35.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.339 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.8 ptm -60.75 -17.21 47.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.953 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.31 152.03 0.13 Allowed 'General case' 0 C--N 1.341 0.231 0 O-C-N 123.869 0.731 . . . . 0.0 109.542 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.1 m 73.59 5.91 4.97 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.841 0.713 . . . . 0.0 110.7 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -108.05 133.1 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-O 121.201 0.524 . . . . 0.0 110.795 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -85.87 -51.75 6.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.975 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -149.04 155.02 40.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.3 t -133.56 128.7 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.237 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.8 m -124.98 132.38 53.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.584 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -90.92 116.98 29.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 109.978 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.7 t -108.11 128.25 54.52 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.087 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 82.9 p -66.02 159.49 25.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.126 0.489 . . . . 0.0 110.86 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -63.98 -33.31 75.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.287 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -63.47 -36.72 84.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.131 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.86 -38.64 83.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.643 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -66.85 -40.9 88.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.647 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -64.71 -43.41 93.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.721 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -64.12 -40.44 96.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.275 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -64.35 -41.75 96.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.933 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 81.7 mt -68.4 -38.72 81.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.895 -179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 81.2 p -71.38 -32.73 68.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.369 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.25 -40.44 86.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.929 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 37.8 pt -79.17 -36.1 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.992 -178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 22.3 mmt -76.28 -37.43 57.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.849 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.11 -137.96 14.49 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -96.12 17.7 15.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.666 0.269 . . . . 0.0 110.621 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -123.18 -160.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 65.81 148.6 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.36 -70.64 0.13 Allowed 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 124.013 0.821 . . . . 0.0 110.589 -179.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER 56.12 103.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.165 0.507 . . . . 0.0 110.691 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -164.3 -61.15 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.742 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -173.6 -29.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.645 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 108.51 -25.0 20.97 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -102.22 9.85 39.74 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.733 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.33 158.27 22.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.853 0.358 . . . . 0.0 110.7 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -129.03 70.64 81.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.592 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.32 -27.65 55.45 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.842 2.361 . . . . 0.0 112.186 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.21 173.79 7.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.286 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.21 -165.99 1.56 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.059 0.457 . . . . 0.0 110.718 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.01 147.96 52.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.589 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -130.01 146.5 51.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.702 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -113.34 108.98 17.97 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 40.2 mt -86.5 111.32 21.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 6.4 m -119.4 149.8 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-O 121.115 0.483 . . . . 0.0 109.904 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -105.76 107.52 18.55 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.909 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.09 149.3 43.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.53 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.435 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 47.7 t-20 -79.61 87.86 5.15 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.95 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.435 ' CB ' ' O ' ' A' ' 142' ' ' ASN . . . 95.96 153.36 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 125.104 1.502 . . . . 0.0 109.662 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -63.76 -15.45 48.95 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.135 1.89 . . . . 0.0 112.206 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -88.33 -10.21 50.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.304 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -96.16 -15.48 22.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.338 0.113 . . . . 0.0 111.012 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 34.3 m -56.92 -31.96 37.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.47 62.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.246 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.7 m -69.95 -40.15 75.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.194 0.521 . . . . 0.0 110.357 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 21.5 mm -66.07 -41.33 89.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.255 -179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -65.86 -40.89 92.09 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.521 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -67.13 -40.54 86.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.585 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -70.06 -39.97 75.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.426 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.99 74.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.734 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -62.13 -20.29 63.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.797 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -86.64 -2.77 58.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.7 mm -83.46 129.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 120.917 0.389 . . . . 0.0 110.119 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.54 140.03 58.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.163 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 91.48 -6.99 80.52 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.2 p -66.26 131.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 117.295 0.548 . . . . 0.0 110.131 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.7 t -105.62 -48.75 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.475 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -161.66 147.49 13.74 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.725 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.06 141.71 45.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.196 0.522 . . . . 0.0 111.207 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -138.49 135.88 35.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.55 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -90.28 156.32 18.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.909 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.586 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.774 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.8 p30 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.705 0.288 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 59' ' ' ARG . 61.1 t -57.33 130.5 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 58' ' ' VAL . 10.6 tpt180 158.98 115.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.638 1.211 . . . . 0.0 110.413 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -129.39 134.42 63.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.812 0.339 . . . . 0.0 110.424 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.36 122.58 68.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.93 116.42 52.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -86.98 137.54 32.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.794 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 24.6 mt -105.37 146.53 12.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.495 -179.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . 0.535 ' O ' ' C ' ' A' ' 66' ' ' LYS . 13.2 mmt180 -46.3 138.22 5.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.823 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 65' ' ' ARG . 18.4 mmtm 8.69 -99.2 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.684 1.24 . . . . 0.0 111.452 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -138.82 69.05 1.37 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.02 53.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.705 -179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 65.8 -74.38 0.06 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.599 0.562 . . . . 0.0 110.591 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 51.16 -139.96 0.91 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.647 178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -87.37 38.01 0.8 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.764 0.316 . . . . 0.0 110.617 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.9 m -96.97 -147.61 0.31 Allowed 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -170.59 137.59 1.37 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.5 p 59.83 116.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.143 0.497 . . . . 0.0 110.262 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 mm -113.09 137.29 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 0.0 110.402 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -85.48 122.59 29.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.037 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -132.62 152.42 51.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.44 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -43.58 -29.49 0.49 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.601 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.45 45.05 2.4 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.12 -168.44 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.921 0.391 . . . . 0.0 110.39 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.0 m -73.01 130.64 40.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.017 0.437 . . . . 0.0 109.834 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.09 137.87 55.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.297 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.2 p -49.42 137.13 15.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.736 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -78.46 -178.38 5.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -150.17 179.04 8.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.056 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.475 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER 47.15 24.85 0.45 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.305 0.574 . . . . 0.0 110.967 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -45.29 -41.08 8.32 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.199 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -124.2 60.49 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.646 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.37 -55.06 2.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.153 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.7 t -66.82 -36.47 77.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.418 0.628 . . . . 0.0 109.401 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -65.61 -41.05 93.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.431 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -63.55 -40.77 97.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.523 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.0 p -65.66 -36.28 83.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.509 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.9 mt -80.34 -16.85 53.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.712 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -33.28 14.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.912 0.386 . . . . 0.0 111.567 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -93.91 6.55 48.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.866 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -19.43 2.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.439 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 80.04 -50.64 0.36 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 123.322 0.389 . . . . 0.0 110.935 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 14.2 m -83.81 22.46 1.12 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.936 0.398 . . . . 0.0 111.348 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.7 m -118.99 150.23 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.082 0.467 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -106.5 -32.77 7.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.492 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.0 t -164.2 148.53 9.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 98.2 t -132.61 128.13 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.386 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.7 m -120.89 124.38 44.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.92 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -85.07 115.6 22.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.949 0.404 . . . . 0.0 109.933 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.4 t -101.28 113.12 25.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.587 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 85.7 p -66.86 160.87 25.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.88 0.372 . . . . 0.0 110.491 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.96 -31.45 72.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.305 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.95 -38.94 89.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.627 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -67.52 -41.02 85.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.5 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 21.8 mt-30 -66.96 -38.35 85.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -67.44 -37.05 82.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.874 -179.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.92 -39.18 93.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.085 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -65.93 -39.3 90.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.479 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.72 -37.36 82.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.659 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 82.8 p -69.64 -33.36 72.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.427 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -68.25 -38.33 81.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.305 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 38.7 pt -84.7 -29.95 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.191 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 37.4 mmt -94.44 -67.71 0.84 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 110.137 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 178.49 166.5 34.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -89.28 8.06 32.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.654 0.264 . . . . 0.0 110.599 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -142.02 32.15 1.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.443 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -103.24 -11.36 18.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.432 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.7 ptmt -87.75 141.37 28.65 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.853 0.358 . . . . 0.0 110.788 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -157.68 134.39 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.005 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.23 26.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.939 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 64.68 -80.85 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 O-C-N 123.159 0.287 . . . . 0.0 110.681 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.48 -93.49 1.09 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -89.0 -164.8 1.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 72.01 131.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.729 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -160.95 154.88 18.93 Favored Pre-proline 0 N--CA 1.448 -0.569 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.8 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.28 -13.59 38.17 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.904 2.403 . . . . 0.0 112.312 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.37 153.03 20.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.966 0.412 . . . . 0.0 110.768 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.45 -170.62 2.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.318 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.92 143.76 57.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.775 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.93 148.11 51.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.132 0.491 . . . . 0.0 110.309 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -121.24 111.87 17.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.418 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.61 109.96 21.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 98.4 t -115.68 139.73 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.94 0.4 . . . . 0.0 111.008 -178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -100.3 105.7 17.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.805 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.91 151.61 38.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.472 ' O ' ' CB ' ' A' ' 143' ' ' ALA . 53.6 t-20 -78.52 89.83 4.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.142 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.472 ' CB ' ' O ' ' A' ' 142' ' ' ASN . . . 93.44 152.18 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.265 0 O-C-N 124.613 1.196 . . . . 0.0 110.176 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.59 -19.95 62.41 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.43 2.087 . . . . 0.0 112.356 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -86.01 -6.9 58.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.512 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -101.19 -15.66 17.27 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.959 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 24.3 m -57.96 -35.28 51.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.135 0.493 . . . . 0.0 110.073 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -74.66 -32.61 62.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.995 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.2 m -71.46 -39.52 70.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.551 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 36.8 mm -65.04 -41.35 91.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.4 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.13 98.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.232 0.539 . . . . 0.0 110.282 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.9 -38.46 79.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -69.77 -37.45 76.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.608 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.14 80.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.607 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -62.85 -18.05 62.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.709 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -101.67 7.46 42.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.357 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.9 mt -79.23 -64.78 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.749 0.309 . . . . 0.0 111.46 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -143.07 -89.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.934 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -141.11 78.5 0.29 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 89.2 t -81.39 109.32 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.12 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.2 p -65.19 -39.9 93.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -150.76 155.96 40.31 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.67 123.72 16.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.994 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.43 127.92 49.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.656 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.99 102.92 12.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.453 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.877 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 . . . . . 0 CA--C 1.523 -0.082 0 CA-C-O 120.795 0.331 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.2 m -131.25 160.63 42.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.961 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.12 96.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.053 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.46 126.33 75.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.3 t -114.02 119.96 62.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.205 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.4 t -108.95 113.53 44.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -86.18 134.17 33.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.434 HG22 HD13 ' A' ' 64' ' ' ILE . 93.9 mt -110.16 140.82 27.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.751 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -47.12 163.55 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.199 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 -12.6 33.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.198 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -83.98 7.56 18.0 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.638 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.56 135.02 43.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.737 0.303 . . . . 0.0 110.358 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -112.14 91.58 3.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.613 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.22 -69.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.778 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -97.34 67.51 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 111.093 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.61 -38.98 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.422 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 63.11 145.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.539 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.89 126.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.261 0.553 . . . . 0.0 110.687 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.1 mt -124.87 140.38 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.37 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.94 113.31 21.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.292 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -132.76 137.33 46.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 57.38 28.09 14.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.482 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.66 16.74 79.06 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -129.53 140.27 51.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.874 0.369 . . . . 0.0 110.583 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.5 m -87.21 120.77 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.194 0.521 . . . . 0.0 110.449 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.07 158.43 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.185 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.7 p -59.5 147.78 35.51 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.667 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -83.02 -37.24 24.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.616 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 68.31 3.03 3.52 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.899 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -140.2 72.9 1.41 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -90.04 -67.89 0.82 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.71 87.02 2.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.318 . . . . 0.0 111.552 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HG3' ' H ' ' A' ' 90' ' ' VAL . 14.4 ptmt -122.26 -49.41 2.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.277 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.41 ' H ' ' HG3' ' A' ' 89' ' ' LYS . 99.1 t -71.48 -37.77 65.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.489 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 37.0 t80 -64.95 -40.01 94.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.869 -179.189 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -66.04 -41.25 91.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.432 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.5 m -66.79 -42.2 86.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.336 0.588 . . . . 0.0 110.217 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.5 mt -69.36 -22.68 63.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.457 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 27.4 mmtt -86.79 -31.31 20.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.934 0.397 . . . . 0.0 111.525 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -88.89 -5.14 58.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.999 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.3 ttm -50.71 -19.88 1.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 78.57 -49.45 0.46 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.671 0.388 . . . . 0.0 111.127 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 17.6 m -82.18 12.22 4.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.951 0.405 . . . . 0.0 111.214 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.7 141.43 15.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.349 0.595 . . . . 0.0 111.294 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -103.92 -40.02 6.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.579 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.3 t -161.18 148.26 15.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.523 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . . . . . . . . . 65.9 t -127.77 126.23 66.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.131 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.457 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 85.1 m -116.28 131.17 57.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.103 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -89.02 124.69 34.52 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 135' ' ' ASP . 0.1 OUTLIER -113.81 90.42 3.34 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.316 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.1 t -47.8 142.49 4.73 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 120.874 0.369 . . . . 0.0 110.766 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -60.66 -39.01 86.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.655 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -41.8 81.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.944 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -69.6 -37.88 77.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.329 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.8 tp-100 -65.3 -39.55 92.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.086 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -62.67 -42.09 99.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.767 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.52 -39.94 94.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.143 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -65.53 -39.24 91.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.794 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -67.11 -36.45 81.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.67 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 70.3 p -69.95 -34.32 73.27 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.675 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.2 -39.55 82.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.926 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.7 pt -77.91 -27.18 14.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.065 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -72.65 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.265 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.85 -170.49 41.33 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -76.45 126.67 31.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.685 0.279 . . . . 0.0 110.745 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 30.7 m120 55.76 57.75 5.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.021 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 12.1 p-90 -91.28 -17.27 26.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.714 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -133.48 -176.84 4.29 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.707 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.87 158.17 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.14 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.47 63.42 0.8 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.953 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.38 -18.12 59.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.641 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.14 -156.3 7.46 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.49 -39.89 89.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.289 . . . . 0.0 110.682 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -168.61 -73.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.882 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -111.05 132.74 21.53 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.39 -24.31 26.91 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.775 2.317 . . . . 0.0 112.086 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -78.72 168.16 20.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 -179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -123.38 -174.03 2.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.831 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . 0.565 ' O ' ' O ' ' A' ' 136' ' ' ALA . 89.9 m-20 -55.09 -23.34 20.03 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.181 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . 0.565 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . 42.02 124.67 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.699 0 O-C-N 124.795 1.309 . . . . 0.0 112.357 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -120.27 106.94 12.39 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.66 -0.65 . . . . 0.0 109.7 179.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 32.0 mt -86.89 108.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . . . . . . . . . 77.4 t -105.8 139.06 28.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.991 0.424 . . . . 0.0 110.666 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -103.05 110.61 22.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.057 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.28 148.69 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.171 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -57.69 -40.09 78.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.04 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -132.52 158.18 76.35 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.884 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -63.09 -12.17 28.57 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.721 2.281 . . . . 0.0 112.043 179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -99.5 -3.97 32.33 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.975 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -96.68 -15.69 21.33 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 122.513 0.325 . . . . 0.0 111.11 -179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -34.76 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -71.88 -34.71 69.41 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.746 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 64.9 m -73.56 -38.76 65.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.572 0.701 . . . . 0.0 110.557 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.04 -41.64 87.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.452 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.94 -39.56 93.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -70.75 -30.12 66.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.476 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -74.87 -38.68 61.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.756 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.09 -26.28 64.84 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.906 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -62.63 -23.06 66.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -105.83 7.21 32.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.603 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.2 132.9 30.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.707 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 33.69 -129.43 0.06 Allowed 'General case' 0 CA--C 1.543 0.703 0 O-C-N 124.218 0.949 . . . . 0.0 111.463 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.14 41.6 2.17 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.3 p -43.13 135.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 110.77 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 41.1 t -77.11 -45.96 25.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.977 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -168.39 148.44 4.65 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.035 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.1 t -120.41 128.88 76.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.143 0.497 . . . . 0.0 110.698 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -116.27 119.23 35.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.38 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.64 155.64 16.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.918 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.481 0.181 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.39 134.76 65.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.5 t -122.08 126.69 74.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.816 0.341 . . . . 0.0 110.827 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 94.2 t -109.05 115.3 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -84.79 135.75 33.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.446 0.641 . . . . 0.0 110.047 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.558 HD11 ' CD1' ' A' ' 137' ' ' TYR . 1.2 mt -107.51 157.89 7.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.327 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? . . . . . 0 CA--C 1.514 -0.416 0 O-C-N 123.632 0.583 . . . . 0.0 110.229 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.6 tptt . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 120.973 0.416 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.6 t -70.41 -38.57 74.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.908 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.78 -44.17 96.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.216 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.47 -39.75 92.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.528 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.3 p -67.84 -36.35 80.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.398 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.92 -17.82 54.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.99 -35.76 20.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.063 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -87.32 6.93 31.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.574 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.5 mtt -50.98 -20.18 1.27 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 77.95 -53.63 0.51 Allowed 'General case' 0 C--N 1.345 0.373 0 O-C-N 123.86 0.725 . . . . 0.0 110.323 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 99' ' ' THR . 28.4 m -85.12 13.48 6.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.312 0.577 . . . . 0.0 110.576 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.52 HG23 HG13 ' A' ' 139' ' ' VAL . 4.5 p -98.41 147.71 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.985 0.422 . . . . 0.0 110.732 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -102.75 -42.88 5.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.348 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.6 t -159.9 146.61 16.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.59 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 139' ' ' VAL . 54.8 t -128.79 126.31 64.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.7 m -124.37 128.78 49.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 110.439 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -86.7 116.89 25.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.086 0.469 . . . . 0.0 110.705 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 t -105.67 114.0 27.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.95 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.6 p -64.59 162.08 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.097 0.475 . . . . 0.0 110.799 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.4 pttt . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.759 -179.333 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.862 0.363 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.92 144.28 53.37 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.332 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.22 144.87 50.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.07 0.462 . . . . 0.0 110.684 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.558 ' CD1' HD11 ' A' ' 64' ' ' ILE . 1.6 m-85 -118.81 106.34 12.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.36 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -80.24 110.77 16.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.099 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 103' ' ' VAL . 90.3 t -114.55 134.12 58.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.263 0.554 . . . . 0.0 110.821 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -100.79 107.48 19.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.656 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.64 147.2 52.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -58.11 -39.47 78.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.725 0.298 . . . . 0.0 110.291 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.531 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -137.06 160.22 66.9 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.452 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.531 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 23.2 Cg_endo -60.78 -24.13 78.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.787 2.325 . . . . 0.0 112.118 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -88.12 -6.17 58.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.486 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -93.41 -19.28 21.45 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 120.631 0.253 . . . . 0.0 110.353 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 144' ' ' PRO . 8.0 m -57.22 -29.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.254 0.549 . . . . 0.0 109.548 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.11 -37.88 57.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.974 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 95.9 m -72.02 -36.42 69.7 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 121.567 0.699 . . . . 0.0 110.055 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.2 mm -68.2 -39.8 81.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.364 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.421 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -67.93 -39.25 83.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.374 0.607 . . . . 0.0 111.318 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 149' ' ' THR . 1.3 pp20? -71.23 -26.01 62.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.635 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.54 -38.58 23.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.397 0.617 . . . . 0.0 109.774 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.547 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -70.96 -22.56 62.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.63 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.584 ' C ' HG11 ' A' ' 160' ' ' VAL . 5.5 mtpm? -65.74 -17.16 64.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.46 7.12 22.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 154' ' ' ALA . 39.9 mt -87.21 127.78 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.664 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 36.01 -129.12 0.12 Allowed 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.421 1.075 . . . . 0.0 111.043 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -107.13 67.49 0.23 Allowed Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.584 HG11 ' C ' ' A' ' 155' ' ' LYS . 3.7 p -74.36 107.42 4.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.055 0.455 . . . . 0.0 110.122 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 t -61.13 -44.62 97.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.788 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -169.46 159.32 8.47 Favored 'General case' 0 C--O 1.202 -1.441 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.846 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 151' ' ' ALA . 68.2 t -128.71 133.4 66.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 120.719 0.295 . . . . 0.0 110.263 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -119.88 124.27 45.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.921 0.391 . . . . 0.0 110.74 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -90.11 115.81 27.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.736 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.824 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 . . . . . 0 C--O 1.227 -0.099 0 CA-C-O 120.866 0.365 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.1 t -144.41 144.88 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.237 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.618 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 57.4 t -120.71 127.4 75.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.807 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 63.2 t -108.82 117.07 53.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -83.97 138.78 32.95 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.765 0.793 . . . . 0.0 110.54 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.746 HD11 ' CE1' ' A' ' 137' ' ' TYR . 61.6 mt -106.31 161.24 5.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.704 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.499 ' N ' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.214 0 O-C-N 123.661 0.601 . . . . 0.0 110.454 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 tptt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.405 HG13 HG21 ' A' ' 157' ' ' ILE . 95.1 t -69.75 -39.27 77.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.881 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -64.82 -41.16 95.98 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.553 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -66.91 -39.57 87.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.339 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.6 m -65.55 -42.12 92.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.172 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.02 -39.27 66.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.015 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -37.67 84.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.018 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -95.56 6.47 48.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.683 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.2 ttm -63.31 -19.26 64.45 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.612 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 t 72.47 160.71 0.23 Allowed 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 99' ' ' THR . 14.3 m 72.21 2.16 4.21 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 124.111 0.882 . . . . 0.0 110.925 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.636 HG13 HD12 ' A' ' 150' ' ' ILE . 5.3 m -112.23 139.49 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 110.543 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -40.71 28.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.537 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 85.4 p -164.81 162.0 20.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 139' ' ' VAL . 96.0 t -133.59 131.81 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.146 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.1 m -125.76 136.74 53.49 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 121.012 0.434 . . . . 0.0 110.973 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -87.37 124.67 33.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.188 0.518 . . . . 0.0 110.137 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.732 ' OG ' ' HB3' ' A' ' 136' ' ' ALA . 18.7 p -116.75 108.98 16.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.953 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.6 m -61.38 165.65 4.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.445 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.995 0.426 . . . . 0.0 110.143 -179.462 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.75 143.59 57.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.224 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.732 ' HB3' ' OG ' ' A' ' 106' ' ' SER . . . -134.01 137.68 44.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.007 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.746 ' CE1' HD11 ' A' ' 64' ' ' ILE . 4.6 m-85 -101.99 113.33 26.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.5 mt -88.7 109.9 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 150' ' ' ILE . 4.4 m -116.14 148.39 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.175 0.512 . . . . 0.0 109.815 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -105.84 107.12 17.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.217 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.514 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -62.42 141.4 58.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.824 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -52.89 -26.52 15.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.296 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -161.38 165.77 16.13 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-O 121.262 0.553 . . . . 0.0 110.75 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.644 ' O ' HG22 ' A' ' 147' ' ' VAL . 43.1 Cg_exo -56.69 -30.33 83.52 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.747 2.298 . . . . 0.0 111.715 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -84.09 -7.49 59.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -96.99 -20.06 18.33 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.617 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 144' ' ' PRO . 13.0 m -56.12 -31.12 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.233 0.539 . . . . 0.0 110.034 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.491 ' HG3' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -78.34 -33.93 48.83 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.045 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.8 m -71.1 -39.51 72.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.335 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.636 HD12 HG13 ' A' ' 100' ' ' VAL . 46.3 mm -67.72 -40.39 83.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.392 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.464 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -63.87 -41.55 97.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.366 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.5 -38.91 81.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.821 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.18 -35.99 74.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.533 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.8 81.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.503 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.598 ' HA ' HG11 ' A' ' 160' ' ' VAL . 96.0 mttt -65.25 -17.08 64.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.091 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -98.69 7.77 45.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.99 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 158' ' ' GLU . 12.0 mm -65.02 -86.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.435 ' N ' HG22 ' A' ' 157' ' ' ILE . 4.5 mt-10 -165.37 -79.03 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.808 0.337 . . . . 0.0 110.549 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -93.78 34.66 4.52 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 155' ' ' LYS . 7.4 p -76.79 94.68 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.476 0.655 . . . . 0.0 110.723 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.0 t -63.95 -45.41 89.31 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.27 165.13 37.62 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.914 0.387 . . . . 0.0 110.375 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.465 HG21 ' HG3' ' A' ' 155' ' ' LYS . 21.7 t -142.14 138.26 30.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.788 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -140.31 138.16 34.72 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.644 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -80.61 178.39 8.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.897 0.38 . . . . 0.0 110.686 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.619 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.373 0.606 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.34 140.36 48.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.453 HG13 ' HB1' ' A' ' 136' ' ' ALA . 75.1 t -120.25 126.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.534 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 49.7 t -111.04 124.76 68.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.184 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -91.9 136.23 33.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.13 0.49 . . . . 0.0 110.114 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.619 HD11 ' CD1' ' A' ' 137' ' ' TYR . 96.6 mt -110.15 143.94 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.528 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.404 179.682 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.04 0.448 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 94' ' ' LEU . 90.2 t -64.79 -35.77 75.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -64.92 -41.33 95.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.434 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.54 -39.59 77.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.647 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.4 p -68.01 -40.18 83.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.879 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 90' ' ' VAL . 97.7 mt -74.6 -39.91 61.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.019 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -37.69 75.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.666 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -95.89 6.74 48.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.059 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.525 ' HB3' HG23 ' A' ' 100' ' ' VAL . 9.1 ttm -56.79 -17.27 8.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 119.258 -0.401 . . . . 0.0 111.031 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 97' ' ' MET . 0.9 OUTLIER 84.79 -61.35 0.08 Allowed 'General case' 0 C--N 1.353 0.738 0 O-C-N 123.952 0.783 . . . . 0.0 110.762 -179.552 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 99' ' ' THR . 31.9 m -68.13 -7.41 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.029 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 97' ' ' MET . 94.0 t -96.52 118.84 43.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.883 0.373 . . . . 0.0 110.788 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -69.76 -43.58 71.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.81 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -155.4 159.04 39.57 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.323 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.589 HG22 HG12 ' A' ' 139' ' ' VAL . 89.6 t -133.52 129.88 56.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.601 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.413 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 89.4 m -123.13 124.13 42.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -86.81 113.71 22.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.025 0.44 . . . . 0.0 110.542 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.2 t -100.4 105.47 16.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.78 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.2 p -65.11 163.6 14.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.936 0.398 . . . . 0.0 110.098 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.14 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.862 0.363 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -58.36 140.75 53.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.939 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.453 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -123.67 143.3 50.34 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.522 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.619 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -117.06 108.22 15.47 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 38.1 mt -89.06 110.59 21.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 103' ' ' VAL . 14.9 m -119.4 150.49 21.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.134 0.493 . . . . 0.0 110.09 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -102.86 106.89 17.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.167 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.72 144.95 47.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.612 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 4.9 m-80 -69.32 83.57 0.38 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.765 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 90.52 157.43 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 O-C-N 124.281 0.988 . . . . 0.0 110.56 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.658 ' O ' HG22 ' A' ' 147' ' ' VAL . 35.6 Cg_exo -59.89 -24.26 75.48 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.842 2.361 . . . . 0.0 112.582 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -80.1 -10.07 59.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.263 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -97.59 -19.96 17.98 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 120.586 0.231 . . . . 0.0 111.127 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 144' ' ' PRO . 11.0 m -53.63 -31.83 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -76.47 -32.93 58.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.853 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 87.0 m -72.95 -37.88 66.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.516 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.579 HG21 HG21 ' A' ' 139' ' ' VAL . 50.8 mm -71.25 -40.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.319 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.28 -40.36 81.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 149' ' ' THR . 2.3 pp20? -75.12 -31.25 61.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.73 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -78.14 -37.27 46.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.386 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -66.16 -36.12 82.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.968 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -62.55 -15.58 51.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.757 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -96.85 5.94 49.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.089 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 154' ' ' ALA . 84.6 mt -93.06 129.86 42.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.675 0.274 . . . . 0.0 110.614 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 44.05 -121.03 0.76 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.251 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.56 54.76 0.76 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -45.14 146.42 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.5 p -97.02 -35.37 10.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.422 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -170.07 158.91 7.28 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.412 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.05 143.69 39.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.673 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -140.29 132.19 27.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.522 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.66 124.96 48.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.581 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.575 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.808 0.337 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -129.44 137.43 56.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.39 126.04 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 0.0 110.654 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 90.5 t -110.33 118.97 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.386 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -86.17 133.54 33.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.165 0.507 . . . . 0.0 109.715 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.596 HD11 ' CE1' ' A' ' 137' ' ' TYR . 2.6 mt -100.62 149.75 5.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.916 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.706 179.644 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 121.146 0.498 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.58 HG12 HD12 ' A' ' 94' ' ' LEU . 78.0 t -67.12 -38.44 81.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.796 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -63.39 -43.77 96.6 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.04 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.65 -40.13 96.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.652 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.3 t -70.25 -39.52 74.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.239 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.58 HD12 HG12 ' A' ' 90' ' ' VAL . 79.4 mt -76.42 -20.77 56.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.049 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.59 -33.15 16.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -89.68 7.27 37.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -17.63 6.77 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.155 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 77.12 -68.35 0.18 Allowed 'General case' 0 C--N 1.35 0.591 0 O-C-N 123.39 0.431 . . . . 0.0 110.776 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.7 m -58.02 -19.26 29.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.037 0.446 . . . . 0.0 110.531 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.41 133.72 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.137 0.494 . . . . 0.0 110.798 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -82.13 -43.27 18.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.178 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.2 p -160.01 159.27 31.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.237 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.503 HG22 HG12 ' A' ' 139' ' ' VAL . 91.1 t -132.83 128.72 57.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.141 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.0 m -121.07 125.24 46.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.842 0.353 . . . . 0.0 110.243 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -85.66 115.66 23.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.832 0.349 . . . . 0.0 110.112 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.4 t -105.05 108.66 20.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.258 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -59.85 159.95 8.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.431 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.438 . . . . 0.0 110.058 -179.425 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.77 144.7 56.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.087 0.47 . . . . 0.0 110.132 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.67 145.73 50.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.605 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.2 m-85 -117.53 106.97 13.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.763 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.5 mt -92.07 111.13 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 150' ' ' ILE . 6.3 m -116.45 150.21 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.204 0.525 . . . . 0.0 110.133 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -107.55 107.86 18.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.1 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 146' ' ' ASP . . . -63.28 142.21 58.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.614 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -54.59 -34.61 62.25 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.941 0.4 . . . . 0.0 110.119 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -141.74 159.27 60.45 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 121.124 0.488 . . . . 0.0 110.859 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.596 ' O ' HG22 ' A' ' 147' ' ' VAL . 35.9 Cg_exo -56.79 -26.39 66.15 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.652 2.235 . . . . 0.0 111.911 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -88.06 -7.57 56.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.759 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.501 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 91.5 m-20 -92.28 -20.31 21.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.286 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 144' ' ' PRO . 20.0 m -55.98 -33.28 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.312 0.577 . . . . 0.0 109.652 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -33.33 57.61 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.534 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 95.6 m -71.73 -39.34 70.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.393 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.537 HG21 HG21 ' A' ' 139' ' ' VAL . 23.5 mm -67.85 -40.63 83.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.928 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.37 97.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.932 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.84 -38.95 87.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.584 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.95 -37.59 81.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.264 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.31 73.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.768 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -62.56 -23.12 66.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.262 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -92.02 -7.93 47.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.984 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.4 mm -55.65 -23.06 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.031 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 73.84 131.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.166 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.01 82.99 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.4 t -79.14 119.94 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 O-C-N 122.659 -0.318 . . . . 0.0 110.541 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.2 t -62.89 -48.02 80.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -168.5 152.64 5.88 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.407 HG22 HG13 ' A' ' 62' ' ' VAL . 99.2 t -121.15 135.41 61.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.804 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -124.9 126.25 45.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.783 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.6 115.7 27.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.386 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.656 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.689 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.982 0.42 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -125.43 139.82 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.884 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.423 HG11 ' CZ ' ' A' ' 63' ' ' TYR . 89.9 t -120.19 124.28 72.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.939 0.399 . . . . 0.0 110.924 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 69.9 t -114.35 107.76 23.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.724 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.423 ' CZ ' HG11 ' A' ' 61' ' ' VAL . 91.8 m-85 -82.22 146.19 29.64 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.056 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.754 HD11 ' CE1' ' A' ' 137' ' ' TYR . 34.2 mt -113.94 146.2 18.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.728 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 121.419 0.628 . . . . 0.0 111.32 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 tptp . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.086 0.47 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.63 -35.38 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.249 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -67.8 -41.03 83.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.125 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.39 -40.44 95.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.438 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.6 m -66.04 -40.37 90.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.26 -13.89 59.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.696 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -95.74 -32.68 12.61 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.972 0.415 . . . . 0.0 111.531 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -91.59 4.77 51.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.923 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.5 mtt -52.16 -19.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.449 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t 77.15 -65.6 0.28 Allowed 'General case' 0 C--N 1.345 0.403 0 O-C-N 123.331 0.395 . . . . 0.0 110.078 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.7 m -62.81 -19.07 63.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.483 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.57 HG23 HG13 ' A' ' 139' ' ' VAL . 7.1 p -71.96 146.21 11.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.137 0.494 . . . . 0.0 111.496 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -98.57 -44.81 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.648 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -161.19 159.05 28.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.075 0.464 . . . . 0.0 110.472 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.694 HG22 HG22 ' A' ' 139' ' ' VAL . 53.9 t -134.83 129.29 51.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.602 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.439 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 96.3 m -122.18 132.95 54.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.223 0.535 . . . . 0.0 110.653 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -86.14 124.45 32.56 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.488 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -110.83 89.94 3.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.063 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -51.65 145.43 9.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.345 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.7 pttt . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.538 -179.469 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 119.932 -0.08 . . . . 0.0 111.159 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.61 ' CB ' HD12 ' A' ' 64' ' ' ILE . 66.9 m-20 72.73 -48.05 0.68 Allowed 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.138 0.899 . . . . 0.0 112.456 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . 41.44 124.32 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.695 0 O-C-N 124.36 1.037 . . . . 0.0 112.36 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.754 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -114.2 106.44 14.37 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.471 -0.768 . . . . 0.0 110.113 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 57.6 mt -84.25 108.1 16.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.694 HG22 HG22 ' A' ' 103' ' ' VAL . 79.8 t -108.95 137.4 41.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.076 0.465 . . . . 0.0 110.753 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -107.33 111.28 23.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.427 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.6 146.21 46.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.665 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.1 -34.04 54.91 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.225 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -141.44 160.02 58.52 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 120.755 0.312 . . . . 0.0 110.45 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 34.7 Cg_endo -64.47 -20.2 65.84 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.644 2.229 . . . . 0.0 112.197 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.86 -4.3 58.87 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -103.34 -8.62 20.12 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.722 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 148' ' ' LYS . 10.1 m -62.31 -27.49 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 109.757 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.43 ' HG3' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -81.63 -33.4 31.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.992 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 m -72.85 -39.08 66.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.415 0.626 . . . . 0.0 110.525 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 19.1 mm -69.68 -39.93 78.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.287 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.32 -40.53 97.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.576 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -72.1 -29.46 64.11 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.494 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -76.89 -35.87 57.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.561 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.67 -34.57 78.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.649 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.35 -14.11 46.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.81 -1.06 57.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.054 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -91.15 131.28 38.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.332 0.587 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -64.57 141.08 58.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.321 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 64' ' ' ILE . . . 95.87 -14.46 64.68 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.44 127.26 36.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.519 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -94.6 -49.88 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.849 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.88 142.92 24.01 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.85 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.08 132.39 67.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.784 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -136.05 148.6 48.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.221 0.534 . . . . 0.0 110.474 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 58.4 p-10 -87.05 -172.13 3.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.901 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.755 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.697 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 tpp85 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.3 t -128.89 132.24 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.9 t -119.52 121.51 66.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.437 HG21 ' CB ' ' A' ' 154' ' ' ALA . 75.6 t -108.52 118.31 55.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -86.13 132.27 34.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.525 HD11 ' CE1' ' A' ' 137' ' ' TYR . 4.4 mt -91.38 150.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.119 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 . . . . . 0 C--O 1.236 0.365 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.254 179.707 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.9 t -69.1 -38.32 77.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.701 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -62.0 -44.86 95.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.653 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.99 -39.69 95.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.38 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.8 p -67.15 -38.44 85.5 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.414 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.2 mt -69.27 -39.38 78.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.755 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -68.39 -36.37 79.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.558 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -99.76 7.97 44.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.763 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.506 ' CE ' HG23 ' A' ' 150' ' ' ILE . 4.1 ttm -62.25 -18.89 62.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.262 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 t 74.32 158.76 0.21 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 99' ' ' THR . 7.3 m 69.48 4.93 4.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.877 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.29 153.37 14.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 CA-C-O 120.953 0.406 . . . . 0.0 110.298 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -101.28 -37.19 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.786 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.6 t -162.39 152.19 16.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.953 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.655 HG22 HG22 ' A' ' 139' ' ' VAL . 60.6 t -130.97 128.95 63.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.492 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.9 m -123.91 129.37 50.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.635 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -87.35 119.0 27.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.137 0.494 . . . . 0.0 109.928 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.6 t -106.67 116.61 32.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.788 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -63.96 155.68 30.18 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.45 . . . . 0.0 110.084 -179.647 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.918 0.389 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -61.85 150.23 37.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.72 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.56 145.88 45.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.612 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.525 ' CE1' HD11 ' A' ' 64' ' ' ILE . 3.8 m-85 -117.39 114.58 23.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.7 mt -89.79 113.95 26.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.655 HG22 HG22 ' A' ' 103' ' ' VAL . 74.5 t -116.71 136.48 53.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.634 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -100.38 108.74 20.83 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.069 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 145.98 50.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.772 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -59.28 -41.09 88.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.278 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -132.16 159.57 71.6 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.577 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 147' ' ' VAL . 32.7 Cg_endo -63.42 -22.98 71.51 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.592 2.195 . . . . 0.0 112.223 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -89.53 -5.06 57.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.212 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.424 ' O ' HG12 ' A' ' 150' ' ' ILE . 96.7 m-20 -97.57 -16.37 20.09 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.35 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 144' ' ' PRO . 29.6 m -55.0 -34.03 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.549 0.69 . . . . 0.0 109.322 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -73.73 -33.26 64.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.933 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.5 m -71.14 -38.77 72.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.456 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.506 HG23 ' CE ' ' A' ' 97' ' ' MET . 43.7 mm -66.59 -40.92 87.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.962 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.583 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -63.28 -39.43 94.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.742 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.47 -33.69 71.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.62 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -71.45 -39.31 71.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.974 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -63.07 -35.08 79.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.277 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.402 ' HG3' HG21 ' A' ' 163' ' ' VAL . 6.1 mttp -61.88 -25.93 67.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.708 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -105.88 -4.62 20.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.565 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 154' ' ' ALA . 2.5 mt -60.66 -51.56 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.384 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.403 ' N ' HG22 ' A' ' 157' ' ' ILE . 67.5 mm-40 -151.76 -97.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.02 80.66 0.22 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.1 m -92.7 134.14 31.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.1 p -69.28 -34.38 74.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.161 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -172.41 163.9 5.63 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.645 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.583 HG11 ' HB1' ' A' ' 151' ' ' ALA . 47.8 t -133.97 138.17 50.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -130.07 133.12 46.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.16 135.25 41.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.995 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 179.853 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.5 t -126.65 140.23 49.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -119.58 124.86 73.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.12 0.486 . . . . 0.0 110.604 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.602 HG13 HG22 ' A' ' 163' ' ' VAL . 59.5 t -114.0 110.01 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -78.48 144.23 35.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.116 0.484 . . . . 0.0 110.316 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.725 HD11 ' CE1' ' A' ' 137' ' ' TYR . 49.3 mt -111.64 137.0 46.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.837 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.619 -179.662 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 121.057 0.456 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.78 -39.37 84.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.177 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.1 -43.6 98.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.635 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.82 -39.01 90.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.504 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.2 m -66.59 -42.29 87.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.406 0.622 . . . . 0.0 110.52 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.0 mt -72.58 -33.8 67.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.704 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -80.89 -27.37 36.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.846 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -93.95 -3.58 51.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.117 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.79 -19.02 2.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.977 -0.535 . . . . 0.0 111.025 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.24 -54.51 0.43 Allowed 'General case' 0 C--N 1.346 0.431 0 O-C-N 123.992 0.808 . . . . 0.0 110.543 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 99' ' ' THR . 31.6 m -72.21 -5.17 33.88 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.767 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.666 HG13 HG13 ' A' ' 139' ' ' VAL . 24.8 t -91.0 123.97 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.948 0.404 . . . . 0.0 111.2 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.99 -43.53 64.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.868 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.0 t -161.74 157.54 24.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.109 0.48 . . . . 0.0 110.53 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.642 HG22 HG22 ' A' ' 139' ' ' VAL . 63.6 t -131.35 127.66 60.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.214 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.511 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 98.8 m -120.92 129.22 53.38 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 120.968 0.413 . . . . 0.0 110.027 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -90.97 109.68 20.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.167 0.508 . . . . 0.0 110.779 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.1 t -96.07 114.27 25.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.305 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.6 p -67.96 162.62 23.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.929 0.395 . . . . 0.0 110.534 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 121.033 0.444 . . . . 0.0 109.98 -179.761 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.889 0.376 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -65.92 141.1 58.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.54 144.75 50.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.465 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.725 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.4 m-85 -112.23 108.74 18.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.023 0.44 . . . . 0.0 110.551 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 59.6 mt -86.34 104.37 13.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.666 HG13 HG13 ' A' ' 100' ' ' VAL . 92.5 t -110.79 137.61 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.167 0.508 . . . . 0.0 111.074 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -101.36 105.53 16.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.112 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.41 144.81 51.42 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.833 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.642 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 14.0 t-20 -69.36 84.57 0.39 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.04 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 92.24 149.67 0.05 OUTLIER Pre-proline 0 N--CA 1.451 -0.396 0 O-C-N 124.301 1.001 . . . . 0.0 110.553 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 147' ' ' VAL . 34.4 Cg_exo -57.97 -21.25 48.85 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.629 2.22 . . . . 0.0 112.709 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -82.7 -6.31 59.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.244 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -104.36 -13.49 16.09 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.925 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 144' ' ' PRO . 10.4 m -58.89 -30.89 43.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -75.71 -33.24 60.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.721 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.1 m -72.56 -40.18 66.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.678 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.53 HD12 HG23 ' A' ' 100' ' ' VAL . 47.5 mm -68.57 -40.02 81.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.753 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.481 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -63.97 -39.68 94.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.682 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -70.16 -38.53 75.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.053 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.08 -36.92 72.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.42 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.805 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -65.62 -16.59 63.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.62 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -91.56 -1.43 57.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.47 134.76 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.038 0.447 . . . . 0.0 110.535 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.02 143.47 57.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.623 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 90.55 -10.09 75.62 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.48 137.09 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 120.88 0.371 . . . . 0.0 110.637 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t -108.36 -51.43 2.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -154.42 141.08 18.98 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.602 HG22 HG13 ' A' ' 62' ' ' VAL . 40.0 t -125.06 135.58 63.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.775 0.322 . . . . 0.0 110.793 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -138.29 144.81 40.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.988 0.423 . . . . 0.0 110.288 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -110.03 155.3 22.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.733 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.613 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.864 0.364 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.38 127.06 68.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.3 t -115.36 118.76 59.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 96.7 t -105.91 119.18 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 110.424 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -88.1 129.1 35.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.57 HD11 ' CD1' ' A' ' 137' ' ' TYR . 1.9 mt -98.12 143.54 12.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.965 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 121.142 0.496 . . . . 0.0 110.985 179.589 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm . . . . . 0 N--CA 1.446 -0.644 0 CA-C-O 121.188 0.518 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.1 t -66.33 -38.59 82.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.099 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -61.46 -43.2 99.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.542 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -65.34 -40.37 93.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.235 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.7 m -66.03 -40.8 91.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.508 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -76.72 -21.1 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.946 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -89.92 -25.81 20.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.152 0.501 . . . . 0.0 111.253 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -94.02 9.54 37.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.281 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 67.8 mmm -56.84 -18.14 11.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.024 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 82.02 -49.52 0.22 Allowed 'General case' 0 C--N 1.349 0.557 0 O-C-N 123.531 0.519 . . . . 0.0 110.956 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.789 ' HB ' HD11 ' A' ' 150' ' ' ILE . 32.8 m -81.28 -13.97 57.89 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.757 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.463 HG22 ' CG1' ' A' ' 139' ' ' VAL . 37.8 t -82.78 141.96 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.915 0.388 . . . . 0.0 111.366 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -98.33 -43.51 6.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.042 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.6 t -153.74 149.81 27.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.093 0.473 . . . . 0.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 139' ' ' VAL . 55.4 t -131.11 129.93 63.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.973 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.1 m -122.66 127.43 49.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.233 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -83.96 120.59 26.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.918 0.39 . . . . 0.0 110.325 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 29.1 t -108.01 107.06 17.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.892 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.0 m -61.62 159.64 12.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.189 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.259 0.552 . . . . 0.0 110.147 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.74 0.305 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -68.51 150.16 48.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.482 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -128.96 150.0 50.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.347 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.57 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -125.98 110.86 14.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.3 mt -88.71 109.79 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 103' ' ' VAL . 35.0 t -109.82 137.68 40.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.265 0.555 . . . . 0.0 111.152 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -100.95 107.81 19.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.798 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.555 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -72.49 150.3 43.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.34 -40.98 79.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.891 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -136.97 159.99 67.92 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.676 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.537 ' O ' HG22 ' A' ' 147' ' ' VAL . 33.7 Cg_exo -59.04 -23.34 68.29 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.694 2.263 . . . . 0.0 112.168 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -91.32 -4.53 55.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.378 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -99.04 -12.71 20.32 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 141' ' ' ALA . 22.3 m -61.91 -32.66 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -74.25 -35.33 63.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.934 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.4 m -71.61 -40.04 70.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.487 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.789 HD11 ' HB ' ' A' ' 99' ' ' THR . 30.2 mm -67.43 -39.54 82.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.495 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.443 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -62.81 -39.97 95.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.968 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.52 -38.76 90.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.725 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -69.91 -37.27 75.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.656 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -61.09 -35.71 77.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.465 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.92 -16.94 61.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.728 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -97.61 6.25 48.3 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.993 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 154' ' ' ALA . 96.3 mt -98.41 129.01 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 40.48 -117.64 0.3 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.624 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.33 77.89 0.39 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 154' ' ' ALA . 43.3 t -78.47 122.09 32.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.9 p -68.17 -40.85 82.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.155 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -174.87 152.69 1.58 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.917 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.443 HG11 ' HB1' ' A' ' 151' ' ' ALA . 57.5 t -124.91 133.83 68.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.948 0.404 . . . . 0.0 110.784 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -122.54 129.86 52.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.845 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -104.35 128.56 52.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.655 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.693 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.5 140.12 49.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.862 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.6 t -117.46 115.35 48.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.337 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -99.1 109.51 24.44 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.608 ' CD2' ' HB2' ' A' ' 136' ' ' ALA . 58.3 m-85 -80.0 139.19 37.08 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.068 0.461 . . . . 0.0 110.848 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.692 HD12 ' OD2' ' A' ' 135' ' ' ASP . 72.2 mt -111.22 159.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.69 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.445 ' N ' HG22 ' A' ' 64' ' ' ILE . 35.9 mmt180 . . . . . 0 N--CA 1.463 0.211 0 O-C-N 123.558 0.536 . . . . 0.0 110.541 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.088 0.47 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.98 -40.66 81.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.345 0.593 . . . . 0.0 109.853 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -63.06 -44.81 94.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.501 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.36 -40.58 96.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.644 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.2 m -66.12 -38.64 88.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.253 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.65 -11.85 59.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.82 -39.53 16.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.812 0.339 . . . . 0.0 111.681 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -85.69 7.17 24.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -52.04 -19.8 2.08 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.295 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 77.02 -62.22 0.41 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.497 0.319 . . . . 0.0 110.759 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.735 ' HB ' HD11 ' A' ' 150' ' ' ILE . 91.2 m -65.48 -11.87 47.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.63 HG23 HG13 ' A' ' 139' ' ' VAL . 7.1 p -79.53 139.49 18.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.636 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -95.71 -43.47 7.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.289 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.3 p -158.55 154.24 26.32 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.389 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 139' ' ' VAL . 57.3 t -135.22 127.95 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.751 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.1 m -127.32 134.25 50.01 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.007 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -79.29 121.77 25.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.214 0.531 . . . . 0.0 109.901 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.7 t -115.64 122.99 47.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.151 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.3 t -67.98 163.15 22.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.37 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 pttt . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.711 -179.655 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.104 0 N-CA-C 110.421 -0.215 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.692 ' OD2' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -51.91 140.43 19.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.91 179.35 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.608 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . . . -142.48 151.36 41.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.729 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.545 ' CE1' HD11 ' A' ' 64' ' ' ILE . 14.1 m-85 -98.98 120.46 39.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.388 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 58.0 mt -82.6 100.23 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.63 HG13 HG23 ' A' ' 100' ' ' VAL . 73.6 t -101.41 131.14 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.597 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -99.5 107.78 20.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.989 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.419 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -66.98 146.28 54.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.439 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -57.87 -36.91 73.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.079 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -139.64 159.2 66.26 Favored Pre-proline 0 C--N 1.328 -0.326 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.859 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.584 ' O ' HG22 ' A' ' 147' ' ' VAL . 34.0 Cg_exo -57.91 -28.1 81.38 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.501 2.134 . . . . 0.0 112.033 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -86.16 -5.49 59.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.225 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -95.65 -14.67 23.28 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.399 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 144' ' ' PRO . 16.2 m -62.68 -32.52 55.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -75.56 -37.85 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.075 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.1 m -69.72 -40.59 76.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.17 0.51 . . . . 0.0 110.456 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.735 HD11 ' HB ' ' A' ' 99' ' ' THR . 31.6 mm -67.47 -39.58 82.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.464 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.59 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -63.55 -41.7 98.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.152 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.26 -39.59 82.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.859 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.14 -38.05 75.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.001 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.37 -27.85 67.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.663 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -61.76 -20.95 64.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.806 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.64 -8.96 57.0 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.694 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 14.1 mm -74.46 130.36 36.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.098 0.475 . . . . 0.0 110.818 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -65.91 138.76 58.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.273 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 94.9 -14.14 65.87 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.484 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.26 127.35 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 122.339 -0.507 . . . . 0.0 110.91 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.8 p -95.15 -32.48 13.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.015 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -170.84 160.39 6.78 Favored 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.186 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 151' ' ' ALA . 19.5 t -133.97 134.56 55.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.318 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -131.96 124.18 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.743 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -79.11 178.4 8.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 0.0 110.761 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.608 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.175 0 CA-C-O 121.029 0.442 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.3 t -128.11 140.69 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.048 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 136' ' ' ALA . 91.9 t -120.12 126.54 75.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.9 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 65.1 t -114.33 112.21 39.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -79.52 139.17 37.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.21 0.529 . . . . 0.0 110.091 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.614 HD11 ' HD1' ' A' ' 137' ' ' TYR . 3.9 mm -96.86 156.78 3.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.041 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HA ' ' HB3' ' A' ' 161' ' ' SER . 13.7 mmt180 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.433 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.123 0.487 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.0 t -70.3 -39.72 77.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.017 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.519 ' HE1' HG13 ' A' ' 103' ' ' VAL . 81.5 t80 -63.12 -44.62 95.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.517 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.23 -39.91 94.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.806 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.435 ' HB3' HD12 ' A' ' 157' ' ' ILE . 67.8 m -68.93 -40.15 79.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.345 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.56 -30.34 67.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.653 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -34.61 66.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -84.57 6.36 24.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 7.7 mmm -57.53 -19.18 23.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 119.634 -0.222 . . . . 0.0 110.884 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 75.34 -68.22 0.21 Allowed 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.4 0.438 . . . . 0.0 110.687 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 99' ' ' THR . 86.7 m -60.83 -14.79 24.11 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.806 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.623 HG23 HG13 ' A' ' 139' ' ' VAL . 10.8 p -73.22 145.62 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.129 0.49 . . . . 0.0 111.304 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.35 -43.46 5.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.583 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.2 t -159.23 149.02 18.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.275 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.519 HG13 ' HE1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -136.04 130.45 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.232 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.0 m -125.24 131.04 53.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.311 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 87.1 t80 -87.69 113.75 23.66 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.927 0.394 . . . . 0.0 110.543 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.1 t -97.16 106.54 18.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.726 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -64.09 156.02 29.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.151 0.501 . . . . 0.0 110.364 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.418 -179.71 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.099 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.403 ' HB3' ' CE1' ' A' ' 105' ' ' PHE . 45.8 m-20 -79.84 167.89 19.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.674 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -141.23 149.4 41.3 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.785 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.614 ' HD1' HD11 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -118.05 105.48 11.9 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.7 mt -80.73 103.35 7.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.623 HG13 HG23 ' A' ' 100' ' ' VAL . 73.8 t -106.69 137.3 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.099 0.476 . . . . 0.0 111.261 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -102.18 108.01 19.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.295 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.439 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -69.5 142.93 53.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.721 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.92 -32.73 34.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.631 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -149.91 163.16 25.71 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-O 121.235 0.541 . . . . 0.0 111.307 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.622 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.7 Cg_exo -58.17 -28.64 84.7 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.591 2.194 . . . . 0.0 112.004 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -86.52 -5.41 59.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.232 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.55 -16.99 19.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 144' ' ' PRO . 20.1 m -58.12 -34.08 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -33.99 63.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.885 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.4 m -71.35 -39.35 71.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.654 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.423 HG21 HG11 ' A' ' 139' ' ' VAL . 22.9 mm -66.37 -40.66 87.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.622 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.17 96.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.468 0.651 . . . . 0.0 110.523 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -68.8 -39.43 80.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.847 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -71.06 -36.28 72.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.12 -35.46 78.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.329 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -61.44 -18.7 60.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.16 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.43 -14.7 39.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.679 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 93' ' ' SER . 9.9 mm -57.86 -100.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.757 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 171.17 138.43 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 78.78 13.75 82.79 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.644 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.1 t -81.84 127.21 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.618 -0.342 . . . . 0.0 110.335 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 77.8 p -96.58 -34.88 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.481 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.32 157.95 6.42 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.917 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.25 142.28 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.091 0.472 . . . . 0.0 110.389 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -142.11 119.89 11.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.854 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -82.12 173.26 12.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.784 0.326 . . . . 0.0 110.874 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.694 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.933 0.397 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.894 HG22 HG23 ' A' ' 147' ' ' VAL . 15.1 t -129.24 137.16 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.964 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.03 122.81 70.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.707 HG13 HG22 ' A' ' 163' ' ' VAL . 3.5 t -112.32 105.0 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -74.36 146.34 43.09 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.728 HD11 ' CD1' ' A' ' 137' ' ' TYR . 65.9 mt -120.07 135.12 61.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.732 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.644 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.603 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 12.4 tptp . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.994 0.426 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.7 t -65.21 -42.99 95.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.207 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -66.95 -42.45 85.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.66 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.74 -38.69 83.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.449 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 t -68.17 -42.77 79.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.487 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.29 -26.02 62.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.915 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -91.64 -30.53 16.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.699 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -99.88 2.87 44.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.446 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -15.93 61.72 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 72.7 158.54 0.2 Allowed 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 123.643 0.589 . . . . 0.0 109.711 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.572 ' HB ' HD11 ' A' ' 150' ' ' ILE . 4.5 m 72.66 5.6 5.26 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.908 0.755 . . . . 0.0 110.818 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 100' ' ' VAL . 27.6 m -110.39 121.13 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -61.86 -44.95 95.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.0 p -163.39 163.72 24.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.22 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 139' ' ' VAL . 49.2 t -134.69 129.27 51.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.266 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.1 m -121.92 132.38 54.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.981 0.419 . . . . 0.0 110.719 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.465 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 84.4 t80 -88.79 106.95 18.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.439 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.2 t -95.67 118.5 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.004 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.2 p -70.82 160.81 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.379 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.6 pttm . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 121.075 0.464 . . . . 0.0 110.571 179.684 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.522 -0.122 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.465 ' HB3' ' CE1' ' A' ' 105' ' ' PHE . 93.7 m-20 -74.5 131.96 41.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.659 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.86 137.32 54.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.072 0.463 . . . . 0.0 111.361 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.728 ' CD1' HD11 ' A' ' 64' ' ' ILE . 8.4 m-85 -95.48 120.3 35.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 51.4 mt -92.63 104.4 15.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 103' ' ' VAL . 85.0 t -105.65 132.74 51.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.4 . . . . 0.0 110.355 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -98.99 107.09 19.44 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.484 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.44 142.92 57.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.954 0.407 . . . . 0.0 110.684 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -59.44 -40.22 86.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.208 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.525 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -136.84 160.7 65.31 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 121.15 0.5 . . . . 0.0 110.91 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 30.3 Cg_endo -62.94 -15.22 46.17 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.701 2.267 . . . . 0.0 111.87 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -96.81 -5.66 37.88 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.406 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -98.19 -24.15 15.4 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 120.71 0.29 . . . . 0.0 110.581 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.894 HG23 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -55.5 -36.57 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.19 179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -71.54 -35.71 70.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.926 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.9 m -73.05 -39.7 65.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.454 0.645 . . . . 0.0 110.58 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 99' ' ' THR . 25.5 mm -69.31 -38.99 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.39 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.23 -40.05 95.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.238 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -66.08 -40.03 90.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.57 -37.39 73.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.865 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.01 72.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.774 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HG3' HG21 ' A' ' 163' ' ' VAL . 60.5 mtpt -72.66 -13.07 61.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.081 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -107.57 9.99 29.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.859 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.411 HG22 ' N ' ' A' ' 158' ' ' GLU . 8.5 mm -55.08 -88.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.51 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.411 ' N ' HG22 ' A' ' 157' ' ' ILE . 67.2 mm-40 -151.93 -84.56 0.08 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.631 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.89 35.66 4.71 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.49 143.84 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.993 0.425 . . . . 0.0 109.952 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.7 t -97.34 -51.33 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -166.46 145.89 5.8 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.001 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.707 HG22 HG13 ' A' ' 62' ' ' VAL . 95.1 t -117.99 129.26 74.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.023 0.439 . . . . 0.0 111.013 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -128.25 128.27 44.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.762 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -77.61 168.97 19.11 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.424 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.5 131.61 57.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.582 HG13 ' HB1' ' A' ' 136' ' ' ALA . 87.8 t -121.07 124.01 71.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.74 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 80.0 t -111.38 114.71 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.136 0.494 . . . . 0.0 111.463 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -79.31 134.77 36.62 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.121 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.839 HD11 ' CD1' ' A' ' 137' ' ' TYR . 54.5 mt -117.5 139.33 45.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.734 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.589 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.5 tptp . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.357 0.598 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.484 HG13 HG21 ' A' ' 157' ' ' ILE . 79.0 t -69.23 -38.83 78.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.631 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -60.37 -45.85 92.04 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.017 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.54 -39.91 92.28 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.585 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 t -65.9 -42.25 90.47 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.409 0.623 . . . . 0.0 110.425 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.413 HD12 HG12 ' A' ' 90' ' ' VAL . 91.6 mt -73.19 -36.23 66.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.883 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -37.37 68.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.023 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -91.57 6.91 43.83 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.805 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.38 -19.88 0.95 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.539 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t 67.77 67.55 0.36 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.671 ' CG2' HD11 ' A' ' 150' ' ' ILE . 1.0 OUTLIER 167.21 -23.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.809 0.693 . . . . 0.0 110.257 179.198 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.2 m -85.78 149.27 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.113 0.482 . . . . 0.0 111.413 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -91.62 -43.17 9.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.016 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.9 p -154.22 152.75 30.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.082 0.468 . . . . 0.0 110.491 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.625 HG22 HG22 ' A' ' 139' ' ' VAL . 77.3 t -132.56 128.64 58.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.766 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.5 m -124.68 131.34 53.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.781 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.495 ' HE1' HD12 ' A' ' 64' ' ' ILE . 53.0 t80 -92.58 122.2 34.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.548 0.689 . . . . 0.0 110.108 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -101.17 106.95 18.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.702 178.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.0 m -66.43 145.33 55.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 110.88 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.9 pttt . . . . . 0 CA--C 1.514 -0.42 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.928 179.621 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.986 0.422 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.73 -169.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.582 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -161.73 127.78 3.7 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.839 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -105.96 106.38 16.85 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.4 mt -82.9 110.58 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.625 HG22 HG22 ' A' ' 103' ' ' VAL . 84.3 t -115.41 137.02 50.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.048 0.451 . . . . 0.0 110.47 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -101.34 109.33 21.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.041 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.51 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -70.65 147.39 49.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.587 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -57.53 -40.0 77.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.041 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -135.2 159.95 69.98 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.638 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 147' ' ' VAL . 25.0 Cg_endo -61.07 -19.34 62.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.379 2.053 . . . . 0.0 112.215 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -91.52 -5.49 54.07 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.234 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.462 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 83.3 m-20 -98.92 -16.12 18.91 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.241 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 144' ' ' PRO . 28.3 m -60.0 -33.17 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 121.18 0.514 . . . . 0.0 109.736 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -38.25 63.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.454 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.8 m -68.73 -40.35 79.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.3 0.571 . . . . 0.0 110.797 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.671 HD11 ' CG2' ' A' ' 99' ' ' THR . 31.2 mm -64.43 -41.27 91.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.494 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.31 98.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.314 0.578 . . . . 0.0 109.965 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.42 -40.21 89.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.745 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.06 -37.47 78.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.765 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.424 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -62.53 -32.94 73.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.382 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -61.72 -19.93 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.102 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -92.86 6.59 47.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.998 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.484 HG21 HG13 ' A' ' 90' ' ' VAL . 17.3 mm -88.14 120.98 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 41.91 -97.06 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.464 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -159.95 52.16 0.36 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.1 m -46.7 163.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-O 120.723 0.297 . . . . 0.0 110.362 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.4 t -83.93 -50.36 8.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.165 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -169.48 148.76 3.84 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.706 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.41 HG12 HG13 ' A' ' 62' ' ' VAL . 22.4 m -120.22 148.56 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.253 0.549 . . . . 0.0 110.484 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -142.01 148.82 39.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.652 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.46 135.48 51.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.451 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.766 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.101 0.476 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.84 137.48 53.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.983 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.41 123.8 72.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.856 0.36 . . . . 0.0 110.47 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 90.1 t -108.52 116.13 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.24 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -85.35 134.58 34.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 137' ' ' TYR . 71.6 mt -98.61 147.8 6.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.743 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.721 179.631 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 tptt . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.868 0.366 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.4 t -66.68 -40.28 85.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.782 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -66.71 -41.71 87.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.489 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -65.01 -40.56 95.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.385 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.6 m -68.24 -37.32 80.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.124 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.3 mt -79.14 -11.48 59.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.018 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -94.81 -32.87 13.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.866 0.365 . . . . 0.0 111.407 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -89.55 8.52 30.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.185 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 77.5 mmm -53.46 -20.16 4.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.841 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.35 -48.22 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.613 0.571 . . . . 0.0 110.74 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.454 ' HB ' HD11 ' A' ' 150' ' ' ILE . 3.9 m -88.17 17.76 4.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 0.0 110.83 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 139' ' ' VAL . 6.3 p -107.25 138.55 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.12 0.486 . . . . 0.0 111.262 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -95.54 -42.24 8.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.795 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.6 t -157.98 150.1 22.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.585 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 139' ' ' VAL . 58.2 t -131.58 128.84 61.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.736 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.401 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 99.3 m -125.42 132.47 52.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.546 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -86.9 118.77 26.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.006 0.431 . . . . 0.0 110.599 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.2 t -105.83 118.01 35.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.403 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.1 m -69.14 150.34 47.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.088 0.471 . . . . 0.0 110.601 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.6 pttt . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.787 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.796 0.331 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.59 140.39 51.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.11 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.57 151.14 49.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.197 0.523 . . . . 0.0 110.696 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.574 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.3 m-85 -120.08 110.48 16.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.159 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 51.6 mt -83.43 108.25 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 103' ' ' VAL . 69.4 t -113.28 137.19 47.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.17 0.509 . . . . 0.0 110.979 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -99.21 106.9 19.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.18 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.614 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -75.87 146.51 39.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.584 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 5.3 m120 -75.32 88.79 2.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.604 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 87.95 156.66 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 O-C-N 123.945 0.778 . . . . 0.0 110.716 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.689 ' O ' HG22 ' A' ' 147' ' ' VAL . 36.6 Cg_exo -59.74 -24.84 77.2 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.584 2.189 . . . . 0.0 112.468 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -78.35 -13.62 59.77 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.513 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 142' ' ' ASN . 82.5 m-20 -97.73 -17.08 19.61 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 120.651 0.262 . . . . 0.0 111.309 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 144' ' ' PRO . 4.6 m -61.17 -32.97 54.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -75.83 -34.24 60.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.62 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.7 m -70.98 -40.03 72.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.42 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.454 HD11 ' HB ' ' A' ' 99' ' ' THR . 33.4 mm -65.69 -41.1 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.297 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.23 95.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.321 0.581 . . . . 0.0 110.166 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -66.85 -40.48 87.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.719 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.47 -32.77 66.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.265 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.04 69.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.771 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.569 ' HA ' HG11 ' A' ' 160' ' ' VAL . 68.0 mttm -62.2 -18.05 59.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.323 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.64 8.27 45.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.73 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 17.6 mm -84.59 117.87 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.682 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 38.49 -115.31 0.15 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.09 0.869 . . . . 0.0 111.519 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -120.7 40.57 2.12 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 155' ' ' LYS . 11.5 p -42.96 146.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.0 p -92.74 -47.44 7.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.222 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -165.39 154.12 11.91 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.819 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.02 140.96 47.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.774 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -143.28 137.36 28.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -90.2 179.11 5.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.713 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.661 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.808 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.915 0.388 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -138.23 141.19 38.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.388 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.6 t -116.19 125.04 73.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.489 HG21 ' HB1' ' A' ' 154' ' ' ALA . 61.0 t -109.16 116.63 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.182 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -84.35 138.65 32.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.561 HD11 ' CE1' ' A' ' 137' ' ' TYR . 1.5 mt -102.11 153.28 5.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.122 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 . . . . . 0 C--O 1.236 0.382 0 CA-C-O 121.728 0.775 . . . . 0.0 110.831 179.469 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 tttp . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.153 0.502 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.8 -37.52 69.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.441 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -64.48 -43.54 93.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.914 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.34 -37.62 74.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.422 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -64.92 -42.13 94.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.4 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.1 mt -69.32 -39.77 78.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.834 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -68.82 -24.3 64.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.076 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -90.56 4.53 50.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.477 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.8 mmt -59.83 -23.37 63.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.653 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.32 -62.22 0.45 Allowed 'General case' 0 C--N 1.349 0.585 0 O-C-N 123.466 0.479 . . . . 0.0 111.196 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.575 ' HB ' HD11 ' A' ' 150' ' ' ILE . 53.7 m -59.39 -17.25 28.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.114 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.3 m -86.38 149.89 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.773 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -90.83 -42.36 10.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.916 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.5 p -157.57 156.47 32.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.528 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 139' ' ' VAL . 59.7 t -134.84 129.89 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.913 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.2 m -125.76 131.76 52.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.003 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -87.03 116.26 24.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.064 0.459 . . . . 0.0 110.379 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.4 t -104.74 119.89 40.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.607 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.3 t -62.41 160.4 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.028 0.442 . . . . 0.0 110.207 -179.853 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.796 0.332 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.87 154.26 22.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.46 151.28 41.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.871 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.561 ' CE1' HD11 ' A' ' 64' ' ' ILE . 4.7 m-85 -123.06 112.19 17.47 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.209 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.3 mt -86.85 111.24 21.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 103' ' ' VAL . 78.4 t -114.8 138.27 45.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.366 0.603 . . . . 0.0 110.82 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -104.85 108.31 19.74 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.25 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -66.58 145.95 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -57.45 -39.3 76.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.796 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -137.39 161.33 61.39 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.813 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.522 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.0 Cg_exo -59.64 -19.94 55.45 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.848 2.365 . . . . 0.0 112.062 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -95.16 -4.79 45.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.641 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -97.61 -22.11 16.68 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 120.762 0.315 . . . . 0.0 110.574 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.568 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 6.6 p -57.8 -35.07 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.004 0.43 . . . . 0.0 109.961 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -71.88 -34.99 69.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.813 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 59.7 m -73.25 -38.75 65.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.98 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.575 HD11 ' HB ' ' A' ' 99' ' ' THR . 33.4 mm -69.06 -40.46 80.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.37 95.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.635 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 149' ' ' THR . 1.0 OUTLIER -76.87 -24.46 52.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.129 -179.581 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -85.1 -34.85 22.12 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.253 0.549 . . . . 0.0 110.547 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.489 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -69.49 -30.02 67.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -67.84 -12.18 60.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 110.998 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -105.65 9.12 33.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.078 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.501 HG22 ' HG2' ' A' ' 158' ' ' GLU . 7.0 mm -53.78 -78.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.77 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.501 ' HG2' HG22 ' A' ' 157' ' ' ILE . 81.5 mm-40 -145.44 -80.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.135 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.04 62.11 0.52 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.72 156.66 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 110.28 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.4 t -109.81 -42.77 4.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.322 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -166.63 153.62 9.14 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.614 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.75 135.5 60.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.5 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -137.8 133.56 34.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -78.23 178.43 7.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.833 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.829 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 . . . . . 0 N--CA 1.448 -0.531 0 CA-C-O 121.091 0.472 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.4 ' CG2' HG23 ' A' ' 147' ' ' VAL . 95.5 t -125.42 133.43 69.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.646 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.513 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 78.9 t -115.5 122.46 69.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.47 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.1 t -106.74 108.71 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.108 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 136' ' ' ALA . 82.4 m-85 -81.18 145.61 30.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.998 0.427 . . . . 0.0 110.026 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.726 HD11 ' CE1' ' A' ' 137' ' ' TYR . 78.3 mt -111.82 157.75 12.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.853 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ARG . . . . . 0.458 ' N ' HG22 ' A' ' 64' ' ' ILE . 28.1 mmt85 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.569 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.02 -38.99 79.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.121 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -61.01 -41.79 97.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.418 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -36.81 73.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.41 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.6 m -67.05 -41.98 85.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.351 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.9 mt -71.71 -39.55 70.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.975 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -66.85 -31.56 72.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.274 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -82.56 5.23 21.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.402 ' HE3' ' HB2' ' A' ' 153' ' ' ASP . 3.1 mmt -55.81 -24.63 37.31 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.865 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 76.47 -56.18 0.57 Allowed 'General case' 0 C--N 1.343 0.322 0 O-C-N 123.365 0.416 . . . . 0.0 110.469 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 99' ' ' THR . 92.6 m -71.07 -10.95 60.64 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.454 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.28 137.93 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 120.891 0.377 . . . . 0.0 110.96 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -86.34 -43.22 13.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.494 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.4 t -156.35 151.24 26.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.434 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.576 HG22 HG12 ' A' ' 139' ' ' VAL . 95.7 t -130.25 128.79 64.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.983 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.6 m -119.02 130.42 55.64 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 110.578 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -90.76 113.67 25.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.077 0.465 . . . . 0.0 110.66 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.7 t -94.02 107.54 19.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.058 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.1 t -57.72 142.42 45.34 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.319 0.58 . . . . 0.0 110.862 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.015 -179.742 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.649 0.261 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.86 149.62 24.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.68 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.513 ' HB1' ' CG1' ' A' ' 61' ' ' VAL . . . -131.4 141.62 49.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.726 ' CE1' HD11 ' A' ' 64' ' ' ILE . 13.7 m-85 -99.04 115.71 29.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.816 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.7 mt -93.88 111.38 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 150' ' ' ILE . 4.7 m -115.49 150.83 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.054 0.454 . . . . 0.0 110.312 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -108.74 107.7 18.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.42 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.83 139.11 58.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -58.32 -39.15 78.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -134.95 162.14 59.49 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-O 121.16 0.505 . . . . 0.0 110.711 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 29.2 Cg_endo -63.42 -15.08 46.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.76 2.307 . . . . 0.0 111.385 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.73 -5.21 31.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.711 0.291 . . . . 0.0 110.301 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -92.38 -25.81 18.34 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 120.706 0.289 . . . . 0.0 110.731 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.427 ' H ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -49.65 -35.22 9.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.816 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -33.03 60.66 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.685 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.401 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 84.3 m -72.1 -39.87 68.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.406 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.665 HG21 HG21 ' A' ' 139' ' ' VAL . 40.1 mm -69.88 -40.51 78.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.513 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.91 -41.76 86.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 149' ' ' THR . 25.1 pt-20 -73.59 -33.85 64.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.558 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.402 ' HB2' ' HE3' ' A' ' 97' ' ' MET . 95.7 m-20 -71.65 -35.76 70.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.559 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.07 73.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.345 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -61.13 -20.46 62.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -3.67 58.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.62 120.4 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.472 0.653 . . . . 0.0 110.477 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -58.28 147.48 30.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.646 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 91.58 -9.49 76.97 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 160' ' ' VAL . 10.9 p -66.5 129.73 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 120.988 0.423 . . . . 0.0 110.266 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 62.1 p -100.65 -42.77 6.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.467 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -167.81 145.61 4.46 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.16 133.92 67.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.441 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -139.62 136.81 34.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.391 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -88.82 179.7 6.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.8 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.765 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.601 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 120.921 0.391 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.565 HG13 ' HB ' ' A' ' 139' ' ' VAL . 0.9 OUTLIER -128.06 139.73 51.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.86 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.604 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 63.7 t -117.25 122.97 71.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.829 0.347 . . . . 0.0 110.742 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 91.3 t -103.58 115.67 45.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.118 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -79.7 132.02 36.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.996 0.426 . . . . 0.0 110.121 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.843 HD11 ' CD1' ' A' ' 137' ' ' TYR . 64.4 mt -109.82 135.16 49.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.883 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.807 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.869 0.366 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.03 -35.65 75.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.794 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -64.6 -40.17 95.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.898 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -67.94 -40.18 83.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.704 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.646 ' HB3' HD12 ' A' ' 157' ' ' ILE . 65.9 m -67.03 -40.24 87.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.476 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.419 ' O ' HG11 ' A' ' 100' ' ' VAL . 75.6 mt -70.96 -37.71 72.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -65.99 -30.5 71.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.268 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -87.23 4.25 43.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.3 mmt -56.49 -23.61 40.53 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.81 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.79 -47.45 0.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.335 0.397 . . . . 0.0 110.38 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' HD11 ' A' ' 150' ' ' ILE . 16.9 m -88.53 18.77 4.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.278 0.561 . . . . 0.0 110.676 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 139' ' ' VAL . 3.3 p -104.04 141.37 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.152 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -101.06 -40.87 7.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.228 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.5 t -160.27 148.84 16.92 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.453 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 139' ' ' VAL . 58.9 t -127.24 126.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.548 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.577 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 99.9 m -117.68 126.03 51.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.18 0.514 . . . . 0.0 110.571 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 43.4 t80 -92.59 119.16 31.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.677 ' O ' ' O ' ' A' ' 135' ' ' ASP . 7.4 t -110.94 87.68 2.6 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.07 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 106' ' ' SER . 30.9 t -39.72 139.52 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.942 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.8 pttt . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.931 -178.597 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 . . . . . 0 C--O 1.225 -0.22 0 CA-C-O 120.949 0.404 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.677 ' O ' ' O ' ' A' ' 106' ' ' SER . 96.8 m-20 -58.31 -30.3 66.57 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.868 0.842 . . . . 0.0 110.856 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.604 ' HB1' ' CG1' ' A' ' 61' ' ' VAL . . . 51.98 125.6 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.629 0.728 . . . . 0.0 111.392 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.843 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -112.65 103.65 11.7 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.628 -0.67 . . . . 0.0 109.588 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 1.4 mp -79.27 108.58 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.828 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 100' ' ' VAL . 99.6 t -111.18 135.49 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.407 0.622 . . . . 0.0 111.313 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -96.34 106.36 18.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.327 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 146' ' ' ASP . . . -69.68 147.2 50.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.647 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -52.34 -35.33 50.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.222 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -148.75 164.03 23.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.744 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.497 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.2 Cg_exo -57.73 -29.4 85.57 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.936 2.424 . . . . 0.0 112.071 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -83.64 -3.82 58.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.71 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.494 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 83.8 m-20 -98.73 -10.69 22.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 144' ' ' PRO . 8.6 m -62.44 -29.03 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.461 ' HG3' HG23 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -80.32 -34.16 36.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.02 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 97.5 m -72.34 -40.0 67.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.172 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.57 HD11 ' HB ' ' A' ' 99' ' ' THR . 28.9 mm -66.71 -40.86 87.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.287 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.609 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.24 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.16 -39.11 82.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.708 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -72.3 -34.98 68.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.624 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.07 82.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.43 -17.88 60.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.861 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -93.9 8.07 42.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 93' ' ' SER . 18.2 mm -92.32 119.94 40.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 44.58 -98.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.683 0.615 . . . . 0.0 111.025 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -159.16 48.77 0.41 Allowed Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.3 m -50.5 143.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.355 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.0 t -61.8 -48.38 80.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.942 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -174.39 154.56 2.15 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.552 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.609 HG11 ' HA ' ' A' ' 151' ' ' ALA . 45.1 t -115.96 131.94 66.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.47 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -127.7 127.14 43.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -78.1 174.18 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.575 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.7 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.832 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.366 0.603 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.21 137.04 58.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.989 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.402 HG13 ' HB1' ' A' ' 136' ' ' ALA . 95.7 t -116.82 122.98 71.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.569 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.451 ' CG1' HG23 ' A' ' 160' ' ' VAL . 58.5 t -109.98 117.12 53.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -83.91 139.02 32.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.022 0.439 . . . . 0.0 110.282 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.692 HD11 ' CE1' ' A' ' 137' ' ' TYR . 32.8 mt -100.78 148.64 6.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.472 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? . . . . . 0 C--N 1.332 -0.184 0 CA-C-O 121.336 0.589 . . . . 0.0 111.017 179.947 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.964 0.411 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.17 -36.76 78.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -62.09 -40.99 97.7 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.089 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -68.56 -39.88 80.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.52 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.6 t -66.99 -42.01 85.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.441 0.639 . . . . 0.0 110.316 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.402 HD23 ' HE2' ' A' ' 97' ' ' MET . 78.1 mt -73.51 -39.57 64.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.261 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -68.47 -39.56 81.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.572 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -92.77 6.35 47.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.427 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.402 ' HE2' HD23 ' A' ' 94' ' ' LEU . 2.4 ttm -61.62 -17.46 55.35 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.739 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.53 157.38 0.19 Allowed 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 123.879 0.737 . . . . 0.0 109.457 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 99' ' ' THR . 22.0 m 70.5 5.31 5.32 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.895 0.747 . . . . 0.0 110.896 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 100' ' ' VAL . 32.7 m -112.79 124.86 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.163 0.506 . . . . 0.0 110.488 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -66.82 -44.21 81.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.159 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.8 p -163.28 162.37 25.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.303 0.573 . . . . 0.0 110.355 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 139' ' ' VAL . 42.5 t -132.7 129.19 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.69 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 98.3 m -119.65 128.93 54.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 0.0 110.072 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -87.31 120.69 28.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.295 0.569 . . . . 0.0 110.634 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.4 t -105.3 116.94 32.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.452 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.5 t -65.43 146.95 54.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.758 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.283 -179.754 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.807 0.337 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.412 ' CB ' HD12 ' A' ' 64' ' ' ILE . 98.0 m-20 -60.89 147.33 43.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.47 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -130.92 145.22 51.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.692 ' CE1' HD11 ' A' ' 64' ' ' ILE . 3.5 m-85 -115.59 114.07 24.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.127 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 49.8 mt -89.01 106.53 16.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 103' ' ' VAL . 71.8 t -110.74 136.91 45.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.97 0.414 . . . . 0.0 110.751 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -98.72 106.87 19.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.696 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -74.83 150.83 39.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.855 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.589 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 34.0 t-20 -80.91 91.23 5.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.849 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 92.76 149.74 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 O-C-N 124.564 1.165 . . . . 0.0 110.47 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.615 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.7 Cg_exo -60.15 -19.84 58.68 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.862 2.375 . . . . 0.0 112.58 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -86.72 -5.34 59.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.63 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -101.19 -17.85 16.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.784 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 144' ' ' PRO . 18.9 m -58.94 -33.51 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.091 0.472 . . . . 0.0 109.756 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -38.36 65.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.15 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.3 m -68.76 -39.18 80.38 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.524 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.43 -40.3 86.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.403 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.66 -40.43 95.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.472 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.52 -39.39 85.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.723 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -73.3 -35.02 66.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.622 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 157' ' ' ILE . . . -63.52 -34.86 78.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.517 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.525 ' HA ' HG11 ' A' ' 160' ' ' VAL . 68.3 mttm -64.82 -15.14 61.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.023 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -101.39 8.74 42.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 154' ' ' ALA . 8.6 mm -59.45 -69.6 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.18 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 171.87 -77.6 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 123.73 0.643 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -93.23 31.03 6.6 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' A' ' 155' ' ' LYS . 14.4 p -82.43 131.84 32.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.0 t -96.34 -53.97 3.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.929 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -152.93 153.77 33.67 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.62 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 98.3 t -122.78 134.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -118.52 115.57 24.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.472 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.32 114.06 21.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.956 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.545 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.737 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.448 HH11 HG23 ' A' ' 138' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.317 0 CA-C-O 121.307 0.575 . . . . 0.0 111.17 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.9 t -148.52 147.3 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.403 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.544 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 59.2 t -121.7 126.01 74.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.208 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.65 115.35 49.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 CA-C-O 120.946 0.403 . . . . 0.0 110.041 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -85.67 141.13 29.98 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.286 0.565 . . . . 0.0 109.92 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.742 HD11 ' CD1' ' A' ' 137' ' ' TYR . 80.7 mt -115.45 144.7 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.931 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 CA--C 1.516 -0.35 0 CA-C-O 118.824 -0.608 . . . . 0.0 109.374 179.476 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.494 HG12 HD12 ' A' ' 94' ' ' LEU . 86.3 t -69.77 -39.29 77.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.032 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.55 -43.96 97.52 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.181 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.98 -40.87 97.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.599 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -67.98 -41.69 81.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.256 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.494 HD12 HG12 ' A' ' 90' ' ' VAL . 73.3 mt -70.73 -25.69 63.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.654 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -28.7 25.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.042 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -103.51 3.71 35.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.339 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.8 ptm -60.75 -17.21 47.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.953 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.31 152.03 0.13 Allowed 'General case' 0 C--N 1.341 0.231 0 O-C-N 123.869 0.731 . . . . 0.0 109.542 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.1 m 73.59 5.91 4.97 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.841 0.713 . . . . 0.0 110.7 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -108.05 133.1 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-O 121.201 0.524 . . . . 0.0 110.795 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -85.87 -51.75 6.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.975 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -149.04 155.02 40.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.606 HG22 HG12 ' A' ' 139' ' ' VAL . 98.3 t -133.56 128.7 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.237 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.8 m -124.98 132.38 53.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.584 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -90.92 116.98 29.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 109.978 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.7 t -108.11 128.25 54.52 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.087 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 82.9 p -66.02 159.49 25.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.126 0.489 . . . . 0.0 110.86 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.287 -179.515 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 121.059 0.457 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.01 147.96 52.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.589 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.544 ' HB1' ' CG1' ' A' ' 61' ' ' VAL . . . -130.01 146.5 51.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.702 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.742 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -113.34 108.98 17.97 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.846 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.448 HG23 HH11 ' A' ' 59' ' ' ARG . 40.2 mt -86.5 111.32 21.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.652 HG21 HG21 ' A' ' 150' ' ' ILE . 6.4 m -119.4 149.8 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-O 121.115 0.483 . . . . 0.0 109.904 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -105.76 107.52 18.55 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.909 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.09 149.3 43.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.53 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 47.7 t-20 -79.61 87.86 5.15 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.95 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 95.96 153.36 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 125.104 1.502 . . . . 0.0 109.662 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.608 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.4 Cg_endo -63.76 -15.45 48.95 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.135 1.89 . . . . 0.0 112.206 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -88.33 -10.21 50.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.304 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -96.16 -15.48 22.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.338 0.113 . . . . 0.0 111.012 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 144' ' ' PRO . 34.3 m -56.92 -31.96 37.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.47 62.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.246 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.7 m -69.95 -40.15 75.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.194 0.521 . . . . 0.0 110.357 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ILE . . . . . 0.652 HG21 HG21 ' A' ' 139' ' ' VAL . 21.5 mm -66.07 -41.33 89.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.255 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.483 ' CB ' HG21 ' A' ' 163' ' ' VAL . . . -65.86 -40.89 92.09 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.521 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -67.13 -40.54 86.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.585 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -70.06 -39.97 75.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.426 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.99 74.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.734 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -62.13 -20.29 63.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.797 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -86.64 -2.77 58.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.7 mm -83.46 129.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 120.917 0.389 . . . . 0.0 110.119 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.54 140.03 58.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.163 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 91.48 -6.99 80.52 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 160' ' ' VAL . 14.2 p -66.26 131.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 117.295 0.548 . . . . 0.0 110.131 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.7 t -105.62 -48.75 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.475 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -161.66 147.49 13.74 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.725 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.483 HG21 ' CB ' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -131.06 141.71 45.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.196 0.522 . . . . 0.0 111.207 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -138.49 135.88 35.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.55 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -90.28 156.32 18.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.909 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.586 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.774 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -129.39 134.42 63.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.812 0.339 . . . . 0.0 110.424 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.36 122.58 68.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.93 116.42 52.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -86.98 137.54 32.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.794 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.669 HD11 ' CE1' ' A' ' 137' ' ' TYR . 24.6 mt -105.37 146.53 12.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.495 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.823 179.191 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 120.829 0.347 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.7 t -66.82 -36.47 77.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.418 0.628 . . . . 0.0 109.401 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -65.61 -41.05 93.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.431 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -63.55 -40.77 97.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.523 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.0 p -65.66 -36.28 83.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.509 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.423 ' O ' HG21 ' A' ' 103' ' ' VAL . 73.9 mt -80.34 -16.85 53.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.712 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -33.28 14.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.912 0.386 . . . . 0.0 111.567 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -93.91 6.55 48.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.866 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -19.43 2.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.439 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 80.04 -50.64 0.36 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 123.322 0.389 . . . . 0.0 110.935 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 99' ' ' THR . 14.2 m -83.81 22.46 1.12 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.936 0.398 . . . . 0.0 111.348 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.7 m -118.99 150.23 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.082 0.467 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -106.5 -32.77 7.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.492 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.0 t -164.2 148.53 9.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.682 HG22 HG22 ' A' ' 139' ' ' VAL . 98.2 t -132.61 128.13 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.386 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.7 m -120.89 124.38 44.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.92 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -85.07 115.6 22.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.949 0.404 . . . . 0.0 109.933 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.4 t -101.28 113.12 25.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.587 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 85.7 p -66.86 160.87 25.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.88 0.372 . . . . 0.0 110.491 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.9 pttt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.305 -179.62 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.226 -0.169 0 CA-C-O 120.83 0.347 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.92 143.76 57.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.775 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.93 148.11 51.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.132 0.491 . . . . 0.0 110.309 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.669 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.1 m-85 -121.24 111.87 17.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.418 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.61 109.96 21.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.682 HG22 HG22 ' A' ' 103' ' ' VAL . 98.4 t -115.68 139.73 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.94 0.4 . . . . 0.0 111.008 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -100.3 105.7 17.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.805 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.91 151.61 38.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.571 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 53.6 t-20 -78.52 89.83 4.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.142 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 93.44 152.18 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.265 0 O-C-N 124.613 1.196 . . . . 0.0 110.176 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.67 ' O ' HG22 ' A' ' 147' ' ' VAL . 33.2 Cg_exo -60.59 -19.95 62.41 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.43 2.087 . . . . 0.0 112.356 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -86.01 -6.9 58.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.512 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -101.19 -15.66 17.27 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.959 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 144' ' ' PRO . 24.3 m -57.96 -35.28 51.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.135 0.493 . . . . 0.0 110.073 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -74.66 -32.61 62.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.995 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.2 m -71.46 -39.52 70.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.551 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 36.8 mm -65.04 -41.35 91.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.4 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.13 98.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.232 0.539 . . . . 0.0 110.282 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.9 -38.46 79.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -69.77 -37.45 76.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.608 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.14 80.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.607 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -62.85 -18.05 62.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.709 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -101.67 7.46 42.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.357 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.9 mt -79.23 -64.78 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.749 0.309 . . . . 0.0 111.46 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -143.07 -89.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.934 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -141.11 78.5 0.29 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.511 HG11 HG13 ' A' ' 163' ' ' VAL . 89.2 t -81.39 109.32 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.12 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.2 p -65.19 -39.9 93.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -150.76 155.96 40.31 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.511 HG13 HG11 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -140.67 123.72 16.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.994 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.43 127.92 49.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.656 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.99 102.92 12.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.453 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.877 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.702 0.287 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.46 126.33 75.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.3 t -114.02 119.96 62.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.205 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 59.4 t -108.95 113.53 44.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -86.18 134.17 33.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.665 HD11 ' CD1' ' A' ' 137' ' ' TYR . 93.9 mt -110.16 140.82 27.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.751 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.199 179.914 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.436 ' HG3' ' H ' ' A' ' 90' ' ' VAL . 14.4 ptmt . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.043 0.449 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.436 ' H ' ' HG3' ' A' ' 89' ' ' LYS . 99.1 t -71.48 -37.77 65.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.489 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.413 ' CE2' ' HG3' ' A' ' 95' ' ' LYS . 37.0 t80 -64.95 -40.01 94.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.869 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -66.04 -41.25 91.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.432 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.5 m -66.79 -42.2 86.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.336 0.588 . . . . 0.0 110.217 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.527 ' O ' HG11 ' A' ' 100' ' ' VAL . 98.5 mt -69.36 -22.68 63.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.457 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 91' ' ' TYR . 27.4 mmtt -86.79 -31.31 20.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.934 0.397 . . . . 0.0 111.525 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -88.89 -5.14 58.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.999 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.3 ttm -50.71 -19.88 1.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 78.57 -49.45 0.46 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.671 0.388 . . . . 0.0 111.127 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 99' ' ' THR . 17.6 m -82.18 12.22 4.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.951 0.405 . . . . 0.0 111.214 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.527 HG11 ' O ' ' A' ' 94' ' ' LEU . 3.5 p -97.7 141.43 15.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.349 0.595 . . . . 0.0 111.294 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -103.92 -40.02 6.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.579 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.3 t -161.18 148.26 15.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.523 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 139' ' ' VAL . 65.9 t -127.77 126.23 66.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.131 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 85.1 m -116.28 131.17 57.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.103 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 39.1 t80 -89.02 124.69 34.52 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' SER . . . . . 0.726 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -113.81 90.42 3.34 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.316 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.1 t -47.8 142.49 4.73 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 120.874 0.369 . . . . 0.0 110.766 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.655 -179.311 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ASP . . . . . 0.565 ' O ' ' O ' ' A' ' 136' ' ' ALA . 89.9 m-20 -55.09 -23.34 20.03 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.181 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ALA . . . . . 0.726 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . 42.02 124.67 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.699 0 O-C-N 124.795 1.309 . . . . 0.0 112.357 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.665 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -120.27 106.94 12.39 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.66 -0.65 . . . . 0.0 109.7 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 32.0 mt -86.89 108.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 103' ' ' VAL . 77.4 t -105.8 139.06 28.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.991 0.424 . . . . 0.0 110.666 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -103.05 110.61 22.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.057 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 146' ' ' ASP . . . -68.28 148.69 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.171 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -57.69 -40.09 78.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.04 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.45 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -132.52 158.18 76.35 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.884 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.45 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 33.2 Cg_endo -63.09 -12.17 28.57 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.721 2.281 . . . . 0.0 112.043 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -99.5 -3.97 32.33 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.975 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 96.6 m-20 -96.68 -15.69 21.33 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 122.513 0.325 . . . . 0.0 111.11 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.446 ' H ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -52.56 -34.76 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -71.88 -34.71 69.41 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.746 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 64.9 m -73.56 -38.76 65.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.572 0.701 . . . . 0.0 110.557 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.04 -41.64 87.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.452 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.94 -39.56 93.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -70.75 -30.12 66.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.476 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -74.87 -38.68 61.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.756 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.09 -26.28 64.84 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.906 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -62.63 -23.06 66.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -105.83 7.21 32.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.603 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.2 132.9 30.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.707 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 33.69 -129.43 0.06 Allowed 'General case' 0 CA--C 1.543 0.703 0 O-C-N 124.218 0.949 . . . . 0.0 111.463 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.14 41.6 2.17 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.3 p -43.13 135.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 110.77 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 41.1 t -77.11 -45.96 25.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.977 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -168.39 148.44 4.65 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.035 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.1 t -120.41 128.88 76.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.143 0.497 . . . . 0.0 110.698 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -116.27 119.23 35.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.38 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.64 155.64 16.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.918 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.689 0.28 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -122.22 49.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.544 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -83.97 111.63 19.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.32 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.39 134.76 65.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.5 t -122.08 126.69 74.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.816 0.341 . . . . 0.0 110.827 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 94.2 t -109.05 115.3 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -84.79 135.75 33.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.446 0.641 . . . . 0.0 110.047 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.813 ' CG2' HG11 ' A' ' 68' ' ' VAL . 1.2 mt -107.51 157.89 7.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.327 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 66' ' ' LYS . 3.3 mpt_? -40.87 154.66 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 123.632 0.583 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 65' ' ' ARG . 46.7 mmtt -30.94 -88.91 0.0 OUTLIER 'General case' 0 C--N 1.342 0.28 0 O-C-N 124.286 0.991 . . . . 0.0 111.552 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.91 53.24 0.7 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.785 0.326 . . . . 0.0 110.568 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.813 HG11 ' CG2' ' A' ' 64' ' ' ILE . 6.7 p -60.32 -26.56 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.657 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.551 ' HB2' HD12 ' A' ' 75' ' ' ILE . 12.5 mt-10 56.93 34.85 25.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.103 0.478 . . . . 0.0 110.649 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.58 ' H ' HG13 ' A' ' 68' ' ' VAL . 2.8 t70 -54.71 -45.12 74.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.721 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -101.72 41.35 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.642 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -126.86 -126.16 0.23 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.804 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 179.62 139.7 0.12 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 57.89 109.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.059 0.457 . . . . 0.0 110.847 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 69' ' ' GLU . 10.8 mm -106.52 134.52 47.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.794 0.331 . . . . 0.0 110.456 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -83.95 100.28 10.93 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.285 0.564 . . . . 0.0 110.267 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -163.29 145.92 10.16 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.694 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 67.48 -76.46 0.05 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 123.893 0.746 . . . . 0.0 110.901 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.47 84.02 0.3 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 60.73 -158.57 0.33 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.472 0.177 . . . . 0.0 110.758 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.0 p -79.67 131.55 35.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.145 0.498 . . . . 0.0 110.478 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.8 p -127.92 135.15 63.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.335 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -40.73 130.6 2.48 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.425 0.453 . . . . 0.0 111.003 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -84.26 111.48 19.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.715 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -71.79 -4.61 28.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.472 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.93 17.8 21.28 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.781 0.324 . . . . 0.0 110.397 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.4 ' HD2' ' N ' ' A' ' 88' ' ' HIS . 0.8 OUTLIER -60.87 115.17 3.49 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.74 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.4 ' N ' ' HD2' ' A' ' 87' ' ' TYR . 22.0 m-70 58.72 16.86 4.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.54 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -69.64 -43.67 72.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.973 0.416 . . . . 0.0 110.586 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.458 HG23 ' OD1' ' A' ' 70' ' ' ASP . 93.6 t -70.41 -38.57 74.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.908 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.78 -44.17 96.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.216 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.47 -39.75 92.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.528 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.3 p -67.84 -36.35 80.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.398 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.92 -17.82 54.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.99 -35.76 20.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.063 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -87.32 6.93 31.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.574 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.5 mtt -50.98 -20.18 1.27 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 77.95 -53.63 0.51 Allowed 'General case' 0 C--N 1.345 0.373 0 O-C-N 123.86 0.725 . . . . 0.0 110.323 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 99' ' ' THR . 28.4 m -85.12 13.48 6.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.312 0.577 . . . . 0.0 110.576 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.52 HG23 HG13 ' A' ' 139' ' ' VAL . 4.5 p -98.41 147.71 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.985 0.422 . . . . 0.0 110.732 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -102.75 -42.88 5.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.348 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.6 t -159.9 146.61 16.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.59 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 139' ' ' VAL . 54.8 t -128.79 126.31 64.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.7 m -124.37 128.78 49.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 110.439 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -86.7 116.89 25.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.086 0.469 . . . . 0.0 110.705 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 t -105.67 114.0 27.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.95 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.6 p -64.59 162.08 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.097 0.475 . . . . 0.0 110.799 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -65.12 -37.71 88.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.759 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 81.9 mm-40 -64.64 -39.55 93.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.464 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.23 -32.9 65.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.429 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -37.7 85.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.541 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.676 ' O ' HG23 ' A' ' 116' ' ' THR . 0.1 OUTLIER -66.43 -41.89 88.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.286 0.565 . . . . 0.0 109.779 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.98 -38.91 83.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.349 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 118' ' ' ILE . 5.0 mmmt -67.96 -39.15 83.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.194 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 118' ' ' ILE . 1.0 OUTLIER -66.04 -38.97 89.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.986 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 112' ' ' TYR . 68.4 p -73.77 -28.73 61.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.284 0.564 . . . . 0.0 110.558 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -72.42 -35.62 68.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.805 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.538 HD11 HD13 ' A' ' 115' ' ' LEU . 50.5 pt -85.05 -26.6 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.671 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.1 tpp -111.58 -66.02 1.12 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.762 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 142.85 -165.19 26.96 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -98.29 24.04 7.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.003 0.43 . . . . 0.0 110.899 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -128.18 33.73 4.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.701 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -125.16 -19.93 5.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.429 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.53 152.27 30.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.419 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.4 tt -168.55 39.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 122.044 0.926 . . . . 0.0 110.535 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -76.27 -62.99 1.43 Allowed 'General case' 0 C--N 1.313 -1.011 0 O-C-N 121.581 -0.699 . . . . 0.0 110.671 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 174.48 179.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.795 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.13 128.79 42.63 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 55.74 31.47 17.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.843 0.354 . . . . 0.0 110.393 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.64 152.97 37.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -128.01 67.99 75.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.768 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.86 -26.92 15.12 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.961 2.441 . . . . 0.0 111.778 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 80.3 mt -110.75 154.04 24.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.388 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 -163.33 1.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.92 144.28 53.37 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.332 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.22 144.87 50.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.07 0.462 . . . . 0.0 110.684 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.558 ' CD1' HD11 ' A' ' 64' ' ' ILE . 1.6 m-85 -118.81 106.34 12.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.36 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -80.24 110.77 16.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.099 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 103' ' ' VAL . 90.3 t -114.55 134.12 58.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.263 0.554 . . . . 0.0 110.821 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -100.79 107.48 19.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.656 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.64 147.2 52.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -58.11 -39.47 78.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.725 0.298 . . . . 0.0 110.291 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.531 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -137.06 160.22 66.9 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.452 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.531 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 23.2 Cg_endo -60.78 -24.13 78.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.787 2.325 . . . . 0.0 112.118 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -88.12 -6.17 58.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.486 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -93.41 -19.28 21.45 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 120.631 0.253 . . . . 0.0 110.353 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 144' ' ' PRO . 8.0 m -57.22 -29.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.254 0.549 . . . . 0.0 109.548 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.11 -37.88 57.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.974 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 95.9 m -72.02 -36.42 69.7 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 121.567 0.699 . . . . 0.0 110.055 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.2 mm -68.2 -39.8 81.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.364 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.421 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -67.93 -39.25 83.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.374 0.607 . . . . 0.0 111.318 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 149' ' ' THR . 1.3 pp20? -71.23 -26.01 62.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.635 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.54 -38.58 23.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.397 0.617 . . . . 0.0 109.774 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.547 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -70.96 -22.56 62.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.63 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.584 ' C ' HG11 ' A' ' 160' ' ' VAL . 5.5 mtpm? -65.74 -17.16 64.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.46 7.12 22.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 154' ' ' ALA . 39.9 mt -87.21 127.78 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.664 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 36.01 -129.12 0.12 Allowed 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.421 1.075 . . . . 0.0 111.043 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -107.13 67.49 0.23 Allowed Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.584 HG11 ' C ' ' A' ' 155' ' ' LYS . 3.7 p -74.36 107.42 4.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.055 0.455 . . . . 0.0 110.122 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 t -61.13 -44.62 97.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.788 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -169.46 159.32 8.47 Favored 'General case' 0 C--O 1.202 -1.441 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.846 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 151' ' ' ALA . 68.2 t -128.71 133.4 66.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 120.719 0.295 . . . . 0.0 110.263 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -119.88 124.27 45.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.921 0.391 . . . . 0.0 110.74 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -90.11 115.81 27.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.736 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.824 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 CA--C 1.523 -0.074 0 CA-C-O 120.791 0.329 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HA ' HG11 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -177.89 170.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.998 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.413 ' N ' HG13 ' A' ' 58' ' ' VAL . 5.0 ttm180 71.28 141.44 0.05 Allowed 'General case' 0 C--O 1.227 -0.099 0 O-C-N 123.611 0.569 . . . . 0.0 111.135 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.1 t -144.41 144.88 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.237 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.618 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 57.4 t -120.71 127.4 75.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.807 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 63.2 t -108.82 117.07 53.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -83.97 138.78 32.95 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.765 0.793 . . . . 0.0 110.54 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.746 HD11 ' CE1' ' A' ' 137' ' ' TYR . 61.6 mt -106.31 161.24 5.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.704 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.499 ' N ' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -42.49 161.04 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.661 0.601 . . . . 0.0 110.454 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.6 -50.56 1.61 Allowed 'General case' 0 C--N 1.332 -0.175 0 O-C-N 123.619 0.574 . . . . 0.0 111.29 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -168.04 91.46 0.32 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.438 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.16 7.67 6.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.833 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 62.83 146.32 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.069 0.461 . . . . 0.0 110.228 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.596 ' OD2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -157.92 -74.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.114 -179.546 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.73 -15.06 62.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -63.66 -120.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 O-C-N 123.249 0.343 . . . . 0.0 110.614 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 176.82 -29.97 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.1 p -136.19 158.68 43.84 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.586 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.9 mt -115.47 133.86 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -95.05 122.99 38.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.266 0.555 . . . . 0.0 110.944 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -132.77 119.89 20.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.402 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 48.11 41.39 15.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.655 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.69 25.99 72.63 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.73 115.38 21.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.013 0.435 . . . . 0.0 110.589 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.61 117.73 23.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.144 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.6 t -123.86 132.22 71.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.193 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 t -49.15 141.02 8.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.019 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -96.09 114.62 26.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -65.0 -29.09 69.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.885 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -91.73 18.12 8.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.79 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -59.53 125.61 24.33 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.078 0.466 . . . . 0.0 110.685 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.11 18.05 3.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.811 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -71.64 -45.07 63.15 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.774 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.405 HG13 HG21 ' A' ' 157' ' ' ILE . 95.1 t -69.75 -39.27 77.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.881 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -64.82 -41.16 95.98 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.553 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -66.91 -39.57 87.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.339 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.6 m -65.55 -42.12 92.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.172 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.02 -39.27 66.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.015 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -37.67 84.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.018 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -95.56 6.47 48.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.683 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.2 ttm -63.31 -19.26 64.45 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.612 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 t 72.47 160.71 0.23 Allowed 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 99' ' ' THR . 14.3 m 72.21 2.16 4.21 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 124.111 0.882 . . . . 0.0 110.925 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.636 HG13 HD12 ' A' ' 150' ' ' ILE . 5.3 m -112.23 139.49 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 110.543 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -40.71 28.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.537 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 85.4 p -164.81 162.0 20.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 139' ' ' VAL . 96.0 t -133.59 131.81 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.146 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.1 m -125.76 136.74 53.49 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 121.012 0.434 . . . . 0.0 110.973 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -87.37 124.67 33.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.188 0.518 . . . . 0.0 110.137 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.732 ' OG ' ' HB3' ' A' ' 136' ' ' ALA . 18.7 p -116.75 108.98 16.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.953 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.6 m -61.38 165.65 4.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.445 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -62.65 -36.41 82.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.995 0.426 . . . . 0.0 110.143 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -68.68 -41.15 79.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.179 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -70.49 -38.28 74.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.32 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.458 ' NE2' ' HB2' ' A' ' 136' ' ' ALA . 10.9 tt0 -65.54 -40.62 93.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.383 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -62.74 -42.43 99.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.344 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.7 -38.44 90.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.211 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.48 ' O ' HG23 ' A' ' 118' ' ' ILE . 13.2 mmtp -70.48 -38.31 74.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.626 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.82 HD13 HD11 ' A' ' 118' ' ' ILE . 2.3 mm? -69.52 -39.18 77.69 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.201 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.9 t -73.21 -30.74 63.73 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.365 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.66 -38.71 77.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.791 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.82 HD11 HD13 ' A' ' 115' ' ' LEU . 48.5 pt -78.36 -28.89 14.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.19 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.26 -72.76 0.59 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.496 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.92 -172.52 45.54 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -74.95 119.23 18.85 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.501 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.7 t30 50.57 52.02 15.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.743 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -67.51 -26.59 66.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.818 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.89 -177.88 3.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.703 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.6 mm -112.34 128.56 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.52 48.26 1.15 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.859 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -93.38 123.74 36.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.89 -38.38 3.36 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 56.0 p-10 -166.07 165.96 17.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 110.526 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -93.94 -3.03 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.7 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -125.64 79.19 68.05 Favored Pre-proline 0 N--CA 1.455 -0.188 0 CA-C-O 120.729 0.299 . . . . 0.0 110.209 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.73 158.63 57.02 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.976 2.451 . . . . 0.0 111.704 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 38.6 mt 63.9 174.16 0.18 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.394 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.96 -161.95 1.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.354 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.75 143.59 57.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.224 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.732 ' HB3' ' OG ' ' A' ' 106' ' ' SER . . . -134.01 137.68 44.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.007 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.746 ' CE1' HD11 ' A' ' 64' ' ' ILE . 4.6 m-85 -101.99 113.33 26.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.5 mt -88.7 109.9 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 150' ' ' ILE . 4.4 m -116.14 148.39 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.175 0.512 . . . . 0.0 109.815 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -105.84 107.12 17.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.217 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.514 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -62.42 141.4 58.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.824 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -52.89 -26.52 15.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.296 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -161.38 165.77 16.13 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-O 121.262 0.553 . . . . 0.0 110.75 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.644 ' O ' HG22 ' A' ' 147' ' ' VAL . 43.1 Cg_exo -56.69 -30.33 83.52 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.747 2.298 . . . . 0.0 111.715 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -84.09 -7.49 59.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -96.99 -20.06 18.33 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.617 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 144' ' ' PRO . 13.0 m -56.12 -31.12 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.233 0.539 . . . . 0.0 110.034 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.491 ' HG3' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -78.34 -33.93 48.83 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.045 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.8 m -71.1 -39.51 72.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.335 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.636 HD12 HG13 ' A' ' 100' ' ' VAL . 46.3 mm -67.72 -40.39 83.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.392 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.464 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -63.87 -41.55 97.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.366 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.5 -38.91 81.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.821 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.18 -35.99 74.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.533 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.8 81.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.503 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.598 ' HA ' HG11 ' A' ' 160' ' ' VAL . 96.0 mttt -65.25 -17.08 64.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.091 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -98.69 7.77 45.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.99 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 158' ' ' GLU . 12.0 mm -65.02 -86.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.435 ' N ' HG22 ' A' ' 157' ' ' ILE . 4.5 mt-10 -165.37 -79.03 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.808 0.337 . . . . 0.0 110.549 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -93.78 34.66 4.52 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 155' ' ' LYS . 7.4 p -76.79 94.68 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.476 0.655 . . . . 0.0 110.723 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.0 t -63.95 -45.41 89.31 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.27 165.13 37.62 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.914 0.387 . . . . 0.0 110.375 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.465 HG21 ' HG3' ' A' ' 155' ' ' LYS . 21.7 t -142.14 138.26 30.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.788 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -140.31 138.16 34.72 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.644 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -80.61 178.39 8.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.897 0.38 . . . . 0.0 110.686 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.619 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.42 ' O ' HG12 ' A' ' 58' ' ' VAL . 1.1 m-20 . . . . . 0 CA--C 1.523 -0.078 0 N-CA-C 110.889 -0.041 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.4 OUTLIER 73.44 -3.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 123.612 0.57 . . . . 0.0 111.29 -179.284 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -91.15 132.32 36.14 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.373 0.606 . . . . 0.0 111.034 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.34 140.36 48.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.453 HG13 ' HB1' ' A' ' 136' ' ' ALA . 75.1 t -120.25 126.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.534 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 49.7 t -111.04 124.76 68.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.184 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -91.9 136.23 33.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.13 0.49 . . . . 0.0 110.114 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.619 HD11 ' CD1' ' A' ' 137' ' ' TYR . 96.6 mt -110.15 143.94 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.528 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -58.02 157.39 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.404 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.07 -32.06 25.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.22 -22.11 65.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.735 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.8 p -102.67 146.81 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.834 0.35 . . . . 0.0 110.804 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -56.14 178.08 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.532 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.13 85.62 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.944 0.402 . . . . 0.0 110.51 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 51.66 43.75 29.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.609 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -128.19 118.88 24.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.694 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -72.2 -13.47 61.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.765 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.1 t -147.28 147.96 30.93 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.886 0.374 . . . . 0.0 110.252 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.54 150.19 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.506 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.47 ' HG2' HG22 ' A' ' 81' ' ' THR . 45.9 mt-10 -102.38 127.96 49.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.452 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -144.64 131.55 20.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.439 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 54.64 32.25 16.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.509 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.13 24.25 77.24 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -127.33 131.19 50.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.506 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.47 HG22 ' HG2' ' A' ' 76' ' ' GLU . 1.2 p -91.35 121.63 33.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.315 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.72 151.3 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.044 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -66.96 152.87 44.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.409 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -92.37 -166.72 1.6 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.454 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -138.61 152.99 48.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.62 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 96.4 m-20 47.74 41.86 14.63 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.775 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -46.31 147.64 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.337 0.398 . . . . 0.0 110.617 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 64.7 83.83 0.16 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.95 0.405 . . . . 0.0 110.812 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -123.38 -66.7 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.779 -179.199 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 94' ' ' LEU . 90.2 t -64.79 -35.77 75.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -64.92 -41.33 95.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.434 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.54 -39.59 77.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.647 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.4 p -68.01 -40.18 83.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.879 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 90' ' ' VAL . 97.7 mt -74.6 -39.91 61.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.019 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -37.69 75.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.666 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -95.89 6.74 48.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.059 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.525 ' HB3' HG23 ' A' ' 100' ' ' VAL . 9.1 ttm -56.79 -17.27 8.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 119.258 -0.401 . . . . 0.0 111.031 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 97' ' ' MET . 0.9 OUTLIER 84.79 -61.35 0.08 Allowed 'General case' 0 C--N 1.353 0.738 0 O-C-N 123.952 0.783 . . . . 0.0 110.762 -179.552 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 99' ' ' THR . 31.9 m -68.13 -7.41 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.029 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 97' ' ' MET . 94.0 t -96.52 118.84 43.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.883 0.373 . . . . 0.0 110.788 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -69.76 -43.58 71.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.81 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -155.4 159.04 39.57 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.323 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.589 HG22 HG12 ' A' ' 139' ' ' VAL . 89.6 t -133.52 129.88 56.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.601 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.413 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 89.4 m -123.13 124.13 42.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -86.81 113.71 22.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.025 0.44 . . . . 0.0 110.542 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.2 t -100.4 105.47 16.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.78 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.2 p -65.11 163.6 14.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.936 0.398 . . . . 0.0 110.098 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -32.58 73.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.14 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -67.57 -40.81 84.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.091 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -70.01 -39.64 75.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.46 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.527 ' HG2' HD13 ' A' ' 133' ' ' LEU . 16.5 tt0 -67.31 -37.7 83.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.686 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.605 ' O ' HG23 ' A' ' 116' ' ' THR . 22.5 t80 -62.73 -40.79 98.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.768 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -65.91 -39.17 90.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.352 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -66.51 -38.02 86.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.541 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.46 HD22 HD11 ' A' ' 133' ' ' LEU . 1.1 mp -66.77 -37.47 84.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.714 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 112' ' ' TYR . 75.7 p -69.71 -30.99 68.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.657 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.74 -38.72 73.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.832 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.0 pt -80.12 -33.16 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.556 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.66 -13.64 27.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.72 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.21 -167.32 54.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -86.89 70.3 10.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.735 0.303 . . . . 0.0 110.445 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -174.25 58.69 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.352 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -174.16 -18.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.19 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -44.64 120.46 2.28 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.034 0.445 . . . . 0.0 110.752 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.7 tp -138.79 140.3 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.23 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -103.63 -34.09 8.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.691 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 48.95 46.02 22.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.905 0.383 . . . . 0.0 110.757 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.72 -106.96 0.57 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -109.39 -64.95 1.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.871 0.367 . . . . 0.0 110.652 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -170.7 -179.36 2.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.518 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 57.05 62.37 5.92 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 121.294 0.569 . . . . 0.0 111.218 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.75 -21.93 8.08 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.501 2.134 . . . . 0.0 112.132 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 111' ' ' GLN . 86.9 mt -96.19 167.08 11.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.877 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -107.94 156.72 18.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.951 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -58.36 140.75 53.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.939 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.453 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -123.67 143.3 50.34 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.522 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.619 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -117.06 108.22 15.47 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 38.1 mt -89.06 110.59 21.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 103' ' ' VAL . 14.9 m -119.4 150.49 21.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.134 0.493 . . . . 0.0 110.09 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -102.86 106.89 17.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.167 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.72 144.95 47.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.612 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 4.9 m-80 -69.32 83.57 0.38 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.765 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 90.52 157.43 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 O-C-N 124.281 0.988 . . . . 0.0 110.56 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.658 ' O ' HG22 ' A' ' 147' ' ' VAL . 35.6 Cg_exo -59.89 -24.26 75.48 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.842 2.361 . . . . 0.0 112.582 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -80.1 -10.07 59.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.263 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -97.59 -19.96 17.98 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 120.586 0.231 . . . . 0.0 111.127 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 144' ' ' PRO . 11.0 m -53.63 -31.83 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -76.47 -32.93 58.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.853 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 87.0 m -72.95 -37.88 66.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.516 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.579 HG21 HG21 ' A' ' 139' ' ' VAL . 50.8 mm -71.25 -40.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.319 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.28 -40.36 81.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 149' ' ' THR . 2.3 pp20? -75.12 -31.25 61.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.73 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -78.14 -37.27 46.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.386 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -66.16 -36.12 82.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.968 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -62.55 -15.58 51.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.757 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -96.85 5.94 49.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.089 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 154' ' ' ALA . 84.6 mt -93.06 129.86 42.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.675 0.274 . . . . 0.0 110.614 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 44.05 -121.03 0.76 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.251 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.56 54.76 0.76 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -45.14 146.42 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.5 p -97.02 -35.37 10.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.422 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -170.07 158.91 7.28 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.412 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.05 143.69 39.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.673 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -140.29 132.19 27.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.522 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.66 124.96 48.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.581 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.575 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.584 0.23 . . . . 0.0 111.207 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.423 ' O ' ' CB ' ' A' ' 59' ' ' ARG . 85.8 t -53.63 103.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 58' ' ' VAL . 7.0 tpt180 155.86 111.04 0.0 OUTLIER 'General case' 0 C--N 1.349 0.574 0 O-C-N 125.156 1.535 . . . . 0.0 110.69 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -129.44 137.43 56.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.39 126.04 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 0.0 110.654 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 90.5 t -110.33 118.97 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.386 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -86.17 133.54 33.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.165 0.507 . . . . 0.0 109.715 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.596 HD11 ' CE1' ' A' ' 137' ' ' TYR . 2.6 mt -100.62 149.75 5.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.916 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -52.83 150.08 5.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.706 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -60.27 -28.24 67.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.753 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -92.92 11.0 28.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.713 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 64' ' ' ILE . 55.2 t -132.54 126.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.88 0.371 . . . . 0.0 110.035 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 71' ' ' ASN . 97.9 mt-10 -120.73 -22.69 6.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 90' ' ' VAL . 4.5 t70 61.43 -78.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 O-C-N 123.883 0.74 . . . . 0.0 111.157 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 69' ' ' GLU . 49.7 t-20 -76.12 61.99 1.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.0 p -140.33 -141.18 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.236 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.81 -31.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t -156.66 151.3 25.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.721 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.2 pt -127.41 157.43 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.183 0.516 . . . . 0.0 109.908 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.77 118.07 24.22 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.615 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -133.09 131.27 40.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.719 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 47.15 28.49 0.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.7 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -50.1 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -71.81 175.74 5.51 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.509 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.3 p -116.1 129.06 56.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.133 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.3 m -118.82 141.47 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.281 0.562 . . . . 0.0 110.242 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.6 m -60.69 132.15 52.96 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.99 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -80.37 160.04 25.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.676 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 -104.04 171.47 7.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.445 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 54.06 47.09 24.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.555 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -67.67 123.29 20.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.58 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 m170 57.57 20.32 6.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.172 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -76.96 -48.0 19.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.146 0.498 . . . . 0.0 110.831 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.58 HG12 HD12 ' A' ' 94' ' ' LEU . 78.0 t -67.12 -38.44 81.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.796 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -63.39 -43.77 96.6 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.04 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.65 -40.13 96.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.652 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.3 t -70.25 -39.52 74.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.239 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.58 HD12 HG12 ' A' ' 90' ' ' VAL . 79.4 mt -76.42 -20.77 56.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.049 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.59 -33.15 16.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -89.68 7.27 37.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -17.63 6.77 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.155 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 77.12 -68.35 0.18 Allowed 'General case' 0 C--N 1.35 0.591 0 O-C-N 123.39 0.431 . . . . 0.0 110.776 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.7 m -58.02 -19.26 29.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.037 0.446 . . . . 0.0 110.531 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.41 133.72 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.137 0.494 . . . . 0.0 110.798 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -82.13 -43.27 18.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.178 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.2 p -160.01 159.27 31.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.237 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.503 HG22 HG12 ' A' ' 139' ' ' VAL . 91.1 t -132.83 128.72 57.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.141 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.0 m -121.07 125.24 46.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.842 0.353 . . . . 0.0 110.243 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -85.66 115.66 23.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.832 0.349 . . . . 0.0 110.112 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.4 t -105.05 108.66 20.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.258 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -59.85 159.95 8.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.431 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -62.76 -35.42 79.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.438 . . . . 0.0 110.058 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -70.64 -39.72 73.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.131 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.19 -39.63 75.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.249 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -67.37 -39.1 85.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.345 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.723 ' O ' HG23 ' A' ' 116' ' ' THR . 68.9 t80 -64.33 -38.96 92.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.922 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.47 -38.59 90.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.162 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.94 -37.94 85.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.219 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -34.63 74.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.668 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 112' ' ' TYR . 78.1 p -70.48 -33.01 70.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -69.74 -40.04 76.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.722 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 119' ' ' MET . 36.4 pt -76.61 -36.8 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.981 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.417 ' N ' HG13 ' A' ' 118' ' ' ILE . 33.1 mmt -67.74 -39.62 84.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.061 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 144.85 -122.04 1.67 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -130.3 116.34 18.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 0.0 110.569 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 61.0 t30 53.2 42.45 32.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.393 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.58 ' HE1' HG22 ' A' ' 116' ' ' THR . 28.2 p-90 -60.06 -29.3 68.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.045 0.45 . . . . 0.0 110.248 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.92 164.31 25.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.371 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.0 tt -143.2 14.71 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.631 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.61 -4.79 58.94 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.1 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 75.11 -8.95 1.46 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 123.741 0.65 . . . . 0.0 110.832 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.79 -164.97 19.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 56.87 35.54 26.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.806 0.336 . . . . 0.0 110.579 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -130.53 -44.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.451 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 48.24 67.84 4.1 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.727 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.55 -23.41 74.81 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.882 2.388 . . . . 0.0 112.315 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 69.8 mt -107.98 169.14 8.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.52 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.58 -158.52 0.86 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.549 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.77 144.7 56.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.087 0.47 . . . . 0.0 110.132 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.67 145.73 50.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.605 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.2 m-85 -117.53 106.97 13.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.763 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.5 mt -92.07 111.13 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 150' ' ' ILE . 6.3 m -116.45 150.21 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.204 0.525 . . . . 0.0 110.133 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -107.55 107.86 18.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.1 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 146' ' ' ASP . . . -63.28 142.21 58.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.614 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -54.59 -34.61 62.25 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.941 0.4 . . . . 0.0 110.119 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -141.74 159.27 60.45 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 121.124 0.488 . . . . 0.0 110.859 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.596 ' O ' HG22 ' A' ' 147' ' ' VAL . 35.9 Cg_exo -56.79 -26.39 66.15 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.652 2.235 . . . . 0.0 111.911 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -88.06 -7.57 56.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.759 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.501 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 91.5 m-20 -92.28 -20.31 21.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.286 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 144' ' ' PRO . 20.0 m -55.98 -33.28 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.312 0.577 . . . . 0.0 109.652 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -33.33 57.61 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.534 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 95.6 m -71.73 -39.34 70.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.393 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.537 HG21 HG21 ' A' ' 139' ' ' VAL . 23.5 mm -67.85 -40.63 83.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.928 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.37 97.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.932 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.84 -38.95 87.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.584 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.95 -37.59 81.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.264 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.31 73.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.768 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -62.56 -23.12 66.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.262 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -92.02 -7.93 47.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.984 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.4 mm -55.65 -23.06 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.031 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 73.84 131.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.166 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.01 82.99 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.4 t -79.14 119.94 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 O-C-N 122.659 -0.318 . . . . 0.0 110.541 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.2 t -62.89 -48.02 80.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -168.5 152.64 5.88 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.407 HG22 HG13 ' A' ' 62' ' ' VAL . 99.2 t -121.15 135.41 61.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.804 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -124.9 126.25 45.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.783 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.6 115.7 27.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.386 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.656 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.689 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 . . . . . 0 C--O 1.231 0.106 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 73.86 -11.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.446 0.467 . . . . 0.0 111.737 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -97.21 126.77 42.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.982 0.42 . . . . 0.0 110.717 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -125.43 139.82 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.884 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.423 HG11 ' CZ ' ' A' ' 63' ' ' TYR . 89.9 t -120.19 124.28 72.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.939 0.399 . . . . 0.0 110.924 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 69.9 t -114.35 107.76 23.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.724 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.553 ' CE2' HD12 ' A' ' 133' ' ' LEU . 91.8 m-85 -82.22 146.19 29.64 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.056 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.754 HD11 ' CE1' ' A' ' 137' ' ' TYR . 34.2 mt -113.94 146.2 18.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.728 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.98 141.08 1.78 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.419 0.628 . . . . 0.0 111.32 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -71.69 -19.99 61.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.481 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -87.51 5.16 40.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.989 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.1 m -138.89 152.4 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.368 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -106.45 -174.78 2.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.545 ' OD2' HD13 ' A' ' 64' ' ' ILE . 2.0 m-20 -172.76 147.33 1.73 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.015 0.436 . . . . 0.0 110.153 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.28 24.53 2.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.471 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.7 m -135.81 -27.53 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.762 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 65.98 155.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.148 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 63.54 131.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.593 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.2 mt -125.47 137.02 59.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.645 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -86.32 114.98 23.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.261 0.553 . . . . 0.0 110.064 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -126.43 134.02 51.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.725 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 57.27 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.757 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -143.13 25.05 2.22 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -148.17 173.75 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.748 0.309 . . . . 0.0 110.34 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.8 p -114.81 133.86 55.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.384 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.2 m -121.62 147.82 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.217 0.532 . . . . 0.0 109.945 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.2 m -69.66 131.77 45.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.061 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -86.97 145.13 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.099 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.11 -14.3 24.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.909 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -110.75 42.73 1.54 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.639 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.51 ' CE2' ' CE1' ' A' ' 88' ' ' HIS . 50.0 t80 -58.2 -49.47 76.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.768 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.51 ' CE1' ' CE2' ' A' ' 87' ' ' TYR . 0.9 OUTLIER -125.81 56.94 1.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.005 0.431 . . . . 0.0 110.728 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -103.96 -53.68 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.086 0.47 . . . . 0.0 110.518 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.63 -35.38 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.249 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -67.8 -41.03 83.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.125 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.39 -40.44 95.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.438 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.6 m -66.04 -40.37 90.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.26 -13.89 59.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.696 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -95.74 -32.68 12.61 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.972 0.415 . . . . 0.0 111.531 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -91.59 4.77 51.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.923 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.5 mtt -52.16 -19.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.449 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t 77.15 -65.6 0.28 Allowed 'General case' 0 C--N 1.345 0.403 0 O-C-N 123.331 0.395 . . . . 0.0 110.078 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.7 m -62.81 -19.07 63.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.483 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.57 HG23 HG13 ' A' ' 139' ' ' VAL . 7.1 p -71.96 146.21 11.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.137 0.494 . . . . 0.0 111.496 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -98.57 -44.81 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.648 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -161.19 159.05 28.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.075 0.464 . . . . 0.0 110.472 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.694 HG22 HG22 ' A' ' 139' ' ' VAL . 53.9 t -134.83 129.29 51.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.602 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.439 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 96.3 m -122.18 132.95 54.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.223 0.535 . . . . 0.0 110.653 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -86.14 124.45 32.56 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.488 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -110.83 89.94 3.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.063 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -51.65 145.43 9.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.345 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -59.84 -35.49 74.86 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.538 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -68.46 -41.25 80.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.34 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -70.54 -39.28 74.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.724 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -66.73 -39.04 87.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.275 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.744 ' O ' HG23 ' A' ' 116' ' ' THR . 87.3 t80 -62.17 -42.91 99.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.763 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -62.92 -40.74 98.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -67.23 -39.05 86.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.862 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.46 ' CD1' HD21 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -66.62 -35.78 81.02 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.717 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 112' ' ' TYR . 81.7 p -70.45 -31.63 68.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.416 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.16 -38.99 79.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.395 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.411 HG13 ' HG2' ' A' ' 119' ' ' MET . 38.7 pt -85.86 -32.91 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.701 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.411 ' HG2' HG13 ' A' ' 118' ' ' ILE . 39.1 mmt -92.34 -6.24 50.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.614 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.73 174.99 45.75 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -94.61 16.31 15.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.795 0.331 . . . . 0.0 110.447 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -106.84 -22.17 12.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' HE1' HG22 ' A' ' 116' ' ' THR . 0.2 OUTLIER -81.31 156.83 25.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.51 -179.425 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -172.22 -70.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 125' ' ' ILE . 1.8 mp 44.96 32.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 121.276 0.56 . . . . 0.0 110.933 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -154.12 64.59 0.7 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.551 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -55.99 142.27 36.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.53 -139.72 15.6 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 97.7 m-20 -61.43 -37.68 84.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.538 0.209 . . . . 0.0 110.477 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 129' ' ' ASP . . . 69.39 77.04 0.22 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -128.76 72.22 81.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.432 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.41 -43.29 47.43 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.524 2.149 . . . . 0.0 112.574 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.553 HD12 ' CE2' ' A' ' 63' ' ' TYR . 1.5 mm? -106.68 165.62 11.17 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.085 0.469 . . . . 0.0 110.121 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -142.54 104.81 4.45 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.159 -177.748 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.61 ' CB ' HD12 ' A' ' 64' ' ' ILE . 66.9 m-20 72.73 -48.05 0.68 Allowed 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.138 0.899 . . . . 0.0 112.456 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . 41.44 124.32 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.695 0 O-C-N 124.36 1.037 . . . . 0.0 112.36 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.754 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -114.2 106.44 14.37 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.471 -0.768 . . . . 0.0 110.113 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 57.6 mt -84.25 108.1 16.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.694 HG22 HG22 ' A' ' 103' ' ' VAL . 79.8 t -108.95 137.4 41.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.076 0.465 . . . . 0.0 110.753 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -107.33 111.28 23.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.427 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.6 146.21 46.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.665 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.1 -34.04 54.91 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.225 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -141.44 160.02 58.52 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 120.755 0.312 . . . . 0.0 110.45 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 34.7 Cg_endo -64.47 -20.2 65.84 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.644 2.229 . . . . 0.0 112.197 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.86 -4.3 58.87 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -103.34 -8.62 20.12 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.722 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 148' ' ' LYS . 10.1 m -62.31 -27.49 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 109.757 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.43 ' HG3' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -81.63 -33.4 31.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.992 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 m -72.85 -39.08 66.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.415 0.626 . . . . 0.0 110.525 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 19.1 mm -69.68 -39.93 78.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.287 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.32 -40.53 97.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.576 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -72.1 -29.46 64.11 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.494 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -76.89 -35.87 57.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.561 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.67 -34.57 78.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.649 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.35 -14.11 46.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.81 -1.06 57.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.054 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -91.15 131.28 38.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.332 0.587 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -64.57 141.08 58.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.321 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 64' ' ' ILE . . . 95.87 -14.46 64.68 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.44 127.26 36.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.519 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -94.6 -49.88 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.849 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.88 142.92 24.01 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.85 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.08 132.39 67.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.784 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -136.05 148.6 48.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.221 0.534 . . . . 0.0 110.474 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 58.4 p-10 -87.05 -172.13 3.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.901 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.755 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.697 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.051 0.453 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.86 153.62 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.414 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 tpp85 158.45 115.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.608 1.193 . . . . 0.0 110.2 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.3 t -128.89 132.24 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.9 t -119.52 121.51 66.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.437 HG21 ' CB ' ' A' ' 154' ' ' ALA . 75.6 t -108.52 118.31 55.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.443 ' CE2' ' NE2' ' A' ' 111' ' ' GLN . 64.0 m-85 -86.13 132.27 34.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.525 HD11 ' CE1' ' A' ' 137' ' ' TYR . 4.4 mt -91.38 150.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.119 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -46.41 142.41 3.05 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.254 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -78.5 75.78 5.01 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.9 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.48 -10.14 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.068 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 68' ' ' VAL . 8.3 p -123.91 129.49 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.39 -24.51 24.19 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.444 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.0 -64.14 0.34 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.753 0.658 . . . . 0.0 111.241 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -68.82 -9.32 50.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.957 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.6 p -92.15 133.68 35.56 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.48 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -73.1 -17.94 61.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.997 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.1 t -148.76 158.95 44.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.941 0.4 . . . . 0.0 110.57 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.515 ' O ' HD12 ' A' ' 75' ' ' ILE . 2.8 pp -133.31 155.42 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.617 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -87.73 108.25 19.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.793 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 78' ' ' GLU . 6.8 mttp -143.01 148.11 36.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.3 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 77' ' ' LYS . 1.6 mt-10 -25.22 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.832 1.333 . . . . 0.0 110.909 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.4 24.29 1.79 Allowed Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 75.19 -160.33 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.699 0.285 . . . . 0.0 110.711 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.5 p -73.58 120.87 19.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.064 0.459 . . . . 0.0 109.794 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.49 133.12 67.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.84 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 83' ' ' THR . 9.4 t -47.07 126.83 9.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.118 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -64.18 -35.67 81.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.697 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 66.85 16.86 10.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.394 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -140.03 37.33 1.94 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.184 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.8 121.14 13.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.628 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 50.87 32.26 7.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.915 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -47.19 26.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.9 t -69.1 -38.32 77.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.701 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -62.0 -44.86 95.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.653 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.99 -39.69 95.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.38 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.8 p -67.15 -38.44 85.5 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.414 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.2 mt -69.27 -39.38 78.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.755 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -68.39 -36.37 79.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.558 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -99.76 7.97 44.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.763 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.506 ' CE ' HG23 ' A' ' 150' ' ' ILE . 4.1 ttm -62.25 -18.89 62.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.262 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 t 74.32 158.76 0.21 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 99' ' ' THR . 7.3 m 69.48 4.93 4.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.877 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.29 153.37 14.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 CA-C-O 120.953 0.406 . . . . 0.0 110.298 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -101.28 -37.19 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.786 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.6 t -162.39 152.19 16.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.953 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.655 HG22 HG22 ' A' ' 139' ' ' VAL . 60.6 t -130.97 128.95 63.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.492 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.9 m -123.91 129.37 50.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.635 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -87.35 119.0 27.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.137 0.494 . . . . 0.0 109.928 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.6 t -106.67 116.61 32.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.788 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -63.96 155.68 30.18 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -61.72 -34.35 75.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.45 . . . . 0.0 110.084 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.31 -39.35 82.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.078 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -73.97 -36.33 64.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.59 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.443 ' NE2' ' CE2' ' A' ' 63' ' ' TYR . 29.6 tt0 -64.37 -41.23 96.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.395 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.589 ' O ' HG23 ' A' ' 116' ' ' THR . 69.7 t80 -66.32 -41.49 89.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.276 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.32 -39.64 94.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.523 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -67.85 -37.68 82.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.678 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.25 -35.59 80.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 112' ' ' TYR . 74.9 p -70.81 -34.39 71.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.506 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -68.09 -40.1 82.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.06 0.457 . . . . 0.0 110.284 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 31.9 pt -80.85 -35.09 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.214 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.5 mmt -77.0 -53.93 7.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.115 0.483 . . . . 0.0 110.803 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.46 -168.39 26.49 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 56.07 18.07 2.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.684 0.278 . . . . 0.0 110.938 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 53.12 48.32 22.52 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.74 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.484 ' CG ' ' N ' ' A' ' 124' ' ' LYS . 1.0 OUTLIER -56.69 -165.83 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' CG ' ' A' ' 123' ' ' TRP . 6.5 ttmt -27.99 109.97 0.04 OUTLIER 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.12 0.485 . . . . 0.0 111.667 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.2 tt -67.37 173.82 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.401 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -46.99 -71.69 0.07 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.101 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.64 152.45 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.87 0.367 . . . . 0.0 110.412 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.45 -172.53 52.37 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.89 -50.69 71.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.249 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -132.56 -70.82 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.23 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -134.17 148.38 67.67 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.431 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.2 -23.58 11.76 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.997 2.465 . . . . 0.0 112.269 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 84.0 mt -99.0 168.09 10.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -121.85 -165.24 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.993 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -61.85 150.23 37.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.72 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.56 145.88 45.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.612 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.525 ' CE1' HD11 ' A' ' 64' ' ' ILE . 3.8 m-85 -117.39 114.58 23.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.7 mt -89.79 113.95 26.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.655 HG22 HG22 ' A' ' 103' ' ' VAL . 74.5 t -116.71 136.48 53.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.634 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -100.38 108.74 20.83 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.069 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 145.98 50.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.772 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -59.28 -41.09 88.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.278 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -132.16 159.57 71.6 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.577 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 147' ' ' VAL . 32.7 Cg_endo -63.42 -22.98 71.51 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.592 2.195 . . . . 0.0 112.223 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -89.53 -5.06 57.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.212 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.424 ' O ' HG12 ' A' ' 150' ' ' ILE . 96.7 m-20 -97.57 -16.37 20.09 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.35 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 144' ' ' PRO . 29.6 m -55.0 -34.03 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.549 0.69 . . . . 0.0 109.322 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -73.73 -33.26 64.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.933 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.5 m -71.14 -38.77 72.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.456 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.506 HG23 ' CE ' ' A' ' 97' ' ' MET . 43.7 mm -66.59 -40.92 87.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.962 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.583 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -63.28 -39.43 94.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.742 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.47 -33.69 71.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.62 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -71.45 -39.31 71.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.974 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -63.07 -35.08 79.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.277 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.402 ' HG3' HG21 ' A' ' 163' ' ' VAL . 6.1 mttp -61.88 -25.93 67.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.708 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -105.88 -4.62 20.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.565 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 154' ' ' ALA . 2.5 mt -60.66 -51.56 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.384 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.403 ' N ' HG22 ' A' ' 157' ' ' ILE . 67.5 mm-40 -151.76 -97.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.02 80.66 0.22 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.1 m -92.7 134.14 31.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.1 p -69.28 -34.38 74.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.161 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -172.41 163.9 5.63 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.645 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.583 HG11 ' HB1' ' A' ' 151' ' ' ALA . 47.8 t -133.97 138.17 50.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -130.07 133.12 46.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.16 135.25 41.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.995 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 179.853 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 119.601 -0.238 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.5 ' HA ' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER 43.4 -158.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 73.55 118.33 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.735 0.647 . . . . 0.0 110.93 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.5 t -126.65 140.23 49.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -119.58 124.86 73.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.12 0.486 . . . . 0.0 110.604 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG13 HG22 ' A' ' 163' ' ' VAL . 59.5 t -114.0 110.01 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -78.48 144.23 35.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.116 0.484 . . . . 0.0 110.316 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.725 HD11 ' CE1' ' A' ' 137' ' ' TYR . 49.3 mt -111.64 137.0 46.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.837 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -48.83 154.16 0.75 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.619 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -76.55 -27.05 55.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.846 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.5 -13.2 61.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.621 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.15 137.89 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 120.876 0.37 . . . . 0.0 110.484 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -115.27 90.35 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.02 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' CB ' HD13 ' A' ' 64' ' ' ILE . 3.5 t70 -70.11 163.48 26.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.211 0.529 . . . . 0.0 110.88 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 49.78 41.19 21.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.973 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.2 t -140.4 123.4 16.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.422 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.443 ' C ' HG23 ' A' ' 74' ' ' THR . 5.6 mm-40 -68.63 120.72 15.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.161 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.443 HG23 ' C ' ' A' ' 73' ' ' GLN . 1.4 p 60.36 154.03 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.466 0.479 . . . . 0.0 110.645 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 84' ' ' ASN . 33.6 pt -132.92 158.64 43.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.318 0.58 . . . . 0.0 110.505 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -89.37 109.98 20.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.985 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -130.84 130.71 43.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.869 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 66.83 23.13 10.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.678 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.81 8.34 87.59 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -126.28 161.69 27.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.526 0.203 . . . . 0.0 110.664 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.9 m -100.56 123.75 45.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.736 0.303 . . . . 0.0 110.481 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.61 154.68 40.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.24 0.543 . . . . 0.0 110.458 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 54.8 m -62.54 132.99 54.27 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.495 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.477 ' HB2' HG23 ' A' ' 75' ' ' ILE . 62.3 t30 -95.68 126.29 40.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.73 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -64.21 -25.24 67.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.618 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.41 66.89 0.64 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.631 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -58.63 -47.77 83.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.069 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.33 47.41 0.75 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.132 0.491 . . . . 0.0 110.731 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -65.38 -38.82 91.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.78 -39.37 84.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.177 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.1 -43.6 98.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.635 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.82 -39.01 90.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.504 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.2 m -66.59 -42.29 87.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.406 0.622 . . . . 0.0 110.52 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.0 mt -72.58 -33.8 67.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.704 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -80.89 -27.37 36.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.846 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -93.95 -3.58 51.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.117 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.79 -19.02 2.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.977 -0.535 . . . . 0.0 111.025 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.24 -54.51 0.43 Allowed 'General case' 0 C--N 1.346 0.431 0 O-C-N 123.992 0.808 . . . . 0.0 110.543 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 99' ' ' THR . 31.6 m -72.21 -5.17 33.88 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.767 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.666 HG13 HG13 ' A' ' 139' ' ' VAL . 24.8 t -91.0 123.97 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.948 0.404 . . . . 0.0 111.2 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.99 -43.53 64.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.868 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.0 t -161.74 157.54 24.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.109 0.48 . . . . 0.0 110.53 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.642 HG22 HG22 ' A' ' 139' ' ' VAL . 63.6 t -131.35 127.66 60.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.214 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.511 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 98.8 m -120.92 129.22 53.38 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 120.968 0.413 . . . . 0.0 110.027 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -90.97 109.68 20.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.167 0.508 . . . . 0.0 110.779 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.1 t -96.07 114.27 25.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.305 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.6 p -67.96 162.62 23.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.929 0.395 . . . . 0.0 110.534 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -62.5 -27.22 68.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.033 0.444 . . . . 0.0 109.98 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.97 -38.61 88.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.022 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.34 -40.84 85.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.883 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -64.83 -36.71 85.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.362 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.529 ' O ' HG23 ' A' ' 116' ' ' THR . 33.8 t80 -68.14 -37.46 81.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.77 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -61.11 -39.36 89.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.403 0.62 . . . . 0.0 110.134 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -67.54 -36.41 80.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.991 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.558 HD13 HD11 ' A' ' 118' ' ' ILE . 1.4 mm? -66.2 -37.7 86.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.828 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 112' ' ' TYR . 80.9 p -69.2 -34.34 74.73 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.387 0.43 . . . . 0.0 110.684 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.72 -38.71 87.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.226 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.558 HD11 HD13 ' A' ' 115' ' ' LEU . 40.3 pt -85.79 -25.39 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.797 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.6 mmt -87.66 71.62 9.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.459 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.04 -129.24 47.67 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -126.48 0.6 6.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.62 0.247 . . . . 0.0 110.719 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -168.99 131.25 1.25 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.342 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.448 ' CD1' HG22 ' A' ' 116' ' ' THR . 0.6 OUTLIER -169.5 145.94 3.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.292 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -148.09 138.21 22.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.988 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.6 tt -141.06 -5.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.01 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.431 ' O ' ' CG ' ' A' ' 126' ' ' PHE . 1.4 p90 -138.75 132.39 30.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.085 0.945 . . . . 0.0 110.073 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -134.99 38.2 3.0 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.719 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -167.09 -158.32 11.34 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.86 -38.26 84.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.557 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.19 135.25 57.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -149.48 128.65 6.25 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.446 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.37 -39.35 81.81 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.598 2.199 . . . . 0.0 112.152 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 73.1 mt -110.03 164.86 12.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.583 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.28 -165.1 1.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.29 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -65.92 141.1 58.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.54 144.75 50.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.465 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.725 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.4 m-85 -112.23 108.74 18.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.023 0.44 . . . . 0.0 110.551 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 59.6 mt -86.34 104.37 13.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.666 HG13 HG13 ' A' ' 100' ' ' VAL . 92.5 t -110.79 137.61 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.167 0.508 . . . . 0.0 111.074 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -101.36 105.53 16.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.112 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.41 144.81 51.42 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.833 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.642 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 14.0 t-20 -69.36 84.57 0.39 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.04 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 92.24 149.67 0.05 OUTLIER Pre-proline 0 N--CA 1.451 -0.396 0 O-C-N 124.301 1.001 . . . . 0.0 110.553 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 147' ' ' VAL . 34.4 Cg_exo -57.97 -21.25 48.85 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.629 2.22 . . . . 0.0 112.709 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -82.7 -6.31 59.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.244 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -104.36 -13.49 16.09 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.925 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 144' ' ' PRO . 10.4 m -58.89 -30.89 43.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -75.71 -33.24 60.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.721 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.1 m -72.56 -40.18 66.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.678 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.53 HD12 HG23 ' A' ' 100' ' ' VAL . 47.5 mm -68.57 -40.02 81.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.753 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.481 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -63.97 -39.68 94.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.682 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -70.16 -38.53 75.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.053 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.08 -36.92 72.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.42 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.805 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -65.62 -16.59 63.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.62 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -91.56 -1.43 57.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.47 134.76 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.038 0.447 . . . . 0.0 110.535 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.02 143.47 57.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.623 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 90.55 -10.09 75.62 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.48 137.09 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 120.88 0.371 . . . . 0.0 110.637 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t -108.36 -51.43 2.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -154.42 141.08 18.98 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.602 HG22 HG13 ' A' ' 62' ' ' VAL . 40.0 t -125.06 135.58 63.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.775 0.322 . . . . 0.0 110.793 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -138.29 144.81 40.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.988 0.423 . . . . 0.0 110.288 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -110.03 155.3 22.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.733 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.613 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.89 0.376 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.425 ' HA ' HG11 ' A' ' 147' ' ' VAL . 28.8 m -95.15 143.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 165.64 92.15 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.939 0.774 . . . . 0.0 111.239 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.38 127.06 68.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.3 t -115.36 118.76 59.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 96.7 t -105.91 119.18 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 110.424 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -88.1 129.1 35.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.57 HD11 ' CD1' ' A' ' 137' ' ' TYR . 1.9 mt -98.12 143.54 12.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.965 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -49.4 146.33 4.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.142 0.496 . . . . 0.0 110.985 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -60.26 -26.65 66.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.46 14.39 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' HB ' HG22 ' A' ' 64' ' ' ILE . 57.8 t -126.94 128.34 70.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.396 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -126.79 85.68 2.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.651 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -81.91 30.43 0.38 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.496 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -147.46 10.56 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.44 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.7 t -127.28 129.75 48.3 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.526 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.459 ' HG2' ' CE2' ' A' ' 87' ' ' TYR . 22.7 mt-30 -63.64 -37.98 89.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.118 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.7 p -136.2 151.49 49.77 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.514 -0.475 . . . . 0.0 110.163 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.47 150.76 30.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.069 0.462 . . . . 0.0 110.552 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.448 ' HG2' HG22 ' A' ' 81' ' ' THR . 99.4 mt-10 -87.95 112.59 22.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.358 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 78' ' ' GLU . 62.9 tttp -153.65 146.02 23.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.641 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 77' ' ' LYS . 0.6 OUTLIER -17.05 105.5 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.988 1.43 . . . . 0.0 110.996 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.34 24.08 4.58 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 73.61 -161.03 0.09 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-O 120.691 0.281 . . . . 0.0 110.592 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.448 HG22 ' HG2' ' A' ' 76' ' ' GLU . 60.4 p -76.19 127.47 32.98 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.144 0.497 . . . . 0.0 109.949 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 m -117.53 136.62 54.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.134 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.9 t -68.54 144.97 54.4 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.912 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -115.06 22.47 13.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.971 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 66.25 -143.91 0.18 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.44 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.436 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 98.6 m-20 -61.55 -10.86 8.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.824 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CE2' ' HG2' ' A' ' 73' ' ' GLN . 46.1 p90 41.63 25.78 0.04 OUTLIER 'General case' 0 C--N 1.35 0.596 0 CA-C-O 121.103 0.478 . . . . 0.0 110.956 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.27 27.87 2.1 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 121.83 -0.544 . . . . 0.0 110.692 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -63.5 -38.85 92.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.213 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.1 t -66.33 -38.59 82.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.099 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -61.46 -43.2 99.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.542 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -65.34 -40.37 93.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.235 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.7 m -66.03 -40.8 91.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.508 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -76.72 -21.1 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.946 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -89.92 -25.81 20.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.152 0.501 . . . . 0.0 111.253 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -94.02 9.54 37.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.281 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 67.8 mmm -56.84 -18.14 11.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.024 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 82.02 -49.52 0.22 Allowed 'General case' 0 C--N 1.349 0.557 0 O-C-N 123.531 0.519 . . . . 0.0 110.956 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.789 ' HB ' HD11 ' A' ' 150' ' ' ILE . 32.8 m -81.28 -13.97 57.89 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.757 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.463 HG22 ' CG1' ' A' ' 139' ' ' VAL . 37.8 t -82.78 141.96 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.915 0.388 . . . . 0.0 111.366 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -98.33 -43.51 6.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.042 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.6 t -153.74 149.81 27.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.093 0.473 . . . . 0.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 139' ' ' VAL . 55.4 t -131.11 129.93 63.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.973 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.1 m -122.66 127.43 49.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.233 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -83.96 120.59 26.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.918 0.39 . . . . 0.0 110.325 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 29.1 t -108.01 107.06 17.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.892 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.0 m -61.62 159.64 12.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.189 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -29.6 68.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.259 0.552 . . . . 0.0 110.147 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.36 -34.64 41.87 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.163 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -68.54 -41.38 79.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 0.0 110.649 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -73.22 -33.35 65.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.132 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -64.8 -41.68 95.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.157 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 116' ' ' THR . 53.5 tp10 -65.69 -38.57 89.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.208 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 118' ' ' ILE . 3.8 mmmt -70.37 -39.54 74.53 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.746 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.584 HD23 HD11 ' A' ' 118' ' ' ILE . 75.6 mt -67.16 -38.51 85.58 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.25 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 113' ' ' GLU . 8.9 t -73.44 -30.87 63.49 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.111 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -69.57 -38.84 77.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.584 HD11 HD23 ' A' ' 115' ' ' LEU . 46.7 pt -77.34 -27.05 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.918 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -51.51 6.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 110.801 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.57 -89.85 0.08 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.01 128.78 2.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 110.642 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 53.45 41.27 32.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.757 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.08 173.54 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.21 -167.85 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.58 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 7.8 tt -113.86 154.62 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -113.94 9.96 17.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.418 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -63.66 -29.77 70.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.757 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -74.03 67.26 1.76 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 54.09 36.3 24.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.749 0.309 . . . . 0.0 110.496 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 60.08 31.7 20.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.904 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -179.54 95.33 0.2 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.633 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.52 -23.65 57.29 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.395 2.063 . . . . 0.0 112.297 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 75.8 mt -101.07 -171.29 1.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.561 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.62 -160.34 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.345 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -68.51 150.16 48.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.482 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -128.96 150.0 50.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.347 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.57 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -125.98 110.86 14.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.3 mt -88.71 109.79 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 103' ' ' VAL . 35.0 t -109.82 137.68 40.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.265 0.555 . . . . 0.0 111.152 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -100.95 107.81 19.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.798 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.555 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -72.49 150.3 43.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.34 -40.98 79.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.891 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -136.97 159.99 67.92 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.676 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.537 ' O ' HG22 ' A' ' 147' ' ' VAL . 33.7 Cg_exo -59.04 -23.34 68.29 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.694 2.263 . . . . 0.0 112.168 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -91.32 -4.53 55.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.378 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -99.04 -12.71 20.32 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 141' ' ' ALA . 22.3 m -61.91 -32.66 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -74.25 -35.33 63.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.934 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.4 m -71.61 -40.04 70.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.487 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.789 HD11 ' HB ' ' A' ' 99' ' ' THR . 30.2 mm -67.43 -39.54 82.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.495 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.443 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -62.81 -39.97 95.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.968 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.52 -38.76 90.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.725 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -69.91 -37.27 75.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.656 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -61.09 -35.71 77.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.465 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.92 -16.94 61.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.728 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -97.61 6.25 48.3 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.993 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 154' ' ' ALA . 96.3 mt -98.41 129.01 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 40.48 -117.64 0.3 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.624 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.33 77.89 0.39 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 154' ' ' ALA . 43.3 t -78.47 122.09 32.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.9 p -68.17 -40.85 82.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.155 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -174.87 152.69 1.58 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.917 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.443 HG11 ' HB1' ' A' ' 151' ' ' ALA . 57.5 t -124.91 133.83 68.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.948 0.404 . . . . 0.0 110.784 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -122.54 129.86 52.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.845 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -104.35 128.56 52.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.655 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.693 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.902 0.382 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HA ' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -105.21 -156.99 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.227 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? 77.37 116.22 0.06 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.54 0.525 . . . . 0.0 111.102 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.5 140.12 49.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.862 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.6 t -117.46 115.35 48.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.337 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -99.1 109.51 24.44 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.608 ' CD2' ' HB2' ' A' ' 136' ' ' ALA . 58.3 m-85 -80.0 139.19 37.08 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.068 0.461 . . . . 0.0 110.848 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.692 HD12 ' OD2' ' A' ' 135' ' ' ASP . 72.2 mt -111.22 159.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.69 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.789 ' HB2' HG23 ' A' ' 68' ' ' VAL . 35.9 mmt180 -40.95 156.32 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.558 0.536 . . . . 0.0 110.541 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -35.57 -38.79 0.12 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.747 0.654 . . . . 0.0 111.719 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -165.44 95.56 0.65 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.117 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.789 HG23 ' HB2' ' A' ' 65' ' ' ARG . 1.4 t -98.48 -24.79 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.435 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.415 ' HG3' HG22 ' A' ' 75' ' ' ILE . 15.6 mm-40 64.72 37.64 7.4 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.349 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.79 -40.97 85.59 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.912 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -90.22 6.61 42.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.07 109.55 21.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.976 0.417 . . . . 0.0 110.405 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -32.21 67.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.988 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 47.5 p -137.47 161.31 36.71 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.324 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.415 HG22 ' HG3' ' A' ' 69' ' ' GLU . 45.6 pt -127.78 148.69 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.073 0.463 . . . . 0.0 110.215 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -100.67 130.33 46.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.254 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -152.01 136.89 17.17 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.764 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 51.39 34.82 12.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.6 27.21 73.97 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -135.4 143.54 46.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.683 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.1 p -103.64 123.27 46.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.099 0.476 . . . . 0.0 110.446 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 p -134.15 144.71 34.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.511 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.4 t -49.9 148.33 3.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.607 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -90.96 167.39 12.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.002 0.429 . . . . 0.0 110.586 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -106.31 143.02 35.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.233 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 58.08 46.86 15.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.957 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -64.71 129.17 38.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.946 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.5 m170 56.9 23.08 7.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.317 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -72.16 -44.25 63.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.47 . . . . 0.0 110.708 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.98 -40.66 81.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.345 0.593 . . . . 0.0 109.853 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -63.06 -44.81 94.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.501 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.36 -40.58 96.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.644 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.2 m -66.12 -38.64 88.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.253 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.65 -11.85 59.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.82 -39.53 16.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.812 0.339 . . . . 0.0 111.681 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -85.69 7.17 24.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -52.04 -19.8 2.08 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.295 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 77.02 -62.22 0.41 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.497 0.319 . . . . 0.0 110.759 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.735 ' HB ' HD11 ' A' ' 150' ' ' ILE . 91.2 m -65.48 -11.87 47.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.63 HG23 HG13 ' A' ' 139' ' ' VAL . 7.1 p -79.53 139.49 18.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.636 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -95.71 -43.47 7.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.289 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.3 p -158.55 154.24 26.32 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.389 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 139' ' ' VAL . 57.3 t -135.22 127.95 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.751 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.1 m -127.32 134.25 50.01 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.007 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -79.29 121.77 25.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.214 0.531 . . . . 0.0 109.901 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.7 t -115.64 122.99 47.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.151 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.3 t -67.98 163.15 22.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.37 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -64.91 -34.07 77.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.711 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.01 -39.21 93.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.82 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.29 -38.86 85.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.718 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.488 HE21 ' HE2' ' A' ' 63' ' ' TYR . 29.5 mt-30 -66.18 -38.51 88.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.693 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.771 ' O ' HG23 ' A' ' 116' ' ' THR . 33.7 t80 -64.55 -40.81 96.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.086 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.48 -39.74 88.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.285 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -66.73 -38.93 87.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.756 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.55 HD23 HD11 ' A' ' 118' ' ' ILE . 14.7 mt -64.81 -38.99 92.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.662 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 112' ' ' TYR . 59.6 p -67.27 -35.56 79.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.634 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.76 -39.49 84.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.887 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.55 HD11 HD23 ' A' ' 115' ' ' LEU . 41.4 pt -84.1 -27.24 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.475 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.4 mmt -89.86 -69.44 0.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.702 0.287 . . . . 0.0 110.874 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.09 169.15 40.86 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -61.08 120.21 9.84 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.976 0.417 . . . . 0.0 110.525 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.2 t30 50.43 42.17 25.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.877 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.74 ' HD1' HG22 ' A' ' 116' ' ' THR . 0.2 OUTLIER -64.53 169.93 4.43 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.487 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 54.45 -162.12 0.13 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.961 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.8 tp -141.43 143.56 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 120.967 0.413 . . . . 0.0 110.193 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -117.88 22.9 12.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.781 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.14 -41.33 92.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.371 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.96 134.97 13.21 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 59.11 162.65 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.087 0.47 . . . . 0.0 110.694 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.07 -42.45 98.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.77 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -158.6 135.27 6.58 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.353 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.66 -178.58 3.51 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.421 2.081 . . . . 0.0 112.099 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 61.19 166.67 0.09 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.464 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.429 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 0.0 OUTLIER -132.8 173.72 11.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.421 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.692 ' OD2' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -51.91 140.43 19.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.91 179.35 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.608 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . . . -142.48 151.36 41.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.729 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.545 ' CE1' HD11 ' A' ' 64' ' ' ILE . 14.1 m-85 -98.98 120.46 39.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.388 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 58.0 mt -82.6 100.23 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.63 HG13 HG23 ' A' ' 100' ' ' VAL . 73.6 t -101.41 131.14 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.597 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -99.5 107.78 20.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.989 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.419 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -66.98 146.28 54.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.439 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -57.87 -36.91 73.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.079 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -139.64 159.2 66.26 Favored Pre-proline 0 C--N 1.328 -0.326 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.859 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.584 ' O ' HG22 ' A' ' 147' ' ' VAL . 34.0 Cg_exo -57.91 -28.1 81.38 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.501 2.134 . . . . 0.0 112.033 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -86.16 -5.49 59.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.225 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -95.65 -14.67 23.28 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.399 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 144' ' ' PRO . 16.2 m -62.68 -32.52 55.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -75.56 -37.85 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.075 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.1 m -69.72 -40.59 76.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.17 0.51 . . . . 0.0 110.456 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.735 HD11 ' HB ' ' A' ' 99' ' ' THR . 31.6 mm -67.47 -39.58 82.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.464 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.59 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -63.55 -41.7 98.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.152 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.26 -39.59 82.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.859 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.14 -38.05 75.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.001 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.37 -27.85 67.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.663 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -61.76 -20.95 64.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.806 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.64 -8.96 57.0 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.694 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 14.1 mm -74.46 130.36 36.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.098 0.475 . . . . 0.0 110.818 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -65.91 138.76 58.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.273 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 94.9 -14.14 65.87 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.484 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.26 127.35 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 122.339 -0.507 . . . . 0.0 110.91 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.8 p -95.15 -32.48 13.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.015 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -170.84 160.39 6.78 Favored 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.186 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 151' ' ' ALA . 19.5 t -133.97 134.56 55.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.318 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -131.96 124.18 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.743 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -79.11 178.4 8.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 0.0 110.761 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.608 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.1 t30 . . . . . 0 C--O 1.227 -0.129 0 CA-C-O 120.926 0.393 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' HA ' HG11 ' A' ' 147' ' ' VAL . 16.7 m -122.69 -156.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER 82.28 114.21 0.06 Allowed 'General case' 0 C--N 1.346 0.453 0 O-C-N 124.177 0.923 . . . . 0.0 110.885 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.3 t -128.11 140.69 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.048 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 136' ' ' ALA . 91.9 t -120.12 126.54 75.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.9 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 65.1 t -114.33 112.21 39.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -79.52 139.17 37.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.21 0.529 . . . . 0.0 110.091 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.614 HD11 ' HD1' ' A' ' 137' ' ' TYR . 3.9 mm -96.86 156.78 3.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.041 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HA ' ' HB3' ' A' ' 161' ' ' SER . 13.7 mmt180 -50.45 175.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.433 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -45.9 -41.51 11.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.301 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -115.67 -117.64 0.32 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.438 ' O ' HG21 ' A' ' 64' ' ' ILE . 0.2 OUTLIER 41.81 48.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.515 0 CA-C-O 121.304 0.573 . . . . 0.0 110.664 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -53.81 -23.4 12.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.589 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.3 t70 67.16 -71.59 0.1 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.975 0.417 . . . . 0.0 111.267 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -63.47 -15.02 56.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.794 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.9 t -79.05 120.4 23.55 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.702 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -64.04 -36.7 84.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.595 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.2 p -135.13 148.04 49.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.459 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.7 pt -132.32 152.78 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 110.549 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -87.06 107.33 18.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.758 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -165.86 144.43 5.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.382 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 70.12 -72.02 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.89 0.744 . . . . 0.0 110.683 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.71 86.52 0.21 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 60.85 -157.07 0.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.555 0.217 . . . . 0.0 110.534 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 46.8 p -75.56 128.18 34.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.186 0.517 . . . . 0.0 110.216 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.64 146.35 31.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.136 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.3 p -55.93 136.86 51.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.595 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -80.99 129.65 34.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.597 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -68.15 -27.39 66.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.456 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -112.88 74.02 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -92.06 125.4 36.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.555 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 58.02 18.37 5.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.55 -43.27 73.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.123 0.487 . . . . 0.0 110.824 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.0 t -70.3 -39.72 77.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.017 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.519 ' HE1' HG13 ' A' ' 103' ' ' VAL . 81.5 t80 -63.12 -44.62 95.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.517 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.23 -39.91 94.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.806 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.435 ' HB3' HD12 ' A' ' 157' ' ' ILE . 67.8 m -68.93 -40.15 79.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.345 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.56 -30.34 67.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.653 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -34.61 66.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -84.57 6.36 24.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 7.7 mmm -57.53 -19.18 23.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 119.634 -0.222 . . . . 0.0 110.884 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 75.34 -68.22 0.21 Allowed 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.4 0.438 . . . . 0.0 110.687 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 99' ' ' THR . 86.7 m -60.83 -14.79 24.11 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.806 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.623 HG23 HG13 ' A' ' 139' ' ' VAL . 10.8 p -73.22 145.62 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.129 0.49 . . . . 0.0 111.304 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.35 -43.46 5.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.583 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.2 t -159.23 149.02 18.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.275 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.519 HG13 ' HE1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -136.04 130.45 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.232 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.0 m -125.24 131.04 53.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.311 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 87.1 t80 -87.69 113.75 23.66 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.927 0.394 . . . . 0.0 110.543 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.1 t -97.16 106.54 18.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.726 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -64.09 156.02 29.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.151 0.501 . . . . 0.0 110.364 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -63.2 -29.55 70.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.418 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.56 -38.7 91.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.836 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.07 -39.87 78.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.516 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -68.08 -36.17 79.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.767 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 116' ' ' THR . 0.2 OUTLIER -67.45 -40.41 85.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.515 0.674 . . . . 0.0 109.771 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -61.96 -40.67 96.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.148 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -67.36 -39.18 85.69 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.522 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.31 -35.92 76.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.475 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 112' ' ' TYR . 73.4 p -70.04 -34.46 73.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.435 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -68.06 -41.09 82.51 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.318 0.58 . . . . 0.0 110.543 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.1 pt -74.74 -27.27 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.125 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.27 0.48 32.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.566 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.2 12.29 84.49 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.02 174.18 0.15 Allowed 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 28.7 m120 61.67 26.75 16.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.525 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.648 ' HE1' HG22 ' A' ' 116' ' ' THR . 2.6 p-90 -109.82 0.25 18.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.306 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -115.82 138.36 51.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.959 0.409 . . . . 0.0 110.705 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.9 tp -149.3 10.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.764 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -107.52 29.29 7.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.164 0.507 . . . . 0.0 110.299 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.99 130.71 47.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.78 84.33 0.59 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.1 t0 57.45 51.69 9.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.071 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -110.33 -85.43 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.261 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.8 m120 48.88 72.95 1.09 Allowed Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.556 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.69 -28.63 76.76 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.631 2.221 . . . . 0.0 111.761 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.53 173.93 7.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.409 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.83 -170.08 2.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.007 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.403 ' HB3' ' CE1' ' A' ' 105' ' ' PHE . 45.8 m-20 -79.84 167.89 19.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.674 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -141.23 149.4 41.3 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.785 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.614 ' HD1' HD11 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -118.05 105.48 11.9 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.7 mt -80.73 103.35 7.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.623 HG13 HG23 ' A' ' 100' ' ' VAL . 73.8 t -106.69 137.3 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.099 0.476 . . . . 0.0 111.261 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -102.18 108.01 19.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.295 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.439 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -69.5 142.93 53.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.721 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.92 -32.73 34.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.631 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -149.91 163.16 25.71 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-O 121.235 0.541 . . . . 0.0 111.307 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.622 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.7 Cg_exo -58.17 -28.64 84.7 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.591 2.194 . . . . 0.0 112.004 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -86.52 -5.41 59.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.232 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.55 -16.99 19.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 144' ' ' PRO . 20.1 m -58.12 -34.08 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -33.99 63.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.885 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.4 m -71.35 -39.35 71.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.654 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.423 HG21 HG11 ' A' ' 139' ' ' VAL . 22.9 mm -66.37 -40.66 87.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.622 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.17 96.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.468 0.651 . . . . 0.0 110.523 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -68.8 -39.43 80.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.847 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -71.06 -36.28 72.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.12 -35.46 78.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.329 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -61.44 -18.7 60.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.16 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.43 -14.7 39.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.679 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 93' ' ' SER . 9.9 mm -57.86 -100.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.757 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 171.17 138.43 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 78.78 13.75 82.79 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.644 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.1 t -81.84 127.21 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.618 -0.342 . . . . 0.0 110.335 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 77.8 p -96.58 -34.88 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.481 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.32 157.95 6.42 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.917 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.25 142.28 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.091 0.472 . . . . 0.0 110.389 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -142.11 119.89 11.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.854 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -82.12 173.26 12.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.784 0.326 . . . . 0.0 110.874 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.694 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.765 0.317 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -105.7 -151.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 73.84 120.76 0.04 OUTLIER 'General case' 0 C--N 1.347 0.477 0 O-C-N 123.686 0.616 . . . . 0.0 110.321 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.894 HG22 HG23 ' A' ' 147' ' ' VAL . 15.1 t -129.24 137.16 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.964 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.03 122.81 70.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.707 HG13 HG22 ' A' ' 163' ' ' VAL . 3.5 t -112.32 105.0 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -74.36 146.34 43.09 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.728 HD11 ' CD1' ' A' ' 137' ' ' TYR . 65.9 mt -120.07 135.12 61.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.732 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.95 159.26 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.603 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -71.41 -66.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.335 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -55.96 -21.64 22.0 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.958 0.786 . . . . 0.0 110.035 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 69' ' ' GLU . 13.2 t -71.43 -48.0 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.484 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.4 tp10 51.61 176.75 0.02 OUTLIER 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.322 0.582 . . . . 0.0 110.932 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -175.92 -176.72 0.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 74.05 -54.97 0.67 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.154 0.909 . . . . 0.0 110.746 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.2 m -129.93 131.41 45.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.303 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.41 ' HA ' ' ND2' ' A' ' 84' ' ' ASN . 5.1 pt20 -74.12 68.07 1.39 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.801 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.67 109.02 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.852 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.61 153.87 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.305 0.574 . . . . 0.0 110.403 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -94.65 121.56 36.34 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.696 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -127.9 144.18 51.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.384 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -37.57 110.04 0.11 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.656 1.223 . . . . 0.0 110.2 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.86 -47.38 1.02 Allowed Glycine 0 CA--C 1.532 1.136 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.43 -154.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.21 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.6 m -109.35 128.43 55.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.74 143.59 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.242 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.0 p -80.09 159.3 26.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.92 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.457 ' ND2' ' HB3' ' A' ' 87' ' ' TYR . 1.1 p-10 -122.81 -177.46 3.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.329 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -122.62 172.32 8.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.095 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 47.78 24.99 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.758 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.457 ' HB3' ' ND2' ' A' ' 84' ' ' ASN . 48.6 p90 -69.4 -32.44 71.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.798 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -100.45 0.32 39.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.719 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -69.79 -36.85 76.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.527 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.7 t -65.21 -42.99 95.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.207 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -66.95 -42.45 85.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.66 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.74 -38.69 83.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.449 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 t -68.17 -42.77 79.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.487 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.29 -26.02 62.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.915 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -91.64 -30.53 16.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.699 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -99.88 2.87 44.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.446 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -15.93 61.72 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 72.7 158.54 0.2 Allowed 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 123.643 0.589 . . . . 0.0 109.711 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.572 ' HB ' HD11 ' A' ' 150' ' ' ILE . 4.5 m 72.66 5.6 5.26 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.908 0.755 . . . . 0.0 110.818 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 100' ' ' VAL . 27.6 m -110.39 121.13 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -61.86 -44.95 95.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.0 p -163.39 163.72 24.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.22 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 139' ' ' VAL . 49.2 t -134.69 129.27 51.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.266 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.1 m -121.92 132.38 54.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.981 0.419 . . . . 0.0 110.719 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.465 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 84.4 t80 -88.79 106.95 18.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.439 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.2 t -95.67 118.5 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.004 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.2 p -70.82 160.81 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.379 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -66.27 -31.84 72.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.075 0.464 . . . . 0.0 110.571 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.9 -36.98 78.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.32 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.56 -36.44 76.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.701 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 134' ' ' TYR . 57.4 mt-30 -65.42 -38.31 89.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.574 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -67.19 -40.36 86.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.36 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -68.33 -35.92 78.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.794 0.807 . . . . 0.0 110.126 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -70.17 -37.08 75.08 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.494 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.522 HD23 HD11 ' A' ' 118' ' ' ILE . 50.1 mt -65.59 -39.08 91.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.221 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.6 t -73.39 -29.44 62.61 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.406 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -69.34 -36.87 77.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.991 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.522 HD11 HD23 ' A' ' 115' ' ' LEU . 50.2 pt -86.01 -27.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.941 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 13.3 mmt -93.16 -63.35 1.22 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.95 0.405 . . . . 0.0 110.715 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.63 -176.95 54.16 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.7 t0 63.67 25.7 14.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.498 0.189 . . . . 0.0 110.649 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 63.8 t30 51.21 66.89 1.05 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.099 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -76.23 -1.59 27.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.369 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -53.96 -83.57 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.956 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 mp 41.29 62.71 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 CA-C-O 121.452 0.644 . . . . 0.0 111.183 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -158.0 5.3 0.12 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.053 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 58.51 167.65 0.05 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.167 0.508 . . . . 0.0 110.674 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -93.79 8.81 73.76 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -92.77 10.77 29.41 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.661 0.267 . . . . 0.0 110.686 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -137.26 152.76 50.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.916 0.389 . . . . 0.0 110.322 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -129.04 72.03 81.98 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.277 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.47 -19.62 68.05 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.867 2.378 . . . . 0.0 112.349 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.73 153.79 32.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.442 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TYR . . . . . 0.435 ' O ' ' NE2' ' A' ' 111' ' ' GLN . 0.9 OUTLIER -128.53 -171.19 2.4 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.465 ' HB3' ' CE1' ' A' ' 105' ' ' PHE . 93.7 m-20 -74.5 131.96 41.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.659 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.86 137.32 54.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.072 0.463 . . . . 0.0 111.361 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.728 ' CD1' HD11 ' A' ' 64' ' ' ILE . 8.4 m-85 -95.48 120.3 35.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 51.4 mt -92.63 104.4 15.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 103' ' ' VAL . 85.0 t -105.65 132.74 51.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.4 . . . . 0.0 110.355 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -98.99 107.09 19.44 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.484 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.44 142.92 57.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.954 0.407 . . . . 0.0 110.684 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -59.44 -40.22 86.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.208 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.525 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -136.84 160.7 65.31 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 121.15 0.5 . . . . 0.0 110.91 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 30.3 Cg_endo -62.94 -15.22 46.17 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.701 2.267 . . . . 0.0 111.87 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -96.81 -5.66 37.88 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.406 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -98.19 -24.15 15.4 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 120.71 0.29 . . . . 0.0 110.581 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.894 HG23 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -55.5 -36.57 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.19 179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -71.54 -35.71 70.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.926 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.9 m -73.05 -39.7 65.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.454 0.645 . . . . 0.0 110.58 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 99' ' ' THR . 25.5 mm -69.31 -38.99 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.39 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.23 -40.05 95.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.238 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -66.08 -40.03 90.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.57 -37.39 73.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.865 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.01 72.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.774 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HG3' HG21 ' A' ' 163' ' ' VAL . 60.5 mtpt -72.66 -13.07 61.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.081 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -107.57 9.99 29.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.859 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.411 HG22 ' N ' ' A' ' 158' ' ' GLU . 8.5 mm -55.08 -88.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.51 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.411 ' N ' HG22 ' A' ' 157' ' ' ILE . 67.2 mm-40 -151.93 -84.56 0.08 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.631 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.89 35.66 4.71 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.49 143.84 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.993 0.425 . . . . 0.0 109.952 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.7 t -97.34 -51.33 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -166.46 145.89 5.8 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.001 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.707 HG22 HG13 ' A' ' 62' ' ' VAL . 95.1 t -117.99 129.26 74.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.023 0.439 . . . . 0.0 111.013 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -128.25 128.27 44.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.762 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -77.61 168.97 19.11 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.424 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.726 0.298 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.9 m -71.6 138.22 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 162.03 115.0 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.129 0.893 . . . . 0.0 110.248 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.5 131.61 57.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.582 HG13 ' HB1' ' A' ' 136' ' ' ALA . 87.8 t -121.07 124.01 71.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.74 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 80.0 t -111.38 114.71 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.136 0.494 . . . . 0.0 111.463 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -79.31 134.77 36.62 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.121 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.839 HD11 ' CD1' ' A' ' 137' ' ' TYR . 54.5 mt -117.5 139.33 45.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.734 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.08 168.94 0.19 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.589 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt -88.63 -10.43 48.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.421 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -100.31 31.55 3.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.893 0.378 . . . . 0.0 110.805 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 68' ' ' VAL . 10.0 p -168.6 38.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.602 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -55.27 98.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 110.266 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -63.19 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.561 -178.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -87.29 69.37 9.98 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.108 0.48 . . . . 0.0 110.137 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.2 p -140.27 -38.91 0.44 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.811 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 76.58 -45.86 0.51 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.724 0.64 . . . . 0.0 111.086 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.9 t -147.43 153.52 39.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.3 pt -125.44 151.92 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.26 0.552 . . . . 0.0 110.109 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -89.44 118.24 28.95 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.029 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -124.95 134.32 52.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.876 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -33.15 109.98 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.058 0.849 . . . . 0.0 111.037 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.49 -48.62 0.94 Allowed Glycine 0 CA--C 1.528 0.9 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.396 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -168.78 -157.06 0.18 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.58 -0.365 . . . . 0.0 111.171 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.6 p -116.08 133.05 56.44 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.16 134.26 62.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.323 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.4 m -60.72 133.49 56.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.609 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -82.97 155.71 23.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.756 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -94.25 168.31 10.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.419 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 54.01 44.53 29.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.871 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -64.67 125.79 25.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.512 . . . . 0.0 110.44 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 54.15 18.17 1.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.94 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -71.01 -43.8 67.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.357 0.598 . . . . 0.0 110.518 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.484 HG13 HG21 ' A' ' 157' ' ' ILE . 79.0 t -69.23 -38.83 78.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.631 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -60.37 -45.85 92.04 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.017 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.54 -39.91 92.28 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.585 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 t -65.9 -42.25 90.47 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.409 0.623 . . . . 0.0 110.425 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.413 HD12 HG12 ' A' ' 90' ' ' VAL . 91.6 mt -73.19 -36.23 66.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.883 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -37.37 68.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.023 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -91.57 6.91 43.83 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.805 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.38 -19.88 0.95 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.539 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t 67.77 67.55 0.36 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.671 ' CG2' HD11 ' A' ' 150' ' ' ILE . 1.0 OUTLIER 167.21 -23.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.809 0.693 . . . . 0.0 110.257 179.198 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.2 m -85.78 149.27 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.113 0.482 . . . . 0.0 111.413 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -91.62 -43.17 9.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.016 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.9 p -154.22 152.75 30.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.082 0.468 . . . . 0.0 110.491 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.625 HG22 HG22 ' A' ' 139' ' ' VAL . 77.3 t -132.56 128.64 58.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.766 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.5 m -124.68 131.34 53.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.781 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.495 ' HE1' HD12 ' A' ' 64' ' ' ILE . 53.0 t80 -92.58 122.2 34.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.548 0.689 . . . . 0.0 110.108 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -101.17 106.95 18.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.702 178.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.0 m -66.43 145.33 55.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 110.88 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -70.75 -26.36 63.33 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.928 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -64.65 -41.01 96.42 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.7 tm-20 -68.2 -40.77 82.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.251 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.411 ' HG2' HD13 ' A' ' 133' ' ' LEU . 6.6 tt0 -65.16 -39.81 93.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.803 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.57 ' O ' HG23 ' A' ' 116' ' ' THR . 73.7 t80 -62.25 -41.61 98.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.062 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.2 -38.88 90.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.086 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -65.65 -38.17 88.6 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.484 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.499 ' CD1' HD11 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -68.25 -34.75 76.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.93 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.574 HG22 ' HE1' ' A' ' 123' ' ' TRP . 79.0 p -70.22 -35.42 73.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.371 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -66.48 -42.92 86.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.728 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 115' ' ' LEU . 44.1 pt -73.15 -28.43 26.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.768 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.409 ' HB3' ' HB3' ' A' ' 123' ' ' TRP . 14.2 mmt -81.05 -8.58 59.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.312 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.2 17.73 71.06 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.485 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.8 t0 60.31 36.38 20.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.514 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -142.85 50.93 1.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.701 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.574 ' HE1' HG22 ' A' ' 116' ' ' THR . 4.4 p-90 -141.67 3.6 1.68 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.785 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -82.38 103.12 11.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.92 0.39 . . . . 0.0 110.288 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.33 -22.82 4.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.552 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -89.74 13.47 14.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.899 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 61.95 160.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.62 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -75.06 -174.16 33.64 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 58.9 31.18 21.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.727 0.299 . . . . 0.0 110.232 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -116.29 -44.13 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.327 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.9 m120 49.01 62.26 12.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.591 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.53 -19.08 66.64 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.808 2.339 . . . . 0.0 112.373 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.499 HD11 ' CD1' ' A' ' 115' ' ' LEU . 48.5 mt -89.4 168.5 12.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.012 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -117.97 161.1 20.35 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.823 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.73 -169.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.582 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -161.73 127.78 3.7 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.839 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -105.96 106.38 16.85 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.4 mt -82.9 110.58 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.625 HG22 HG22 ' A' ' 103' ' ' VAL . 84.3 t -115.41 137.02 50.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.048 0.451 . . . . 0.0 110.47 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -101.34 109.33 21.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.041 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.51 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -70.65 147.39 49.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.587 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -57.53 -40.0 77.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.041 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -135.2 159.95 69.98 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.638 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 147' ' ' VAL . 25.0 Cg_endo -61.07 -19.34 62.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.379 2.053 . . . . 0.0 112.215 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -91.52 -5.49 54.07 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.234 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.462 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 83.3 m-20 -98.92 -16.12 18.91 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.241 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 144' ' ' PRO . 28.3 m -60.0 -33.17 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 121.18 0.514 . . . . 0.0 109.736 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -38.25 63.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.454 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.8 m -68.73 -40.35 79.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.3 0.571 . . . . 0.0 110.797 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.671 HD11 ' CG2' ' A' ' 99' ' ' THR . 31.2 mm -64.43 -41.27 91.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.494 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.31 98.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.314 0.578 . . . . 0.0 109.965 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.42 -40.21 89.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.745 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.06 -37.47 78.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.765 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.424 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -62.53 -32.94 73.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.382 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -61.72 -19.93 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.102 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -92.86 6.59 47.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.998 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.484 HG21 HG13 ' A' ' 90' ' ' VAL . 17.3 mm -88.14 120.98 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 41.91 -97.06 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.464 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -159.95 52.16 0.36 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.1 m -46.7 163.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-O 120.723 0.297 . . . . 0.0 110.362 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.4 t -83.93 -50.36 8.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.165 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -169.48 148.76 3.84 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.706 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.41 HG12 HG13 ' A' ' 62' ' ' VAL . 22.4 m -120.22 148.56 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.253 0.549 . . . . 0.0 110.484 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -142.01 148.82 39.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.652 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.46 135.48 51.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.451 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.766 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.797 0.332 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -99.97 50.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -98.52 122.16 41.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.58 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.84 137.48 53.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.983 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.41 123.8 72.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.856 0.36 . . . . 0.0 110.47 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 90.1 t -108.52 116.13 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.24 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -85.35 134.58 34.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 137' ' ' TYR . 71.6 mt -98.61 147.8 6.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.743 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -45.61 164.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.721 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 7.3 tttm -88.26 139.2 30.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.115 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 66' ' ' LYS . 12.0 t0 82.89 25.98 0.13 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 124.037 0.836 . . . . 0.0 110.752 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 p -147.32 108.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.531 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -107.87 98.44 8.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.92 0.391 . . . . 0.0 110.676 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.02 -48.11 83.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.026 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -96.37 68.26 2.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.834 0.35 . . . . 0.0 111.007 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.6 p -146.98 -31.54 0.33 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.986 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 67.95 3.91 3.77 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.681 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -171.13 156.96 4.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 84.6 mt -114.86 133.1 62.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -106.51 142.24 36.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.895 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.468 ' O ' ' C ' ' A' ' 78' ' ' GLU . 60.7 tttp -151.44 141.8 22.44 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.058 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 77' ' ' LYS . 20.3 tt0 -17.98 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 O-C-N 124.551 1.157 . . . . 0.0 111.726 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 80' ' ' GLN . . . 48.18 90.37 0.01 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 57.6 tp60 143.92 116.06 0.0 OUTLIER 'General case' 0 C--N 1.361 1.104 0 O-C-N 124.964 1.038 . . . . 0.0 110.371 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.3 p -121.27 133.81 55.15 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.0 m -133.12 165.12 33.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-O 121.166 0.508 . . . . 0.0 110.301 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.6 p -61.26 163.78 6.07 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.212 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -113.7 -171.23 1.85 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 110.797 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -135.05 153.59 52.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.368 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 53.06 46.26 27.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.634 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.422 ' CE2' ' CE1' ' A' ' 88' ' ' HIS . 48.2 t80 -55.51 -47.57 76.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -178.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.422 ' CE1' ' CE2' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -118.73 45.04 2.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.874 0.369 . . . . 0.0 110.645 179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -101.67 -51.42 3.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.75 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.4 t -66.68 -40.28 85.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.782 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -66.71 -41.71 87.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.489 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -65.01 -40.56 95.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.385 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.6 m -68.24 -37.32 80.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.124 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.3 mt -79.14 -11.48 59.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.018 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -94.81 -32.87 13.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.866 0.365 . . . . 0.0 111.407 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -89.55 8.52 30.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.185 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 77.5 mmm -53.46 -20.16 4.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.841 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.35 -48.22 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.613 0.571 . . . . 0.0 110.74 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.454 ' HB ' HD11 ' A' ' 150' ' ' ILE . 3.9 m -88.17 17.76 4.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 0.0 110.83 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 139' ' ' VAL . 6.3 p -107.25 138.55 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.12 0.486 . . . . 0.0 111.262 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -95.54 -42.24 8.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.795 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.6 t -157.98 150.1 22.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.585 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 139' ' ' VAL . 58.2 t -131.58 128.84 61.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.736 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.401 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 99.3 m -125.42 132.47 52.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.546 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -86.9 118.77 26.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.006 0.431 . . . . 0.0 110.599 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.2 t -105.83 118.01 35.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.403 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.1 m -69.14 150.34 47.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.088 0.471 . . . . 0.0 110.601 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -64.52 -31.8 73.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -64.7 -39.75 94.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.509 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.07 -38.4 79.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.319 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -66.29 -38.56 88.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.445 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.555 ' O ' HG23 ' A' ' 116' ' ' THR . 58.0 t80 -63.68 -41.47 98.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.917 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.62 -39.17 93.23 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.249 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -66.63 -38.32 86.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.576 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.78 -37.79 85.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.646 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 112' ' ' TYR . 74.0 p -69.13 -35.26 76.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.78 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.78 -39.71 87.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.773 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.0 pt -78.09 -28.11 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.88 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -19.12 34.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.464 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.5 -159.05 44.15 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -77.62 71.64 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 0.0 110.158 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.05 -166.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.342 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.412 ' HE1' HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER 66.35 126.98 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.855 0.36 . . . . 0.0 110.427 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.3 mttt 172.55 65.97 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.59 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.01 -46.14 97.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 0.0 110.619 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -112.74 68.56 0.67 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.9 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.78 161.24 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.664 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.88 -153.62 43.99 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -80.29 114.34 19.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.049 0.452 . . . . 0.0 110.521 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -169.23 -41.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.339 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 25.0 m120 53.23 82.6 0.24 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.765 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -48.18 -34.62 24.56 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.683 2.255 . . . . 0.0 111.847 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.5 mp -109.19 167.89 9.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.809 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.97 -165.5 1.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.449 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.59 140.39 51.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.11 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.57 151.14 49.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.197 0.523 . . . . 0.0 110.696 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.574 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.3 m-85 -120.08 110.48 16.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.159 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 51.6 mt -83.43 108.25 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 103' ' ' VAL . 69.4 t -113.28 137.19 47.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.17 0.509 . . . . 0.0 110.979 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -99.21 106.9 19.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.18 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.614 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -75.87 146.51 39.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.584 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 5.3 m120 -75.32 88.79 2.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.604 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 87.95 156.66 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 O-C-N 123.945 0.778 . . . . 0.0 110.716 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.689 ' O ' HG22 ' A' ' 147' ' ' VAL . 36.6 Cg_exo -59.74 -24.84 77.2 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.584 2.189 . . . . 0.0 112.468 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -78.35 -13.62 59.77 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.513 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 142' ' ' ASN . 82.5 m-20 -97.73 -17.08 19.61 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 120.651 0.262 . . . . 0.0 111.309 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 144' ' ' PRO . 4.6 m -61.17 -32.97 54.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -75.83 -34.24 60.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.62 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.7 m -70.98 -40.03 72.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.42 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.454 HD11 ' HB ' ' A' ' 99' ' ' THR . 33.4 mm -65.69 -41.1 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.297 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.23 95.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.321 0.581 . . . . 0.0 110.166 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -66.85 -40.48 87.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.719 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.47 -32.77 66.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.265 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.04 69.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.771 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.569 ' HA ' HG11 ' A' ' 160' ' ' VAL . 68.0 mttm -62.2 -18.05 59.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.323 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.64 8.27 45.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.73 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 17.6 mm -84.59 117.87 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.682 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 38.49 -115.31 0.15 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.09 0.869 . . . . 0.0 111.519 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -120.7 40.57 2.12 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 155' ' ' LYS . 11.5 p -42.96 146.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.0 p -92.74 -47.44 7.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.222 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -165.39 154.12 11.91 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.819 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.02 140.96 47.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.774 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -143.28 137.36 28.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -90.2 179.11 5.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.713 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.661 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.808 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 m120 . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.531 0.205 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -145.39 173.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.441 ' N ' HG13 ' A' ' 58' ' ' VAL . 0.3 OUTLIER 71.71 137.06 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 123.643 0.589 . . . . 0.0 110.363 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -138.23 141.19 38.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.388 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.6 t -116.19 125.04 73.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.489 HG21 ' HB1' ' A' ' 154' ' ' ALA . 61.0 t -109.16 116.63 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.182 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -84.35 138.65 32.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.608 ' CG2' HG11 ' A' ' 68' ' ' VAL . 1.5 mt -102.11 153.28 5.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.122 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -59.02 149.02 28.69 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.728 0.775 . . . . 0.0 110.831 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.79 135.56 54.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.024 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t0 69.15 26.07 5.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.902 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.625 HG13 ' H ' ' A' ' 70' ' ' ASP . 9.1 p -73.23 -29.43 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.996 0.427 . . . . 0.0 110.451 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 54.66 32.81 17.98 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.932 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.625 ' H ' HG13 ' A' ' 68' ' ' VAL . 12.6 p-10 -59.83 -37.75 80.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.015 0.436 . . . . 0.0 110.511 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.53 22.86 14.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.631 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.425 ' O ' ' CE2' ' A' ' 87' ' ' TYR . 5.3 t -85.97 -139.43 0.08 Allowed 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -164.95 -32.35 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.33 145.24 16.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.983 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.5 pt -130.41 152.23 37.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.244 0.545 . . . . 0.0 110.429 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -99.68 120.89 40.42 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.933 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -145.17 138.13 26.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.244 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 57.6 29.27 16.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.717 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.82 11.88 74.09 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -122.9 141.25 52.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.9 m -96.48 125.68 41.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.876 0.369 . . . . 0.0 110.147 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.71 155.94 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.293 0.568 . . . . 0.0 109.883 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.4 p -70.55 147.71 49.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.666 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.67 152.85 17.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.927 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.19 102.57 0.17 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.244 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 87' ' ' TYR . 23.8 m-20 45.42 72.18 0.23 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.627 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.461 ' C ' ' O ' ' A' ' 86' ' ' ASP . 1.2 t80 -32.44 128.28 0.24 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.48 1.113 . . . . 0.0 109.909 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 63.15 41.78 7.74 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 123.245 0.341 . . . . 0.0 110.996 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -71.96 -46.72 56.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.153 0.502 . . . . 0.0 110.309 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.8 -37.52 69.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.441 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -64.48 -43.54 93.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.914 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.34 -37.62 74.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.422 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -64.92 -42.13 94.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.4 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.1 mt -69.32 -39.77 78.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.834 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -68.82 -24.3 64.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.076 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -90.56 4.53 50.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.477 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.8 mmt -59.83 -23.37 63.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.653 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.32 -62.22 0.45 Allowed 'General case' 0 C--N 1.349 0.585 0 O-C-N 123.466 0.479 . . . . 0.0 111.196 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.575 ' HB ' HD11 ' A' ' 150' ' ' ILE . 53.7 m -59.39 -17.25 28.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.114 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.3 m -86.38 149.89 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.773 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -90.83 -42.36 10.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.916 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.5 p -157.57 156.47 32.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.528 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 139' ' ' VAL . 59.7 t -134.84 129.89 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.913 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.2 m -125.76 131.76 52.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.003 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -87.03 116.26 24.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.064 0.459 . . . . 0.0 110.379 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.4 t -104.74 119.89 40.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.607 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.3 t -62.41 160.4 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -62.61 -37.12 85.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.028 0.442 . . . . 0.0 110.207 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -69.19 -40.46 78.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.926 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -70.43 -38.58 74.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.493 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 66.4 tp60 -66.65 -40.5 88.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.36 -179.112 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.629 ' O ' HG23 ' A' ' 116' ' ' THR . 16.1 t80 -63.54 -43.92 95.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.646 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.78 -39.45 87.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -67.27 -39.75 86.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.95 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.771 HD23 HD11 ' A' ' 118' ' ' ILE . 70.7 mt -66.29 -38.09 86.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 112' ' ' TYR . 76.6 p -69.08 -33.64 73.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.183 0.515 . . . . 0.0 110.664 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -68.3 -38.63 81.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.98 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.771 HD11 HD23 ' A' ' 115' ' ' LEU . 41.5 pt -80.43 -33.07 13.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.568 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.89 8.13 45.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.425 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.19 -149.21 47.93 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -75.46 150.34 38.28 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.286 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.423 ' HA ' HD13 ' A' ' 125' ' ' ILE . 8.2 t-20 75.18 -150.89 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 124.166 0.916 . . . . 0.0 110.048 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 75.93 -29.68 0.18 Allowed 'General case' 0 C--N 1.344 0.329 0 O-C-N 123.562 0.539 . . . . 0.0 110.778 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 122' ' ' ASN . 1.6 mmtm -145.23 -83.09 0.14 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.51 HG22 ' O ' ' A' ' 125' ' ' ILE . 1.3 mp 58.58 106.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.189 0.519 . . . . 0.0 110.003 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.6 t80 179.51 97.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.355 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -149.72 33.71 0.69 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.586 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -99.3 -19.02 22.28 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.52 -64.31 0.85 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.847 0.356 . . . . 0.0 110.763 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -151.15 165.49 33.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -59.33 132.14 87.89 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.134 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.02 -25.74 31.73 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.115 2.543 . . . . 0.0 112.405 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 58.2 mt -112.5 -176.57 2.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.853 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.92 -162.65 1.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.49 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.87 154.26 22.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.46 151.28 41.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.871 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.561 ' CE1' HD11 ' A' ' 64' ' ' ILE . 4.7 m-85 -123.06 112.19 17.47 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.209 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.3 mt -86.85 111.24 21.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 103' ' ' VAL . 78.4 t -114.8 138.27 45.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.366 0.603 . . . . 0.0 110.82 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -104.85 108.31 19.74 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.25 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -66.58 145.95 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -57.45 -39.3 76.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.796 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -137.39 161.33 61.39 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.813 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.522 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.0 Cg_exo -59.64 -19.94 55.45 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.848 2.365 . . . . 0.0 112.062 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -95.16 -4.79 45.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.641 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -97.61 -22.11 16.68 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 120.762 0.315 . . . . 0.0 110.574 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.568 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 6.6 p -57.8 -35.07 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.004 0.43 . . . . 0.0 109.961 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -71.88 -34.99 69.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.813 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 59.7 m -73.25 -38.75 65.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.98 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.575 HD11 ' HB ' ' A' ' 99' ' ' THR . 33.4 mm -69.06 -40.46 80.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.37 95.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.635 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 149' ' ' THR . 1.0 OUTLIER -76.87 -24.46 52.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.129 -179.581 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -85.1 -34.85 22.12 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.253 0.549 . . . . 0.0 110.547 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.489 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -69.49 -30.02 67.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -67.84 -12.18 60.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 110.998 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -105.65 9.12 33.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.078 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.501 HG22 ' HG2' ' A' ' 158' ' ' GLU . 7.0 mm -53.78 -78.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.77 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.501 ' HG2' HG22 ' A' ' 157' ' ' ILE . 81.5 mm-40 -145.44 -80.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.135 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.04 62.11 0.52 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.72 156.66 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 110.28 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.4 t -109.81 -42.77 4.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.322 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -166.63 153.62 9.14 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.614 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.75 135.5 60.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.5 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -137.8 133.56 34.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -78.23 178.43 7.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.833 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.829 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -177.52 -22.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.088 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -90.53 135.35 33.76 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.091 0.472 . . . . 0.0 110.246 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.4 ' CG2' HG23 ' A' ' 147' ' ' VAL . 95.5 t -125.42 133.43 69.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.646 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.513 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 78.9 t -115.5 122.46 69.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.47 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.1 t -106.74 108.71 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.108 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 136' ' ' ALA . 82.4 m-85 -81.18 145.61 30.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.998 0.427 . . . . 0.0 110.026 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.726 HD11 ' CE1' ' A' ' 137' ' ' TYR . 78.3 mt -111.82 157.75 12.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.853 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' N ' HG22 ' A' ' 64' ' ' ILE . 28.1 mmt85 -50.2 173.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.569 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -59.33 -117.07 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.367 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -84.94 55.26 3.4 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.641 -0.662 . . . . 0.0 110.318 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 68' ' ' VAL . 7.1 p -84.81 -11.13 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.593 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 68.21 131.9 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.222 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -149.17 -91.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.291 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -89.37 65.11 7.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.476 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.6 m -128.89 -125.64 0.22 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.796 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 180.0 -39.0 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.1 p -140.99 147.89 39.44 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.506 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.8 pt -129.87 148.79 33.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.553 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -97.7 122.7 41.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.372 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.78 134.88 24.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.886 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 55.39 31.48 16.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.425 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.87 21.99 76.84 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -131.04 137.2 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.749 0.309 . . . . 0.0 110.445 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.1 m -93.08 122.44 35.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.491 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.6 m -128.38 155.7 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.22 0.533 . . . . 0.0 110.099 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.8 p -73.03 153.16 41.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.585 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -82.05 -176.34 6.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -130.24 -34.44 1.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.768 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -97.95 56.75 1.26 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.206 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 89' ' ' LYS . 15.6 t80 -56.08 123.08 13.22 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.593 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 88' ' ' HIS . 7.3 p-80 26.46 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 125.372 1.67 . . . . 0.0 111.11 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 87' ' ' TYR . 85.7 tttt -66.58 -40.36 88.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.61 -0.682 . . . . 0.0 110.466 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.02 -38.99 79.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.121 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.421 ' HD2' ' HD2' ' A' ' 88' ' ' HIS . 35.7 t80 -61.01 -41.79 97.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.418 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -36.81 73.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.41 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.6 m -67.05 -41.98 85.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.351 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.9 mt -71.71 -39.55 70.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.975 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -66.85 -31.56 72.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.274 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -82.56 5.23 21.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.402 ' HE3' ' HB2' ' A' ' 153' ' ' ASP . 3.1 mmt -55.81 -24.63 37.31 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.865 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 76.47 -56.18 0.57 Allowed 'General case' 0 C--N 1.343 0.322 0 O-C-N 123.365 0.416 . . . . 0.0 110.469 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 99' ' ' THR . 92.6 m -71.07 -10.95 60.64 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.454 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.28 137.93 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 120.891 0.377 . . . . 0.0 110.96 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -86.34 -43.22 13.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.494 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.4 t -156.35 151.24 26.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.434 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.576 HG22 HG12 ' A' ' 139' ' ' VAL . 95.7 t -130.25 128.79 64.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.983 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.6 m -119.02 130.42 55.64 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 110.578 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -90.76 113.67 25.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.077 0.465 . . . . 0.0 110.66 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.7 t -94.02 107.54 19.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.058 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.1 t -57.72 142.42 45.34 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.319 0.58 . . . . 0.0 110.862 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -58.35 -32.23 68.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.015 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -63.51 -30.94 71.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -71.16 -38.34 72.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.818 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' A' ' 136' ' ' ALA . 23.0 mm-40 -67.31 -39.29 85.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.275 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.445 ' O ' HG23 ' A' ' 116' ' ' THR . 85.8 t80 -65.12 -40.02 93.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.337 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.78 -38.11 89.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.966 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -64.99 -38.76 92.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.215 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.543 HD23 HD11 ' A' ' 118' ' ' ILE . 92.1 mt -64.84 -38.78 92.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.426 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 112' ' ' TYR . 80.7 p -69.46 -30.83 68.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.518 0.675 . . . . 0.0 110.51 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -69.91 -36.64 75.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.716 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.543 HD11 HD23 ' A' ' 115' ' ' LEU . 46.1 pt -87.42 -29.71 5.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.582 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -113.09 22.9 13.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.97 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.57 -167.44 10.37 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -104.31 20.18 18.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.894 0.378 . . . . 0.0 110.779 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -101.26 -13.0 18.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.934 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -91.64 0.33 57.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.374 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -60.29 137.52 58.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.723 0.297 . . . . 0.0 110.663 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.3 tp -148.96 145.61 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.338 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 130' ' ' ALA . 5.2 m-85 59.45 77.86 0.29 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.547 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -83.85 12.09 6.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.706 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -84.63 32.5 3.39 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.3 t0 64.88 17.63 11.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.609 0.242 . . . . 0.0 110.597 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 126' ' ' PHE . . . -62.57 -41.67 99.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.358 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.412 ' ND2' ' O ' ' A' ' 133' ' ' LEU . 0.7 OUTLIER 48.12 80.92 0.27 Allowed Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.412 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.75 -39.0 47.82 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.654 2.236 . . . . 0.0 111.762 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.459 ' HG ' HD11 ' A' ' 115' ' ' LEU . 2.4 mm? -79.09 174.09 11.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.66 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.74 -171.62 2.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.693 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.86 149.62 24.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.68 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.513 ' HB1' ' CG1' ' A' ' 61' ' ' VAL . . . -131.4 141.62 49.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.726 ' CE1' HD11 ' A' ' 64' ' ' ILE . 13.7 m-85 -99.04 115.71 29.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.816 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.7 mt -93.88 111.38 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 150' ' ' ILE . 4.7 m -115.49 150.83 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.054 0.454 . . . . 0.0 110.312 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -108.74 107.7 18.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.42 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.83 139.11 58.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -58.32 -39.15 78.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -134.95 162.14 59.49 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-O 121.16 0.505 . . . . 0.0 110.711 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 29.2 Cg_endo -63.42 -15.08 46.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.76 2.307 . . . . 0.0 111.385 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.73 -5.21 31.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.711 0.291 . . . . 0.0 110.301 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -92.38 -25.81 18.34 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 120.706 0.289 . . . . 0.0 110.731 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -49.65 -35.22 9.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.816 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -33.03 60.66 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.685 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.401 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 84.3 m -72.1 -39.87 68.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.406 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.665 HG21 HG21 ' A' ' 139' ' ' VAL . 40.1 mm -69.88 -40.51 78.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.513 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.91 -41.76 86.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 149' ' ' THR . 25.1 pt-20 -73.59 -33.85 64.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.558 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.402 ' HB2' ' HE3' ' A' ' 97' ' ' MET . 95.7 m-20 -71.65 -35.76 70.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.559 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.07 73.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.345 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -61.13 -20.46 62.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -3.67 58.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.62 120.4 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.472 0.653 . . . . 0.0 110.477 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -58.28 147.48 30.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.646 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 91.58 -9.49 76.97 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 160' ' ' VAL . 10.9 p -66.5 129.73 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 120.988 0.423 . . . . 0.0 110.266 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 62.1 p -100.65 -42.77 6.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.467 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -167.81 145.61 4.46 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.16 133.92 67.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.441 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -139.62 136.81 34.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.391 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -88.82 179.7 6.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.8 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.765 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.601 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.5 OUTLIER 72.94 -9.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 123.365 0.415 . . . . 0.0 111.162 -179.309 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -105.79 129.29 54.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.921 0.391 . . . . 0.0 110.859 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.565 HG13 ' HB ' ' A' ' 139' ' ' VAL . 0.9 OUTLIER -128.06 139.73 51.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.86 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.604 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 63.7 t -117.25 122.97 71.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.829 0.347 . . . . 0.0 110.742 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 91.3 t -103.58 115.67 45.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.118 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -79.7 132.02 36.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.996 0.426 . . . . 0.0 110.121 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.843 HD11 ' CD1' ' A' ' 137' ' ' TYR . 64.4 mt -109.82 135.16 49.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.883 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.01 169.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.75 157.31 21.07 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.15 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.64 -6.46 1.62 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.45 0.469 . . . . 0.0 110.917 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.8 t -66.21 -45.11 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 120.841 0.353 . . . . 0.0 110.776 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 48.86 42.91 21.01 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.47 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.631 ' CG ' HD13 ' A' ' 64' ' ' ILE . 5.6 p-10 -56.43 -45.18 80.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.806 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -120.34 10.04 11.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.788 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -98.45 103.01 14.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.444 ' C ' HG23 ' A' ' 74' ' ' THR . 13.1 pt20 -52.67 141.75 20.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.398 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 73' ' ' GLN . 1.3 p 59.12 161.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.755 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 71.3 mt -125.35 135.16 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.115 -179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.47 120.15 40.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.474 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -131.88 129.18 40.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.696 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 56.99 -87.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.339 0.399 . . . . 0.0 110.707 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.69 25.79 1.33 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -134.54 148.05 50.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.71 133.8 55.6 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.082 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.46 167.76 19.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.304 0.573 . . . . 0.0 110.128 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.2 m -75.01 131.74 40.84 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.188 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.452 ' ND2' ' N ' ' A' ' 87' ' ' TYR . 46.3 t30 -90.8 101.5 14.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.047 0.451 . . . . 0.0 110.54 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -74.61 -4.74 38.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -103.47 12.41 35.21 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.51 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.452 ' N ' ' ND2' ' A' ' 84' ' ' ASN . 91.7 t80 -57.45 133.75 55.47 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.01 0.433 . . . . 0.0 110.382 -179.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 62.16 63.36 1.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.453 0.644 . . . . 0.0 111.138 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -113.63 -57.86 2.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.637 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.03 -35.65 75.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.794 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -64.6 -40.17 95.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.898 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -67.94 -40.18 83.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.704 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.646 ' HB3' HD12 ' A' ' 157' ' ' ILE . 65.9 m -67.03 -40.24 87.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.476 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.419 ' O ' HG11 ' A' ' 100' ' ' VAL . 75.6 mt -70.96 -37.71 72.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -65.99 -30.5 71.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.268 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -87.23 4.25 43.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.3 mmt -56.49 -23.61 40.53 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.81 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.79 -47.45 0.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.335 0.397 . . . . 0.0 110.38 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' HD11 ' A' ' 150' ' ' ILE . 16.9 m -88.53 18.77 4.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.278 0.561 . . . . 0.0 110.676 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 139' ' ' VAL . 3.3 p -104.04 141.37 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.152 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -101.06 -40.87 7.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.228 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.5 t -160.27 148.84 16.92 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.453 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 139' ' ' VAL . 58.9 t -127.24 126.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.548 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.577 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 99.9 m -117.68 126.03 51.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.18 0.514 . . . . 0.0 110.571 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 43.4 t80 -92.59 119.16 31.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.677 ' O ' ' O ' ' A' ' 135' ' ' ASP . 7.4 t -110.94 87.68 2.6 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.07 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 106' ' ' SER . 30.9 t -39.72 139.52 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.942 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -50.79 -35.52 32.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.931 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -68.65 -38.98 80.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.288 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.07 -35.68 66.71 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.627 0.727 . . . . 0.0 110.685 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -74.24 -33.61 63.39 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.482 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.711 ' O ' HG23 ' A' ' 116' ' ' THR . 42.9 t80 -67.42 -42.04 83.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.339 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -68.98 -35.29 76.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.444 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -69.71 -38.17 76.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.66 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.418 ' HA ' HG12 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -67.52 -35.86 79.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.581 -179.791 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 112' ' ' TYR . 81.2 p -69.99 -32.69 71.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.1 0.476 . . . . 0.0 110.573 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -68.99 -37.99 79.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.853 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 115' ' ' LEU . 44.3 pt -82.01 -30.49 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.505 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.36 7.36 38.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.773 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.71 -173.82 43.66 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -95.78 29.09 2.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.953 0.406 . . . . 0.0 110.585 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -125.71 42.9 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.114 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.526 ' HE1' HG22 ' A' ' 116' ' ' THR . 0.3 OUTLIER -141.67 -26.57 0.68 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.637 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -59.14 138.08 57.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.211 0.529 . . . . 0.0 110.753 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.401 ' C ' ' CG ' ' A' ' 126' ' ' PHE . 5.5 tp -139.82 -23.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.348 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PHE . . . . . 0.401 ' CG ' ' C ' ' A' ' 125' ' ' ILE . 11.2 p90 34.27 56.3 0.64 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.957 0.786 . . . . 0.0 110.665 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.6 tm-20 -114.8 128.53 56.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.835 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.24 -107.81 3.36 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 47.3 t0 -59.89 -27.52 66.78 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.585 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 129' ' ' ASP . . . 77.3 -14.24 0.86 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.792 0.683 . . . . 0.0 110.674 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -132.44 71.74 78.86 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-O 120.736 0.303 . . . . 0.0 110.256 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.37 -31.82 59.04 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.674 2.25 . . . . 0.0 111.637 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.5 mm? -100.82 153.58 19.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -116.49 -175.14 2.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.034 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.677 ' O ' ' O ' ' A' ' 106' ' ' SER . 96.8 m-20 -58.31 -30.3 66.57 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.868 0.842 . . . . 0.0 110.856 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.604 ' HB1' ' CG1' ' A' ' 61' ' ' VAL . . . 51.98 125.6 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.629 0.728 . . . . 0.0 111.392 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.843 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -112.65 103.65 11.7 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.628 -0.67 . . . . 0.0 109.588 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 1.4 mp -79.27 108.58 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.828 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 100' ' ' VAL . 99.6 t -111.18 135.49 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.407 0.622 . . . . 0.0 111.313 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -96.34 106.36 18.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.327 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 146' ' ' ASP . . . -69.68 147.2 50.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.647 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -52.34 -35.33 50.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.222 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -148.75 164.03 23.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.744 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.497 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.2 Cg_exo -57.73 -29.4 85.57 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.936 2.424 . . . . 0.0 112.071 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -83.64 -3.82 58.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.71 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.494 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 83.8 m-20 -98.73 -10.69 22.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 144' ' ' PRO . 8.6 m -62.44 -29.03 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.461 ' HG3' HG23 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -80.32 -34.16 36.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.02 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 97.5 m -72.34 -40.0 67.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.172 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.57 HD11 ' HB ' ' A' ' 99' ' ' THR . 28.9 mm -66.71 -40.86 87.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.287 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.609 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.24 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.16 -39.11 82.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.708 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -72.3 -34.98 68.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.624 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.07 82.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.43 -17.88 60.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.861 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -93.9 8.07 42.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 93' ' ' SER . 18.2 mm -92.32 119.94 40.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 44.58 -98.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.683 0.615 . . . . 0.0 111.025 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -159.16 48.77 0.41 Allowed Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.3 m -50.5 143.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.355 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.0 t -61.8 -48.38 80.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.942 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -174.39 154.56 2.15 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.552 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.609 HG11 ' HA ' ' A' ' 151' ' ' ALA . 45.1 t -115.96 131.94 66.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.47 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -127.7 127.14 43.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -78.1 174.18 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.575 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.7 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.832 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.3 m120 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.508 0.194 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.403 ' HA ' HG11 ' A' ' 147' ' ' VAL . 0.4 OUTLIER 46.77 35.63 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.076 0.465 . . . . 0.0 111.016 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -101.1 133.63 45.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.82 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.21 137.04 58.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.989 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.402 HG13 ' HB1' ' A' ' 136' ' ' ALA . 95.7 t -116.82 122.98 71.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.569 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.451 ' CG1' HG23 ' A' ' 160' ' ' VAL . 58.5 t -109.98 117.12 53.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -83.91 139.02 32.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.022 0.439 . . . . 0.0 110.282 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.692 HD11 ' CE1' ' A' ' 137' ' ' TYR . 32.8 mt -100.78 148.64 6.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.472 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -46.71 154.95 0.28 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.336 0.589 . . . . 0.0 111.017 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.93 -36.76 85.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.637 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.97 70.75 1.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.489 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.415 HG13 HG22 ' A' ' 64' ' ' ILE . 1.5 p 176.67 126.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.117 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -122.03 89.94 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.031 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.12 -87.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.79 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -93.9 58.14 2.57 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.063 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 m -107.97 -30.02 8.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 71.6 95.87 0.07 Allowed 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.859 0.724 . . . . 0.0 110.157 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 71.25 144.94 0.06 Allowed 'General case' 0 C--O 1.232 0.182 0 O-C-N 123.567 0.542 . . . . 0.0 110.334 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.6 pt -119.35 151.74 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.247 0.546 . . . . 0.0 109.786 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -119.35 138.05 53.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.797 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -143.52 135.58 26.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.451 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 58.17 -86.25 0.02 OUTLIER 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.684 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.92 30.64 0.81 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -137.11 148.26 46.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.874 0.368 . . . . 0.0 110.869 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.9 m -112.39 129.16 56.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.094 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.3 t -127.37 135.28 63.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.528 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.7 151.64 20.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.548 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -97.48 172.81 7.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 0.0 110.791 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -122.4 -20.2 6.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.016 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -108.35 53.67 0.68 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.044 0.45 . . . . 0.0 110.686 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -60.25 -48.18 82.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.867 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.94 99.21 5.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.531 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -140.21 -64.0 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.21 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.17 -36.76 78.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -62.09 -40.99 97.7 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.089 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -68.56 -39.88 80.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.52 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.6 t -66.99 -42.01 85.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.441 0.639 . . . . 0.0 110.316 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.402 HD23 ' HE2' ' A' ' 97' ' ' MET . 78.1 mt -73.51 -39.57 64.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.261 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -68.47 -39.56 81.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.572 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -92.77 6.35 47.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.427 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.402 ' HE2' HD23 ' A' ' 94' ' ' LEU . 2.4 ttm -61.62 -17.46 55.35 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.739 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.53 157.38 0.19 Allowed 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 123.879 0.737 . . . . 0.0 109.457 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 99' ' ' THR . 22.0 m 70.5 5.31 5.32 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.895 0.747 . . . . 0.0 110.896 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 100' ' ' VAL . 32.7 m -112.79 124.86 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.163 0.506 . . . . 0.0 110.488 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -66.82 -44.21 81.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.159 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.8 p -163.28 162.37 25.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.303 0.573 . . . . 0.0 110.355 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 139' ' ' VAL . 42.5 t -132.7 129.19 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.69 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 98.3 m -119.65 128.93 54.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 0.0 110.072 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -87.31 120.69 28.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.295 0.569 . . . . 0.0 110.634 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.4 t -105.3 116.94 32.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.452 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.5 t -65.43 146.95 54.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.758 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -65.61 -34.62 78.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.283 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -65.87 -40.25 91.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.942 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -69.86 -37.75 76.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.056 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -65.66 -40.27 92.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.097 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -68.8 -38.66 80.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.673 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.26 -37.1 85.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.148 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.421 ' O ' HG12 ' A' ' 118' ' ' ILE . 70.0 mmtt -70.5 -39.25 74.26 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.086 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 118' ' ' ILE . 14.8 mt -65.78 -39.67 91.21 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 123.471 0.482 . . . . 0.0 111.667 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 t -71.66 -33.91 69.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.635 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -69.32 -39.05 78.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.052 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.456 HD11 HD23 ' A' ' 115' ' ' LEU . 39.1 pt -80.76 -33.15 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.362 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 21.7 mmt -80.87 -20.75 41.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.94 102.97 1.4 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.55 -173.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -70.05 77.91 0.5 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.916 0.389 . . . . 0.0 110.324 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -62.05 -32.38 72.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.986 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -102.88 147.25 27.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.656 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.4 mm -101.5 116.31 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.215 0.531 . . . . 0.0 110.658 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.22 26.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -53.95 118.02 3.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.219 0.533 . . . . 0.0 110.792 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 154.09 -157.23 27.34 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -89.33 4.48 48.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.695 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -111.4 149.74 30.79 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -121.58 152.63 58.71 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.582 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.18 -27.9 34.71 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.91 2.406 . . . . 0.0 112.297 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.91 177.56 6.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.915 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.98 -169.9 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.555 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.412 ' CB ' HD12 ' A' ' 64' ' ' ILE . 98.0 m-20 -60.89 147.33 43.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.47 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -130.92 145.22 51.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.692 ' CE1' HD11 ' A' ' 64' ' ' ILE . 3.5 m-85 -115.59 114.07 24.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.127 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 49.8 mt -89.01 106.53 16.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 103' ' ' VAL . 71.8 t -110.74 136.91 45.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.97 0.414 . . . . 0.0 110.751 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -98.72 106.87 19.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.696 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -74.83 150.83 39.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.855 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.589 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 34.0 t-20 -80.91 91.23 5.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.849 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 92.76 149.74 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 O-C-N 124.564 1.165 . . . . 0.0 110.47 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.615 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.7 Cg_exo -60.15 -19.84 58.68 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.862 2.375 . . . . 0.0 112.58 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -86.72 -5.34 59.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.63 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -101.19 -17.85 16.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.784 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 144' ' ' PRO . 18.9 m -58.94 -33.51 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.091 0.472 . . . . 0.0 109.756 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -38.36 65.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.15 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.3 m -68.76 -39.18 80.38 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.524 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.43 -40.3 86.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.403 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.66 -40.43 95.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.472 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.52 -39.39 85.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.723 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -73.3 -35.02 66.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.622 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 157' ' ' ILE . . . -63.52 -34.86 78.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.517 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.525 ' HA ' HG11 ' A' ' 160' ' ' VAL . 68.3 mttm -64.82 -15.14 61.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.023 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -101.39 8.74 42.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 154' ' ' ALA . 8.6 mm -59.45 -69.6 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.18 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 171.87 -77.6 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 123.73 0.643 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -93.23 31.03 6.6 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' A' ' 155' ' ' LYS . 14.4 p -82.43 131.84 32.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.0 t -96.34 -53.97 3.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.929 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -152.93 153.77 33.67 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.62 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 98.3 t -122.78 134.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -118.52 115.57 24.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.472 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.32 114.06 21.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.956 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.545 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.737 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.462 ' C ' HG23 ' A' ' 58' ' ' VAL . 6.9 m120 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 110.548 -0.167 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER 56.38 176.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.497 ' H ' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER 71.57 144.42 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.307 0.575 . . . . 0.0 111.17 179.425 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.9 t -148.52 147.3 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.403 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.544 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 59.2 t -121.7 126.01 74.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.208 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.65 115.35 49.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 CA-C-O 120.946 0.403 . . . . 0.0 110.041 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -85.67 141.13 29.98 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.286 0.565 . . . . 0.0 109.92 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.742 HD11 ' CD1' ' A' ' 137' ' ' TYR . 80.7 mt -115.45 144.7 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.931 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.496 ' O ' ' C ' ' A' ' 66' ' ' LYS . 1.6 mpt_? -44.98 139.17 3.26 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 118.824 -0.608 . . . . 0.0 109.374 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 65' ' ' ARG . 17.5 mttm -5.48 -90.21 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 O-C-N 125.326 1.641 . . . . 0.0 111.466 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.8 p30 -140.14 50.59 1.71 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 69' ' ' GLU . 5.9 p -49.77 -51.71 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.547 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.469 ' N ' HG13 ' A' ' 68' ' ' VAL . 21.8 pt-20 174.64 25.22 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.167 0.292 . . . . 0.0 110.239 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.421 ' HB3' HG21 ' A' ' 64' ' ' ILE . 32.6 p-10 -62.68 -150.69 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.449 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -78.4 60.82 2.68 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.287 0.565 . . . . 0.0 110.089 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.2 t -129.87 92.54 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.547 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -56.84 120.24 7.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 m 61.4 122.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.277 0.56 . . . . 0.0 111.041 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.5 pt -124.1 155.51 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.273 0.559 . . . . 0.0 110.126 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -87.23 111.69 21.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.999 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 78' ' ' GLU . 2.5 mttt -144.18 148.97 35.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.219 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -27.1 102.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.803 1.314 . . . . 0.0 111.076 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.17 22.4 2.9 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 78.12 -159.86 0.03 OUTLIER 'General case' 0 C--N 1.345 0.396 0 O-C-N 123.827 0.369 . . . . 0.0 110.442 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 82.3 p -70.44 120.4 16.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.088 0.47 . . . . 0.0 109.938 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.2 t -118.82 132.17 69.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.153 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.9 p -66.75 151.02 48.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.552 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -92.42 174.57 7.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.957 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -124.37 -4.4 7.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.233 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -128.89 54.63 1.78 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.955 0.407 . . . . 0.0 109.922 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -57.68 -49.42 76.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.841 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -122.95 26.73 8.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.721 0.296 . . . . 0.0 110.673 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -69.55 -45.77 67.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.494 HG12 HD12 ' A' ' 94' ' ' LEU . 86.3 t -69.77 -39.29 77.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.032 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.55 -43.96 97.52 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.181 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.98 -40.87 97.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.599 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -67.98 -41.69 81.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.256 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.494 HD12 HG12 ' A' ' 90' ' ' VAL . 73.3 mt -70.73 -25.69 63.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.654 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -28.7 25.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.042 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -103.51 3.71 35.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.339 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.8 ptm -60.75 -17.21 47.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.953 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.31 152.03 0.13 Allowed 'General case' 0 C--N 1.341 0.231 0 O-C-N 123.869 0.731 . . . . 0.0 109.542 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.1 m 73.59 5.91 4.97 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.841 0.713 . . . . 0.0 110.7 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -108.05 133.1 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-O 121.201 0.524 . . . . 0.0 110.795 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -85.87 -51.75 6.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.975 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -149.04 155.02 40.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.606 HG22 HG12 ' A' ' 139' ' ' VAL . 98.3 t -133.56 128.7 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.237 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.8 m -124.98 132.38 53.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.584 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -90.92 116.98 29.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 109.978 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.7 t -108.11 128.25 54.52 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.087 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 82.9 p -66.02 159.49 25.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.126 0.489 . . . . 0.0 110.86 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -63.98 -33.31 75.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.287 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -63.47 -36.72 84.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.131 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.86 -38.64 83.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.643 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -66.85 -40.9 88.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.647 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.708 ' O ' HG23 ' A' ' 116' ' ' THR . 61.5 t80 -64.71 -43.41 93.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.721 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -64.12 -40.44 96.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.275 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -64.35 -41.75 96.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.933 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.546 HD23 HD11 ' A' ' 118' ' ' ILE . 81.7 mt -68.4 -38.72 81.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.895 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 112' ' ' TYR . 81.2 p -71.38 -32.73 68.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.369 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.25 -40.44 86.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.929 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.546 HD11 HD23 ' A' ' 115' ' ' LEU . 37.8 pt -79.17 -36.1 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.992 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 22.3 mmt -76.28 -37.43 57.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.849 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.11 -137.96 14.49 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -96.12 17.7 15.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.666 0.269 . . . . 0.0 110.621 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -123.18 -160.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 65.81 148.6 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.573 ' HE2' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER 76.36 -70.64 0.13 Allowed 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 124.013 0.821 . . . . 0.0 110.589 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 125' ' ' ILE . 1.0 OUTLIER 56.12 103.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.165 0.507 . . . . 0.0 110.691 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -164.3 -61.15 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.742 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -173.6 -29.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.645 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 108.51 -25.0 20.97 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -102.22 9.85 39.74 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.733 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.573 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . . . -83.33 158.27 22.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.853 0.358 . . . . 0.0 110.7 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -129.03 70.64 81.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.592 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.32 -27.65 55.45 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.842 2.361 . . . . 0.0 112.186 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.21 173.79 7.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.286 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.21 -165.99 1.56 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.059 0.457 . . . . 0.0 110.718 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.01 147.96 52.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.589 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.544 ' HB1' ' CG1' ' A' ' 61' ' ' VAL . . . -130.01 146.5 51.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.702 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.742 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -113.34 108.98 17.97 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.448 HG23 HH11 ' A' ' 59' ' ' ARG . 40.2 mt -86.5 111.32 21.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.652 HG21 HG21 ' A' ' 150' ' ' ILE . 6.4 m -119.4 149.8 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-O 121.115 0.483 . . . . 0.0 109.904 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -105.76 107.52 18.55 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.909 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.09 149.3 43.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.53 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 47.7 t-20 -79.61 87.86 5.15 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.95 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 95.96 153.36 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 125.104 1.502 . . . . 0.0 109.662 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.608 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.4 Cg_endo -63.76 -15.45 48.95 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.135 1.89 . . . . 0.0 112.206 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -88.33 -10.21 50.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.304 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -96.16 -15.48 22.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.338 0.113 . . . . 0.0 111.012 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 144' ' ' PRO . 34.3 m -56.92 -31.96 37.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.47 62.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.246 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.7 m -69.95 -40.15 75.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.194 0.521 . . . . 0.0 110.357 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ILE . . . . . 0.652 HG21 HG21 ' A' ' 139' ' ' VAL . 21.5 mm -66.07 -41.33 89.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.255 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.483 ' CB ' HG21 ' A' ' 163' ' ' VAL . . . -65.86 -40.89 92.09 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.521 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -67.13 -40.54 86.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.585 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -70.06 -39.97 75.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.426 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.99 74.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.734 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -62.13 -20.29 63.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.797 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -86.64 -2.77 58.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.7 mm -83.46 129.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 120.917 0.389 . . . . 0.0 110.119 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.54 140.03 58.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.163 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 91.48 -6.99 80.52 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 160' ' ' VAL . 14.2 p -66.26 131.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 117.295 0.548 . . . . 0.0 110.131 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.7 t -105.62 -48.75 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.475 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -161.66 147.49 13.74 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.725 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.483 HG21 ' CB ' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -131.06 141.71 45.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.196 0.522 . . . . 0.0 111.207 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -138.49 135.88 35.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.55 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -90.28 156.32 18.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.909 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.586 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.774 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.8 p30 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.705 0.288 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 59' ' ' ARG . 61.1 t -57.33 130.5 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 58' ' ' VAL . 10.6 tpt180 158.98 115.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.638 1.211 . . . . 0.0 110.413 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -129.39 134.42 63.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.812 0.339 . . . . 0.0 110.424 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.36 122.58 68.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.93 116.42 52.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -86.98 137.54 32.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.794 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.669 HD11 ' CE1' ' A' ' 137' ' ' TYR . 24.6 mt -105.37 146.53 12.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.495 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ARG . . . . . 0.535 ' O ' ' C ' ' A' ' 66' ' ' LYS . 13.2 mmt180 -46.3 138.22 5.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.823 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 65' ' ' ARG . 18.4 mmtm 8.69 -99.2 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.684 1.24 . . . . 0.0 111.452 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -138.82 69.05 1.37 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.489 HG21 ' HB2' ' A' ' 65' ' ' ARG . 3.3 t -79.02 53.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.705 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 65.8 -74.38 0.06 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.599 0.562 . . . . 0.0 110.591 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.408 ' CG ' HG21 ' A' ' 64' ' ' ILE . 12.1 m-20 51.16 -139.96 0.91 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.647 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -87.37 38.01 0.8 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.764 0.316 . . . . 0.0 110.617 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.9 m -96.97 -147.61 0.31 Allowed 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.406 ' C ' HG23 ' A' ' 74' ' ' THR . 9.8 pt20 -170.59 137.59 1.37 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 73' ' ' GLN . 1.5 p 59.83 116.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.143 0.497 . . . . 0.0 110.262 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 mm -113.09 137.29 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 0.0 110.402 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -85.48 122.59 29.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.037 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -132.62 152.42 51.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.44 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -43.58 -29.49 0.49 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.601 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.45 45.05 2.4 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.12 -168.44 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.921 0.391 . . . . 0.0 110.39 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.0 m -73.01 130.64 40.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.017 0.437 . . . . 0.0 109.834 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.09 137.87 55.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.297 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.2 p -49.42 137.13 15.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.736 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -78.46 -178.38 5.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -150.17 179.04 8.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.056 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.475 ' O ' ' CG ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER 47.15 24.85 0.45 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.305 0.574 . . . . 0.0 110.967 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -45.29 -41.08 8.32 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.199 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.2 60.49 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.646 178.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.37 -55.06 2.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.153 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.7 t -66.82 -36.47 77.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.418 0.628 . . . . 0.0 109.401 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -65.61 -41.05 93.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.431 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -63.55 -40.77 97.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.523 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.0 p -65.66 -36.28 83.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.509 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.423 ' O ' HG21 ' A' ' 103' ' ' VAL . 73.9 mt -80.34 -16.85 53.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.712 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -33.28 14.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.912 0.386 . . . . 0.0 111.567 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -93.91 6.55 48.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.866 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -19.43 2.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.439 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 80.04 -50.64 0.36 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 123.322 0.389 . . . . 0.0 110.935 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 99' ' ' THR . 14.2 m -83.81 22.46 1.12 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.936 0.398 . . . . 0.0 111.348 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.7 m -118.99 150.23 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.082 0.467 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -106.5 -32.77 7.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.492 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.0 t -164.2 148.53 9.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.682 HG22 HG22 ' A' ' 139' ' ' VAL . 98.2 t -132.61 128.13 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.386 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.7 m -120.89 124.38 44.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.92 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -85.07 115.6 22.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.949 0.404 . . . . 0.0 109.933 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.4 t -101.28 113.12 25.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.587 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 85.7 p -66.86 160.87 25.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.88 0.372 . . . . 0.0 110.491 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.96 -31.45 72.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.305 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.95 -38.94 89.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.627 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -67.52 -41.02 85.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.5 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -66.96 -38.35 85.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.749 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.685 ' O ' HG23 ' A' ' 116' ' ' THR . 0.6 OUTLIER -67.44 -37.05 82.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.874 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.92 -39.18 93.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.085 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -65.93 -39.3 90.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.479 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.72 -37.36 82.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.659 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 112' ' ' TYR . 82.8 p -69.64 -33.36 72.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.427 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -68.25 -38.33 81.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.305 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.407 HG13 ' HG2' ' A' ' 119' ' ' MET . 38.7 pt -84.7 -29.95 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.191 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' MET . . . . . 0.407 ' HG2' HG13 ' A' ' 118' ' ' ILE . 37.4 mmt -94.44 -67.71 0.84 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 110.137 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 178.49 166.5 34.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -89.28 8.06 32.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.654 0.264 . . . . 0.0 110.599 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -142.02 32.15 1.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.443 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -103.24 -11.36 18.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.432 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.415 ' O ' HG23 ' A' ' 125' ' ' ILE . 15.7 ptmt -87.75 141.37 28.65 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.853 0.358 . . . . 0.0 110.788 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -157.68 134.39 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.005 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.23 26.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.939 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 64.68 -80.85 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 O-C-N 123.159 0.287 . . . . 0.0 110.681 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.48 -93.49 1.09 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 45.0 p-10 -89.0 -164.8 1.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 129' ' ' ASP . . . 72.01 131.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.729 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -160.95 154.88 18.93 Favored Pre-proline 0 N--CA 1.448 -0.569 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.8 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.28 -13.59 38.17 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.904 2.403 . . . . 0.0 112.312 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.37 153.03 20.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.966 0.412 . . . . 0.0 110.768 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.45 -170.62 2.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.318 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.92 143.76 57.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.775 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.93 148.11 51.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.132 0.491 . . . . 0.0 110.309 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.669 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.1 m-85 -121.24 111.87 17.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.418 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.61 109.96 21.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.682 HG22 HG22 ' A' ' 103' ' ' VAL . 98.4 t -115.68 139.73 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.94 0.4 . . . . 0.0 111.008 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -100.3 105.7 17.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.805 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.91 151.61 38.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.571 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 53.6 t-20 -78.52 89.83 4.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.142 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 93.44 152.18 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.265 0 O-C-N 124.613 1.196 . . . . 0.0 110.176 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.67 ' O ' HG22 ' A' ' 147' ' ' VAL . 33.2 Cg_exo -60.59 -19.95 62.41 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.43 2.087 . . . . 0.0 112.356 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -86.01 -6.9 58.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.512 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -101.19 -15.66 17.27 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.959 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 144' ' ' PRO . 24.3 m -57.96 -35.28 51.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.135 0.493 . . . . 0.0 110.073 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -74.66 -32.61 62.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.995 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.2 m -71.46 -39.52 70.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.551 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 36.8 mm -65.04 -41.35 91.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.4 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.13 98.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.232 0.539 . . . . 0.0 110.282 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.9 -38.46 79.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -69.77 -37.45 76.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.608 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.14 80.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.607 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -62.85 -18.05 62.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.709 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -101.67 7.46 42.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.357 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.9 mt -79.23 -64.78 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.749 0.309 . . . . 0.0 111.46 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -143.07 -89.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.934 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -141.11 78.5 0.29 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.511 HG11 HG13 ' A' ' 163' ' ' VAL . 89.2 t -81.39 109.32 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.12 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.2 p -65.19 -39.9 93.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -150.76 155.96 40.31 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.511 HG13 HG11 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -140.67 123.72 16.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.994 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.43 127.92 49.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.656 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.99 102.92 12.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.453 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.877 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 . . . . . 0 CA--C 1.523 -0.082 0 CA-C-O 120.795 0.331 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.2 m -131.25 160.63 42.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.961 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.12 96.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.053 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.46 126.33 75.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.3 t -114.02 119.96 62.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.205 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 59.4 t -108.95 113.53 44.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -86.18 134.17 33.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.665 HD11 ' CD1' ' A' ' 137' ' ' TYR . 93.9 mt -110.16 140.82 27.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.751 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -47.12 163.55 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.199 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 -12.6 33.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.198 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -83.98 7.56 18.0 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.638 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.56 135.02 43.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.737 0.303 . . . . 0.0 110.358 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -112.14 91.58 3.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.613 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.22 -69.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.778 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -97.34 67.51 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 111.093 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.61 -38.98 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.422 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 63.11 145.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.539 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.89 126.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.261 0.553 . . . . 0.0 110.687 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.1 mt -124.87 140.38 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.37 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.94 113.31 21.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.292 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -132.76 137.33 46.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 57.38 28.09 14.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.482 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.66 16.74 79.06 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -129.53 140.27 51.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.874 0.369 . . . . 0.0 110.583 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.5 m -87.21 120.77 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.194 0.521 . . . . 0.0 110.449 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.07 158.43 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.185 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.7 p -59.5 147.78 35.51 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.667 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -83.02 -37.24 24.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.616 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 68.31 3.03 3.52 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.899 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -140.2 72.9 1.41 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -90.04 -67.89 0.82 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.71 87.02 2.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.318 . . . . 0.0 111.552 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.436 ' HG3' ' H ' ' A' ' 90' ' ' VAL . 14.4 ptmt -122.26 -49.41 2.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.277 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.436 ' H ' ' HG3' ' A' ' 89' ' ' LYS . 99.1 t -71.48 -37.77 65.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.489 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.413 ' CE2' ' HG3' ' A' ' 95' ' ' LYS . 37.0 t80 -64.95 -40.01 94.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.869 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -66.04 -41.25 91.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.432 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.5 m -66.79 -42.2 86.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.336 0.588 . . . . 0.0 110.217 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.527 ' O ' HG11 ' A' ' 100' ' ' VAL . 98.5 mt -69.36 -22.68 63.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.457 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 91' ' ' TYR . 27.4 mmtt -86.79 -31.31 20.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.934 0.397 . . . . 0.0 111.525 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -88.89 -5.14 58.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.999 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.3 ttm -50.71 -19.88 1.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 78.57 -49.45 0.46 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.671 0.388 . . . . 0.0 111.127 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 99' ' ' THR . 17.6 m -82.18 12.22 4.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.951 0.405 . . . . 0.0 111.214 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.527 HG11 ' O ' ' A' ' 94' ' ' LEU . 3.5 p -97.7 141.43 15.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.349 0.595 . . . . 0.0 111.294 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -103.92 -40.02 6.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.579 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.3 t -161.18 148.26 15.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.523 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 139' ' ' VAL . 65.9 t -127.77 126.23 66.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.131 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 85.1 m -116.28 131.17 57.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.103 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 39.1 t80 -89.02 124.69 34.52 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' SER . . . . . 0.726 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -113.81 90.42 3.34 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.316 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.1 t -47.8 142.49 4.73 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 120.874 0.369 . . . . 0.0 110.766 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -60.66 -39.01 86.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.655 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -41.8 81.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.944 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -69.6 -37.88 77.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.329 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLN . . . . . 0.506 HE21 HD23 ' A' ' 115' ' ' LEU . 70.1 tp60 -65.3 -39.55 92.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.086 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.662 ' O ' HG23 ' A' ' 116' ' ' THR . 49.2 t80 -62.67 -42.09 99.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.767 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.52 -39.94 94.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.143 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -65.53 -39.24 91.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.794 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.949 HD13 HD11 ' A' ' 118' ' ' ILE . 2.2 mm? -67.11 -36.45 81.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.67 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 112' ' ' TYR . 70.3 p -69.95 -34.32 73.27 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.675 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.2 -39.55 82.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.926 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.949 HD11 HD13 ' A' ' 115' ' ' LEU . 44.7 pt -77.91 -27.18 14.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.065 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -72.65 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.265 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.85 -170.49 41.33 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -76.45 126.67 31.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.685 0.279 . . . . 0.0 110.745 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 30.7 m120 55.76 57.75 5.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.021 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' HG22 ' A' ' 116' ' ' THR . 12.1 p-90 -91.28 -17.27 26.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.714 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -133.48 -176.84 4.29 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.707 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.87 158.17 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.14 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.47 63.42 0.8 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.953 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.38 -18.12 59.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.641 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.14 -156.3 7.46 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.49 -39.89 89.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.289 . . . . 0.0 110.682 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -168.61 -73.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.882 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -111.05 132.74 21.53 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.39 -24.31 26.91 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.775 2.317 . . . . 0.0 112.086 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.499 HD12 ' HG2' ' A' ' 111' ' ' GLN . 3.5 mm? -78.72 168.16 20.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -123.38 -174.03 2.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.831 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . 0.565 ' O ' ' O ' ' A' ' 136' ' ' ALA . 89.9 m-20 -55.09 -23.34 20.03 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.181 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ALA . . . . . 0.726 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . 42.02 124.67 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.699 0 O-C-N 124.795 1.309 . . . . 0.0 112.357 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.665 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -120.27 106.94 12.39 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.66 -0.65 . . . . 0.0 109.7 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 32.0 mt -86.89 108.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 103' ' ' VAL . 77.4 t -105.8 139.06 28.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.991 0.424 . . . . 0.0 110.666 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -103.05 110.61 22.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.057 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 146' ' ' ASP . . . -68.28 148.69 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.171 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -57.69 -40.09 78.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.04 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.45 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -132.52 158.18 76.35 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.884 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.45 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 33.2 Cg_endo -63.09 -12.17 28.57 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.721 2.281 . . . . 0.0 112.043 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -99.5 -3.97 32.33 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.975 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 96.6 m-20 -96.68 -15.69 21.33 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 122.513 0.325 . . . . 0.0 111.11 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.446 ' H ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -52.56 -34.76 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -71.88 -34.71 69.41 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.746 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 64.9 m -73.56 -38.76 65.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.572 0.701 . . . . 0.0 110.557 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.04 -41.64 87.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.452 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.94 -39.56 93.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -70.75 -30.12 66.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.476 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -74.87 -38.68 61.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.756 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.09 -26.28 64.84 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.906 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -62.63 -23.06 66.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -105.83 7.21 32.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.603 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.2 132.9 30.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.707 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 33.69 -129.43 0.06 Allowed 'General case' 0 CA--C 1.543 0.703 0 O-C-N 124.218 0.949 . . . . 0.0 111.463 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.14 41.6 2.17 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.3 p -43.13 135.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 110.77 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 41.1 t -77.11 -45.96 25.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.977 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -168.39 148.44 4.65 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.035 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.1 t -120.41 128.88 76.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.143 0.497 . . . . 0.0 110.698 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -116.27 119.23 35.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.38 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.64 155.64 16.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.918 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.481 0.181 . . . . 0.0 111.32 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.39 134.76 65.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.5 t -122.08 126.69 74.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.816 0.341 . . . . 0.0 110.827 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 94.2 t -109.05 115.3 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -84.79 135.75 33.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.446 0.641 . . . . 0.0 110.047 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.558 HD11 ' CD1' ' A' ' 137' ' ' TYR . 1.2 mt -107.51 157.89 7.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.327 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 3.3 mpt_? . . . . . 0 CA--C 1.514 -0.416 0 O-C-N 123.632 0.583 . . . . 0.0 110.229 -179.958 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.6 tptt . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 120.973 0.416 . . . . 0.0 110.586 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.6 t -70.41 -38.57 74.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.908 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.78 -44.17 96.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.216 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.47 -39.75 92.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.528 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.3 p -67.84 -36.35 80.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.398 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.92 -17.82 54.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.99 -35.76 20.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.063 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -87.32 6.93 31.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.574 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.5 mtt -50.98 -20.18 1.27 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 77.95 -53.63 0.51 Allowed 'General case' 0 C--N 1.345 0.373 0 O-C-N 123.86 0.725 . . . . 0.0 110.323 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 99' ' ' THR . 28.4 m -85.12 13.48 6.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.312 0.577 . . . . 0.0 110.576 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.52 HG23 HG13 ' A' ' 139' ' ' VAL . 4.5 p -98.41 147.71 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.985 0.422 . . . . 0.0 110.732 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -102.75 -42.88 5.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.348 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.6 t -159.9 146.61 16.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.59 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 139' ' ' VAL . 54.8 t -128.79 126.31 64.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.7 m -124.37 128.78 49.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 110.439 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -86.7 116.89 25.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.086 0.469 . . . . 0.0 110.705 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 t -105.67 114.0 27.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.95 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.6 p -64.59 162.08 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.097 0.475 . . . . 0.0 110.799 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.4 pttt . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.759 -179.333 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.148 0 CA-C-O 120.862 0.363 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.92 144.28 53.37 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.332 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.22 144.87 50.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.07 0.462 . . . . 0.0 110.684 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.558 ' CD1' HD11 ' A' ' 64' ' ' ILE . 1.6 m-85 -118.81 106.34 12.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.36 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -80.24 110.77 16.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.099 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 103' ' ' VAL . 90.3 t -114.55 134.12 58.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.263 0.554 . . . . 0.0 110.821 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -100.79 107.48 19.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.656 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.64 147.2 52.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -58.11 -39.47 78.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.725 0.298 . . . . 0.0 110.291 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.531 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -137.06 160.22 66.9 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.452 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.531 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 23.2 Cg_endo -60.78 -24.13 78.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.787 2.325 . . . . 0.0 112.118 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -88.12 -6.17 58.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.486 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -93.41 -19.28 21.45 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 120.631 0.253 . . . . 0.0 110.353 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 144' ' ' PRO . 8.0 m -57.22 -29.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.254 0.549 . . . . 0.0 109.548 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.11 -37.88 57.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.974 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 95.9 m -72.02 -36.42 69.7 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 121.567 0.699 . . . . 0.0 110.055 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.2 mm -68.2 -39.8 81.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.364 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.421 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -67.93 -39.25 83.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.374 0.607 . . . . 0.0 111.318 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 149' ' ' THR . 1.3 pp20? -71.23 -26.01 62.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.635 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.54 -38.58 23.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.397 0.617 . . . . 0.0 109.774 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.547 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -70.96 -22.56 62.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.63 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.584 ' C ' HG11 ' A' ' 160' ' ' VAL . 5.5 mtpm? -65.74 -17.16 64.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.46 7.12 22.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 154' ' ' ALA . 39.9 mt -87.21 127.78 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.664 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 36.01 -129.12 0.12 Allowed 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.421 1.075 . . . . 0.0 111.043 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -107.13 67.49 0.23 Allowed Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.584 HG11 ' C ' ' A' ' 155' ' ' LYS . 3.7 p -74.36 107.42 4.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.055 0.455 . . . . 0.0 110.122 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 t -61.13 -44.62 97.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.788 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -169.46 159.32 8.47 Favored 'General case' 0 C--O 1.202 -1.441 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.846 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 151' ' ' ALA . 68.2 t -128.71 133.4 66.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 120.719 0.295 . . . . 0.0 110.263 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -119.88 124.27 45.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.921 0.391 . . . . 0.0 110.74 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -90.11 115.81 27.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.736 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.824 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 . . . . . 0 C--O 1.227 -0.099 0 CA-C-O 120.866 0.365 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.1 t -144.41 144.88 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.237 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.618 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 57.4 t -120.71 127.4 75.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.807 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 63.2 t -108.82 117.07 53.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -83.97 138.78 32.95 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.765 0.793 . . . . 0.0 110.54 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.746 HD11 ' CE1' ' A' ' 137' ' ' TYR . 61.6 mt -106.31 161.24 5.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.704 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.499 ' N ' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.214 0 O-C-N 123.661 0.601 . . . . 0.0 110.454 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 tptt . . . . . 0 N--CA 1.446 -0.633 0 CA-C-O 120.948 0.404 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.405 HG13 HG21 ' A' ' 157' ' ' ILE . 95.1 t -69.75 -39.27 77.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.881 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -64.82 -41.16 95.98 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.553 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -66.91 -39.57 87.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.339 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.6 m -65.55 -42.12 92.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.172 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.02 -39.27 66.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.015 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -37.67 84.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.018 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -95.56 6.47 48.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.683 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.2 ttm -63.31 -19.26 64.45 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.612 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 t 72.47 160.71 0.23 Allowed 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 99' ' ' THR . 14.3 m 72.21 2.16 4.21 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 124.111 0.882 . . . . 0.0 110.925 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.636 HG13 HD12 ' A' ' 150' ' ' ILE . 5.3 m -112.23 139.49 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 110.543 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -40.71 28.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.537 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 85.4 p -164.81 162.0 20.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 139' ' ' VAL . 96.0 t -133.59 131.81 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.146 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.1 m -125.76 136.74 53.49 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 121.012 0.434 . . . . 0.0 110.973 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -87.37 124.67 33.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.188 0.518 . . . . 0.0 110.137 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.732 ' OG ' ' HB3' ' A' ' 136' ' ' ALA . 18.7 p -116.75 108.98 16.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.953 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.6 m -61.38 165.65 4.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.445 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? . . . . . 0 C--N 1.328 -0.358 0 CA-C-O 120.995 0.426 . . . . 0.0 110.143 -179.462 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.153 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.75 143.59 57.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.224 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.732 ' HB3' ' OG ' ' A' ' 106' ' ' SER . . . -134.01 137.68 44.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.007 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.746 ' CE1' HD11 ' A' ' 64' ' ' ILE . 4.6 m-85 -101.99 113.33 26.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.5 mt -88.7 109.9 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 150' ' ' ILE . 4.4 m -116.14 148.39 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.175 0.512 . . . . 0.0 109.815 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -105.84 107.12 17.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.217 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.514 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -62.42 141.4 58.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.824 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -52.89 -26.52 15.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.296 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -161.38 165.77 16.13 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-O 121.262 0.553 . . . . 0.0 110.75 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.644 ' O ' HG22 ' A' ' 147' ' ' VAL . 43.1 Cg_exo -56.69 -30.33 83.52 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.747 2.298 . . . . 0.0 111.715 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -84.09 -7.49 59.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -96.99 -20.06 18.33 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.617 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 144' ' ' PRO . 13.0 m -56.12 -31.12 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.233 0.539 . . . . 0.0 110.034 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.491 ' HG3' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -78.34 -33.93 48.83 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.045 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.8 m -71.1 -39.51 72.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.335 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.636 HD12 HG13 ' A' ' 100' ' ' VAL . 46.3 mm -67.72 -40.39 83.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.392 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.464 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -63.87 -41.55 97.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.366 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.5 -38.91 81.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.821 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.18 -35.99 74.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.533 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.8 81.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.503 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.598 ' HA ' HG11 ' A' ' 160' ' ' VAL . 96.0 mttt -65.25 -17.08 64.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.091 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -98.69 7.77 45.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.99 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 158' ' ' GLU . 12.0 mm -65.02 -86.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.435 ' N ' HG22 ' A' ' 157' ' ' ILE . 4.5 mt-10 -165.37 -79.03 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.808 0.337 . . . . 0.0 110.549 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -93.78 34.66 4.52 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 155' ' ' LYS . 7.4 p -76.79 94.68 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.476 0.655 . . . . 0.0 110.723 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.0 t -63.95 -45.41 89.31 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.27 165.13 37.62 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.914 0.387 . . . . 0.0 110.375 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.465 HG21 ' HG3' ' A' ' 155' ' ' LYS . 21.7 t -142.14 138.26 30.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.788 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -140.31 138.16 34.72 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.644 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -80.61 178.39 8.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.897 0.38 . . . . 0.0 110.686 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.619 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? . . . . . 0 N--CA 1.445 -0.698 0 CA-C-O 121.373 0.606 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.34 140.36 48.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.453 HG13 ' HB1' ' A' ' 136' ' ' ALA . 75.1 t -120.25 126.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.534 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 49.7 t -111.04 124.76 68.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.184 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -91.9 136.23 33.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.13 0.49 . . . . 0.0 110.114 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.619 HD11 ' CD1' ' A' ' 137' ' ' TYR . 96.6 mt -110.15 143.94 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.528 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.404 179.682 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.04 0.448 . . . . 0.0 110.779 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 94' ' ' LEU . 90.2 t -64.79 -35.77 75.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -64.92 -41.33 95.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.434 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.54 -39.59 77.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.647 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.4 p -68.01 -40.18 83.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.879 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 90' ' ' VAL . 97.7 mt -74.6 -39.91 61.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.019 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -37.69 75.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.666 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -95.89 6.74 48.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.059 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.525 ' HB3' HG23 ' A' ' 100' ' ' VAL . 9.1 ttm -56.79 -17.27 8.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 119.258 -0.401 . . . . 0.0 111.031 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 97' ' ' MET . 0.9 OUTLIER 84.79 -61.35 0.08 Allowed 'General case' 0 C--N 1.353 0.738 0 O-C-N 123.952 0.783 . . . . 0.0 110.762 -179.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 99' ' ' THR . 31.9 m -68.13 -7.41 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.029 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 97' ' ' MET . 94.0 t -96.52 118.84 43.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.883 0.373 . . . . 0.0 110.788 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -69.76 -43.58 71.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.81 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -155.4 159.04 39.57 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.323 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.589 HG22 HG12 ' A' ' 139' ' ' VAL . 89.6 t -133.52 129.88 56.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.601 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.413 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 89.4 m -123.13 124.13 42.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -86.81 113.71 22.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.025 0.44 . . . . 0.0 110.542 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.2 t -100.4 105.47 16.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.78 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.2 p -65.11 163.6 14.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.936 0.398 . . . . 0.0 110.098 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.574 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.14 -179.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.862 0.363 . . . . 0.0 110.951 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -58.36 140.75 53.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.939 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.453 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -123.67 143.3 50.34 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.522 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.619 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -117.06 108.22 15.47 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 38.1 mt -89.06 110.59 21.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 103' ' ' VAL . 14.9 m -119.4 150.49 21.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.134 0.493 . . . . 0.0 110.09 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -102.86 106.89 17.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.167 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.72 144.95 47.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.612 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 4.9 m-80 -69.32 83.57 0.38 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.765 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 90.52 157.43 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 O-C-N 124.281 0.988 . . . . 0.0 110.56 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.658 ' O ' HG22 ' A' ' 147' ' ' VAL . 35.6 Cg_exo -59.89 -24.26 75.48 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.842 2.361 . . . . 0.0 112.582 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -80.1 -10.07 59.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.263 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -97.59 -19.96 17.98 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 120.586 0.231 . . . . 0.0 111.127 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 144' ' ' PRO . 11.0 m -53.63 -31.83 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -76.47 -32.93 58.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.853 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 87.0 m -72.95 -37.88 66.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.516 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.579 HG21 HG21 ' A' ' 139' ' ' VAL . 50.8 mm -71.25 -40.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.319 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.28 -40.36 81.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 149' ' ' THR . 2.3 pp20? -75.12 -31.25 61.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.73 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -78.14 -37.27 46.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.386 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -66.16 -36.12 82.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.968 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -62.55 -15.58 51.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.757 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -96.85 5.94 49.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.089 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 154' ' ' ALA . 84.6 mt -93.06 129.86 42.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.675 0.274 . . . . 0.0 110.614 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 44.05 -121.03 0.76 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.251 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.56 54.76 0.76 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -45.14 146.42 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.5 p -97.02 -35.37 10.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.422 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -170.07 158.91 7.28 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.412 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.05 143.69 39.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.673 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -140.29 132.19 27.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.522 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.66 124.96 48.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.581 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.575 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 . . . . . 0 N--CA 1.469 0.519 0 CA-C-O 120.808 0.337 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -129.44 137.43 56.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.39 126.04 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 0.0 110.654 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 90.5 t -110.33 118.97 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.386 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -86.17 133.54 33.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.165 0.507 . . . . 0.0 109.715 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.596 HD11 ' CE1' ' A' ' 137' ' ' TYR . 2.6 mt -100.62 149.75 5.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.916 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.706 179.644 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 121.146 0.498 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.58 HG12 HD12 ' A' ' 94' ' ' LEU . 78.0 t -67.12 -38.44 81.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.796 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -63.39 -43.77 96.6 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.04 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.65 -40.13 96.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.652 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.3 t -70.25 -39.52 74.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.239 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.58 HD12 HG12 ' A' ' 90' ' ' VAL . 79.4 mt -76.42 -20.77 56.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.049 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.59 -33.15 16.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -89.68 7.27 37.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -17.63 6.77 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.155 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 77.12 -68.35 0.18 Allowed 'General case' 0 C--N 1.35 0.591 0 O-C-N 123.39 0.431 . . . . 0.0 110.776 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.7 m -58.02 -19.26 29.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.037 0.446 . . . . 0.0 110.531 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.41 133.72 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.137 0.494 . . . . 0.0 110.798 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -82.13 -43.27 18.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.178 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.2 p -160.01 159.27 31.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.237 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.503 HG22 HG12 ' A' ' 139' ' ' VAL . 91.1 t -132.83 128.72 57.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.141 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.0 m -121.07 125.24 46.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.842 0.353 . . . . 0.0 110.243 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -85.66 115.66 23.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.832 0.349 . . . . 0.0 110.112 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.4 t -105.05 108.66 20.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.258 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -59.85 159.95 8.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.431 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.438 . . . . 0.0 110.058 -179.425 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 110.549 -0.167 . . . . 0.0 110.549 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.77 144.7 56.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.087 0.47 . . . . 0.0 110.132 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.67 145.73 50.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.605 -179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.2 m-85 -117.53 106.97 13.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.763 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.5 mt -92.07 111.13 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 150' ' ' ILE . 6.3 m -116.45 150.21 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.204 0.525 . . . . 0.0 110.133 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -107.55 107.86 18.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.1 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 146' ' ' ASP . . . -63.28 142.21 58.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.614 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -54.59 -34.61 62.25 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.941 0.4 . . . . 0.0 110.119 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -141.74 159.27 60.45 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 121.124 0.488 . . . . 0.0 110.859 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.596 ' O ' HG22 ' A' ' 147' ' ' VAL . 35.9 Cg_exo -56.79 -26.39 66.15 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.652 2.235 . . . . 0.0 111.911 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -88.06 -7.57 56.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.759 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.501 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 91.5 m-20 -92.28 -20.31 21.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.286 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 144' ' ' PRO . 20.0 m -55.98 -33.28 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.312 0.577 . . . . 0.0 109.652 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -33.33 57.61 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.534 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 95.6 m -71.73 -39.34 70.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.393 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.537 HG21 HG21 ' A' ' 139' ' ' VAL . 23.5 mm -67.85 -40.63 83.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.928 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.37 97.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.932 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.84 -38.95 87.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.584 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.95 -37.59 81.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.264 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.31 73.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.768 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -62.56 -23.12 66.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.262 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -92.02 -7.93 47.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.984 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.4 mm -55.65 -23.06 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.031 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 73.84 131.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.166 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.01 82.99 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.4 t -79.14 119.94 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 O-C-N 122.659 -0.318 . . . . 0.0 110.541 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.2 t -62.89 -48.02 80.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -168.5 152.64 5.88 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.407 HG22 HG13 ' A' ' 62' ' ' VAL . 99.2 t -121.15 135.41 61.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.804 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -124.9 126.25 45.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.783 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.6 115.7 27.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.386 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.656 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.689 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.982 0.42 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -125.43 139.82 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.884 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.423 HG11 ' CZ ' ' A' ' 63' ' ' TYR . 89.9 t -120.19 124.28 72.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.939 0.399 . . . . 0.0 110.924 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 69.9 t -114.35 107.76 23.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.724 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.423 ' CZ ' HG11 ' A' ' 61' ' ' VAL . 91.8 m-85 -82.22 146.19 29.64 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.056 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.754 HD11 ' CE1' ' A' ' 137' ' ' TYR . 34.2 mt -113.94 146.2 18.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.728 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.532 0.282 0 CA-C-O 121.419 0.628 . . . . 0.0 111.32 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 tptp . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.086 0.47 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.63 -35.38 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.249 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -67.8 -41.03 83.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.125 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.39 -40.44 95.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.438 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.6 m -66.04 -40.37 90.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.26 -13.89 59.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.696 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -95.74 -32.68 12.61 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.972 0.415 . . . . 0.0 111.531 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -91.59 4.77 51.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.923 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.5 mtt -52.16 -19.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.449 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t 77.15 -65.6 0.28 Allowed 'General case' 0 C--N 1.345 0.403 0 O-C-N 123.331 0.395 . . . . 0.0 110.078 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.7 m -62.81 -19.07 63.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.483 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.57 HG23 HG13 ' A' ' 139' ' ' VAL . 7.1 p -71.96 146.21 11.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.137 0.494 . . . . 0.0 111.496 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -98.57 -44.81 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.648 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -161.19 159.05 28.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.075 0.464 . . . . 0.0 110.472 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.694 HG22 HG22 ' A' ' 139' ' ' VAL . 53.9 t -134.83 129.29 51.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.602 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.439 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 96.3 m -122.18 132.95 54.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.223 0.535 . . . . 0.0 110.653 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -86.14 124.45 32.56 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.488 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -110.83 89.94 3.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.063 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -51.65 145.43 9.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.345 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.7 pttt . . . . . 0 C--N 1.323 -0.546 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.538 -179.469 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.491 0 CA-C-O 119.932 -0.08 . . . . 0.0 111.159 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.61 ' CB ' HD12 ' A' ' 64' ' ' ILE . 66.9 m-20 72.73 -48.05 0.68 Allowed 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.138 0.899 . . . . 0.0 112.456 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . 41.44 124.32 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.695 0 O-C-N 124.36 1.037 . . . . 0.0 112.36 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.754 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -114.2 106.44 14.37 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.471 -0.768 . . . . 0.0 110.113 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 57.6 mt -84.25 108.1 16.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.694 HG22 HG22 ' A' ' 103' ' ' VAL . 79.8 t -108.95 137.4 41.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.076 0.465 . . . . 0.0 110.753 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -107.33 111.28 23.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.427 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.6 146.21 46.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.665 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.1 -34.04 54.91 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.225 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -141.44 160.02 58.52 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 120.755 0.312 . . . . 0.0 110.45 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 34.7 Cg_endo -64.47 -20.2 65.84 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.644 2.229 . . . . 0.0 112.197 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.86 -4.3 58.87 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -103.34 -8.62 20.12 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.722 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 148' ' ' LYS . 10.1 m -62.31 -27.49 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 109.757 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.43 ' HG3' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -81.63 -33.4 31.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.992 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 m -72.85 -39.08 66.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.415 0.626 . . . . 0.0 110.525 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 19.1 mm -69.68 -39.93 78.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.287 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.32 -40.53 97.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.576 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -72.1 -29.46 64.11 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.494 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -76.89 -35.87 57.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.561 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.67 -34.57 78.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.649 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.35 -14.11 46.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.81 -1.06 57.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.054 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -91.15 131.28 38.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.332 0.587 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -64.57 141.08 58.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.321 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 64' ' ' ILE . . . 95.87 -14.46 64.68 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.44 127.26 36.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.519 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -94.6 -49.88 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.849 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.88 142.92 24.01 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.85 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.08 132.39 67.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.784 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -136.05 148.6 48.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.221 0.534 . . . . 0.0 110.474 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 58.4 p-10 -87.05 -172.13 3.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.901 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.755 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.697 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 tpp85 . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.3 t -128.89 132.24 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.9 t -119.52 121.51 66.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.437 HG21 ' CB ' ' A' ' 154' ' ' ALA . 75.6 t -108.52 118.31 55.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -86.13 132.27 34.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.525 HD11 ' CE1' ' A' ' 137' ' ' TYR . 4.4 mt -91.38 150.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.119 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 . . . . . 0 C--O 1.236 0.365 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.254 179.707 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.52 -0.194 0 CA-C-O 120.903 0.382 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.9 t -69.1 -38.32 77.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.701 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -62.0 -44.86 95.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.653 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.99 -39.69 95.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.38 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.8 p -67.15 -38.44 85.5 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.414 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.2 mt -69.27 -39.38 78.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.755 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -68.39 -36.37 79.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.558 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -99.76 7.97 44.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.763 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.506 ' CE ' HG23 ' A' ' 150' ' ' ILE . 4.1 ttm -62.25 -18.89 62.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.262 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 t 74.32 158.76 0.21 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 99' ' ' THR . 7.3 m 69.48 4.93 4.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.877 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.29 153.37 14.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 CA-C-O 120.953 0.406 . . . . 0.0 110.298 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -101.28 -37.19 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.786 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.6 t -162.39 152.19 16.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.953 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.655 HG22 HG22 ' A' ' 139' ' ' VAL . 60.6 t -130.97 128.95 63.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.492 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.9 m -123.91 129.37 50.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.635 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -87.35 119.0 27.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.137 0.494 . . . . 0.0 109.928 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.6 t -106.67 116.61 32.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.788 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -63.96 155.68 30.18 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.5 pttm . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.45 . . . . 0.0 110.084 -179.647 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.918 0.389 . . . . 0.0 109.993 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -61.85 150.23 37.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.72 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.56 145.88 45.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.612 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.525 ' CE1' HD11 ' A' ' 64' ' ' ILE . 3.8 m-85 -117.39 114.58 23.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.7 mt -89.79 113.95 26.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.655 HG22 HG22 ' A' ' 103' ' ' VAL . 74.5 t -116.71 136.48 53.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.634 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -100.38 108.74 20.83 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.069 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 145.98 50.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.772 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -59.28 -41.09 88.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.278 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -132.16 159.57 71.6 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.577 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 147' ' ' VAL . 32.7 Cg_endo -63.42 -22.98 71.51 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.592 2.195 . . . . 0.0 112.223 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -89.53 -5.06 57.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.212 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.424 ' O ' HG12 ' A' ' 150' ' ' ILE . 96.7 m-20 -97.57 -16.37 20.09 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.35 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 144' ' ' PRO . 29.6 m -55.0 -34.03 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.549 0.69 . . . . 0.0 109.322 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -73.73 -33.26 64.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.933 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.5 m -71.14 -38.77 72.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.456 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.506 HG23 ' CE ' ' A' ' 97' ' ' MET . 43.7 mm -66.59 -40.92 87.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.962 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.583 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -63.28 -39.43 94.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.742 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.47 -33.69 71.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.62 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -71.45 -39.31 71.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.974 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -63.07 -35.08 79.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.277 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.402 ' HG3' HG21 ' A' ' 163' ' ' VAL . 6.1 mttp -61.88 -25.93 67.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.708 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -105.88 -4.62 20.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.565 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 154' ' ' ALA . 2.5 mt -60.66 -51.56 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.384 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.403 ' N ' HG22 ' A' ' 157' ' ' ILE . 67.5 mm-40 -151.76 -97.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.02 80.66 0.22 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.1 m -92.7 134.14 31.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.1 p -69.28 -34.38 74.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.161 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -172.41 163.9 5.63 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.645 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.583 HG11 ' HB1' ' A' ' 151' ' ' ALA . 47.8 t -133.97 138.17 50.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -130.07 133.12 46.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.16 135.25 41.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.995 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 179.853 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 CA-C-O 120.861 0.362 . . . . 0.0 110.93 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.5 t -126.65 140.23 49.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -119.58 124.86 73.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.12 0.486 . . . . 0.0 110.604 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.602 HG13 HG22 ' A' ' 163' ' ' VAL . 59.5 t -114.0 110.01 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -78.48 144.23 35.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.116 0.484 . . . . 0.0 110.316 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.725 HD11 ' CE1' ' A' ' 137' ' ' TYR . 49.3 mt -111.64 137.0 46.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.837 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 . . . . . 0 C--N 1.325 -0.479 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.619 -179.662 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 121.057 0.456 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.78 -39.37 84.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.177 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.1 -43.6 98.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.635 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.82 -39.01 90.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.504 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.2 m -66.59 -42.29 87.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.406 0.622 . . . . 0.0 110.52 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.0 mt -72.58 -33.8 67.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.704 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -80.89 -27.37 36.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.846 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -93.95 -3.58 51.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.117 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.79 -19.02 2.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.977 -0.535 . . . . 0.0 111.025 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.24 -54.51 0.43 Allowed 'General case' 0 C--N 1.346 0.431 0 O-C-N 123.992 0.808 . . . . 0.0 110.543 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 99' ' ' THR . 31.6 m -72.21 -5.17 33.88 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.767 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.666 HG13 HG13 ' A' ' 139' ' ' VAL . 24.8 t -91.0 123.97 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.948 0.404 . . . . 0.0 111.2 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.99 -43.53 64.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.868 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.0 t -161.74 157.54 24.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.109 0.48 . . . . 0.0 110.53 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.642 HG22 HG22 ' A' ' 139' ' ' VAL . 63.6 t -131.35 127.66 60.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.214 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.511 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 98.8 m -120.92 129.22 53.38 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 120.968 0.413 . . . . 0.0 110.027 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -90.97 109.68 20.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.167 0.508 . . . . 0.0 110.779 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.1 t -96.07 114.27 25.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.305 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.6 p -67.96 162.62 23.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.929 0.395 . . . . 0.0 110.534 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt . . . . . 0 C--N 1.322 -0.62 0 CA-C-O 121.033 0.444 . . . . 0.0 109.98 -179.761 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.527 0.066 0 CA-C-O 120.889 0.376 . . . . 0.0 110.29 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -65.92 141.1 58.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.54 144.75 50.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.465 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.725 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.4 m-85 -112.23 108.74 18.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.023 0.44 . . . . 0.0 110.551 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 59.6 mt -86.34 104.37 13.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.666 HG13 HG13 ' A' ' 100' ' ' VAL . 92.5 t -110.79 137.61 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.167 0.508 . . . . 0.0 111.074 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -101.36 105.53 16.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.112 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.41 144.81 51.42 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.833 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.642 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 14.0 t-20 -69.36 84.57 0.39 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.04 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 92.24 149.67 0.05 OUTLIER Pre-proline 0 N--CA 1.451 -0.396 0 O-C-N 124.301 1.001 . . . . 0.0 110.553 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 147' ' ' VAL . 34.4 Cg_exo -57.97 -21.25 48.85 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.629 2.22 . . . . 0.0 112.709 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -82.7 -6.31 59.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.244 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -104.36 -13.49 16.09 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.925 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 144' ' ' PRO . 10.4 m -58.89 -30.89 43.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -75.71 -33.24 60.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.721 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.1 m -72.56 -40.18 66.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.678 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.53 HD12 HG23 ' A' ' 100' ' ' VAL . 47.5 mm -68.57 -40.02 81.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.753 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.481 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -63.97 -39.68 94.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.682 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -70.16 -38.53 75.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.053 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.08 -36.92 72.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.42 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.805 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -65.62 -16.59 63.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.62 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -91.56 -1.43 57.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.47 134.76 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.038 0.447 . . . . 0.0 110.535 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.02 143.47 57.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.623 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 90.55 -10.09 75.62 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.48 137.09 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 120.88 0.371 . . . . 0.0 110.637 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t -108.36 -51.43 2.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -154.42 141.08 18.98 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.602 HG22 HG13 ' A' ' 62' ' ' VAL . 40.0 t -125.06 135.58 63.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.775 0.322 . . . . 0.0 110.793 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -138.29 144.81 40.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.988 0.423 . . . . 0.0 110.288 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -110.03 155.3 22.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.733 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.613 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.518 0 CA-C-O 120.864 0.364 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.38 127.06 68.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.3 t -115.36 118.76 59.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 96.7 t -105.91 119.18 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 110.424 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -88.1 129.1 35.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.57 HD11 ' CD1' ' A' ' 137' ' ' TYR . 1.9 mt -98.12 143.54 12.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.965 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 . . . . . 0 C--N 1.328 -0.349 0 CA-C-O 121.142 0.496 . . . . 0.0 110.985 179.589 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm . . . . . 0 N--CA 1.446 -0.644 0 CA-C-O 121.188 0.518 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.1 t -66.33 -38.59 82.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.099 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -61.46 -43.2 99.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.542 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -65.34 -40.37 93.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.235 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.7 m -66.03 -40.8 91.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.508 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -76.72 -21.1 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.946 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -89.92 -25.81 20.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.152 0.501 . . . . 0.0 111.253 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -94.02 9.54 37.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.281 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 67.8 mmm -56.84 -18.14 11.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.024 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 82.02 -49.52 0.22 Allowed 'General case' 0 C--N 1.349 0.557 0 O-C-N 123.531 0.519 . . . . 0.0 110.956 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.789 ' HB ' HD11 ' A' ' 150' ' ' ILE . 32.8 m -81.28 -13.97 57.89 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.757 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.463 HG22 ' CG1' ' A' ' 139' ' ' VAL . 37.8 t -82.78 141.96 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.915 0.388 . . . . 0.0 111.366 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -98.33 -43.51 6.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.042 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.6 t -153.74 149.81 27.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.093 0.473 . . . . 0.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 139' ' ' VAL . 55.4 t -131.11 129.93 63.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.973 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.1 m -122.66 127.43 49.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.233 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -83.96 120.59 26.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.918 0.39 . . . . 0.0 110.325 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 29.1 t -108.01 107.06 17.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.892 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.0 m -61.62 159.64 12.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.189 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.31 0 CA-C-O 121.259 0.552 . . . . 0.0 110.147 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.199 0 CA-C-O 120.74 0.305 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -68.51 150.16 48.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.482 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -128.96 150.0 50.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.347 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.57 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -125.98 110.86 14.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.3 mt -88.71 109.79 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 103' ' ' VAL . 35.0 t -109.82 137.68 40.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.265 0.555 . . . . 0.0 111.152 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -100.95 107.81 19.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.798 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.555 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -72.49 150.3 43.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.34 -40.98 79.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.891 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -136.97 159.99 67.92 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.676 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.537 ' O ' HG22 ' A' ' 147' ' ' VAL . 33.7 Cg_exo -59.04 -23.34 68.29 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.694 2.263 . . . . 0.0 112.168 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -91.32 -4.53 55.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.378 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -99.04 -12.71 20.32 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 141' ' ' ALA . 22.3 m -61.91 -32.66 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -74.25 -35.33 63.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.934 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.4 m -71.61 -40.04 70.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.487 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.789 HD11 ' HB ' ' A' ' 99' ' ' THR . 30.2 mm -67.43 -39.54 82.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.495 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.443 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -62.81 -39.97 95.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.968 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.52 -38.76 90.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.725 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -69.91 -37.27 75.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.656 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -61.09 -35.71 77.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.465 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.92 -16.94 61.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.728 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -97.61 6.25 48.3 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.993 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 154' ' ' ALA . 96.3 mt -98.41 129.01 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 40.48 -117.64 0.3 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.624 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.33 77.89 0.39 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 154' ' ' ALA . 43.3 t -78.47 122.09 32.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.9 p -68.17 -40.85 82.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.155 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -174.87 152.69 1.58 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.917 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.443 HG11 ' HB1' ' A' ' 151' ' ' ALA . 57.5 t -124.91 133.83 68.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.948 0.404 . . . . 0.0 110.784 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -122.54 129.86 52.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.845 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -104.35 128.56 52.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.655 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.693 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? . . . . . 0 C--O 1.235 0.309 0 CA-C-O 120.952 0.406 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.5 140.12 49.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.862 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.6 t -117.46 115.35 48.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.337 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -99.1 109.51 24.44 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.608 ' CD2' ' HB2' ' A' ' 136' ' ' ALA . 58.3 m-85 -80.0 139.19 37.08 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.068 0.461 . . . . 0.0 110.848 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.692 HD12 ' OD2' ' A' ' 135' ' ' ASP . 72.2 mt -111.22 159.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.69 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.445 ' N ' HG22 ' A' ' 64' ' ' ILE . 35.9 mmt180 . . . . . 0 N--CA 1.463 0.211 0 O-C-N 123.558 0.536 . . . . 0.0 110.541 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? . . . . . 0 N--CA 1.454 -0.236 0 CA-C-O 121.088 0.47 . . . . 0.0 110.708 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.98 -40.66 81.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.345 0.593 . . . . 0.0 109.853 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -63.06 -44.81 94.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.501 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.36 -40.58 96.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.644 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.2 m -66.12 -38.64 88.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.253 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.65 -11.85 59.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.82 -39.53 16.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.812 0.339 . . . . 0.0 111.681 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -85.69 7.17 24.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -52.04 -19.8 2.08 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.295 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 77.02 -62.22 0.41 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.497 0.319 . . . . 0.0 110.759 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.735 ' HB ' HD11 ' A' ' 150' ' ' ILE . 91.2 m -65.48 -11.87 47.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.63 HG23 HG13 ' A' ' 139' ' ' VAL . 7.1 p -79.53 139.49 18.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.636 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -95.71 -43.47 7.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.289 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.3 p -158.55 154.24 26.32 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.389 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 139' ' ' VAL . 57.3 t -135.22 127.95 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.751 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.1 m -127.32 134.25 50.01 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.007 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -79.29 121.77 25.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.214 0.531 . . . . 0.0 109.901 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.7 t -115.64 122.99 47.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.151 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.3 t -67.98 163.15 22.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.37 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 pttt . . . . . 0 C--N 1.327 -0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.711 -179.655 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.104 0 N-CA-C 110.421 -0.215 . . . . 0.0 110.421 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.692 ' OD2' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -51.91 140.43 19.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.91 179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.608 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . . . -142.48 151.36 41.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.729 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.545 ' CE1' HD11 ' A' ' 64' ' ' ILE . 14.1 m-85 -98.98 120.46 39.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.388 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 58.0 mt -82.6 100.23 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.63 HG13 HG23 ' A' ' 100' ' ' VAL . 73.6 t -101.41 131.14 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.597 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -99.5 107.78 20.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.989 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.419 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -66.98 146.28 54.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.439 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -57.87 -36.91 73.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.079 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -139.64 159.2 66.26 Favored Pre-proline 0 C--N 1.328 -0.326 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.859 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.584 ' O ' HG22 ' A' ' 147' ' ' VAL . 34.0 Cg_exo -57.91 -28.1 81.38 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.501 2.134 . . . . 0.0 112.033 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -86.16 -5.49 59.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.225 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -95.65 -14.67 23.28 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.399 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 144' ' ' PRO . 16.2 m -62.68 -32.52 55.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -75.56 -37.85 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.075 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.1 m -69.72 -40.59 76.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.17 0.51 . . . . 0.0 110.456 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.735 HD11 ' HB ' ' A' ' 99' ' ' THR . 31.6 mm -67.47 -39.58 82.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.464 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.59 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -63.55 -41.7 98.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.152 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.26 -39.59 82.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.859 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.14 -38.05 75.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.001 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.37 -27.85 67.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.663 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -61.76 -20.95 64.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.806 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.64 -8.96 57.0 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.694 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 14.1 mm -74.46 130.36 36.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.098 0.475 . . . . 0.0 110.818 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -65.91 138.76 58.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.273 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 94.9 -14.14 65.87 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.484 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.26 127.35 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 122.339 -0.507 . . . . 0.0 110.91 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.8 p -95.15 -32.48 13.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.015 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -170.84 160.39 6.78 Favored 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.186 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 151' ' ' ALA . 19.5 t -133.97 134.56 55.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.318 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -131.96 124.18 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.743 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -79.11 178.4 8.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 0.0 110.761 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.608 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.463 0.175 0 CA-C-O 121.029 0.442 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.3 t -128.11 140.69 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.048 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 136' ' ' ALA . 91.9 t -120.12 126.54 75.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.9 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 65.1 t -114.33 112.21 39.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -79.52 139.17 37.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.21 0.529 . . . . 0.0 110.091 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.614 HD11 ' HD1' ' A' ' 137' ' ' TYR . 3.9 mm -96.86 156.78 3.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.041 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HA ' ' HB3' ' A' ' 161' ' ' SER . 13.7 mmt180 . . . . . 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.433 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.382 0 CA-C-O 121.123 0.487 . . . . 0.0 110.824 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.0 t -70.3 -39.72 77.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.017 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.519 ' HE1' HG13 ' A' ' 103' ' ' VAL . 81.5 t80 -63.12 -44.62 95.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.517 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.23 -39.91 94.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.806 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.435 ' HB3' HD12 ' A' ' 157' ' ' ILE . 67.8 m -68.93 -40.15 79.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.345 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.56 -30.34 67.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.653 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -34.61 66.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -84.57 6.36 24.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 7.7 mmm -57.53 -19.18 23.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 119.634 -0.222 . . . . 0.0 110.884 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 75.34 -68.22 0.21 Allowed 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.4 0.438 . . . . 0.0 110.687 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 99' ' ' THR . 86.7 m -60.83 -14.79 24.11 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.806 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.623 HG23 HG13 ' A' ' 139' ' ' VAL . 10.8 p -73.22 145.62 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.129 0.49 . . . . 0.0 111.304 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.35 -43.46 5.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.583 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.2 t -159.23 149.02 18.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.275 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.519 HG13 ' HE1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -136.04 130.45 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.232 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.0 m -125.24 131.04 53.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.311 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 87.1 t80 -87.69 113.75 23.66 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.927 0.394 . . . . 0.0 110.543 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.1 t -97.16 106.54 18.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.726 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -64.09 156.02 29.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.151 0.501 . . . . 0.0 110.364 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.418 -179.71 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.099 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.403 ' HB3' ' CE1' ' A' ' 105' ' ' PHE . 45.8 m-20 -79.84 167.89 19.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.674 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -141.23 149.4 41.3 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.785 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.614 ' HD1' HD11 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -118.05 105.48 11.9 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.7 mt -80.73 103.35 7.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.623 HG13 HG23 ' A' ' 100' ' ' VAL . 73.8 t -106.69 137.3 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.099 0.476 . . . . 0.0 111.261 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -102.18 108.01 19.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.295 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.439 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -69.5 142.93 53.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.721 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.92 -32.73 34.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.631 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -149.91 163.16 25.71 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-O 121.235 0.541 . . . . 0.0 111.307 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.622 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.7 Cg_exo -58.17 -28.64 84.7 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.591 2.194 . . . . 0.0 112.004 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -86.52 -5.41 59.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.232 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.55 -16.99 19.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 144' ' ' PRO . 20.1 m -58.12 -34.08 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -33.99 63.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.885 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.4 m -71.35 -39.35 71.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.654 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.423 HG21 HG11 ' A' ' 139' ' ' VAL . 22.9 mm -66.37 -40.66 87.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.622 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.17 96.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.468 0.651 . . . . 0.0 110.523 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -68.8 -39.43 80.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.847 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -71.06 -36.28 72.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.12 -35.46 78.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.329 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -61.44 -18.7 60.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.16 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.43 -14.7 39.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.679 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 93' ' ' SER . 9.9 mm -57.86 -100.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.757 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 171.17 138.43 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 78.78 13.75 82.79 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.644 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.1 t -81.84 127.21 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.618 -0.342 . . . . 0.0 110.335 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 77.8 p -96.58 -34.88 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.481 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.32 157.95 6.42 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.917 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.25 142.28 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.091 0.472 . . . . 0.0 110.389 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -142.11 119.89 11.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.854 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -82.12 173.26 12.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.784 0.326 . . . . 0.0 110.874 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.694 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 120.933 0.397 . . . . 0.0 110.321 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.894 HG22 HG23 ' A' ' 147' ' ' VAL . 15.1 t -129.24 137.16 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.964 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.03 122.81 70.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.707 HG13 HG22 ' A' ' 163' ' ' VAL . 3.5 t -112.32 105.0 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -74.36 146.34 43.09 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.728 HD11 ' CD1' ' A' ' 137' ' ' TYR . 65.9 mt -120.07 135.12 61.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.732 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.321 -0.644 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.603 179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 12.4 tptp . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 120.994 0.426 . . . . 0.0 110.527 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.7 t -65.21 -42.99 95.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.207 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -66.95 -42.45 85.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.66 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.74 -38.69 83.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.449 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 t -68.17 -42.77 79.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.487 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.29 -26.02 62.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.915 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -91.64 -30.53 16.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.699 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -99.88 2.87 44.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.446 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -15.93 61.72 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 72.7 158.54 0.2 Allowed 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 123.643 0.589 . . . . 0.0 109.711 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.572 ' HB ' HD11 ' A' ' 150' ' ' ILE . 4.5 m 72.66 5.6 5.26 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.908 0.755 . . . . 0.0 110.818 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 100' ' ' VAL . 27.6 m -110.39 121.13 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -61.86 -44.95 95.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.0 p -163.39 163.72 24.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.22 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 139' ' ' VAL . 49.2 t -134.69 129.27 51.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.266 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.1 m -121.92 132.38 54.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.981 0.419 . . . . 0.0 110.719 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.465 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 84.4 t80 -88.79 106.95 18.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.439 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.2 t -95.67 118.5 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.004 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.2 p -70.82 160.81 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.379 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.6 pttm . . . . . 0 C--N 1.327 -0.404 0 CA-C-O 121.075 0.464 . . . . 0.0 110.571 179.684 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.522 -0.122 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.465 ' HB3' ' CE1' ' A' ' 105' ' ' PHE . 93.7 m-20 -74.5 131.96 41.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.659 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.86 137.32 54.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.072 0.463 . . . . 0.0 111.361 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.728 ' CD1' HD11 ' A' ' 64' ' ' ILE . 8.4 m-85 -95.48 120.3 35.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 51.4 mt -92.63 104.4 15.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 103' ' ' VAL . 85.0 t -105.65 132.74 51.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.4 . . . . 0.0 110.355 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -98.99 107.09 19.44 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.484 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.44 142.92 57.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.954 0.407 . . . . 0.0 110.684 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -59.44 -40.22 86.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.208 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.525 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -136.84 160.7 65.31 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 121.15 0.5 . . . . 0.0 110.91 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 30.3 Cg_endo -62.94 -15.22 46.17 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.701 2.267 . . . . 0.0 111.87 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -96.81 -5.66 37.88 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.406 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -98.19 -24.15 15.4 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 120.71 0.29 . . . . 0.0 110.581 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.894 HG23 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -55.5 -36.57 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.19 179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -71.54 -35.71 70.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.926 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.9 m -73.05 -39.7 65.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.454 0.645 . . . . 0.0 110.58 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 99' ' ' THR . 25.5 mm -69.31 -38.99 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.39 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.23 -40.05 95.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.238 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -66.08 -40.03 90.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.57 -37.39 73.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.865 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.01 72.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.774 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HG3' HG21 ' A' ' 163' ' ' VAL . 60.5 mtpt -72.66 -13.07 61.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.081 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -107.57 9.99 29.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.859 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.411 HG22 ' N ' ' A' ' 158' ' ' GLU . 8.5 mm -55.08 -88.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.51 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.411 ' N ' HG22 ' A' ' 157' ' ' ILE . 67.2 mm-40 -151.93 -84.56 0.08 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.631 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.89 35.66 4.71 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.49 143.84 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.993 0.425 . . . . 0.0 109.952 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.7 t -97.34 -51.33 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -166.46 145.89 5.8 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.001 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.707 HG22 HG13 ' A' ' 62' ' ' VAL . 95.1 t -117.99 129.26 74.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.023 0.439 . . . . 0.0 111.013 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -128.25 128.27 44.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.762 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -77.61 168.97 19.11 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.424 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.5 131.61 57.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.582 HG13 ' HB1' ' A' ' 136' ' ' ALA . 87.8 t -121.07 124.01 71.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.74 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 80.0 t -111.38 114.71 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.136 0.494 . . . . 0.0 111.463 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -79.31 134.77 36.62 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.121 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.839 HD11 ' CD1' ' A' ' 137' ' ' TYR . 54.5 mt -117.5 139.33 45.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.734 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.589 179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.5 tptp . . . . . 0 C--O 1.233 0.189 0 CA-C-O 121.357 0.598 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.484 HG13 HG21 ' A' ' 157' ' ' ILE . 79.0 t -69.23 -38.83 78.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.631 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -60.37 -45.85 92.04 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.017 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.54 -39.91 92.28 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.585 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 t -65.9 -42.25 90.47 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.409 0.623 . . . . 0.0 110.425 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.413 HD12 HG12 ' A' ' 90' ' ' VAL . 91.6 mt -73.19 -36.23 66.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.883 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -37.37 68.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.023 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -91.57 6.91 43.83 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.805 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.38 -19.88 0.95 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.539 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t 67.77 67.55 0.36 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.671 ' CG2' HD11 ' A' ' 150' ' ' ILE . 1.0 OUTLIER 167.21 -23.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.809 0.693 . . . . 0.0 110.257 179.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.2 m -85.78 149.27 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.113 0.482 . . . . 0.0 111.413 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -91.62 -43.17 9.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.016 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.9 p -154.22 152.75 30.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.082 0.468 . . . . 0.0 110.491 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.625 HG22 HG22 ' A' ' 139' ' ' VAL . 77.3 t -132.56 128.64 58.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.766 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.5 m -124.68 131.34 53.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.781 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.495 ' HE1' HD12 ' A' ' 64' ' ' ILE . 53.0 t80 -92.58 122.2 34.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.548 0.689 . . . . 0.0 110.108 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -101.17 106.95 18.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.702 178.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.0 m -66.43 145.33 55.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 110.88 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.9 pttt . . . . . 0 CA--C 1.514 -0.42 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.928 179.621 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.986 0.422 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.73 -169.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.582 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -161.73 127.78 3.7 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.839 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -105.96 106.38 16.85 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.4 mt -82.9 110.58 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.625 HG22 HG22 ' A' ' 103' ' ' VAL . 84.3 t -115.41 137.02 50.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.048 0.451 . . . . 0.0 110.47 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -101.34 109.33 21.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.041 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.51 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -70.65 147.39 49.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.587 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -57.53 -40.0 77.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.041 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -135.2 159.95 69.98 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.638 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 147' ' ' VAL . 25.0 Cg_endo -61.07 -19.34 62.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.379 2.053 . . . . 0.0 112.215 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -91.52 -5.49 54.07 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.234 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.462 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 83.3 m-20 -98.92 -16.12 18.91 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.241 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 144' ' ' PRO . 28.3 m -60.0 -33.17 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 121.18 0.514 . . . . 0.0 109.736 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -38.25 63.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.454 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.8 m -68.73 -40.35 79.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.3 0.571 . . . . 0.0 110.797 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.671 HD11 ' CG2' ' A' ' 99' ' ' THR . 31.2 mm -64.43 -41.27 91.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.494 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.31 98.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.314 0.578 . . . . 0.0 109.965 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.42 -40.21 89.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.745 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.06 -37.47 78.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.765 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.424 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -62.53 -32.94 73.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.382 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -61.72 -19.93 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.102 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -92.86 6.59 47.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.998 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.484 HG21 HG13 ' A' ' 90' ' ' VAL . 17.3 mm -88.14 120.98 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 41.91 -97.06 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.464 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -159.95 52.16 0.36 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.1 m -46.7 163.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-O 120.723 0.297 . . . . 0.0 110.362 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.4 t -83.93 -50.36 8.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.165 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -169.48 148.76 3.84 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.706 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.41 HG12 HG13 ' A' ' 62' ' ' VAL . 22.4 m -120.22 148.56 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.253 0.549 . . . . 0.0 110.484 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -142.01 148.82 39.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.652 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.46 135.48 51.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.451 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.766 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 121.101 0.476 . . . . 0.0 110.58 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.84 137.48 53.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.983 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.41 123.8 72.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.856 0.36 . . . . 0.0 110.47 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 90.1 t -108.52 116.13 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.24 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -85.35 134.58 34.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 137' ' ' TYR . 71.6 mt -98.61 147.8 6.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.743 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.721 179.631 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 tptt . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.868 0.366 . . . . 0.0 110.75 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.4 t -66.68 -40.28 85.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.782 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -66.71 -41.71 87.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.489 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -65.01 -40.56 95.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.385 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.6 m -68.24 -37.32 80.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.124 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.3 mt -79.14 -11.48 59.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.018 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -94.81 -32.87 13.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.866 0.365 . . . . 0.0 111.407 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -89.55 8.52 30.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.185 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 77.5 mmm -53.46 -20.16 4.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.841 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.35 -48.22 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.613 0.571 . . . . 0.0 110.74 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.454 ' HB ' HD11 ' A' ' 150' ' ' ILE . 3.9 m -88.17 17.76 4.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 0.0 110.83 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 139' ' ' VAL . 6.3 p -107.25 138.55 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.12 0.486 . . . . 0.0 111.262 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -95.54 -42.24 8.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.795 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.6 t -157.98 150.1 22.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.585 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 139' ' ' VAL . 58.2 t -131.58 128.84 61.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.736 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.401 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 99.3 m -125.42 132.47 52.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.546 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -86.9 118.77 26.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.006 0.431 . . . . 0.0 110.599 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.2 t -105.83 118.01 35.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.403 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.1 m -69.14 150.34 47.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.088 0.471 . . . . 0.0 110.601 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.6 pttt . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.787 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.129 0 CA-C-O 120.796 0.331 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.59 140.39 51.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.11 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.57 151.14 49.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.197 0.523 . . . . 0.0 110.696 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.574 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.3 m-85 -120.08 110.48 16.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.159 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 51.6 mt -83.43 108.25 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 103' ' ' VAL . 69.4 t -113.28 137.19 47.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.17 0.509 . . . . 0.0 110.979 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -99.21 106.9 19.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.18 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.614 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -75.87 146.51 39.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.584 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.9 m-80 -75.32 88.79 2.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.604 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 87.95 156.66 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 O-C-N 123.945 0.778 . . . . 0.0 110.716 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.689 ' O ' HG22 ' A' ' 147' ' ' VAL . 36.6 Cg_exo -59.74 -24.84 77.2 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.584 2.189 . . . . 0.0 112.468 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -78.35 -13.62 59.77 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.513 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 142' ' ' ASN . 82.5 m-20 -97.73 -17.08 19.61 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 120.651 0.262 . . . . 0.0 111.309 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 144' ' ' PRO . 4.6 m -61.17 -32.97 54.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -75.83 -34.24 60.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.62 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.7 m -70.98 -40.03 72.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.42 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.454 HD11 ' HB ' ' A' ' 99' ' ' THR . 33.4 mm -65.69 -41.1 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.297 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.23 95.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.321 0.581 . . . . 0.0 110.166 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -66.85 -40.48 87.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.719 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.47 -32.77 66.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.265 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.04 69.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.771 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.569 ' HA ' HG11 ' A' ' 160' ' ' VAL . 68.0 mttm -62.2 -18.05 59.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.323 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.64 8.27 45.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.73 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 17.6 mm -84.59 117.87 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.682 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 38.49 -115.31 0.15 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.09 0.869 . . . . 0.0 111.519 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -120.7 40.57 2.12 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 155' ' ' LYS . 11.5 p -42.96 146.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.0 p -92.74 -47.44 7.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.222 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -165.39 154.12 11.91 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.819 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.02 140.96 47.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.774 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -143.28 137.36 28.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -90.2 179.11 5.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.713 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.661 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.808 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 120.915 0.388 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -138.23 141.19 38.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.388 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.6 t -116.19 125.04 73.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.489 HG21 ' HB1' ' A' ' 154' ' ' ALA . 61.0 t -109.16 116.63 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.182 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -84.35 138.65 32.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.561 HD11 ' CE1' ' A' ' 137' ' ' TYR . 1.5 mt -102.11 153.28 5.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.122 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 . . . . . 0 C--O 1.236 0.382 0 CA-C-O 121.728 0.775 . . . . 0.0 110.831 179.469 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 tttp . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.153 0.502 . . . . 0.0 110.309 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.8 -37.52 69.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.441 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -64.48 -43.54 93.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.914 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.34 -37.62 74.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.422 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -64.92 -42.13 94.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.4 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.1 mt -69.32 -39.77 78.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.834 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -68.82 -24.3 64.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.076 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -90.56 4.53 50.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.477 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.8 mmt -59.83 -23.37 63.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.653 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.32 -62.22 0.45 Allowed 'General case' 0 C--N 1.349 0.585 0 O-C-N 123.466 0.479 . . . . 0.0 111.196 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.575 ' HB ' HD11 ' A' ' 150' ' ' ILE . 53.7 m -59.39 -17.25 28.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.114 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.3 m -86.38 149.89 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.773 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -90.83 -42.36 10.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.916 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.5 p -157.57 156.47 32.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.528 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 139' ' ' VAL . 59.7 t -134.84 129.89 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.913 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.2 m -125.76 131.76 52.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.003 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -87.03 116.26 24.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.064 0.459 . . . . 0.0 110.379 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.4 t -104.74 119.89 40.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.607 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.3 t -62.41 160.4 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.028 0.442 . . . . 0.0 110.207 -179.853 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.796 0.332 . . . . 0.0 110.49 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.87 154.26 22.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -142.46 151.28 41.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.871 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.561 ' CE1' HD11 ' A' ' 64' ' ' ILE . 4.7 m-85 -123.06 112.19 17.47 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.209 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.3 mt -86.85 111.24 21.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 103' ' ' VAL . 78.4 t -114.8 138.27 45.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.366 0.603 . . . . 0.0 110.82 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -104.85 108.31 19.74 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.25 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -66.58 145.95 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -57.45 -39.3 76.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.796 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -137.39 161.33 61.39 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.813 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.522 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.0 Cg_exo -59.64 -19.94 55.45 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.848 2.365 . . . . 0.0 112.062 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -95.16 -4.79 45.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.641 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -97.61 -22.11 16.68 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 120.762 0.315 . . . . 0.0 110.574 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.568 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 6.6 p -57.8 -35.07 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.004 0.43 . . . . 0.0 109.961 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -71.88 -34.99 69.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.813 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 59.7 m -73.25 -38.75 65.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.98 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.575 HD11 ' HB ' ' A' ' 99' ' ' THR . 33.4 mm -69.06 -40.46 80.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.37 95.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.635 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 149' ' ' THR . 1.0 OUTLIER -76.87 -24.46 52.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.129 -179.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -85.1 -34.85 22.12 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.253 0.549 . . . . 0.0 110.547 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.489 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -69.49 -30.02 67.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -67.84 -12.18 60.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 110.998 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -105.65 9.12 33.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.078 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.501 HG22 ' HG2' ' A' ' 158' ' ' GLU . 7.0 mm -53.78 -78.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.77 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.501 ' HG2' HG22 ' A' ' 157' ' ' ILE . 81.5 mm-40 -145.44 -80.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.135 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.04 62.11 0.52 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.72 156.66 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 110.28 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.4 t -109.81 -42.77 4.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.322 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -166.63 153.62 9.14 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.614 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.75 135.5 60.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.5 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -137.8 133.56 34.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -78.23 178.43 7.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.833 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.829 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 . . . . . 0 N--CA 1.448 -0.531 0 CA-C-O 121.091 0.472 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.4 ' CG2' HG23 ' A' ' 147' ' ' VAL . 95.5 t -125.42 133.43 69.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.646 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.513 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 78.9 t -115.5 122.46 69.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.47 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.1 t -106.74 108.71 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.108 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 136' ' ' ALA . 82.4 m-85 -81.18 145.61 30.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.998 0.427 . . . . 0.0 110.026 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.726 HD11 ' CE1' ' A' ' 137' ' ' TYR . 78.3 mt -111.82 157.75 12.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.853 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . 0.458 ' N ' HG22 ' A' ' 64' ' ' ILE . 28.1 mmt85 . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.569 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.313 0.578 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.02 -38.99 79.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.121 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -61.01 -41.79 97.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.418 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -36.81 73.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.41 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.6 m -67.05 -41.98 85.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.351 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.9 mt -71.71 -39.55 70.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.975 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -66.85 -31.56 72.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.274 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -82.56 5.23 21.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.402 ' HE3' ' HB2' ' A' ' 153' ' ' ASP . 3.1 mmt -55.81 -24.63 37.31 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.865 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 76.47 -56.18 0.57 Allowed 'General case' 0 C--N 1.343 0.322 0 O-C-N 123.365 0.416 . . . . 0.0 110.469 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 99' ' ' THR . 92.6 m -71.07 -10.95 60.64 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.454 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.28 137.93 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 120.891 0.377 . . . . 0.0 110.96 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -86.34 -43.22 13.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.494 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.4 t -156.35 151.24 26.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.434 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.576 HG22 HG12 ' A' ' 139' ' ' VAL . 95.7 t -130.25 128.79 64.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.983 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.6 m -119.02 130.42 55.64 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 110.578 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -90.76 113.67 25.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.077 0.465 . . . . 0.0 110.66 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.7 t -94.02 107.54 19.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.058 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.1 t -57.72 142.42 45.34 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.319 0.58 . . . . 0.0 110.862 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.015 -179.742 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.649 0.261 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.86 149.62 24.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.68 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.513 ' HB1' ' CG1' ' A' ' 61' ' ' VAL . . . -131.4 141.62 49.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.726 ' CE1' HD11 ' A' ' 64' ' ' ILE . 13.7 m-85 -99.04 115.71 29.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.816 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.7 mt -93.88 111.38 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 150' ' ' ILE . 4.7 m -115.49 150.83 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.054 0.454 . . . . 0.0 110.312 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -108.74 107.7 18.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.42 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.83 139.11 58.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -58.32 -39.15 78.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -134.95 162.14 59.49 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-O 121.16 0.505 . . . . 0.0 110.711 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 29.2 Cg_endo -63.42 -15.08 46.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.76 2.307 . . . . 0.0 111.385 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.73 -5.21 31.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.711 0.291 . . . . 0.0 110.301 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -92.38 -25.81 18.34 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 120.706 0.289 . . . . 0.0 110.731 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.427 ' H ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -49.65 -35.22 9.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.816 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -33.03 60.66 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.685 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.401 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 84.3 m -72.1 -39.87 68.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.406 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.665 HG21 HG21 ' A' ' 139' ' ' VAL . 40.1 mm -69.88 -40.51 78.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.513 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.91 -41.76 86.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 149' ' ' THR . 25.1 pt-20 -73.59 -33.85 64.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.558 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.402 ' HB2' ' HE3' ' A' ' 97' ' ' MET . 95.7 m-20 -71.65 -35.76 70.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.559 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.07 73.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.345 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -61.13 -20.46 62.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -3.67 58.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.62 120.4 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.472 0.653 . . . . 0.0 110.477 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -58.28 147.48 30.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.646 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 91.58 -9.49 76.97 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 160' ' ' VAL . 10.9 p -66.5 129.73 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 120.988 0.423 . . . . 0.0 110.266 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 62.1 p -100.65 -42.77 6.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.467 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -167.81 145.61 4.46 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.16 133.92 67.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.441 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -139.62 136.81 34.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.391 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -88.82 179.7 6.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.8 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.765 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.601 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 . . . . . 0 N--CA 1.446 -0.668 0 CA-C-O 120.921 0.391 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.565 HG13 ' HB ' ' A' ' 139' ' ' VAL . 0.9 OUTLIER -128.06 139.73 51.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.86 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.604 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 63.7 t -117.25 122.97 71.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.829 0.347 . . . . 0.0 110.742 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 91.3 t -103.58 115.67 45.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.118 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -79.7 132.02 36.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.996 0.426 . . . . 0.0 110.121 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.843 HD11 ' CD1' ' A' ' 137' ' ' TYR . 64.4 mt -109.82 135.16 49.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.883 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.807 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.869 0.366 . . . . 0.0 110.637 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.03 -35.65 75.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.794 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -64.6 -40.17 95.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.898 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -67.94 -40.18 83.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.704 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.646 ' HB3' HD12 ' A' ' 157' ' ' ILE . 65.9 m -67.03 -40.24 87.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.476 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.419 ' O ' HG11 ' A' ' 100' ' ' VAL . 75.6 mt -70.96 -37.71 72.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -65.99 -30.5 71.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.268 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -87.23 4.25 43.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.3 mmt -56.49 -23.61 40.53 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.81 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.79 -47.45 0.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.335 0.397 . . . . 0.0 110.38 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' HD11 ' A' ' 150' ' ' ILE . 16.9 m -88.53 18.77 4.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.278 0.561 . . . . 0.0 110.676 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 139' ' ' VAL . 3.3 p -104.04 141.37 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.152 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -101.06 -40.87 7.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.228 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.5 t -160.27 148.84 16.92 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.453 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 139' ' ' VAL . 58.9 t -127.24 126.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.548 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.577 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 99.9 m -117.68 126.03 51.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.18 0.514 . . . . 0.0 110.571 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 43.4 t80 -92.59 119.16 31.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.677 ' O ' ' O ' ' A' ' 135' ' ' ASP . 7.4 t -110.94 87.68 2.6 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.07 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 106' ' ' SER . 30.9 t -39.72 139.52 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.942 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.8 pttt . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.931 -178.597 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 . . . . . 0 C--O 1.225 -0.22 0 CA-C-O 120.949 0.404 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.677 ' O ' ' O ' ' A' ' 106' ' ' SER . 96.8 m-20 -58.31 -30.3 66.57 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.868 0.842 . . . . 0.0 110.856 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.604 ' HB1' ' CG1' ' A' ' 61' ' ' VAL . . . 51.98 125.6 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.629 0.728 . . . . 0.0 111.392 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.843 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -112.65 103.65 11.7 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.628 -0.67 . . . . 0.0 109.588 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 1.4 mp -79.27 108.58 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.828 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 100' ' ' VAL . 99.6 t -111.18 135.49 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.407 0.622 . . . . 0.0 111.313 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -96.34 106.36 18.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.327 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 146' ' ' ASP . . . -69.68 147.2 50.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.647 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -52.34 -35.33 50.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.222 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -148.75 164.03 23.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.744 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.497 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.2 Cg_exo -57.73 -29.4 85.57 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.936 2.424 . . . . 0.0 112.071 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -83.64 -3.82 58.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.71 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.494 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 83.8 m-20 -98.73 -10.69 22.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 144' ' ' PRO . 8.6 m -62.44 -29.03 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.461 ' HG3' HG23 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -80.32 -34.16 36.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.02 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 97.5 m -72.34 -40.0 67.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.172 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.57 HD11 ' HB ' ' A' ' 99' ' ' THR . 28.9 mm -66.71 -40.86 87.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.287 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.609 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.24 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.16 -39.11 82.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.708 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -72.3 -34.98 68.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.624 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.07 82.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.43 -17.88 60.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.861 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -93.9 8.07 42.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 93' ' ' SER . 18.2 mm -92.32 119.94 40.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 44.58 -98.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.683 0.615 . . . . 0.0 111.025 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -159.16 48.77 0.41 Allowed Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.3 m -50.5 143.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.355 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.0 t -61.8 -48.38 80.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.942 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -174.39 154.56 2.15 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.552 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.609 HG11 ' HA ' ' A' ' 151' ' ' ALA . 45.1 t -115.96 131.94 66.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.47 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -127.7 127.14 43.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -78.1 174.18 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.575 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.7 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.832 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.366 0.603 . . . . 0.0 110.82 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.21 137.04 58.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.989 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.402 HG13 ' HB1' ' A' ' 136' ' ' ALA . 95.7 t -116.82 122.98 71.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.569 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.451 ' CG1' HG23 ' A' ' 160' ' ' VAL . 58.5 t -109.98 117.12 53.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -83.91 139.02 32.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.022 0.439 . . . . 0.0 110.282 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.692 HD11 ' CE1' ' A' ' 137' ' ' TYR . 32.8 mt -100.78 148.64 6.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.472 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? . . . . . 0 C--N 1.332 -0.184 0 CA-C-O 121.336 0.589 . . . . 0.0 111.017 179.947 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.964 0.411 . . . . 0.0 110.21 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.17 -36.76 78.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -62.09 -40.99 97.7 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.089 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -68.56 -39.88 80.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.52 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.6 t -66.99 -42.01 85.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.441 0.639 . . . . 0.0 110.316 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.402 HD23 ' HE2' ' A' ' 97' ' ' MET . 78.1 mt -73.51 -39.57 64.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.261 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -68.47 -39.56 81.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.572 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -92.77 6.35 47.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.427 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.402 ' HE2' HD23 ' A' ' 94' ' ' LEU . 2.4 ttm -61.62 -17.46 55.35 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.739 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.53 157.38 0.19 Allowed 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 123.879 0.737 . . . . 0.0 109.457 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 99' ' ' THR . 22.0 m 70.5 5.31 5.32 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.895 0.747 . . . . 0.0 110.896 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 100' ' ' VAL . 32.7 m -112.79 124.86 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.163 0.506 . . . . 0.0 110.488 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -66.82 -44.21 81.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.159 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.8 p -163.28 162.37 25.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.303 0.573 . . . . 0.0 110.355 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 139' ' ' VAL . 42.5 t -132.7 129.19 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.69 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 98.3 m -119.65 128.93 54.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 0.0 110.072 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -87.31 120.69 28.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.295 0.569 . . . . 0.0 110.634 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.4 t -105.3 116.94 32.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.452 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.5 t -65.43 146.95 54.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.758 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt . . . . . 0 C--N 1.326 -0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.283 -179.754 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.193 0 CA-C-O 120.807 0.337 . . . . 0.0 110.555 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.412 ' CB ' HD12 ' A' ' 64' ' ' ILE . 98.0 m-20 -60.89 147.33 43.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.47 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -130.92 145.22 51.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.692 ' CE1' HD11 ' A' ' 64' ' ' ILE . 3.5 m-85 -115.59 114.07 24.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.127 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 49.8 mt -89.01 106.53 16.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 103' ' ' VAL . 71.8 t -110.74 136.91 45.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.97 0.414 . . . . 0.0 110.751 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -98.72 106.87 19.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.696 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -74.83 150.83 39.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.855 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.589 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 34.0 t-20 -80.91 91.23 5.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.849 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 92.76 149.74 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 O-C-N 124.564 1.165 . . . . 0.0 110.47 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.615 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.7 Cg_exo -60.15 -19.84 58.68 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.862 2.375 . . . . 0.0 112.58 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -86.72 -5.34 59.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.63 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -101.19 -17.85 16.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.784 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 144' ' ' PRO . 18.9 m -58.94 -33.51 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.091 0.472 . . . . 0.0 109.756 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -38.36 65.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.15 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.3 m -68.76 -39.18 80.38 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.524 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.43 -40.3 86.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.403 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.66 -40.43 95.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.472 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.52 -39.39 85.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.723 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -73.3 -35.02 66.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.622 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 157' ' ' ILE . . . -63.52 -34.86 78.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.517 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.525 ' HA ' HG11 ' A' ' 160' ' ' VAL . 68.3 mttm -64.82 -15.14 61.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.023 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -101.39 8.74 42.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 154' ' ' ALA . 8.6 mm -59.45 -69.6 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.18 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 171.87 -77.6 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 123.73 0.643 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -93.23 31.03 6.6 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' A' ' 155' ' ' LYS . 14.4 p -82.43 131.84 32.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.0 t -96.34 -53.97 3.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.929 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -152.93 153.77 33.67 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.62 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 98.3 t -122.78 134.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -118.52 115.57 24.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.472 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.32 114.06 21.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.956 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.545 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.737 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.448 HH11 HG23 ' A' ' 138' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.533 0.317 0 CA-C-O 121.307 0.575 . . . . 0.0 111.17 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.9 t -148.52 147.3 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.403 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.544 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 59.2 t -121.7 126.01 74.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.208 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.65 115.35 49.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 CA-C-O 120.946 0.403 . . . . 0.0 110.041 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -85.67 141.13 29.98 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.286 0.565 . . . . 0.0 109.92 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.742 HD11 ' CD1' ' A' ' 137' ' ' TYR . 80.7 mt -115.45 144.7 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.931 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? . . . . . 0 CA--C 1.516 -0.35 0 CA-C-O 118.824 -0.608 . . . . 0.0 109.374 179.476 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? . . . . . 0 CA--C 1.518 -0.283 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.494 HG12 HD12 ' A' ' 94' ' ' LEU . 86.3 t -69.77 -39.29 77.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.032 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.55 -43.96 97.52 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.181 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.98 -40.87 97.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.599 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -67.98 -41.69 81.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.256 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.494 HD12 HG12 ' A' ' 90' ' ' VAL . 73.3 mt -70.73 -25.69 63.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.654 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -28.7 25.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.042 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -103.51 3.71 35.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.339 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.8 ptm -60.75 -17.21 47.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.953 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.31 152.03 0.13 Allowed 'General case' 0 C--N 1.341 0.231 0 O-C-N 123.869 0.731 . . . . 0.0 109.542 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.1 m 73.59 5.91 4.97 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.841 0.713 . . . . 0.0 110.7 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -108.05 133.1 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-O 121.201 0.524 . . . . 0.0 110.795 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -85.87 -51.75 6.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.975 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -149.04 155.02 40.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.606 HG22 HG12 ' A' ' 139' ' ' VAL . 98.3 t -133.56 128.7 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.237 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.8 m -124.98 132.38 53.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.584 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -90.92 116.98 29.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 109.978 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.7 t -108.11 128.25 54.52 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.087 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 82.9 p -66.02 159.49 25.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.126 0.489 . . . . 0.0 110.86 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 C--N 1.327 -0.401 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.287 -179.515 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.121 0 CA-C-O 121.059 0.457 . . . . 0.0 110.718 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.01 147.96 52.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.589 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.544 ' HB1' ' CG1' ' A' ' 61' ' ' VAL . . . -130.01 146.5 51.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.702 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.742 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -113.34 108.98 17.97 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.448 HG23 HH11 ' A' ' 59' ' ' ARG . 40.2 mt -86.5 111.32 21.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.652 HG21 HG21 ' A' ' 150' ' ' ILE . 6.4 m -119.4 149.8 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-O 121.115 0.483 . . . . 0.0 109.904 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -105.76 107.52 18.55 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.909 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.09 149.3 43.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.53 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 47.7 t-20 -79.61 87.86 5.15 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.95 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 95.96 153.36 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 125.104 1.502 . . . . 0.0 109.662 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.608 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.4 Cg_endo -63.76 -15.45 48.95 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.135 1.89 . . . . 0.0 112.206 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -88.33 -10.21 50.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.304 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -96.16 -15.48 22.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.338 0.113 . . . . 0.0 111.012 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 144' ' ' PRO . 34.3 m -56.92 -31.96 37.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.47 62.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.246 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.7 m -69.95 -40.15 75.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.194 0.521 . . . . 0.0 110.357 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . 0.652 HG21 HG21 ' A' ' 139' ' ' VAL . 21.5 mm -66.07 -41.33 89.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.255 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.483 ' CB ' HG21 ' A' ' 163' ' ' VAL . . . -65.86 -40.89 92.09 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.521 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -67.13 -40.54 86.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.585 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -70.06 -39.97 75.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.426 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.99 74.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.734 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -62.13 -20.29 63.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.797 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -86.64 -2.77 58.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.7 mm -83.46 129.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 120.917 0.389 . . . . 0.0 110.119 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.54 140.03 58.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.163 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 91.48 -6.99 80.52 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 160' ' ' VAL . 14.2 p -66.26 131.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 117.295 0.548 . . . . 0.0 110.131 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.7 t -105.62 -48.75 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.475 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -161.66 147.49 13.74 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.725 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.483 HG21 ' CB ' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -131.06 141.71 45.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.196 0.522 . . . . 0.0 111.207 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -138.49 135.88 35.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.55 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -90.28 156.32 18.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.909 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.586 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.774 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -129.39 134.42 63.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.812 0.339 . . . . 0.0 110.424 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.36 122.58 68.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.93 116.42 52.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -86.98 137.54 32.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.794 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.669 HD11 ' CE1' ' A' ' 137' ' ' TYR . 24.6 mt -105.37 146.53 12.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.495 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.823 179.191 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.109 0 CA-C-O 120.829 0.347 . . . . 0.0 111.153 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.7 t -66.82 -36.47 77.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.418 0.628 . . . . 0.0 109.401 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -65.61 -41.05 93.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.431 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -63.55 -40.77 97.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.523 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.0 p -65.66 -36.28 83.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.509 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.423 ' O ' HG21 ' A' ' 103' ' ' VAL . 73.9 mt -80.34 -16.85 53.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.712 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -33.28 14.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.912 0.386 . . . . 0.0 111.567 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -93.91 6.55 48.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.866 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -19.43 2.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.439 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 80.04 -50.64 0.36 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 123.322 0.389 . . . . 0.0 110.935 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 99' ' ' THR . 14.2 m -83.81 22.46 1.12 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.936 0.398 . . . . 0.0 111.348 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.7 m -118.99 150.23 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.082 0.467 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -106.5 -32.77 7.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.492 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.0 t -164.2 148.53 9.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.682 HG22 HG22 ' A' ' 139' ' ' VAL . 98.2 t -132.61 128.13 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.386 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.7 m -120.89 124.38 44.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.92 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -85.07 115.6 22.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.949 0.404 . . . . 0.0 109.933 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.4 t -101.28 113.12 25.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.587 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 85.7 p -66.86 160.87 25.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.88 0.372 . . . . 0.0 110.491 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.9 pttt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.305 -179.62 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.226 -0.169 0 CA-C-O 120.83 0.347 . . . . 0.0 110.318 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.92 143.76 57.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.775 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -129.93 148.11 51.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.132 0.491 . . . . 0.0 110.309 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.669 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.1 m-85 -121.24 111.87 17.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.418 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.61 109.96 21.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.682 HG22 HG22 ' A' ' 103' ' ' VAL . 98.4 t -115.68 139.73 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.94 0.4 . . . . 0.0 111.008 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -100.3 105.7 17.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.805 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.91 151.61 38.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.571 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 53.6 t-20 -78.52 89.83 4.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.142 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 93.44 152.18 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.265 0 O-C-N 124.613 1.196 . . . . 0.0 110.176 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.67 ' O ' HG22 ' A' ' 147' ' ' VAL . 33.2 Cg_exo -60.59 -19.95 62.41 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.43 2.087 . . . . 0.0 112.356 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -86.01 -6.9 58.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.512 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -101.19 -15.66 17.27 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.959 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 144' ' ' PRO . 24.3 m -57.96 -35.28 51.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.135 0.493 . . . . 0.0 110.073 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -74.66 -32.61 62.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.995 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.2 m -71.46 -39.52 70.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.551 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 36.8 mm -65.04 -41.35 91.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.4 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.13 98.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.232 0.539 . . . . 0.0 110.282 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.9 -38.46 79.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -69.77 -37.45 76.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.608 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.14 80.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.607 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -62.85 -18.05 62.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.709 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -101.67 7.46 42.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.357 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.9 mt -79.23 -64.78 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.749 0.309 . . . . 0.0 111.46 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -143.07 -89.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.934 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -141.11 78.5 0.29 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.511 HG11 HG13 ' A' ' 163' ' ' VAL . 89.2 t -81.39 109.32 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.12 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.2 p -65.19 -39.9 93.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -150.76 155.96 40.31 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.511 HG13 HG11 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -140.67 123.72 16.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.994 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.43 127.92 49.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.656 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.99 102.92 12.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.453 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.877 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.291 0 CA-C-O 120.702 0.287 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.46 126.33 75.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.3 t -114.02 119.96 62.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.205 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 59.4 t -108.95 113.53 44.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -86.18 134.17 33.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.665 HD11 ' CD1' ' A' ' 137' ' ' TYR . 93.9 mt -110.16 140.82 27.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.751 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 . . . . . 0 C--N 1.324 -0.521 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.199 179.914 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.436 ' HG3' ' H ' ' A' ' 90' ' ' VAL . 14.4 ptmt . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.043 0.449 . . . . 0.0 110.277 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.436 ' H ' ' HG3' ' A' ' 89' ' ' LYS . 99.1 t -71.48 -37.77 65.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.489 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.413 ' CE2' ' HG3' ' A' ' 95' ' ' LYS . 37.0 t80 -64.95 -40.01 94.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.869 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -66.04 -41.25 91.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.432 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.5 m -66.79 -42.2 86.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.336 0.588 . . . . 0.0 110.217 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.527 ' O ' HG11 ' A' ' 100' ' ' VAL . 98.5 mt -69.36 -22.68 63.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.457 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 91' ' ' TYR . 27.4 mmtt -86.79 -31.31 20.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.934 0.397 . . . . 0.0 111.525 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -88.89 -5.14 58.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.999 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.3 ttm -50.71 -19.88 1.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 78.57 -49.45 0.46 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.671 0.388 . . . . 0.0 111.127 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 99' ' ' THR . 17.6 m -82.18 12.22 4.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.951 0.405 . . . . 0.0 111.214 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.527 HG11 ' O ' ' A' ' 94' ' ' LEU . 3.5 p -97.7 141.43 15.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.349 0.595 . . . . 0.0 111.294 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -103.92 -40.02 6.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.579 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.3 t -161.18 148.26 15.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.523 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 139' ' ' VAL . 65.9 t -127.77 126.23 66.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.131 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 85.1 m -116.28 131.17 57.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.103 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 39.1 t80 -89.02 124.69 34.52 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' SER . . . . . 0.726 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -113.81 90.42 3.34 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.316 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.1 t -47.8 142.49 4.73 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 120.874 0.369 . . . . 0.0 110.766 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 pttp . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.655 -179.311 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 N--CA 1.454 -0.273 0 CA-C-O 121.056 0.455 . . . . 0.0 110.831 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ASP . . . . . 0.565 ' O ' ' O ' ' A' ' 136' ' ' ALA . 89.9 m-20 -55.09 -23.34 20.03 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.181 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . 0.726 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . 42.02 124.67 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.699 0 O-C-N 124.795 1.309 . . . . 0.0 112.357 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.665 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -120.27 106.94 12.39 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.66 -0.65 . . . . 0.0 109.7 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 32.0 mt -86.89 108.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 103' ' ' VAL . 77.4 t -105.8 139.06 28.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.991 0.424 . . . . 0.0 110.666 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -103.05 110.61 22.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.057 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 146' ' ' ASP . . . -68.28 148.69 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.171 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -57.69 -40.09 78.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.04 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.45 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -132.52 158.18 76.35 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.884 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.45 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 33.2 Cg_endo -63.09 -12.17 28.57 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.721 2.281 . . . . 0.0 112.043 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -99.5 -3.97 32.33 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.975 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 96.6 m-20 -96.68 -15.69 21.33 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 122.513 0.325 . . . . 0.0 111.11 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.446 ' H ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -52.56 -34.76 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -71.88 -34.71 69.41 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.746 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 64.9 m -73.56 -38.76 65.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.572 0.701 . . . . 0.0 110.557 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.04 -41.64 87.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.452 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.94 -39.56 93.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -70.75 -30.12 66.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.476 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -74.87 -38.68 61.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.756 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.09 -26.28 64.84 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.906 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -62.63 -23.06 66.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -105.83 7.21 32.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.603 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.2 132.9 30.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.707 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 33.69 -129.43 0.06 Allowed 'General case' 0 CA--C 1.543 0.703 0 O-C-N 124.218 0.949 . . . . 0.0 111.463 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.14 41.6 2.17 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.3 p -43.13 135.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 110.77 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 41.1 t -77.11 -45.96 25.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.977 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -168.39 148.44 4.65 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.035 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.1 t -120.41 128.88 76.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.143 0.497 . . . . 0.0 110.698 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -116.27 119.23 35.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.38 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.64 155.64 16.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.918 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 . . . . . 0 CA--C 1.527 0.079 0 CA-C-O 120.689 0.28 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.9 m -122.22 49.15 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.544 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -83.97 111.63 19.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.32 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 43.6 t -123.39 134.76 65.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.411 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 80.5 t -122.08 126.69 74.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.816 0.341 . . . . 0.0 110.827 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 94.2 t -109.05 115.3 49.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -84.79 135.75 33.98 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.446 0.641 . . . . 0.0 110.047 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.813 ' CG2' HG11 ' A' ' 68' ' ' VAL . 1.2 mt -107.51 157.89 7.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.327 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.41 ' O ' ' C ' ' A' ' 66' ' ' LYS . 3.3 mpt_? -40.87 154.66 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.416 0 O-C-N 123.632 0.583 . . . . 0.0 110.229 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' C ' ' O ' ' A' ' 65' ' ' ARG . 46.7 mmtt -30.94 -88.91 0.0 OUTLIER 'General case' 0 C--N 1.342 0.28 0 O-C-N 124.286 0.991 . . . . 0.0 111.552 -178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -109.91 53.24 0.7 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 120.785 0.326 . . . . 0.0 110.568 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.813 HG11 ' CG2' ' A' ' 64' ' ' ILE . 6.7 p -60.32 -26.56 37.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.657 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.551 ' HB2' HD12 ' A' ' 75' ' ' ILE . 12.5 mt-10 56.93 34.85 25.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.103 0.478 . . . . 0.0 110.649 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.58 ' H ' HG13 ' A' ' 68' ' ' VAL . 2.8 t70 -54.71 -45.12 74.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.721 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -101.72 41.35 1.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.642 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -126.86 -126.16 0.23 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.804 -179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 179.62 139.7 0.12 Allowed 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER 57.89 109.3 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.059 0.457 . . . . 0.0 110.847 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 69' ' ' GLU . 10.8 mm -106.52 134.52 47.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.794 0.331 . . . . 0.0 110.456 -178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -83.95 100.28 10.93 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.285 0.564 . . . . 0.0 110.267 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -163.29 145.92 10.16 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.694 -179.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 67.48 -76.46 0.05 Allowed 'General case' 0 C--O 1.233 0.194 0 O-C-N 123.893 0.746 . . . . 0.0 110.901 179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -131.47 84.02 0.3 Allowed Glycine 0 CA--C 1.525 0.701 0 N-CA-C 111.586 -0.606 . . . . 0.0 111.586 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 60.73 -158.57 0.33 Allowed 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.472 0.177 . . . . 0.0 110.758 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.0 p -79.67 131.55 35.99 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-O 121.145 0.498 . . . . 0.0 110.478 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.8 p -127.92 135.15 63.7 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.335 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 p -40.73 130.6 2.48 Favored 'General case' 0 C--N 1.331 -0.219 0 O-C-N 123.425 0.453 . . . . 0.0 111.003 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -84.26 111.48 19.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.715 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -71.79 -4.61 28.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.472 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.93 17.8 21.28 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 120.781 0.324 . . . . 0.0 110.397 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.4 ' HD2' ' N ' ' A' ' 88' ' ' HIS . 0.8 OUTLIER -60.87 115.17 3.49 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 120.511 -0.476 . . . . 0.0 110.74 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.4 ' N ' ' HD2' ' A' ' 87' ' ' TYR . 22.0 m-70 58.72 16.86 4.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.54 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.6 tptt -69.64 -43.67 72.14 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-O 120.973 0.416 . . . . 0.0 110.586 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.458 HG23 ' OD1' ' A' ' 70' ' ' ASP . 93.6 t -70.41 -38.57 74.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.908 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.78 -44.17 96.87 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.216 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -65.47 -39.75 92.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.528 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 93.3 p -67.84 -36.35 80.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.398 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 95.0 mt -78.92 -17.82 54.87 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.71 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -85.99 -35.76 20.19 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.063 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -87.32 6.93 31.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.574 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.5 mtt -50.98 -20.18 1.27 Allowed 'General case' 0 CA--C 1.514 -0.431 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.138 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 77.95 -53.63 0.51 Allowed 'General case' 0 C--N 1.345 0.373 0 O-C-N 123.86 0.725 . . . . 0.0 110.323 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 99' ' ' THR . 28.4 m -85.12 13.48 6.19 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 121.312 0.577 . . . . 0.0 110.576 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.52 HG23 HG13 ' A' ' 139' ' ' VAL . 4.5 p -98.41 147.71 6.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.985 0.422 . . . . 0.0 110.732 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -102.75 -42.88 5.73 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.348 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.6 t -159.9 146.61 16.18 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.59 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 139' ' ' VAL . 54.8 t -128.79 126.31 64.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.847 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.7 m -124.37 128.78 49.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 110.439 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -86.7 116.89 25.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.086 0.469 . . . . 0.0 110.705 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 32.0 t -105.67 114.0 27.9 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.95 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 70.6 p -64.59 162.08 16.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.097 0.475 . . . . 0.0 110.799 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.4 pttt -65.12 -37.71 88.31 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.759 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 81.9 mm-40 -64.64 -39.55 93.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.464 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -73.23 -32.9 65.02 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.429 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -37.7 85.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.541 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.676 ' O ' HG23 ' A' ' 116' ' ' THR . 0.1 OUTLIER -66.43 -41.89 88.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.286 0.565 . . . . 0.0 109.779 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.98 -38.91 83.27 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.349 178.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.466 ' O ' HG23 ' A' ' 118' ' ' ILE . 5.0 mmmt -67.96 -39.15 83.43 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.194 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 118' ' ' ILE . 1.0 OUTLIER -66.04 -38.97 89.71 Favored 'General case' 0 CA--C 1.512 -0.482 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.986 179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.676 HG23 ' O ' ' A' ' 112' ' ' TYR . 68.4 p -73.77 -28.73 61.82 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.284 0.564 . . . . 0.0 110.558 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -72.42 -35.62 68.4 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.805 179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.538 HD11 HD13 ' A' ' 115' ' ' LEU . 50.5 pt -85.05 -26.6 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.671 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 2.1 tpp -111.58 -66.02 1.12 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.762 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 142.85 -165.19 26.96 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.924 -0.87 . . . . 0.0 110.924 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -98.29 24.04 7.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.003 0.43 . . . . 0.0 110.899 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -128.18 33.73 4.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.701 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 3.7 p-90 -125.16 -19.93 5.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.429 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.53 152.27 30.46 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.419 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.4 tt -168.55 39.91 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 122.044 0.926 . . . . 0.0 110.535 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -76.27 -62.99 1.43 Allowed 'General case' 0 C--N 1.313 -1.011 0 O-C-N 121.581 -0.699 . . . . 0.0 110.671 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 174.48 179.15 0.12 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.795 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.13 128.79 42.63 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 55.74 31.47 17.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.843 0.354 . . . . 0.0 110.393 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -63.64 152.97 37.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 34.5 m120 -128.01 67.99 75.09 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.768 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -72.86 -26.92 15.12 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.961 2.441 . . . . 0.0 111.778 179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 80.3 mt -110.75 154.04 24.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.388 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -123.57 -163.33 1.12 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.428 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -60.92 144.28 53.37 Favored 'General case' 0 C--O 1.225 -0.227 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.332 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -132.22 144.87 50.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.07 0.462 . . . . 0.0 110.684 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.558 ' CD1' HD11 ' A' ' 64' ' ' ILE . 1.6 m-85 -118.81 106.34 12.43 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.36 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 57.0 mt -80.24 110.77 16.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.099 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.525 HG22 HG22 ' A' ' 103' ' ' VAL . 90.3 t -114.55 134.12 58.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.263 0.554 . . . . 0.0 110.821 -179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.6 mp0 -100.79 107.48 19.05 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.656 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -68.64 147.2 52.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.794 179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -58.11 -39.47 78.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.725 0.298 . . . . 0.0 110.291 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.531 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -137.06 160.22 66.9 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.452 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.531 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 23.2 Cg_endo -60.78 -24.13 78.17 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 C-N-CA 122.787 2.325 . . . . 0.0 112.118 179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -88.12 -6.17 58.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.486 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -93.41 -19.28 21.45 Favored 'General case' 0 C--O 1.215 -0.738 0 CA-C-O 120.631 0.253 . . . . 0.0 110.353 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.5 HG22 ' O ' ' A' ' 144' ' ' PRO . 8.0 m -57.22 -29.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.254 0.549 . . . . 0.0 109.548 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -76.11 -37.88 57.56 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.773 -0.648 . . . . 0.0 109.974 178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.515 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 95.9 m -72.02 -36.42 69.7 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 121.567 0.699 . . . . 0.0 110.055 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 32.2 mm -68.2 -39.8 81.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.364 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.421 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -67.93 -39.25 83.54 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.374 0.607 . . . . 0.0 111.318 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.515 ' HG3' ' O ' ' A' ' 149' ' ' THR . 1.3 pp20? -71.23 -26.01 62.74 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.635 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -82.54 -38.58 23.55 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.397 0.617 . . . . 0.0 109.774 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.547 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -70.96 -22.56 62.19 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.63 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.584 ' C ' HG11 ' A' ' 160' ' ' VAL . 5.5 mtpm? -65.74 -17.16 64.42 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.938 -179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.46 7.12 22.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.986 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.547 HD12 ' HA ' ' A' ' 154' ' ' ALA . 39.9 mt -87.21 127.78 40.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.664 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 36.01 -129.12 0.12 Allowed 'General case' 0 CA--C 1.534 0.333 0 O-C-N 124.421 1.075 . . . . 0.0 111.043 178.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -107.13 67.49 0.23 Allowed Glycine 0 N--CA 1.437 -1.265 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.584 HG11 ' C ' ' A' ' 155' ' ' LYS . 3.7 p -74.36 107.42 4.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.055 0.455 . . . . 0.0 110.122 178.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.1 t -61.13 -44.62 97.05 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.788 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 70.6 tt0 -169.46 159.32 8.47 Favored 'General case' 0 C--O 1.202 -1.441 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.846 -179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 151' ' ' ALA . 68.2 t -128.71 133.4 66.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 120.719 0.295 . . . . 0.0 110.263 179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -119.88 124.27 45.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.921 0.391 . . . . 0.0 110.74 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -90.11 115.81 27.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.736 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.636 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 179.824 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.3 m120 . . . . . 0 CA--C 1.523 -0.074 0 CA-C-O 120.791 0.329 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.446 ' HA ' HG11 ' A' ' 147' ' ' VAL . 0.3 OUTLIER -177.89 170.6 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.998 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.413 ' N ' HG13 ' A' ' 58' ' ' VAL . 5.0 ttm180 71.28 141.44 0.05 Allowed 'General case' 0 C--O 1.227 -0.099 0 O-C-N 123.611 0.569 . . . . 0.0 111.135 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 92.1 t -144.41 144.88 22.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.237 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.618 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 57.4 t -120.71 127.4 75.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.807 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 63.2 t -108.82 117.07 53.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -83.97 138.78 32.95 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.765 0.793 . . . . 0.0 110.54 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.746 HD11 ' CE1' ' A' ' 137' ' ' TYR . 61.6 mt -106.31 161.24 5.67 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.704 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.499 ' N ' HG22 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -42.49 161.04 0.02 OUTLIER 'General case' 0 CA--C 1.519 -0.214 0 O-C-N 123.661 0.601 . . . . 0.0 110.454 179.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -38.6 -50.56 1.61 Allowed 'General case' 0 C--N 1.332 -0.175 0 O-C-N 123.619 0.574 . . . . 0.0 111.29 -178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -168.04 91.46 0.32 Allowed 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 120.78 -0.368 . . . . 0.0 110.438 179.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.16 7.67 6.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.833 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 62.83 146.32 0.02 OUTLIER 'General case' 0 N--CA 1.457 -0.108 0 CA-C-O 121.069 0.461 . . . . 0.0 110.228 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.596 ' OD2' HD13 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -157.92 -74.16 0.09 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.114 -179.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.73 -15.06 62.66 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.898 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 48.7 m -63.66 -120.7 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 O-C-N 123.249 0.343 . . . . 0.0 110.614 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 176.82 -29.97 0.0 OUTLIER 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 59.1 p -136.19 158.68 43.84 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.586 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.9 mt -115.47 133.86 60.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -95.05 122.99 38.29 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.266 0.555 . . . . 0.0 110.944 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -132.77 119.89 20.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.402 179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 48.11 41.39 15.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.655 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 72.69 25.99 72.63 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.73 115.38 21.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.013 0.435 . . . . 0.0 110.589 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -84.61 117.73 23.93 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.144 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.6 t -123.86 132.22 71.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.193 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.8 t -49.15 141.02 8.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.019 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -96.09 114.62 26.34 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.868 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -65.0 -29.09 69.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.885 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 -91.73 18.12 8.04 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.79 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -59.53 125.61 24.33 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-O 121.078 0.466 . . . . 0.0 110.685 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 57.11 18.05 3.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.811 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -71.64 -45.07 63.15 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 120.535 -0.466 . . . . 0.0 110.774 179.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.405 HG13 HG21 ' A' ' 157' ' ' ILE . 95.1 t -69.75 -39.27 77.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.881 -179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -64.82 -41.16 95.98 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.553 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -66.91 -39.57 87.45 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.339 -179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.6 m -65.55 -42.12 92.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.172 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.2 mt -73.02 -39.27 66.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.015 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.98 -37.67 84.67 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.018 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -95.56 6.47 48.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.683 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 4.2 ttm -63.31 -19.26 64.45 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 116.589 -0.278 . . . . 0.0 110.612 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 t 72.47 160.71 0.23 Allowed 'General case' 0 CA--C 1.51 -0.558 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.464 HG22 ' O ' ' A' ' 99' ' ' THR . 14.3 m 72.21 2.16 4.21 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 124.111 0.882 . . . . 0.0 110.925 -179.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.636 HG13 HD12 ' A' ' 150' ' ' ILE . 5.3 m -112.23 139.49 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 121.015 0.436 . . . . 0.0 110.543 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.78 -40.71 28.11 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.537 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 85.4 p -164.81 162.0 20.73 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.555 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 139' ' ' VAL . 96.0 t -133.59 131.81 57.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.146 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 95.1 m -125.76 136.74 53.49 Favored 'General case' 0 C--O 1.225 -0.204 0 CA-C-O 121.012 0.434 . . . . 0.0 110.973 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -87.37 124.67 33.63 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.188 0.518 . . . . 0.0 110.137 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.732 ' OG ' ' HB3' ' A' ' 136' ' ' ALA . 18.7 p -116.75 108.98 16.55 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.953 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 51.6 m -61.38 165.65 4.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.445 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.2 ptpp? -62.65 -36.41 82.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.995 0.426 . . . . 0.0 110.143 -179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -68.68 -41.15 79.62 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.179 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 51.8 tp10 -70.49 -38.28 74.34 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.32 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.458 ' NE2' ' HB2' ' A' ' 136' ' ' ALA . 10.9 tt0 -65.54 -40.62 93.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.383 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -62.74 -42.43 99.67 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.344 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 86.9 tt0 -62.7 -38.44 90.43 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.211 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.48 ' O ' HG23 ' A' ' 118' ' ' ILE . 13.2 mmtp -70.48 -38.31 74.36 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.626 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.82 HD13 HD11 ' A' ' 118' ' ' ILE . 2.3 mm? -69.52 -39.18 77.69 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.201 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.9 t -73.21 -30.74 63.73 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.365 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -69.66 -38.71 77.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.791 179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.82 HD11 HD13 ' A' ' 115' ' ' LEU . 48.5 pt -78.36 -28.89 14.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.19 -179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -93.26 -72.76 0.59 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.496 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 174.92 -172.52 45.54 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.951 -0.86 . . . . 0.0 110.951 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -74.95 119.23 18.85 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.913 -0.315 . . . . 0.0 110.501 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.7 t30 50.57 52.02 15.71 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.743 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 23.5 p-90 -67.51 -26.59 66.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.818 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.89 -177.88 3.46 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.703 -179.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 30.6 mm -112.34 128.56 68.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-O 121.417 0.627 . . . . 0.0 109.913 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -81.52 48.26 1.15 Allowed 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.859 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -93.38 123.74 36.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.911 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 107.89 -38.38 3.36 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 56.0 p-10 -166.07 165.96 17.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 110.526 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -93.94 -3.03 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.7 179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -125.64 79.19 68.05 Favored Pre-proline 0 N--CA 1.455 -0.188 0 CA-C-O 120.729 0.299 . . . . 0.0 110.209 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.73 158.63 57.02 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.976 2.451 . . . . 0.0 111.704 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 38.6 mt 63.9 174.16 0.18 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.394 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.96 -161.95 1.09 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.354 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -65.75 143.59 57.42 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.224 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.732 ' HB3' ' OG ' ' A' ' 106' ' ' SER . . . -134.01 137.68 44.89 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.007 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.746 ' CE1' HD11 ' A' ' 64' ' ' ILE . 4.6 m-85 -101.99 113.33 26.46 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.5 mt -88.7 109.9 20.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.569 HG21 HG21 ' A' ' 150' ' ' ILE . 4.4 m -116.14 148.39 18.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.175 0.512 . . . . 0.0 109.815 -179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -105.84 107.12 17.95 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.217 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.514 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -62.42 141.4 58.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.824 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -52.89 -26.52 15.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.296 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -161.38 165.77 16.13 Favored Pre-proline 0 C--O 1.237 0.411 0 CA-C-O 121.262 0.553 . . . . 0.0 110.75 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.644 ' O ' HG22 ' A' ' 147' ' ' VAL . 43.1 Cg_exo -56.69 -30.33 83.52 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.747 2.298 . . . . 0.0 111.715 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -84.09 -7.49 59.37 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.851 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -96.99 -20.06 18.33 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 120.709 0.29 . . . . 0.0 110.617 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.644 HG22 ' O ' ' A' ' 144' ' ' PRO . 13.0 m -56.12 -31.12 30.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.233 0.539 . . . . 0.0 110.034 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.491 ' HG3' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -78.34 -33.93 48.83 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.045 -179.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.8 m -71.1 -39.51 72.07 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.335 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.636 HD12 HG13 ' A' ' 100' ' ' VAL . 46.3 mm -67.72 -40.39 83.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.58 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.392 -179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.464 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -63.87 -41.55 97.73 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.366 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -68.5 -38.91 81.38 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.821 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.18 -35.99 74.33 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.533 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.86 -35.8 81.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.503 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.598 ' HA ' HG11 ' A' ' 160' ' ' VAL . 96.0 mttt -65.25 -17.08 64.21 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.091 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 17.8 mmtm -98.69 7.77 45.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.99 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.435 HG22 ' N ' ' A' ' 158' ' ' GLU . 12.0 mm -65.02 -86.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.837 -179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.435 ' N ' HG22 ' A' ' 157' ' ' ILE . 4.5 mt-10 -165.37 -79.03 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 120.808 0.337 . . . . 0.0 110.549 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -93.78 34.66 4.52 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.734 -0.546 . . . . 0.0 111.734 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.598 HG11 ' HA ' ' A' ' 155' ' ' LYS . 7.4 p -76.79 94.68 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.476 0.655 . . . . 0.0 110.723 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 47.0 t -63.95 -45.41 89.31 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.569 -0.452 . . . . 0.0 111.079 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.27 165.13 37.62 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-O 120.914 0.387 . . . . 0.0 110.375 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.465 HG21 ' HG3' ' A' ' 155' ' ' LYS . 21.7 t -142.14 138.26 30.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.788 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -140.31 138.16 34.72 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 116.51 -0.314 . . . . 0.0 110.644 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -80.61 178.39 8.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.897 0.38 . . . . 0.0 110.686 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.619 0 N-CA-C 110.853 -0.899 . . . . 0.0 110.853 179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.42 ' O ' HG12 ' A' ' 58' ' ' VAL . 1.1 m-20 . . . . . 0 CA--C 1.523 -0.078 0 N-CA-C 110.889 -0.041 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.448 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.4 OUTLIER 73.44 -3.89 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 O-C-N 123.612 0.57 . . . . 0.0 111.29 -179.284 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.2 tmm_? -91.15 132.32 36.14 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.373 0.606 . . . . 0.0 111.034 -179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.5 t -126.34 140.36 48.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.084 -0.962 . . . . 0.0 110.127 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.453 HG13 ' HB1' ' A' ' 136' ' ' ALA . 75.1 t -120.25 126.32 75.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.534 -179.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.4 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 49.7 t -111.04 124.76 68.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.184 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.5 m-85 -91.9 136.23 33.32 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 121.13 0.49 . . . . 0.0 110.114 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.619 HD11 ' CD1' ' A' ' 137' ' ' TYR . 96.6 mt -110.15 143.94 19.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.528 179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 16.8 mmm180 -58.02 157.39 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.404 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.07 -32.06 25.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.853 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -67.22 -22.11 65.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.735 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.8 p -102.67 146.81 10.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.834 0.35 . . . . 0.0 110.804 -179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.0 pm0 -56.14 178.08 0.05 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.532 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -168.13 85.62 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.944 0.402 . . . . 0.0 110.51 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.9 t-20 51.66 43.75 29.66 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.609 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 68.6 m -128.19 118.88 24.14 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.694 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -72.2 -13.47 61.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.765 178.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 11.1 t -147.28 147.96 30.93 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 120.886 0.374 . . . . 0.0 110.252 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.7 pt -126.54 150.19 32.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.506 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.47 ' HG2' HG22 ' A' ' 81' ' ' THR . 45.9 mt-10 -102.38 127.96 49.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.452 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -144.64 131.55 20.29 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.439 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 54.64 32.25 16.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.509 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.13 24.25 77.24 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -127.33 131.19 50.47 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.808 0.337 . . . . 0.0 110.506 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.47 HG22 ' HG2' ' A' ' 76' ' ' GLU . 1.2 p -91.35 121.63 33.24 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.315 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.72 151.3 35.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.044 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 72.6 p -66.96 152.87 44.93 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.409 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -92.37 -166.72 1.6 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.454 -179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 -138.61 152.99 48.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.62 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.444 ' O ' ' HG3' ' A' ' 89' ' ' LYS . 96.4 m-20 47.74 41.86 14.63 Favored 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.775 179.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -46.31 147.64 1.08 Allowed 'General case' 0 C--N 1.329 -0.315 0 O-C-N 123.337 0.398 . . . . 0.0 110.617 -179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 64.7 83.83 0.16 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.95 0.405 . . . . 0.0 110.812 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER -123.38 -66.7 0.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.779 -179.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.422 HG12 HD12 ' A' ' 94' ' ' LEU . 90.2 t -64.79 -35.77 75.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -64.92 -41.33 95.65 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.434 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -69.54 -39.59 77.36 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.647 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.4 p -68.01 -40.18 83.03 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.879 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.422 HD12 HG12 ' A' ' 90' ' ' VAL . 97.7 mt -74.6 -39.91 61.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.019 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -37.69 75.65 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.666 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -95.89 6.74 48.16 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.059 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.525 ' HB3' HG23 ' A' ' 100' ' ' VAL . 9.1 ttm -56.79 -17.27 8.6 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-O 119.258 -0.401 . . . . 0.0 111.031 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.424 ' CB ' ' O ' ' A' ' 97' ' ' MET . 0.9 OUTLIER 84.79 -61.35 0.08 Allowed 'General case' 0 C--N 1.353 0.738 0 O-C-N 123.952 0.783 . . . . 0.0 110.762 -179.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 99' ' ' THR . 31.9 m -68.13 -7.41 29.52 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.029 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 97' ' ' MET . 94.0 t -96.52 118.84 43.69 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-O 120.883 0.373 . . . . 0.0 110.788 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -69.76 -43.58 71.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.81 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 86.3 p -155.4 159.04 39.57 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.323 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.589 HG22 HG12 ' A' ' 139' ' ' VAL . 89.6 t -133.52 129.88 56.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.692 -0.686 . . . . 0.0 111.601 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.413 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 89.4 m -123.13 124.13 42.38 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -86.81 113.71 22.86 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.025 0.44 . . . . 0.0 110.542 -179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.2 t -100.4 105.47 16.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.78 178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 84.2 p -65.11 163.6 14.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.936 0.398 . . . . 0.0 110.098 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -62.19 -32.58 73.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.14 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.8 mm-40 -67.57 -40.81 84.9 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.091 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -70.01 -39.64 75.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.46 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.527 ' HG2' HD13 ' A' ' 133' ' ' LEU . 16.5 tt0 -67.31 -37.7 83.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.34 -0.845 . . . . 0.0 110.686 179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.605 ' O ' HG23 ' A' ' 116' ' ' THR . 22.5 t80 -62.73 -40.79 98.32 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.768 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -65.91 -39.17 90.33 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.352 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -66.51 -38.02 86.32 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.541 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.46 HD22 HD11 ' A' ' 133' ' ' LEU . 1.1 mp -66.77 -37.47 84.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.714 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 112' ' ' TYR . 75.7 p -69.71 -30.99 68.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.657 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -70.74 -38.72 73.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.832 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.0 pt -80.12 -33.16 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.556 -178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -93.66 -13.64 27.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.72 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.21 -167.32 54.59 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -86.89 70.3 10.32 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.735 0.303 . . . . 0.0 110.445 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -174.25 58.69 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.352 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -174.16 -18.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.19 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 6.2 mttp -44.64 120.46 2.28 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.034 0.445 . . . . 0.0 110.752 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.7 tp -138.79 140.3 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.656 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.23 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -103.63 -34.09 8.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.691 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 48.95 46.02 22.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.905 0.383 . . . . 0.0 110.757 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 136.72 -106.96 0.57 Allowed Glycine 0 CA--C 1.523 0.582 0 N-CA-C 110.578 -1.009 . . . . 0.0 110.578 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -109.39 -64.95 1.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.871 0.367 . . . . 0.0 110.652 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -170.7 -179.36 2.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.518 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 57.05 62.37 5.92 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-O 121.294 0.569 . . . . 0.0 111.218 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -79.75 -21.93 8.08 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.501 2.134 . . . . 0.0 112.132 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.527 HD13 ' HG2' ' A' ' 111' ' ' GLN . 86.9 mt -96.19 167.08 11.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.877 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -107.94 156.72 18.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.951 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -58.36 140.75 53.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.939 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.453 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -123.67 143.3 50.34 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.522 -179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.619 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.7 OUTLIER -117.06 108.22 15.47 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.413 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 38.1 mt -89.06 110.59 21.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 -179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.589 HG12 HG22 ' A' ' 103' ' ' VAL . 14.9 m -119.4 150.49 21.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.134 0.493 . . . . 0.0 110.09 -179.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -102.86 106.89 17.55 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.167 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.72 144.95 47.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.849 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.612 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 4.9 m-80 -69.32 83.57 0.38 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.765 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.612 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 90.52 157.43 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.309 0 O-C-N 124.281 0.988 . . . . 0.0 110.56 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.658 ' O ' HG22 ' A' ' 147' ' ' VAL . 35.6 Cg_exo -59.89 -24.26 75.48 Favored 'Trans proline' 0 N--CA 1.495 1.577 0 C-N-CA 122.842 2.361 . . . . 0.0 112.582 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 34.7 m120 -80.1 -10.07 59.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.263 -179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -97.59 -19.96 17.98 Favored 'General case' 0 C--O 1.224 -0.241 0 CA-C-O 120.586 0.231 . . . . 0.0 111.127 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.658 HG22 ' O ' ' A' ' 144' ' ' PRO . 11.0 m -53.63 -31.83 20.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -76.47 -32.93 58.68 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.853 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.469 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 87.0 m -72.95 -37.88 66.98 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.516 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.579 HG21 HG21 ' A' ' 139' ' ' VAL . 50.8 mm -71.25 -40.36 73.96 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.893 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.319 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.28 -40.36 81.83 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.874 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 149' ' ' THR . 2.3 pp20? -75.12 -31.25 61.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.73 -179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -78.14 -37.27 46.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.386 179.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.508 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -66.16 -36.12 82.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.968 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 3.2 ptmm? -62.55 -15.58 51.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.757 -178.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -96.85 5.94 49.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.089 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.508 HD12 ' HA ' ' A' ' 154' ' ' ALA . 84.6 mt -93.06 129.86 42.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-O 120.675 0.274 . . . . 0.0 110.614 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 44.05 -121.03 0.76 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.251 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -126.56 54.76 0.76 Allowed Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -45.14 146.42 0.43 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.135 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.5 p -97.02 -35.37 10.86 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 120.851 -0.34 . . . . 0.0 110.422 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -170.07 158.91 7.28 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.412 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.05 143.69 39.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.673 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.9 tt0 -140.29 132.19 27.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.522 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -118.66 124.96 48.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.581 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.575 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 C--O 1.234 0.278 0 CA-C-O 120.584 0.23 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.423 ' O ' ' CB ' ' A' ' 59' ' ' ARG . 85.8 t -53.63 103.87 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.506 -0.723 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 179.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.423 ' CB ' ' O ' ' A' ' 58' ' ' VAL . 7.0 tpt180 155.86 111.04 0.0 OUTLIER 'General case' 0 C--N 1.349 0.574 0 O-C-N 125.156 1.535 . . . . 0.0 110.69 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -129.44 137.43 56.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 85.8 t -120.39 126.04 74.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.797 0.332 . . . . 0.0 110.654 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.521 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 90.5 t -110.33 118.97 58.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.386 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 63.4 m-85 -86.17 133.54 33.85 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-O 121.165 0.507 . . . . 0.0 109.715 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.596 HD11 ' CE1' ' A' ' 137' ' ' TYR . 2.6 mt -100.62 149.75 5.98 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.916 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 7.2 mmt-85 -52.83 150.08 5.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.706 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -60.27 -28.24 67.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.753 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -92.92 11.0 28.82 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.713 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.496 ' HB ' HG22 ' A' ' 64' ' ' ILE . 55.2 t -132.54 126.96 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 CA-C-O 120.88 0.371 . . . . 0.0 110.035 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' O ' ' N ' ' A' ' 71' ' ' ASN . 97.9 mt-10 -120.73 -22.69 6.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.996 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.414 ' OD2' ' N ' ' A' ' 90' ' ' VAL . 4.5 t70 61.43 -78.23 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 O-C-N 123.883 0.74 . . . . 0.0 111.157 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 69' ' ' GLU . 49.7 t-20 -76.12 61.99 1.64 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.241 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 57.0 p -140.33 -141.18 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.236 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -174.81 -31.28 0.01 OUTLIER 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.0 t -156.66 151.3 25.71 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.721 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.2 pt -127.41 157.43 39.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 121.183 0.516 . . . . 0.0 109.908 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -84.77 118.07 24.22 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.615 -179.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 51.2 mmtt -133.09 131.27 40.37 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.719 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 47.15 28.49 0.97 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.7 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 99.11 -50.1 1.2 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.36 -0.696 . . . . 0.0 111.36 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -71.81 175.74 5.51 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.509 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.3 p -116.1 129.06 56.16 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.133 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.3 m -118.82 141.47 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 121.281 0.562 . . . . 0.0 110.242 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 73.6 m -60.69 132.15 52.96 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.99 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 30.2 t30 -80.37 160.04 25.53 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.676 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 -104.04 171.47 7.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.445 179.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 54.06 47.09 24.09 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.555 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 52.5 t80 -67.67 123.29 20.08 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.58 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 57.57 20.32 6.1 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.172 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.0 mmtt -76.96 -48.0 19.3 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.146 0.498 . . . . 0.0 110.831 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.58 HG12 HD12 ' A' ' 94' ' ' LEU . 78.0 t -67.12 -38.44 81.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.796 179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -63.39 -43.77 96.6 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.04 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -63.65 -40.13 96.07 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.652 -178.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.3 t -70.25 -39.52 74.95 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.239 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.58 HD12 HG12 ' A' ' 90' ' ' VAL . 79.4 mt -76.42 -20.77 56.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.049 179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -89.59 -33.15 16.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.841 0.353 . . . . 0.0 111.129 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 28.2 m-20 -89.68 7.27 37.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.809 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.84 -17.63 6.77 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.155 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 77.12 -68.35 0.18 Allowed 'General case' 0 C--N 1.35 0.591 0 O-C-N 123.39 0.431 . . . . 0.0 110.776 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 90.7 m -58.02 -19.26 29.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.037 0.446 . . . . 0.0 110.531 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 6.8 p -78.41 133.72 29.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.137 0.494 . . . . 0.0 110.798 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 55.2 tptt -82.13 -43.27 18.0 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.178 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 87.2 p -160.01 159.27 31.88 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.237 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.503 HG22 HG12 ' A' ' 139' ' ' VAL . 91.1 t -132.83 128.72 57.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.141 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 91.0 m -121.07 125.24 46.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.842 0.353 . . . . 0.0 110.243 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -85.66 115.66 23.47 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.832 0.349 . . . . 0.0 110.112 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 35.4 t -105.05 108.66 20.29 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.258 179.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.8 m -59.85 159.95 8.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.431 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.8 ptpp? -62.76 -35.42 79.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.021 0.438 . . . . 0.0 110.058 -179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -70.64 -39.72 73.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.131 179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -70.19 -39.63 75.11 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.249 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.448 ' NE2' ' HB2' ' A' ' 136' ' ' ALA . 10.0 tt0 -67.37 -39.1 85.63 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.345 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.723 ' O ' HG23 ' A' ' 116' ' ' THR . 68.9 t80 -64.33 -38.96 92.9 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.922 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.47 -38.59 90.22 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.162 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.94 -37.94 85.24 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.219 -179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.57 -34.63 74.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.668 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.723 HG23 ' O ' ' A' ' 112' ' ' TYR . 78.1 p -70.48 -33.01 70.76 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.845 -179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -69.74 -40.04 76.43 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.722 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.417 HG13 ' N ' ' A' ' 119' ' ' MET . 36.4 pt -76.61 -36.8 28.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.981 -179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.417 ' N ' HG13 ' A' ' 118' ' ' ILE . 33.1 mmt -67.74 -39.62 84.21 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.061 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 144.85 -122.04 1.67 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.76 -0.936 . . . . 0.0 110.76 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -130.3 116.34 18.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.847 0.356 . . . . 0.0 110.569 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 61.0 t30 53.2 42.45 32.13 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.393 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.58 ' HE1' HG22 ' A' ' 116' ' ' THR . 28.2 p-90 -60.06 -29.3 68.46 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.045 0.45 . . . . 0.0 110.248 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.92 164.31 25.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.371 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 16.0 tt -143.2 14.71 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.631 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -87.61 -4.79 58.94 Favored 'General case' 0 CA--C 1.513 -0.446 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.1 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 75.11 -8.95 1.46 Allowed 'General case' 0 CA--C 1.535 0.377 0 O-C-N 123.741 0.65 . . . . 0.0 110.832 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 99.79 -164.97 19.82 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 56.87 35.54 26.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.806 0.336 . . . . 0.0 110.579 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -130.53 -44.66 1.1 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.451 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 48.24 67.84 4.1 Favored Pre-proline 0 C--O 1.232 0.17 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.727 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -62.55 -23.41 74.81 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.882 2.388 . . . . 0.0 112.315 -179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 69.8 mt -107.98 169.14 8.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.52 -179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -126.58 -158.52 0.86 Allowed 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.549 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -63.77 144.7 56.83 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.087 0.47 . . . . 0.0 110.132 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.448 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . . . -127.67 145.73 50.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.605 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.596 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.2 m-85 -117.53 106.97 13.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.763 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.5 mt -92.07 111.13 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 150' ' ' ILE . 6.3 m -116.45 150.21 18.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.204 0.525 . . . . 0.0 110.133 -179.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -107.55 107.86 18.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.1 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.501 ' HB1' ' HB2' ' A' ' 146' ' ' ASP . . . -63.28 142.21 58.47 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.614 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -54.59 -34.61 62.25 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 120.941 0.4 . . . . 0.0 110.119 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -141.74 159.27 60.45 Favored Pre-proline 0 C--O 1.238 0.489 0 CA-C-O 121.124 0.488 . . . . 0.0 110.859 179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.596 ' O ' HG22 ' A' ' 147' ' ' VAL . 35.9 Cg_exo -56.79 -26.39 66.15 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.652 2.235 . . . . 0.0 111.911 179.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -88.06 -7.57 56.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.759 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.501 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 91.5 m-20 -92.28 -20.31 21.27 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.286 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.596 HG22 ' O ' ' A' ' 144' ' ' PRO . 20.0 m -55.98 -33.28 35.23 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 CA-C-O 121.312 0.577 . . . . 0.0 109.652 -179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -76.99 -33.33 57.61 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.534 179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 95.6 m -71.73 -39.34 70.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.393 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.537 HG21 HG21 ' A' ' 139' ' ' VAL . 23.5 mm -67.85 -40.63 83.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.928 -179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.37 97.74 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.932 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.84 -38.95 87.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.584 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -67.95 -37.59 81.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.264 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.31 73.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.768 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -62.56 -23.12 66.83 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.811 -0.632 . . . . 0.0 111.262 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 3.7 ptpt -92.02 -7.93 47.45 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.984 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 6.4 mm -55.65 -23.06 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.031 -179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 73.84 131.05 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.166 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 89.98 -4.01 82.99 Favored Glycine 0 CA--C 1.526 0.78 0 N-CA-C 110.906 -0.877 . . . . 0.0 110.906 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 79.4 t -79.14 119.94 29.37 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 O-C-N 122.659 -0.318 . . . . 0.0 110.541 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.2 t -62.89 -48.02 80.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.993 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 40.3 tp10 -168.5 152.64 5.88 Favored 'General case' 0 C--O 1.222 -0.381 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.409 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.407 HG22 HG13 ' A' ' 62' ' ' VAL . 99.2 t -121.15 135.41 61.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.804 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -124.9 126.25 45.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.783 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -89.6 115.7 27.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.386 179.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.656 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.689 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 . . . . . 0 C--O 1.231 0.106 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER 73.86 -11.87 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 O-C-N 123.446 0.467 . . . . 0.0 111.737 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.0 tmm_? -97.21 126.77 42.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 120.982 0.42 . . . . 0.0 110.717 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 56.0 t -125.43 139.82 50.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.884 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.423 HG11 ' CZ ' ' A' ' 63' ' ' TYR . 89.9 t -120.19 124.28 72.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.939 0.399 . . . . 0.0 110.924 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.439 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 69.9 t -114.35 107.76 23.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.135 -0.484 . . . . 0.0 109.724 178.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.553 ' CE2' HD12 ' A' ' 133' ' ' LEU . 91.8 m-85 -82.22 146.19 29.64 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.056 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.754 HD11 ' CE1' ' A' ' 137' ' ' TYR . 34.2 mt -113.94 146.2 18.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.728 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -43.98 141.08 1.78 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.419 0.628 . . . . 0.0 111.32 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -71.69 -19.99 61.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.481 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -87.51 5.16 40.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.594 -0.275 . . . . 0.0 110.989 -178.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 15.1 m -138.89 152.4 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.368 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -106.45 -174.78 2.62 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.545 ' OD2' HD13 ' A' ' 64' ' ' ILE . 2.0 m-20 -172.76 147.33 1.73 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.015 0.436 . . . . 0.0 110.153 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 51.28 24.53 2.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.471 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 42.7 m -135.81 -27.53 1.14 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.762 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 65.98 155.05 0.08 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.07 -0.513 . . . . 0.0 110.148 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 63.54 131.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.593 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 95.2 mt -125.47 137.02 59.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.645 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -86.32 114.98 23.56 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.261 0.553 . . . . 0.0 110.064 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.9 tttm -126.43 134.02 51.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.725 -179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.6 mp0 57.27 -92.39 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.757 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -143.13 25.05 2.22 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 110.762 -0.935 . . . . 0.0 110.762 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -148.17 173.75 12.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.748 0.309 . . . . 0.0 110.34 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 69.8 p -114.81 133.86 55.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.384 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.2 m -121.62 147.82 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 CA-C-O 121.217 0.532 . . . . 0.0 109.945 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 90.2 m -69.66 131.77 45.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.061 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -86.97 145.13 26.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.099 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -95.11 -14.3 24.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.909 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -110.75 42.73 1.54 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.639 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 50.0 t80 -58.2 -49.47 76.92 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.768 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.7 m170 -125.81 56.94 1.38 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.005 0.431 . . . . 0.0 110.728 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.8 tptp -103.96 -53.68 2.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.086 0.47 . . . . 0.0 110.518 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.63 -35.38 72.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.249 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -67.8 -41.03 83.78 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.125 179.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -64.39 -40.44 95.82 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.438 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.6 m -66.04 -40.37 90.93 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.549 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.26 -13.89 59.66 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.696 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -95.74 -32.68 12.61 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-O 120.972 0.415 . . . . 0.0 111.531 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -91.59 4.77 51.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.923 -179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.5 mtt -52.16 -19.48 2.0 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.695 -0.23 . . . . 0.0 111.449 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.2 t 77.15 -65.6 0.28 Allowed 'General case' 0 C--N 1.345 0.403 0 O-C-N 123.331 0.395 . . . . 0.0 110.078 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 28.7 m -62.81 -19.07 63.69 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.483 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.57 HG23 HG13 ' A' ' 139' ' ' VAL . 7.1 p -71.96 146.21 11.57 Favored 'Isoleucine or valine' 0 C--O 1.232 0.159 0 CA-C-O 121.137 0.494 . . . . 0.0 111.496 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -98.57 -44.81 6.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.648 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 97.7 p -161.19 159.05 28.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.075 0.464 . . . . 0.0 110.472 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.694 HG22 HG22 ' A' ' 139' ' ' VAL . 53.9 t -134.83 129.29 51.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.602 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.439 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 96.3 m -122.18 132.95 54.71 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.223 0.535 . . . . 0.0 110.653 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -86.14 124.45 32.56 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.488 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 1.0 OUTLIER -110.83 89.94 3.18 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.063 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.5 m -51.65 145.43 9.2 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 120.627 -0.429 . . . . 0.0 110.345 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 7.7 pttt -59.84 -35.49 74.86 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.538 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -68.46 -41.25 80.49 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.34 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 63.8 tt0 -70.54 -39.28 74.12 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.724 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -66.73 -39.04 87.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.275 -179.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.744 ' O ' HG23 ' A' ' 116' ' ' THR . 87.3 t80 -62.17 -42.91 99.71 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.763 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -62.92 -40.74 98.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.99 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -67.23 -39.05 86.16 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.862 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.46 ' CD1' HD21 ' A' ' 133' ' ' LEU . 0.9 OUTLIER -66.62 -35.78 81.02 Favored 'General case' 0 C--O 1.22 -0.475 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.717 179.965 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.744 HG23 ' O ' ' A' ' 112' ' ' TYR . 81.7 p -70.45 -31.63 68.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.416 -179.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -69.16 -38.99 79.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.395 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.411 HG13 ' HG2' ' A' ' 119' ' ' MET . 38.7 pt -85.86 -32.91 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.701 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.411 ' HG2' HG13 ' A' ' 118' ' ' ILE . 39.1 mmt -92.34 -6.24 50.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.704 -0.226 . . . . 0.0 110.614 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 89.73 174.99 45.75 Favored Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.2 p-10 -94.61 16.31 15.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.795 0.331 . . . . 0.0 110.447 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 53.8 t30 -106.84 -22.17 12.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.95 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' HE1' HG22 ' A' ' 116' ' ' THR . 0.2 OUTLIER -81.31 156.83 25.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.51 -179.425 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 3.4 ttmt -172.22 -70.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.839 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.41 HG22 ' O ' ' A' ' 125' ' ' ILE . 1.8 mp 44.96 32.39 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.15 0 CA-C-O 121.276 0.56 . . . . 0.0 110.933 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -154.12 64.59 0.7 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.551 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -55.99 142.27 36.6 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.207 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 110.53 -139.72 15.6 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 97.7 m-20 -61.43 -37.68 84.4 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.538 0.209 . . . . 0.0 110.477 -179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 129' ' ' ASP . . . 69.39 77.04 0.22 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.831 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 33.7 m120 -128.76 72.22 81.27 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.432 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.41 -43.29 47.43 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.524 2.149 . . . . 0.0 112.574 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.553 HD12 ' CE2' ' A' ' 63' ' ' TYR . 1.5 mm? -106.68 165.62 11.17 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.085 0.469 . . . . 0.0 110.121 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 135' ' ' ASP . 0.0 OUTLIER -142.54 104.81 4.45 Favored 'General case' 0 CA--C 1.512 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.159 -177.748 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.61 ' CB ' HD12 ' A' ' 64' ' ' ILE . 66.9 m-20 72.73 -48.05 0.68 Allowed 'General case' 0 C--O 1.22 -0.478 0 O-C-N 124.138 0.899 . . . . 0.0 112.456 179.026 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.561 ' O ' ' O ' ' A' ' 135' ' ' ASP . . . 41.44 124.32 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.695 0 O-C-N 124.36 1.037 . . . . 0.0 112.36 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.754 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -114.2 106.44 14.37 Favored 'General case' 0 C--N 1.315 -0.9 0 O-C-N 121.471 -0.768 . . . . 0.0 110.113 178.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.439 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 57.6 mt -84.25 108.1 16.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.694 HG22 HG22 ' A' ' 103' ' ' VAL . 79.8 t -108.95 137.4 41.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.076 0.465 . . . . 0.0 110.753 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -107.33 111.28 23.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.427 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -72.6 146.21 46.82 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.665 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -53.1 -34.04 54.91 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.225 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.517 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -141.44 160.02 58.52 Favored Pre-proline 0 CA--C 1.532 0.276 0 CA-C-O 120.755 0.312 . . . . 0.0 110.45 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.517 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 34.7 Cg_endo -64.47 -20.2 65.84 Favored 'Trans proline' 0 N--CA 1.495 1.615 0 C-N-CA 122.644 2.229 . . . . 0.0 112.197 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -87.86 -4.3 58.87 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.214 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -103.34 -8.62 20.12 Favored 'General case' 0 C--O 1.222 -0.389 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.722 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.43 HG23 ' HG3' ' A' ' 148' ' ' LYS . 10.1 m -62.31 -27.49 42.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 CA-C-O 121.125 0.488 . . . . 0.0 109.757 -179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.43 ' HG3' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -81.63 -33.4 31.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.992 179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 82.7 m -72.85 -39.08 66.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.415 0.626 . . . . 0.0 110.525 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 19.1 mm -69.68 -39.93 78.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.287 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.32 -40.53 97.58 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.576 -179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -72.1 -29.46 64.11 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.494 -179.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -76.89 -35.87 57.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.561 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.67 -34.57 78.6 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.649 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -63.35 -14.11 46.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.8 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -90.81 -1.06 57.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.054 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.7 mt -91.15 131.28 38.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 CA-C-O 121.332 0.587 . . . . 0.0 110.813 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -64.57 141.08 58.9 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.321 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.406 ' O ' HG23 ' A' ' 64' ' ' ILE . . . 95.87 -14.46 64.68 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 73.5 t -75.44 127.26 36.91 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.079 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.519 179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 29.8 t -94.6 -49.88 5.44 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.849 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -150.88 142.92 24.01 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.85 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 59.4 t -129.08 132.39 67.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.784 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -136.05 148.6 48.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.221 0.534 . . . . 0.0 110.474 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 58.4 p-10 -87.05 -172.13 3.83 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.901 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.755 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.697 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 121.051 0.453 . . . . 0.0 110.594 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.5 m -130.86 153.62 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.571 -0.741 . . . . 0.0 109.414 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.2 tpp85 158.45 115.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.729 0 O-C-N 124.608 1.193 . . . . 0.0 110.2 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 90.3 t -128.89 132.24 67.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.9 t -119.52 121.51 66.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.437 HG21 ' CB ' ' A' ' 154' ' ' ALA . 75.6 t -108.52 118.31 55.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 -179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -86.13 132.27 34.06 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.525 HD11 ' CE1' ' A' ' 137' ' ' TYR . 4.4 mt -91.38 150.91 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.773 -0.648 . . . . 0.0 111.119 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -46.41 142.41 3.05 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.254 179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 3.4 tmtm? -78.5 75.78 5.01 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.9 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 174.48 -10.14 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.068 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 68' ' ' VAL . 8.3 p -123.91 129.49 74.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -87.39 -24.51 24.19 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.485 -0.486 . . . . 0.0 111.444 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 69.0 -64.14 0.34 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.753 0.658 . . . . 0.0 111.241 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -68.82 -9.32 50.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.957 -179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 17.6 p -92.15 133.68 35.56 Favored 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 120.522 -0.471 . . . . 0.0 110.48 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -73.1 -17.94 61.35 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.997 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 14.1 t -148.76 158.95 44.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.941 0.4 . . . . 0.0 110.57 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.515 ' O ' HD12 ' A' ' 75' ' ' ILE . 2.8 pp -133.31 155.42 40.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.617 -179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -87.73 108.25 19.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.793 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.449 ' O ' ' C ' ' A' ' 78' ' ' GLU . 6.8 mttp -143.01 148.11 36.23 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.3 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.449 ' C ' ' O ' ' A' ' 77' ' ' LYS . 1.6 mt-10 -25.22 98.47 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.496 0 O-C-N 124.832 1.333 . . . . 0.0 110.909 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 124.4 24.29 1.79 Allowed Glycine 0 CA--C 1.531 1.068 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -178.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 75.19 -160.33 0.06 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.699 0.285 . . . . 0.0 110.711 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.5 p -73.58 120.87 19.78 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.064 0.459 . . . . 0.0 109.794 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -119.49 133.12 67.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.84 -179.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.444 ' O ' HG23 ' A' ' 83' ' ' THR . 9.4 t -47.07 126.83 9.62 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.118 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -64.18 -35.67 81.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.697 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 66.85 16.86 10.47 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.394 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -140.03 37.33 1.94 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.184 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -64.8 121.14 13.87 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.628 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 21.9 m170 50.87 32.26 7.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.915 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.82 -47.19 26.7 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.903 0.382 . . . . 0.0 110.875 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 94.9 t -69.1 -38.32 77.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.701 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -62.0 -44.86 95.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.653 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -62.99 -39.69 95.51 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.38 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 84.8 p -67.15 -38.44 85.5 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.414 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.2 mt -69.27 -39.38 78.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.755 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 12.2 tptm -68.39 -36.37 79.04 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.375 -0.83 . . . . 0.0 111.558 -178.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -99.76 7.97 44.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.763 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.506 ' CE ' HG23 ' A' ' 150' ' ' ILE . 4.1 ttm -62.25 -18.89 62.45 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.262 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.7 t 74.32 158.76 0.21 Allowed 'General case' 0 C--O 1.233 0.207 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.431 HG22 ' O ' ' A' ' 99' ' ' THR . 7.3 m 69.48 4.93 4.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.877 -178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 34.5 m -113.29 153.37 14.86 Favored 'Isoleucine or valine' 0 C--N 1.338 0.105 0 CA-C-O 120.953 0.406 . . . . 0.0 110.298 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 26.3 mtmm -101.28 -37.19 8.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.786 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.6 t -162.39 152.19 16.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.953 -179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.655 HG22 HG22 ' A' ' 139' ' ' VAL . 60.6 t -130.97 128.95 63.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.492 179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 79.9 m -123.91 129.37 50.87 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.635 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -87.35 119.0 27.17 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.137 0.494 . . . . 0.0 109.928 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.6 t -106.67 116.61 32.23 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.788 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 40.7 t -63.96 155.68 30.18 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 26.5 pttm -61.72 -34.35 75.63 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.044 0.45 . . . . 0.0 110.084 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -68.31 -39.35 82.06 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.078 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -73.97 -36.33 64.56 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.59 179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -64.37 -41.23 96.83 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.395 179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.589 ' O ' HG23 ' A' ' 116' ' ' THR . 69.7 t80 -66.32 -41.49 89.59 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.276 179.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -64.32 -39.64 94.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.523 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -67.85 -37.68 82.16 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.678 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.4 mt -66.25 -35.59 80.8 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.872 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 112' ' ' TYR . 74.9 p -70.81 -34.39 71.68 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.506 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -68.09 -40.1 82.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.06 0.457 . . . . 0.0 110.284 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 31.9 pt -80.85 -35.09 14.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.214 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.5 mmt -77.0 -53.93 7.2 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.115 0.483 . . . . 0.0 110.803 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 64.46 -168.39 26.49 Favored Glycine 0 CA--C 1.52 0.349 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 56.07 18.07 2.99 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.684 0.278 . . . . 0.0 110.938 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 53.12 48.32 22.52 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.74 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.484 ' CG ' ' N ' ' A' ' 124' ' ' LYS . 1.0 OUTLIER -56.69 -165.83 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.484 ' N ' ' CG ' ' A' ' 123' ' ' TRP . 6.5 ttmt -27.99 109.97 0.04 OUTLIER 'General case' 0 C--N 1.343 0.317 0 CA-C-O 121.12 0.485 . . . . 0.0 111.667 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.2 tt -67.37 173.82 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.401 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -46.99 -71.69 0.07 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.101 -179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 63.64 152.45 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.87 0.367 . . . . 0.0 110.412 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.45 -172.53 52.37 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -61.89 -50.69 71.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.804 0.335 . . . . 0.0 111.249 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -132.56 -70.82 0.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.23 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -134.17 148.38 67.67 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.431 179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -76.2 -23.58 11.76 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.997 2.465 . . . . 0.0 112.269 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 84.0 mt -99.0 168.09 10.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.799 -179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -121.85 -165.24 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.993 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -61.85 150.23 37.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.72 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -136.56 145.88 45.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.612 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.525 ' CE1' HD11 ' A' ' 64' ' ' ILE . 3.8 m-85 -117.39 114.58 23.74 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.7 mt -89.79 113.95 26.87 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.655 HG22 HG22 ' A' ' 103' ' ' VAL . 74.5 t -116.71 136.48 53.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.634 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -100.38 108.74 20.83 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.069 179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.66 145.98 50.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.772 -179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -59.28 -41.09 88.09 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.278 179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.478 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -132.16 159.57 71.6 Favored Pre-proline 0 C--N 1.33 -0.24 0 C-N-CA 120.876 -0.329 . . . . 0.0 110.577 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.557 ' O ' HG22 ' A' ' 147' ' ' VAL . 32.7 Cg_endo -63.42 -22.98 71.51 Favored 'Trans proline' 0 N--CA 1.495 1.61 0 C-N-CA 122.592 2.195 . . . . 0.0 112.223 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.2 m120 -89.53 -5.06 57.6 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.212 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.424 ' O ' HG12 ' A' ' 150' ' ' ILE . 96.7 m-20 -97.57 -16.37 20.09 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.35 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 144' ' ' PRO . 29.6 m -55.0 -34.03 30.55 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.47 0 CA-C-O 121.549 0.69 . . . . 0.0 109.322 -179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt -73.73 -33.26 64.26 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.041 -0.982 . . . . 0.0 110.933 179.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.5 m -71.14 -38.77 72.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.456 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.506 HG23 ' CE ' ' A' ' 97' ' ' MET . 43.7 mm -66.59 -40.92 87.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.962 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.583 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -63.28 -39.43 94.55 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.742 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -70.47 -33.69 71.54 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.62 -178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -71.45 -39.31 71.08 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.974 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.475 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -63.07 -35.08 79.05 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.277 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.402 ' HG3' HG21 ' A' ' 163' ' ' VAL . 6.1 mttp -61.88 -25.93 67.84 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.708 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -105.88 -4.62 20.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.565 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 154' ' ' ALA . 2.5 mt -60.66 -51.56 71.65 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.189 0 C-N-CA 120.75 -0.38 . . . . 0.0 111.384 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.403 ' N ' HG22 ' A' ' 157' ' ' ILE . 67.5 mm-40 -151.76 -97.4 0.06 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.963 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -145.02 80.66 0.22 Allowed Glycine 0 C--N 1.333 0.409 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 2.1 m -92.7 134.14 31.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 82.1 p -69.28 -34.38 74.66 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.161 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -172.41 163.9 5.63 Favored 'General case' 0 C--O 1.219 -0.505 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.645 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.583 HG11 ' HB1' ' A' ' 151' ' ' ALA . 47.8 t -133.97 138.17 50.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.802 -179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -130.07 133.12 46.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -100.16 135.25 41.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.995 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.516 0 N-CA-C 110.744 -0.943 . . . . 0.0 110.744 179.853 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 . . . . . 0 N--CA 1.455 -0.212 0 CA-C-O 119.601 -0.238 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.5 ' HA ' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER 43.4 -158.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 73.55 118.33 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.735 0.647 . . . . 0.0 110.93 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 69.5 t -126.65 140.23 49.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.294 179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.4 t -119.58 124.86 73.7 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-O 121.12 0.486 . . . . 0.0 110.604 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.602 HG13 HG22 ' A' ' 163' ' ' VAL . 59.5 t -114.0 110.01 30.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -78.48 144.23 35.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 121.116 0.484 . . . . 0.0 110.316 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.725 HD11 ' CE1' ' A' ' 137' ' ' TYR . 49.3 mt -111.64 137.0 46.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.837 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -48.83 154.16 0.75 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.619 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -76.55 -27.05 55.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.846 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -67.5 -13.2 61.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.621 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.9 p -133.15 137.89 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 120.876 0.37 . . . . 0.0 110.484 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -115.27 90.35 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.02 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' CB ' HD13 ' A' ' 64' ' ' ILE . 3.5 t70 -70.11 163.48 26.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.211 0.529 . . . . 0.0 110.88 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 49.78 41.19 21.9 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.973 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 43.2 t -140.4 123.4 16.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.422 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.443 ' C ' HG23 ' A' ' 74' ' ' THR . 5.6 mm-40 -68.63 120.72 15.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.161 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.443 HG23 ' C ' ' A' ' 73' ' ' GLN . 1.4 p 60.36 154.03 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 O-C-N 123.466 0.479 . . . . 0.0 110.645 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.477 HG23 ' HB2' ' A' ' 84' ' ' ASN . 33.6 pt -132.92 158.64 43.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.318 0.58 . . . . 0.0 110.505 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -89.37 109.98 20.83 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.985 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 69.1 mttt -130.84 130.71 43.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.869 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 66.83 23.13 10.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.678 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 80.81 8.34 87.59 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.235 -0.746 . . . . 0.0 111.235 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -126.28 161.69 27.18 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.526 0.203 . . . . 0.0 110.664 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.9 m -100.56 123.75 45.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.736 0.303 . . . . 0.0 110.481 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.0 m -132.61 154.68 40.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.24 0.543 . . . . 0.0 110.458 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 54.8 m -62.54 132.99 54.27 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.495 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.477 ' HB2' HG23 ' A' ' 75' ' ' ILE . 62.3 t30 -95.68 126.29 40.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.73 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 23.1 m120 -64.21 -25.24 67.98 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.618 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -111.41 66.89 0.64 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.631 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -58.63 -47.77 83.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.069 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.33 47.41 0.75 Allowed 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.132 0.491 . . . . 0.0 110.731 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -65.38 -38.82 91.17 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.605 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 70.1 t -65.78 -39.37 84.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.177 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -61.1 -43.6 98.64 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.635 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -65.82 -39.01 90.45 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.504 -179.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.2 m -66.59 -42.29 87.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.406 0.622 . . . . 0.0 110.52 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 98.0 mt -72.58 -33.8 67.01 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.704 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -80.89 -27.37 36.3 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.846 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.5 t30 -93.95 -3.58 51.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.117 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.79 -19.02 2.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.977 -0.535 . . . . 0.0 111.025 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.24 -54.51 0.43 Allowed 'General case' 0 C--N 1.346 0.431 0 O-C-N 123.992 0.808 . . . . 0.0 110.543 -179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.463 HG22 ' O ' ' A' ' 99' ' ' THR . 31.6 m -72.21 -5.17 33.88 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.767 179.215 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.666 HG13 HG13 ' A' ' 139' ' ' VAL . 24.8 t -91.0 123.97 43.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 CA-C-O 120.948 0.404 . . . . 0.0 111.2 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -71.99 -43.53 64.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.868 179.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 38.0 t -161.74 157.54 24.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.109 0.48 . . . . 0.0 110.53 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.642 HG22 HG22 ' A' ' 139' ' ' VAL . 63.6 t -131.35 127.66 60.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.214 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.511 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 98.8 m -120.92 129.22 53.38 Favored 'General case' 0 C--O 1.225 -0.188 0 CA-C-O 120.968 0.413 . . . . 0.0 110.027 179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -90.97 109.68 20.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.167 0.508 . . . . 0.0 110.779 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 30.1 t -96.07 114.27 25.96 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.305 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 80.6 p -67.96 162.62 23.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.929 0.395 . . . . 0.0 110.534 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -62.5 -27.22 68.99 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.033 0.444 . . . . 0.0 109.98 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -65.97 -38.61 88.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.022 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -67.34 -40.84 85.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.883 178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -64.83 -36.71 85.21 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.362 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.529 ' O ' HG23 ' A' ' 116' ' ' THR . 33.8 t80 -68.14 -37.46 81.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.77 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -61.11 -39.36 89.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.403 0.62 . . . . 0.0 110.134 179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -67.54 -36.41 80.92 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.991 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.558 HD13 HD11 ' A' ' 118' ' ' ILE . 1.4 mm? -66.2 -37.7 86.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.828 179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 112' ' ' TYR . 80.9 p -69.2 -34.34 74.73 Favored 'General case' 0 C--N 1.32 -0.705 0 O-C-N 123.387 0.43 . . . . 0.0 110.684 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 54.0 tp10 -66.72 -38.71 87.23 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.226 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.558 HD11 HD13 ' A' ' 115' ' ' LEU . 40.3 pt -85.79 -25.39 6.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.797 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.6 mmt -87.66 71.62 9.65 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.459 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.04 -129.24 47.67 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -126.48 0.6 6.92 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.62 0.247 . . . . 0.0 110.719 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -168.99 131.25 1.25 Allowed 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.342 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.448 ' CD1' HG22 ' A' ' 116' ' ' THR . 0.6 OUTLIER -169.5 145.94 3.29 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.292 179.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 18.5 mmtt -148.09 138.21 22.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.988 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 17.6 tt -141.06 -5.19 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.01 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.431 ' O ' ' CG ' ' A' ' 126' ' ' PHE . 1.4 p90 -138.75 132.39 30.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 122.085 0.945 . . . . 0.0 110.073 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -134.99 38.2 3.0 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.719 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -167.09 -158.32 11.34 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.894 -0.882 . . . . 0.0 110.894 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -60.86 -38.26 84.96 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.814 0.34 . . . . 0.0 110.557 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -58.19 135.25 57.04 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.32 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 37.0 t-20 -149.48 128.65 6.25 Favored Pre-proline 0 N--CA 1.449 -0.488 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.446 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.37 -39.35 81.81 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.598 2.199 . . . . 0.0 112.152 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 73.1 mt -110.03 164.86 12.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.583 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.28 -165.1 1.43 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.29 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -65.92 141.1 58.35 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.794 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -125.54 144.75 50.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.465 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.725 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.4 m-85 -112.23 108.74 18.08 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.023 0.44 . . . . 0.0 110.551 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.511 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 59.6 mt -86.34 104.37 13.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.666 HG13 HG13 ' A' ' 100' ' ' VAL . 92.5 t -110.79 137.61 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 CA-C-O 121.167 0.508 . . . . 0.0 111.074 -178.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 61.8 mt-10 -101.36 105.53 16.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.112 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -70.41 144.81 51.42 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.833 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.642 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 14.0 t-20 -69.36 84.57 0.39 Allowed 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.04 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.642 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 92.24 149.67 0.05 OUTLIER Pre-proline 0 N--CA 1.451 -0.396 0 O-C-N 124.301 1.001 . . . . 0.0 110.553 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.614 ' O ' HG22 ' A' ' 147' ' ' VAL . 34.4 Cg_exo -57.97 -21.25 48.85 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.629 2.22 . . . . 0.0 112.709 -179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -82.7 -6.31 59.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.244 -179.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -104.36 -13.49 16.09 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.925 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.614 HG22 ' O ' ' A' ' 144' ' ' PRO . 10.4 m -58.89 -30.89 43.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.5 ptmm? -75.71 -33.24 60.3 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.721 179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.1 m -72.56 -40.18 66.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.678 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.53 HD12 HG23 ' A' ' 100' ' ' VAL . 47.5 mm -68.57 -40.02 81.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.753 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.481 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -63.97 -39.68 94.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.682 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -70.16 -38.53 75.48 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.053 179.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -71.08 -36.92 72.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.862 -179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.68 -38.42 89.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.805 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 7.8 ptmt -65.62 -16.59 63.87 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.62 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -91.56 -1.43 57.5 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.01 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 89.3 mt -88.47 134.76 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.038 0.447 . . . . 0.0 110.535 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -63.02 143.47 57.75 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.623 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 90.55 -10.09 75.62 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.726 -0.95 . . . . 0.0 110.726 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 8.0 p -70.48 137.09 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-O 120.88 0.371 . . . . 0.0 110.637 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 23.3 t -108.36 -51.43 2.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.443 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -154.42 141.08 18.98 Favored 'General case' 0 C--O 1.218 -0.56 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.805 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.602 HG22 HG13 ' A' ' 62' ' ' VAL . 40.0 t -125.06 135.58 63.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 120.775 0.322 . . . . 0.0 110.793 -178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -138.29 144.81 40.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.988 0.423 . . . . 0.0 110.288 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 49.6 p-10 -110.03 155.3 22.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.733 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.694 0 N-CA-C 110.923 -0.871 . . . . 0.0 110.923 179.613 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.89 0.376 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.425 ' HA ' HG11 ' A' ' 147' ' ' VAL . 28.8 m -95.15 143.5 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 165.64 92.15 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 O-C-N 123.939 0.774 . . . . 0.0 111.239 179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 94.7 t -111.38 127.06 68.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 83.3 t -115.36 118.76 59.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.948 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.449 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 96.7 t -105.91 119.18 54.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 110.424 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -88.1 129.1 35.4 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.57 HD11 ' CD1' ' A' ' 137' ' ' TYR . 1.9 mt -98.12 143.54 12.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.965 -179.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 25.2 mmt180 -49.4 146.33 4.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.142 0.496 . . . . 0.0 110.985 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -60.26 -26.65 66.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.325 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -86.46 14.39 6.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.837 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.504 ' HB ' HG22 ' A' ' 64' ' ' ILE . 57.8 t -126.94 128.34 70.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.396 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -126.79 85.68 2.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.651 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -81.91 30.43 0.38 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.496 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -147.46 10.56 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.44 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.7 t -127.28 129.75 48.3 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.526 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.459 ' HG2' ' CE2' ' A' ' 87' ' ' TYR . 22.7 mt-30 -63.64 -37.98 89.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.118 -178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.7 p -136.2 151.49 49.77 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.514 -0.475 . . . . 0.0 110.163 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 47.1 pt -125.47 150.76 30.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.069 0.462 . . . . 0.0 110.552 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.448 ' HG2' HG22 ' A' ' 81' ' ' THR . 99.4 mt-10 -87.95 112.59 22.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.358 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.477 ' O ' ' C ' ' A' ' 78' ' ' GLU . 62.9 tttp -153.65 146.02 23.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.641 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.477 ' C ' ' O ' ' A' ' 77' ' ' LYS . 0.6 OUTLIER -17.05 105.5 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 O-C-N 124.988 1.43 . . . . 0.0 110.996 -179.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 114.34 24.08 4.58 Favored Glycine 0 CA--C 1.531 1.043 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 -177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 73.61 -161.03 0.09 Allowed 'General case' 0 C--N 1.343 0.29 0 CA-C-O 120.691 0.281 . . . . 0.0 110.592 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.448 HG22 ' HG2' ' A' ' 76' ' ' GLU . 60.4 p -76.19 127.47 32.98 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.144 0.497 . . . . 0.0 109.949 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.5 m -117.53 136.62 54.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.134 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.9 t -68.54 144.97 54.4 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.912 -179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -115.06 22.47 13.35 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.971 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 66.25 -143.91 0.18 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.44 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.436 ' O ' ' CD2' ' A' ' 87' ' ' TYR . 98.6 m-20 -61.55 -10.86 8.95 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 119.635 -0.221 . . . . 0.0 110.824 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.459 ' CE2' ' HG2' ' A' ' 73' ' ' GLN . 46.1 p90 41.63 25.78 0.04 OUTLIER 'General case' 0 C--N 1.35 0.596 0 CA-C-O 121.103 0.478 . . . . 0.0 110.956 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.27 27.87 2.1 Favored 'General case' 0 CA--C 1.521 -0.143 0 O-C-N 121.83 -0.544 . . . . 0.0 110.692 -178.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -63.5 -38.85 92.73 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.213 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 74.1 t -66.33 -38.59 82.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.099 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 47.3 t80 -61.46 -43.2 99.29 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.542 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -65.34 -40.37 93.57 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.235 -179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.7 m -66.03 -40.8 91.33 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.508 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.1 mt -76.72 -21.1 55.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.946 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -89.92 -25.81 20.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.152 0.501 . . . . 0.0 111.253 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -94.02 9.54 37.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.281 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 67.8 mmm -56.84 -18.14 11.92 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.024 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 82.02 -49.52 0.22 Allowed 'General case' 0 C--N 1.349 0.557 0 O-C-N 123.531 0.519 . . . . 0.0 110.956 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.789 ' HB ' HD11 ' A' ' 150' ' ' ILE . 32.8 m -81.28 -13.97 57.89 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.757 179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.463 HG22 ' CG1' ' A' ' 139' ' ' VAL . 37.8 t -82.78 141.96 14.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.915 0.388 . . . . 0.0 111.366 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -98.33 -43.51 6.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.042 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 32.6 t -153.74 149.81 27.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.093 0.473 . . . . 0.0 110.626 -179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 139' ' ' VAL . 55.4 t -131.11 129.93 63.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.973 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.1 m -122.66 127.43 49.3 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.233 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 65.9 t80 -83.96 120.59 26.29 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.918 0.39 . . . . 0.0 110.325 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.52 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 29.1 t -108.01 107.06 17.58 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.892 178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 63.0 m -61.62 159.64 12.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.189 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.61 -29.6 68.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.259 0.552 . . . . 0.0 110.147 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -79.36 -34.64 41.87 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.163 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -68.54 -41.38 79.93 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.144 0.497 . . . . 0.0 110.649 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -73.22 -33.35 65.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.132 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -64.8 -41.68 95.61 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.157 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.404 ' O ' HG22 ' A' ' 116' ' ' THR . 53.5 tp10 -65.69 -38.57 89.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.569 -0.741 . . . . 0.0 110.208 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.422 ' O ' HG23 ' A' ' 118' ' ' ILE . 3.8 mmmt -70.37 -39.54 74.53 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.746 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.584 HD23 HD11 ' A' ' 118' ' ' ILE . 75.6 mt -67.16 -38.51 85.58 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.25 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 113' ' ' GLU . 8.9 t -73.44 -30.87 63.49 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.111 -179.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -69.57 -38.84 77.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.584 HD11 HD23 ' A' ' 115' ' ' LEU . 46.7 pt -77.34 -27.05 15.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.918 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.71 -51.51 6.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.972 0.415 . . . . 0.0 110.801 -179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 175.57 -89.85 0.08 OUTLIER Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -166.01 128.78 2.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.792 0.33 . . . . 0.0 110.642 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 53.45 41.27 32.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.757 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -70.08 173.54 6.44 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 50.21 -167.85 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.58 178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 7.8 tt -113.86 154.62 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.622 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 26.8 p90 -113.94 9.96 17.54 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.418 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -63.66 -29.77 70.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.757 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -74.03 67.26 1.76 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 54.09 36.3 24.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.749 0.309 . . . . 0.0 110.496 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . 60.08 31.7 20.69 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.904 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -179.54 95.33 0.2 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.633 179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.52 -23.65 57.29 Favored 'Trans proline' 0 N--CA 1.499 1.824 0 C-N-CA 122.395 2.063 . . . . 0.0 112.297 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 75.8 mt -101.07 -171.29 1.97 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.561 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -123.62 -160.34 0.91 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.345 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -68.51 150.16 48.39 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.482 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . -128.96 150.0 50.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.347 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.57 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.4 OUTLIER -125.98 110.86 14.08 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.285 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 21.3 mt -88.71 109.79 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.653 HG22 HG22 ' A' ' 103' ' ' VAL . 35.0 t -109.82 137.68 40.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.265 0.555 . . . . 0.0 111.152 -179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -100.95 107.81 19.39 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.798 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.555 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -72.49 150.3 43.38 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.712 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 -57.34 -40.98 79.14 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.891 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -136.97 159.99 67.92 Favored Pre-proline 0 C--N 1.325 -0.465 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.676 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.537 ' O ' HG22 ' A' ' 147' ' ' VAL . 33.7 Cg_exo -59.04 -23.34 68.29 Favored 'Trans proline' 0 N--CA 1.495 1.595 0 C-N-CA 122.694 2.263 . . . . 0.0 112.168 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -91.32 -4.53 55.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.378 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -99.04 -12.71 20.32 Favored 'General case' 0 C--O 1.224 -0.274 0 N-CA-C 110.305 -0.257 . . . . 0.0 110.305 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 141' ' ' ALA . 22.3 m -61.91 -32.66 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 22.7 ptmt -74.25 -35.33 63.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.934 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.4 m -71.61 -40.04 70.09 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.487 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.789 HD11 ' HB ' ' A' ' 99' ' ' THR . 30.2 mm -67.43 -39.54 82.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.495 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.443 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -62.81 -39.97 95.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.968 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -65.52 -38.76 90.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.725 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -69.91 -37.27 75.92 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.656 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.538 ' HA ' HD12 ' A' ' 157' ' ' ILE . . . -61.09 -35.71 77.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.465 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -62.92 -16.94 61.02 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.728 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -97.61 6.25 48.3 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.993 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.538 HD12 ' HA ' ' A' ' 154' ' ' ALA . 96.3 mt -98.41 129.01 49.33 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.135 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 -179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 40.48 -117.64 0.3 Allowed 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.624 178.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -130.33 77.89 0.39 Allowed Glycine 0 C--N 1.341 0.831 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.492 HG21 ' O ' ' A' ' 154' ' ' ALA . 43.3 t -78.47 122.09 32.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 94.9 p -68.17 -40.85 82.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.155 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -174.87 152.69 1.58 Allowed 'General case' 0 C--O 1.219 -0.519 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.917 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.443 HG11 ' HB1' ' A' ' 151' ' ' ALA . 57.5 t -124.91 133.83 68.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.948 0.404 . . . . 0.0 110.784 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -122.54 129.86 52.4 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.845 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -104.35 128.56 52.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.655 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.676 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 179.693 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.457 -0.098 0 CA-C-O 120.902 0.382 . . . . 0.0 110.506 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HA ' HG11 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -105.21 -156.99 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.227 -179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.5 tmm_? 77.37 116.22 0.06 Allowed 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.54 0.525 . . . . 0.0 111.102 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 59.7 t -129.5 140.12 49.94 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.302 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.862 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 99.6 t -117.46 115.35 48.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.337 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.4 t -99.1 109.51 24.44 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.663 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.608 ' CD2' ' HB2' ' A' ' 136' ' ' ALA . 58.3 m-85 -80.0 139.19 37.08 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-O 121.068 0.461 . . . . 0.0 110.848 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.692 HD12 ' OD2' ' A' ' 135' ' ' ASP . 72.2 mt -111.22 159.41 11.22 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.69 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.789 ' HB2' HG23 ' A' ' 68' ' ' VAL . 35.9 mmt180 -40.95 156.32 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.211 0 O-C-N 123.558 0.536 . . . . 0.0 110.541 179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 1.8 tttm -35.57 -38.79 0.12 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.747 0.654 . . . . 0.0 111.719 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -165.44 95.56 0.65 Allowed 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.646 -0.422 . . . . 0.0 111.117 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.789 HG23 ' HB2' ' A' ' 65' ' ' ARG . 1.4 t -98.48 -24.79 4.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.435 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.415 ' HG3' HG22 ' A' ' 75' ' ' ILE . 15.6 mm-40 64.72 37.64 7.4 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.349 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -58.79 -40.97 85.59 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.912 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -90.22 6.61 42.07 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.938 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -104.07 109.55 21.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.976 0.417 . . . . 0.0 110.405 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.79 -32.21 67.31 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.988 -179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 47.5 p -137.47 161.31 36.71 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.324 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.415 HG22 ' HG3' ' A' ' 69' ' ' GLU . 45.6 pt -127.78 148.69 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 CA-C-O 121.073 0.463 . . . . 0.0 110.215 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -100.67 130.33 46.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.254 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.5 ttpp -152.01 136.89 17.17 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.764 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 51.39 34.82 12.62 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.989 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 68.6 27.21 73.97 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.021 -0.831 . . . . 0.0 111.021 179.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -135.4 143.54 46.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.864 0.364 . . . . 0.0 110.683 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 56.1 p -103.64 123.27 46.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.099 0.476 . . . . 0.0 110.446 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.2 p -134.15 144.71 34.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.511 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.4 t -49.9 148.33 3.26 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.607 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -90.96 167.39 12.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.002 0.429 . . . . 0.0 110.586 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -106.31 143.02 35.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.233 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 58.08 46.86 15.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.957 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -64.71 129.17 38.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.946 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.5 m170 56.9 23.08 7.78 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.317 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -72.16 -44.25 63.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.088 0.47 . . . . 0.0 110.708 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.8 t -68.98 -40.66 81.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.345 0.593 . . . . 0.0 109.853 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -63.06 -44.81 94.8 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.501 179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -64.36 -40.58 96.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.644 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.2 m -66.12 -38.64 88.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.253 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 94.9 mt -80.65 -11.85 59.58 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.908 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.82 -39.53 16.97 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.812 0.339 . . . . 0.0 111.681 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -85.69 7.17 24.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.358 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -52.04 -19.8 2.08 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.295 -179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 77.02 -62.22 0.41 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.497 0.319 . . . . 0.0 110.759 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.735 ' HB ' HD11 ' A' ' 150' ' ' ILE . 91.2 m -65.48 -11.87 47.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.683 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.63 HG23 HG13 ' A' ' 139' ' ' VAL . 7.1 p -79.53 139.49 18.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.636 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -95.71 -43.47 7.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.289 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.3 p -158.55 154.24 26.32 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.389 179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 139' ' ' VAL . 57.3 t -135.22 127.95 48.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.751 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 86.1 m -127.32 134.25 50.01 Favored 'General case' 0 C--O 1.216 -0.686 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.007 -179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -79.29 121.77 25.51 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.214 0.531 . . . . 0.0 109.901 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 38.7 t -115.64 122.99 47.25 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.151 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 37.3 t -67.98 163.15 22.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.37 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -64.91 -34.07 77.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.066 0.46 . . . . 0.0 110.711 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -65.01 -39.21 93.09 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.82 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.29 -38.86 85.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.516 -0.766 . . . . 0.0 110.718 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -66.18 -38.51 88.22 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.693 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.771 ' O ' HG23 ' A' ' 116' ' ' THR . 33.7 t80 -64.55 -40.81 96.26 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.086 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -66.48 -39.74 88.93 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.285 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 43.6 mmtm -66.73 -38.93 87.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.756 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.55 HD23 HD11 ' A' ' 118' ' ' ILE . 14.7 mt -64.81 -38.99 92.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.662 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.771 HG23 ' O ' ' A' ' 112' ' ' TYR . 59.6 p -67.27 -35.56 79.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.634 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -67.76 -39.49 84.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.887 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.55 HD11 HD23 ' A' ' 115' ' ' LEU . 41.4 pt -84.1 -27.24 7.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.729 -0.668 . . . . 0.0 111.475 -178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 19.4 mmt -89.86 -69.44 0.72 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.702 0.287 . . . . 0.0 110.874 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -178.09 169.15 40.86 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.02 -0.832 . . . . 0.0 111.02 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -61.08 120.21 9.84 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 120.976 0.417 . . . . 0.0 110.525 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 64.2 t30 50.43 42.17 25.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.877 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.74 ' HD1' HG22 ' A' ' 116' ' ' THR . 0.2 OUTLIER -64.53 169.93 4.43 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.487 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 54.45 -162.12 0.13 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.961 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.8 tp -141.43 143.56 27.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 CA-C-O 120.967 0.413 . . . . 0.0 110.193 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -117.88 22.9 12.01 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.781 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -60.14 -41.33 92.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.371 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -83.96 134.97 13.21 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 110.457 -1.057 . . . . 0.0 110.457 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 59.11 162.65 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.087 0.47 . . . . 0.0 110.694 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.07 -42.45 98.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.77 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -158.6 135.27 6.58 Favored Pre-proline 0 N--CA 1.449 -0.525 0 C-N-CA 120.457 -0.497 . . . . 0.0 110.353 179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.66 -178.58 3.51 Favored 'Trans proline' 0 C--N 1.313 -1.326 0 C-N-CA 122.421 2.081 . . . . 0.0 112.099 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 3.1 mm? 61.19 166.67 0.09 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.14 -0.936 . . . . 0.0 110.464 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -132.8 173.72 11.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.421 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.692 ' OD2' HD12 ' A' ' 64' ' ' ILE . 0.0 OUTLIER -51.91 140.43 19.88 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.102 -0.499 . . . . 0.0 109.91 179.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.608 ' HB2' ' CD2' ' A' ' 63' ' ' TYR . . . -142.48 151.36 41.63 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.729 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.545 ' CE1' HD11 ' A' ' 64' ' ' ILE . 14.1 m-85 -98.98 120.46 39.46 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.388 179.277 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 58.0 mt -82.6 100.23 6.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.63 HG13 HG23 ' A' ' 100' ' ' VAL . 73.6 t -101.41 131.14 49.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.732 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.597 -179.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -99.5 107.78 20.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.989 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.419 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -66.98 146.28 54.54 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.439 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -57.87 -36.91 73.02 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.079 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -139.64 159.2 66.26 Favored Pre-proline 0 C--N 1.328 -0.326 0 C-N-CA 120.799 -0.36 . . . . 0.0 110.859 179.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.584 ' O ' HG22 ' A' ' 147' ' ' VAL . 34.0 Cg_exo -57.91 -28.1 81.38 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.501 2.134 . . . . 0.0 112.033 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -86.16 -5.49 59.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.225 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -95.65 -14.67 23.28 Favored 'General case' 0 C--O 1.218 -0.605 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.399 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.584 HG22 ' O ' ' A' ' 144' ' ' PRO . 16.2 m -62.68 -32.52 55.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -75.56 -37.85 59.64 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.075 179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.1 m -69.72 -40.59 76.16 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.17 0.51 . . . . 0.0 110.456 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.735 HD11 ' HB ' ' A' ' 99' ' ' THR . 31.6 mm -67.47 -39.58 82.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.464 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.59 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -63.55 -41.7 98.41 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.152 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -68.26 -39.59 82.16 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.859 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -70.14 -38.05 75.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.001 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.37 -27.85 67.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.663 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 30.9 mttm -61.76 -20.95 64.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.806 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.64 -8.96 57.0 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.694 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 14.1 mm -74.46 130.36 36.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.098 0.475 . . . . 0.0 110.818 -179.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 72.7 mt-10 -65.91 138.76 58.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.273 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 94.9 -14.14 65.87 Favored Glycine 0 CA--C 1.526 0.752 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.484 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 54.2 t -75.26 127.35 36.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 O-C-N 122.339 -0.507 . . . . 0.0 110.91 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 87.8 p -95.15 -32.48 13.05 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.015 179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 77.7 tt0 -170.84 160.39 6.78 Favored 'General case' 0 C--O 1.21 -1.02 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.186 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.59 HG11 ' HA ' ' A' ' 151' ' ' ALA . 19.5 t -133.97 134.56 55.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.318 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -131.96 124.18 28.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.743 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 51.2 p-10 -79.11 178.4 8.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.867 0.365 . . . . 0.0 110.761 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.608 0 N-CA-C 110.715 -0.954 . . . . 0.0 110.715 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.1 t30 . . . . . 0 C--O 1.227 -0.129 0 CA-C-O 120.926 0.393 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.471 ' HA ' HG11 ' A' ' 147' ' ' VAL . 16.7 m -122.69 -156.9 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.402 ' CB ' ' O ' ' A' ' 58' ' ' VAL . 0.0 OUTLIER 82.28 114.21 0.06 Allowed 'General case' 0 C--N 1.346 0.453 0 O-C-N 124.177 0.923 . . . . 0.0 110.885 179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 67.3 t -128.11 140.69 48.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.048 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 136' ' ' ALA . 91.9 t -120.12 126.54 75.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.9 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.437 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 65.1 t -114.33 112.21 39.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.275 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 64.5 m-85 -79.52 139.17 37.65 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-O 121.21 0.529 . . . . 0.0 110.091 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.614 HD11 ' HD1' ' A' ' 137' ' ' TYR . 3.9 mm -96.86 156.78 3.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.876 -1.056 . . . . 0.0 110.041 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.435 ' HA ' ' HB3' ' A' ' 161' ' ' SER . 13.7 mmt180 -50.45 175.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.433 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 27.9 mmtm -45.9 -41.51 11.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.301 -178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -115.67 -117.64 0.32 Allowed 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.438 ' O ' HG21 ' A' ' 64' ' ' ILE . 0.2 OUTLIER 41.81 48.44 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.348 0.515 0 CA-C-O 121.304 0.573 . . . . 0.0 110.664 179.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -53.81 -23.4 12.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.589 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 14.3 t70 67.16 -71.59 0.1 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-O 120.975 0.417 . . . . 0.0 111.267 177.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -63.47 -15.02 56.56 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.794 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.9 t -79.05 120.4 23.55 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.702 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -64.04 -36.7 84.87 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.595 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 71.2 p -135.13 148.04 49.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.459 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 45.7 pt -132.32 152.78 37.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 120.976 0.417 . . . . 0.0 110.549 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -87.06 107.33 18.39 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.758 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -165.86 144.43 5.95 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.382 -179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 70.12 -72.02 0.12 Allowed 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.89 0.744 . . . . 0.0 110.683 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -139.71 86.52 0.21 Allowed Glycine 0 CA--C 1.528 0.86 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 60.85 -157.07 0.34 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.555 0.217 . . . . 0.0 110.534 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 46.8 p -75.56 128.18 34.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 121.186 0.517 . . . . 0.0 110.216 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.2 p -134.64 146.35 31.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.136 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.3 p -55.93 136.86 51.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.595 -179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -80.99 129.65 34.63 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.597 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -68.15 -27.39 66.39 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.456 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -112.88 74.02 0.84 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.901 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -92.06 125.4 36.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.555 179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.5 m170 58.02 18.37 5.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.859 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -69.55 -43.27 73.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.123 0.487 . . . . 0.0 110.824 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 85.0 t -70.3 -39.72 77.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.017 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.519 ' HE1' HG13 ' A' ' 103' ' ' VAL . 81.5 t80 -63.12 -44.62 95.09 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.517 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -64.23 -39.91 94.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.806 -179.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.435 ' HB3' HD12 ' A' ' 157' ' ' ILE . 67.8 m -68.93 -40.15 79.18 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.345 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.56 -30.34 67.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.653 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.06 -34.61 66.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 43.4 t30 -84.57 6.36 24.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.95 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 7.7 mmm -57.53 -19.18 23.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 119.634 -0.222 . . . . 0.0 110.884 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 75.34 -68.22 0.21 Allowed 'General case' 0 C--N 1.346 0.419 0 O-C-N 123.4 0.438 . . . . 0.0 110.687 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 99' ' ' THR . 86.7 m -60.83 -14.79 24.11 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.806 179.282 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.623 HG23 HG13 ' A' ' 139' ' ' VAL . 10.8 p -73.22 145.62 11.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.129 0.49 . . . . 0.0 111.304 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.35 -43.46 5.2 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.583 178.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 35.2 t -159.23 149.02 18.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.275 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.519 HG13 ' HE1' ' A' ' 91' ' ' TYR . 0.2 OUTLIER -136.04 130.45 48.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.232 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 97.0 m -125.24 131.04 53.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.311 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.403 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 87.1 t80 -87.69 113.75 23.66 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.927 0.394 . . . . 0.0 110.543 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 34.1 t -97.16 106.54 18.89 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.726 178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 67.9 m -64.09 156.02 29.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.151 0.501 . . . . 0.0 110.364 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 12.8 ptpt -63.2 -29.55 70.87 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.418 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.56 -38.7 91.91 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.836 179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -69.07 -39.87 78.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.516 179.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -68.08 -36.17 79.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.767 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 116' ' ' THR . 0.2 OUTLIER -67.45 -40.41 85.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.515 0.674 . . . . 0.0 109.771 -179.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 54.1 tp10 -61.96 -40.67 96.37 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.148 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -67.36 -39.18 85.69 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.522 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.31 -35.92 76.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.475 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.727 HG23 ' O ' ' A' ' 112' ' ' TYR . 73.4 p -70.04 -34.46 73.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.435 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -68.06 -41.09 82.51 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.318 0.58 . . . . 0.0 110.543 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 47.1 pt -74.74 -27.27 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.125 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.27 0.48 32.58 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.566 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.2 12.29 84.49 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 63.02 174.18 0.15 Allowed 'General case' 0 CA--C 1.519 -0.23 0 CA-C-O 120.791 0.329 . . . . 0.0 110.29 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 28.7 m120 61.67 26.75 16.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.525 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.648 ' HE1' HG22 ' A' ' 116' ' ' THR . 2.6 p-90 -109.82 0.25 18.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.306 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -115.82 138.36 51.21 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 120.959 0.409 . . . . 0.0 110.705 -179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.9 tp -149.3 10.5 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.764 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -107.52 29.29 7.32 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.164 0.507 . . . . 0.0 110.299 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -57.99 130.71 47.79 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.466 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.78 84.33 0.59 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.186 -0.766 . . . . 0.0 111.186 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.1 t0 57.45 51.69 9.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.858 0.361 . . . . 0.0 111.071 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -110.33 -85.43 0.55 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.261 179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 6.8 m120 48.88 72.95 1.09 Allowed Pre-proline 0 CA--C 1.53 0.2 0 C-N-CA 121.098 -0.241 . . . . 0.0 111.556 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.69 -28.63 76.76 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.631 2.221 . . . . 0.0 111.761 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 80.3 mt -93.53 173.93 7.45 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.409 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -122.83 -170.08 2.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.007 -179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.403 ' HB3' ' CE1' ' A' ' 105' ' ' PHE . 45.8 m-20 -79.84 167.89 19.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.674 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -141.23 149.4 41.3 Favored 'General case' 0 C--O 1.221 -0.44 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.785 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.614 ' HD1' HD11 ' A' ' 64' ' ' ILE . 1.0 OUTLIER -118.05 105.48 11.9 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 179.31 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 28.7 mt -80.73 103.35 7.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.623 HG13 HG23 ' A' ' 100' ' ' VAL . 73.8 t -106.69 137.3 38.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.099 0.476 . . . . 0.0 111.261 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -102.18 108.01 19.26 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.295 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.439 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -69.5 142.93 53.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.721 -179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.92 -32.73 34.06 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.631 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -149.91 163.16 25.71 Favored Pre-proline 0 C--O 1.238 0.478 0 CA-C-O 121.235 0.541 . . . . 0.0 111.307 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.622 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.7 Cg_exo -58.17 -28.64 84.7 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.591 2.194 . . . . 0.0 112.004 179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -86.52 -5.41 59.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.232 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -97.55 -16.99 19.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.886 0.374 . . . . 0.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.622 HG22 ' O ' ' A' ' 144' ' ' PRO . 20.1 m -58.12 -34.08 48.45 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.306 0.574 . . . . 0.0 109.495 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.19 -33.99 63.61 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.885 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.4 m -71.35 -39.35 71.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.654 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.423 HG21 HG11 ' A' ' 139' ' ' VAL . 22.9 mm -66.37 -40.66 87.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.622 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.46 -41.17 96.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.468 0.651 . . . . 0.0 110.523 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -68.8 -39.43 80.12 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.847 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -71.06 -36.28 72.23 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.759 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -62.12 -35.46 78.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.329 -179.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 50.0 mttt -61.44 -18.7 60.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.16 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -87.43 -14.7 39.82 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.679 179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 93' ' ' SER . 9.9 mm -57.86 -100.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.757 -178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 171.17 138.43 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 78.78 13.75 82.79 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 121.038 -0.601 . . . . 0.0 111.644 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 76.1 t -81.84 127.21 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 O-C-N 122.618 -0.342 . . . . 0.0 110.335 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.435 ' HB3' ' HA ' ' A' ' 65' ' ' ARG . 77.8 p -96.58 -34.88 11.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.481 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -170.32 157.95 6.42 Favored 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 120.609 -0.436 . . . . 0.0 110.917 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 33.8 m -129.25 142.28 44.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.091 0.472 . . . . 0.0 110.389 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -142.11 119.89 11.89 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.854 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -82.12 173.26 12.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.784 0.326 . . . . 0.0 110.874 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.631 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.694 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.765 0.317 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 19.1 m -105.7 -151.82 0.07 OUTLIER 'Isoleucine or valine' 0 C--O 1.241 0.643 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 73.84 120.76 0.04 OUTLIER 'General case' 0 C--N 1.347 0.477 0 O-C-N 123.686 0.616 . . . . 0.0 110.321 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.894 HG22 HG23 ' A' ' 147' ' ' VAL . 15.1 t -129.24 137.16 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.964 -179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 96.3 t -118.03 122.81 70.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.707 HG13 HG22 ' A' ' 163' ' ' VAL . 3.5 t -112.32 105.0 17.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -74.36 146.34 43.09 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.728 HD11 ' CD1' ' A' ' 137' ' ' TYR . 65.9 mt -120.07 135.12 61.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.732 -178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.95 159.26 0.6 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.603 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.7 mtpp -71.41 -66.93 0.56 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.335 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -55.96 -21.64 22.0 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.958 0.786 . . . . 0.0 110.035 -178.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 69' ' ' GLU . 13.2 t -71.43 -48.0 55.85 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.484 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.416 ' O ' HG12 ' A' ' 68' ' ' VAL . 1.4 tp10 51.61 176.75 0.02 OUTLIER 'General case' 0 C--N 1.341 0.238 0 CA-C-O 121.322 0.582 . . . . 0.0 110.932 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -175.92 -176.72 0.85 Allowed 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 74.05 -54.97 0.67 Allowed 'General case' 0 N--CA 1.47 0.529 0 O-C-N 124.154 0.909 . . . . 0.0 110.746 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 69.2 m -129.93 131.41 45.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.303 179.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -74.12 68.07 1.39 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.801 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -152.67 109.02 3.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.819 0.342 . . . . 0.0 110.852 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.509 HG23 ' ND2' ' A' ' 84' ' ' ASN . 34.0 pt -129.61 153.87 39.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.305 0.574 . . . . 0.0 110.403 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -94.65 121.56 36.34 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.696 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -127.9 144.18 51.1 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.384 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -37.57 110.04 0.11 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.656 1.223 . . . . 0.0 110.2 -179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 123.86 -47.38 1.02 Allowed Glycine 0 CA--C 1.532 1.136 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -177.43 -154.93 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 121.085 -0.246 . . . . 0.0 111.21 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 97.6 m -109.35 128.43 55.1 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 109.951 -0.389 . . . . 0.0 109.951 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.74 143.59 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.242 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 43.0 p -80.09 159.3 26.17 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.92 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.509 ' ND2' HG23 ' A' ' 75' ' ' ILE . 0.1 OUTLIER -122.81 -177.46 3.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.329 -179.976 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 26.0 p30 -122.62 172.32 8.48 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.095 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 96.9 m-20 47.78 24.99 0.64 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.758 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -69.4 -32.44 71.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.798 -179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.408 ' HD2' ' HB3' ' A' ' 91' ' ' TYR . 0.0 OUTLIER -100.45 0.32 39.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.719 179.667 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 12.4 tptp -69.79 -36.85 76.06 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.527 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 72.7 t -65.21 -42.99 95.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.207 -179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.408 ' HB3' ' HD2' ' A' ' 88' ' ' HIS . 25.5 t80 -66.95 -42.45 85.19 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.66 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -67.74 -38.69 83.84 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.449 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.0 t -68.17 -42.77 79.52 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.487 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 86.7 mt -71.29 -26.02 62.69 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.915 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -91.64 -30.53 16.28 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.699 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -99.88 2.87 44.22 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.446 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.52 -15.93 61.72 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.707 -0.224 . . . . 0.0 110.571 179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 72.7 158.54 0.2 Allowed 'General case' 0 CA--C 1.515 -0.394 0 O-C-N 123.643 0.589 . . . . 0.0 109.711 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.572 ' HB ' HD11 ' A' ' 150' ' ' ILE . 4.5 m 72.66 5.6 5.26 Favored 'General case' 0 C--O 1.233 0.214 0 O-C-N 123.908 0.755 . . . . 0.0 110.818 -178.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 100' ' ' VAL . 27.6 m -110.39 121.13 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 CA-C-O 121.013 0.435 . . . . 0.0 110.607 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 36.9 ttmt -61.86 -44.95 95.78 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.932 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 60.0 p -163.39 163.72 24.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.22 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 139' ' ' VAL . 49.2 t -134.69 129.27 51.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.266 179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 89.1 m -121.92 132.38 54.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.981 0.419 . . . . 0.0 110.719 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.465 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 84.4 t80 -88.79 106.95 18.7 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.439 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 45.2 t -95.67 118.5 32.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.004 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 78.2 p -70.82 160.81 32.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.379 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -66.27 -31.84 72.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.075 0.464 . . . . 0.0 110.571 179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -68.9 -36.98 78.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.32 179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.56 -36.44 76.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.701 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -65.42 -38.31 89.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.574 179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -67.19 -40.36 86.52 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.36 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -68.33 -35.92 78.5 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.794 0.807 . . . . 0.0 110.126 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.9 mmmt -70.17 -37.08 75.08 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.494 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.522 HD23 HD11 ' A' ' 118' ' ' ILE . 50.1 mt -65.59 -39.08 91.19 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.221 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.6 t -73.39 -29.44 62.61 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.406 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -69.34 -36.87 77.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.991 179.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.522 HD11 HD23 ' A' ' 115' ' ' LEU . 50.2 pt -86.01 -27.94 6.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.941 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 13.3 mmt -93.16 -63.35 1.22 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.95 0.405 . . . . 0.0 110.715 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.63 -176.95 54.16 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.7 t0 63.67 25.7 14.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.498 0.189 . . . . 0.0 110.649 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 63.8 t30 51.21 66.89 1.05 Allowed 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.099 179.239 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -76.23 -1.59 27.17 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.369 179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -53.96 -83.57 0.01 OUTLIER 'General case' 0 C--O 1.231 0.127 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.956 -179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 mp 41.29 62.71 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.09 0 CA-C-O 121.452 0.644 . . . . 0.0 111.183 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -158.0 5.3 0.12 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.586 -0.733 . . . . 0.0 111.053 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 58.51 167.65 0.05 Allowed 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.167 0.508 . . . . 0.0 110.674 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -93.79 8.81 73.76 Favored Glycine 0 CA--C 1.529 0.935 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -92.77 10.77 29.41 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 120.661 0.267 . . . . 0.0 110.686 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -137.26 152.76 50.17 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-O 120.916 0.389 . . . . 0.0 110.322 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -129.04 72.03 81.98 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.277 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -62.47 -19.62 68.05 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.867 2.378 . . . . 0.0 112.349 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 66.5 mt -117.73 153.79 32.8 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.442 -179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -128.53 -171.19 2.4 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.465 ' HB3' ' CE1' ' A' ' 105' ' ' PHE . 93.7 m-20 -74.5 131.96 41.46 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.659 179.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.86 137.32 54.67 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-O 121.072 0.463 . . . . 0.0 111.361 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.728 ' CD1' HD11 ' A' ' 64' ' ' ILE . 8.4 m-85 -95.48 120.3 35.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 178.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 51.4 mt -92.63 104.4 15.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.56 HG22 HG22 ' A' ' 103' ' ' VAL . 85.0 t -105.65 132.74 51.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.939 0.4 . . . . 0.0 110.355 -179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -98.99 107.09 19.44 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.484 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -66.44 142.92 57.41 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.954 0.407 . . . . 0.0 110.684 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 63.8 t-20 -59.44 -40.22 86.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.208 -179.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.525 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -136.84 160.7 65.31 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 121.15 0.5 . . . . 0.0 110.91 -179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.525 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 30.3 Cg_endo -62.94 -15.22 46.17 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.701 2.267 . . . . 0.0 111.87 179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -96.81 -5.66 37.88 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.559 -0.456 . . . . 0.0 110.406 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -98.19 -24.15 15.4 Favored 'General case' 0 C--O 1.225 -0.234 0 CA-C-O 120.71 0.29 . . . . 0.0 110.581 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.894 HG23 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -55.5 -36.57 42.01 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 CA-C-N 115.958 -0.565 . . . . 0.0 110.19 179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.1 ptmm? -71.54 -35.71 70.76 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.926 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.9 m -73.05 -39.7 65.7 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.454 0.645 . . . . 0.0 110.58 179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.572 HD11 ' HB ' ' A' ' 99' ' ' THR . 25.5 mm -69.31 -38.99 78.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.39 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.23 -40.05 95.22 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.238 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -66.08 -40.03 90.49 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.809 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -70.57 -37.39 73.97 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.865 179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.48 -31.01 72.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.774 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.437 ' HG3' HG21 ' A' ' 163' ' ' VAL . 60.5 mtpt -72.66 -13.07 61.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.081 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.4 mmtt -107.57 9.99 29.29 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.859 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.411 HG22 ' N ' ' A' ' 158' ' ' GLU . 8.5 mm -55.08 -88.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.51 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.411 ' N ' HG22 ' A' ' 157' ' ' ILE . 67.2 mm-40 -151.93 -84.56 0.08 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 121.05 -0.26 . . . . 0.0 110.631 -179.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -100.89 35.66 4.71 Favored Glycine 0 CA--C 1.526 0.739 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.8 p -63.49 143.84 15.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.993 0.425 . . . . 0.0 109.952 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 8.7 t -97.34 -51.33 4.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.409 179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -166.46 145.89 5.8 Favored 'General case' 0 C--O 1.221 -0.423 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.001 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.707 HG22 HG13 ' A' ' 62' ' ' VAL . 95.1 t -117.99 129.26 74.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.023 0.439 . . . . 0.0 111.013 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 4.2 tt0 -128.25 128.27 44.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.762 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.9 p-10 -77.61 168.97 19.11 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.238 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.424 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.993 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.726 0.298 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 16.9 m -71.6 138.22 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.8 tpp85 162.03 115.0 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 O-C-N 124.129 0.893 . . . . 0.0 110.248 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.4 t -133.5 131.61 57.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.582 HG13 ' HB1' ' A' ' 136' ' ' ALA . 87.8 t -121.07 124.01 71.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.74 -179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.478 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 80.0 t -111.38 114.71 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 CA-C-O 121.136 0.494 . . . . 0.0 111.463 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -79.31 134.77 36.62 Favored 'General case' 0 CA--C 1.51 -0.582 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.121 178.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.839 HD11 ' CD1' ' A' ' 137' ' ' TYR . 54.5 mt -117.5 139.33 45.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.625 -1.171 . . . . 0.0 110.734 -179.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.08 168.94 0.19 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.589 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.9 mtpt -88.63 -10.43 48.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.421 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -100.31 31.55 3.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.893 0.378 . . . . 0.0 110.805 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.489 HG13 ' O ' ' A' ' 68' ' ' VAL . 10.0 p -168.6 38.01 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.602 -179.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -55.27 98.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.903 0.382 . . . . 0.0 110.266 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.41 -63.19 1.27 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.561 -178.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -87.29 69.37 9.98 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 121.108 0.48 . . . . 0.0 110.137 -179.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.2 p -140.27 -38.91 0.44 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.811 179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 76.58 -45.86 0.51 Allowed 'General case' 0 N--CA 1.47 0.553 0 O-C-N 123.724 0.64 . . . . 0.0 111.086 -179.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.9 t -147.43 153.52 39.69 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 44.3 pt -125.44 151.92 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 121.26 0.552 . . . . 0.0 110.109 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -89.44 118.24 28.95 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.029 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -124.95 134.32 52.68 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.217 -0.901 . . . . 0.0 109.876 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -33.15 109.98 0.08 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 124.058 0.849 . . . . 0.0 111.037 -179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.49 -48.62 0.94 Allowed Glycine 0 CA--C 1.528 0.9 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.396 -179.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -168.78 -157.06 0.18 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 122.58 -0.365 . . . . 0.0 111.171 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.6 p -116.08 133.05 56.44 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -118.16 134.26 62.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.323 -178.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 92.4 m -60.72 133.49 56.15 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.609 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -82.97 155.71 23.84 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.756 -179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 52.1 p-10 -94.25 168.31 10.99 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.419 178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 54.01 44.53 29.21 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.871 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -64.67 125.79 25.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.512 . . . . 0.0 110.44 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 54.15 18.17 1.68 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.94 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.5 tptp -71.01 -43.8 67.22 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.357 0.598 . . . . 0.0 110.518 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.484 HG13 HG21 ' A' ' 157' ' ' ILE . 79.0 t -69.23 -38.83 78.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.631 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -60.37 -45.85 92.04 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.017 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -65.54 -39.91 92.28 Favored 'General case' 0 C--N 1.316 -0.885 0 C-N-CA 119.857 -0.737 . . . . 0.0 110.585 -178.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 32.9 t -65.9 -42.25 90.47 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.409 0.623 . . . . 0.0 110.425 -179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.413 HD12 HG12 ' A' ' 90' ' ' VAL . 91.6 mt -73.19 -36.23 66.51 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.883 -179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.45 -37.37 68.57 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.023 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 40.2 p-10 -91.57 6.91 43.83 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.984 -0.287 . . . . 0.0 110.805 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.38 -19.88 0.95 Allowed 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 120.867 -0.333 . . . . 0.0 111.539 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 t 67.77 67.55 0.36 Allowed 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.671 ' CG2' HD11 ' A' ' 150' ' ' ILE . 1.0 OUTLIER 167.21 -23.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 O-C-N 123.809 0.693 . . . . 0.0 110.257 179.198 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.2 m -85.78 149.27 4.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.113 0.482 . . . . 0.0 111.413 -178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.5 tttm -91.62 -43.17 9.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.016 179.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 91.9 p -154.22 152.75 30.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.082 0.468 . . . . 0.0 110.491 179.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.625 HG22 HG22 ' A' ' 139' ' ' VAL . 77.3 t -132.56 128.64 58.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.766 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.5 m -124.68 131.34 53.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.781 179.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.495 ' HE1' HD12 ' A' ' 64' ' ' ILE . 53.0 t80 -92.58 122.2 34.77 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.548 0.689 . . . . 0.0 110.108 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.408 ' HB2' ' HB3' ' A' ' 136' ' ' ALA . 0.5 OUTLIER -101.17 106.95 18.23 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.702 178.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 68.0 m -66.43 145.33 55.8 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.158 0.504 . . . . 0.0 110.88 -179.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.9 pttt -70.75 -26.36 63.33 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.928 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -64.65 -41.01 96.42 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 16.7 tm-20 -68.2 -40.77 82.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.641 -0.708 . . . . 0.0 110.251 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.411 ' HG2' HD13 ' A' ' 133' ' ' LEU . 6.6 tt0 -65.16 -39.81 93.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.803 179.719 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.57 ' O ' HG23 ' A' ' 116' ' ' THR . 73.7 t80 -62.25 -41.61 98.59 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.062 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -62.2 -38.88 90.81 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.086 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.1 mmmt -65.65 -38.17 88.6 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.484 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.499 ' CD1' HD11 ' A' ' 133' ' ' LEU . 0.3 OUTLIER -68.25 -34.75 76.79 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.93 -179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.574 HG22 ' HE1' ' A' ' 123' ' ' TRP . 79.0 p -70.22 -35.42 73.85 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.371 -179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -66.48 -42.92 86.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.728 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.415 HG12 ' HA ' ' A' ' 115' ' ' LEU . 44.1 pt -73.15 -28.43 26.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.768 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.409 ' HB3' ' HB3' ' A' ' 123' ' ' TRP . 14.2 mmt -81.05 -8.58 59.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.312 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.2 17.73 71.06 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 120.855 -0.688 . . . . 0.0 111.485 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.8 t0 60.31 36.38 20.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.064 0.459 . . . . 0.0 110.514 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -142.85 50.93 1.43 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.701 179.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.574 ' HE1' HG22 ' A' ' 116' ' ' THR . 4.4 p-90 -141.67 3.6 1.68 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.785 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -82.38 103.12 11.72 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.92 0.39 . . . . 0.0 110.288 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 97.4 mt -116.33 -22.82 4.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.552 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -89.74 13.47 14.22 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.899 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 61.95 160.79 0.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 120.794 -0.363 . . . . 0.0 110.62 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -75.06 -174.16 33.64 Favored Glycine 0 CA--C 1.523 0.555 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 58.9 31.18 21.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.727 0.299 . . . . 0.0 110.232 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -116.29 -44.13 2.9 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.327 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.9 m120 49.01 62.26 12.54 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.591 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -62.53 -19.08 66.64 Favored 'Trans proline' 0 N--CA 1.498 1.768 0 C-N-CA 122.808 2.339 . . . . 0.0 112.373 -179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.499 HD11 ' CD1' ' A' ' 115' ' ' LEU . 48.5 mt -89.4 168.5 12.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.012 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -117.97 161.1 20.35 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.823 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -61.73 -169.4 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 178.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.582 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -161.73 127.78 3.7 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.839 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.2 OUTLIER -105.96 106.38 16.85 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 179.008 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 39.4 mt -82.9 110.58 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.625 HG22 HG22 ' A' ' 103' ' ' VAL . 84.3 t -115.41 137.02 50.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.048 0.451 . . . . 0.0 110.47 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -101.34 109.33 21.15 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.041 179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.51 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -70.65 147.39 49.21 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.587 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -57.53 -40.0 77.83 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.041 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.485 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -135.2 159.95 69.98 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.638 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.564 ' O ' HG22 ' A' ' 147' ' ' VAL . 25.0 Cg_endo -61.07 -19.34 62.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.379 2.053 . . . . 0.0 112.215 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 32.9 m120 -91.52 -5.49 54.07 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.896 -0.322 . . . . 0.0 111.234 179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.462 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 83.3 m-20 -98.92 -16.12 18.91 Favored 'General case' 0 C--O 1.223 -0.299 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.241 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 144' ' ' PRO . 28.3 m -60.0 -33.17 52.05 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 121.18 0.514 . . . . 0.0 109.736 -179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -38.25 63.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.195 -0.911 . . . . 0.0 110.454 179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.8 m -68.73 -40.35 79.92 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.3 0.571 . . . . 0.0 110.797 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.671 HD11 ' CG2' ' A' ' 99' ' ' THR . 31.2 mm -64.43 -41.27 91.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.494 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.62 -41.31 98.3 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.314 0.578 . . . . 0.0 109.965 179.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -66.42 -40.21 89.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.745 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -69.06 -37.47 78.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.765 179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.424 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -62.53 -32.94 73.96 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.382 -179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 13.1 mttt -61.72 -19.93 62.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.102 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 30.6 mttm -92.86 6.59 47.16 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.998 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.484 HG21 HG13 ' A' ' 90' ' ' VAL . 17.3 mm -88.14 120.98 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 41.91 -97.06 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.721 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.464 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -159.95 52.16 0.36 Allowed Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.1 m -46.7 163.14 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.522 -0.131 0 CA-C-O 120.723 0.297 . . . . 0.0 110.362 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 46.4 t -83.93 -50.36 8.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.165 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -169.48 148.76 3.84 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.706 -179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.41 HG12 HG13 ' A' ' 62' ' ' VAL . 22.4 m -120.22 148.56 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-O 121.253 0.549 . . . . 0.0 110.484 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -142.01 148.82 39.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.652 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -110.46 135.48 51.07 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.451 179.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.766 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.844 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.797 0.332 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 27.3 m -99.97 50.31 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -98.52 122.16 41.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.58 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 60.2 t -119.84 137.48 53.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.983 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 95.1 t -118.41 123.8 72.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 120.856 0.36 . . . . 0.0 110.47 -179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 90.1 t -108.52 116.13 50.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.24 179.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -85.35 134.58 34.09 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.574 HD11 ' CE1' ' A' ' 137' ' ' TYR . 71.6 mt -98.61 147.8 6.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.743 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 5.5 mmt-85 -45.61 164.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.721 179.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' O ' ' CB ' ' A' ' 67' ' ' ASP . 7.3 tttm -88.26 139.2 30.73 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.115 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . 0.41 ' CB ' ' O ' ' A' ' 66' ' ' LYS . 12.0 t0 82.89 25.98 0.13 Allowed 'General case' 0 N--CA 1.466 0.359 0 O-C-N 124.037 0.836 . . . . 0.0 110.752 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.2 p -147.32 108.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.531 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -107.87 98.44 8.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.92 0.391 . . . . 0.0 110.676 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -60.02 -48.11 83.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.026 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -96.37 68.26 2.56 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.834 0.35 . . . . 0.0 111.007 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 61.6 p -146.98 -31.54 0.33 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.986 179.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 67.95 3.91 3.77 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.681 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.7 t -171.13 156.96 4.95 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 110.176 -0.305 . . . . 0.0 110.176 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 84.6 mt -114.86 133.1 62.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -106.51 142.24 36.49 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.895 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.468 ' O ' ' C ' ' A' ' 78' ' ' GLU . 60.7 tttp -151.44 141.8 22.44 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.058 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.468 ' C ' ' O ' ' A' ' 77' ' ' LYS . 20.3 tt0 -17.98 97.02 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.85 0 O-C-N 124.551 1.157 . . . . 0.0 111.726 -179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.466 ' O ' ' HB2' ' A' ' 80' ' ' GLN . . . 48.18 90.37 0.01 OUTLIER Glycine 0 CA--C 1.526 0.734 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -178.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 79' ' ' GLY . 57.6 tp60 143.92 116.06 0.0 OUTLIER 'General case' 0 C--N 1.361 1.104 0 O-C-N 124.964 1.038 . . . . 0.0 110.371 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.3 p -121.27 133.81 55.15 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.0 m -133.12 165.12 33.34 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.491 0 CA-C-O 121.166 0.508 . . . . 0.0 110.301 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 82.6 p -61.26 163.78 6.07 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.212 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -113.7 -171.23 1.85 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.833 0.349 . . . . 0.0 110.797 -179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 25.8 p30 -135.05 153.59 52.0 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.368 179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 53.06 46.26 27.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.634 -179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -55.51 -47.57 76.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -118.73 45.04 2.14 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.874 0.369 . . . . 0.0 110.645 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.8 tptt -101.67 -51.42 3.45 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.75 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 71.4 t -66.68 -40.28 85.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.782 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -66.71 -41.71 87.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.489 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -65.01 -40.56 95.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.385 -179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 52.6 m -68.24 -37.32 80.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.124 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.3 mt -79.14 -11.48 59.98 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.018 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt -94.81 -32.87 13.09 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.866 0.365 . . . . 0.0 111.407 -179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 57.4 p30 -89.55 8.52 30.79 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.185 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 77.5 mmm -53.46 -20.16 4.42 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.841 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 79.35 -48.22 0.39 Allowed 'General case' 0 N--CA 1.465 0.293 0 O-C-N 123.613 0.571 . . . . 0.0 110.74 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.454 ' HB ' HD11 ' A' ' 150' ' ' ILE . 3.9 m -88.17 17.76 4.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.914 0.388 . . . . 0.0 110.83 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.628 HG23 HG13 ' A' ' 139' ' ' VAL . 6.3 p -107.25 138.55 32.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-O 121.12 0.486 . . . . 0.0 111.262 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.5 ttpm? -95.54 -42.24 8.54 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.795 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 46.6 t -157.98 150.1 22.08 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.585 -179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 139' ' ' VAL . 58.2 t -131.58 128.84 61.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.736 179.665 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.401 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 99.3 m -125.42 132.47 52.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.546 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -86.9 118.77 26.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.006 0.431 . . . . 0.0 110.599 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 20.2 t -105.83 118.01 35.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.403 179.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 58.1 m -69.14 150.34 47.64 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.088 0.471 . . . . 0.0 110.601 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 56.6 pttt -64.52 -31.8 73.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.787 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 51.4 tp10 -64.7 -39.75 94.19 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.509 -179.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.07 -38.4 79.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.319 179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -66.29 -38.56 88.06 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.445 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.555 ' O ' HG23 ' A' ' 116' ' ' THR . 58.0 t80 -63.68 -41.47 98.15 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.917 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -64.62 -39.17 93.23 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.249 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.3 mmtm -66.63 -38.32 86.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.576 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.78 -37.79 85.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.646 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 112' ' ' TYR . 74.0 p -69.13 -35.26 76.19 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.78 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -66.78 -39.71 87.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.773 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.0 pt -78.09 -28.11 15.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.88 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.09 -19.12 34.83 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.464 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 79.5 -159.05 44.15 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -77.62 71.64 4.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.787 0.327 . . . . 0.0 110.158 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 178.05 -166.74 0.06 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.342 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.412 ' HE1' HG22 ' A' ' 116' ' ' THR . 0.0 OUTLIER 66.35 126.98 0.02 OUTLIER 'General case' 0 C--O 1.236 0.346 0 CA-C-O 120.855 0.36 . . . . 0.0 110.427 -179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 15.3 mttt 172.55 65.97 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.59 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 83.3 mt -61.01 -46.14 97.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.049 0.452 . . . . 0.0 110.619 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -112.74 68.56 0.67 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.762 -0.653 . . . . 0.0 110.9 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -59.78 161.24 6.53 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.664 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 75.88 -153.62 43.99 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 111.099 -0.801 . . . . 0.0 111.099 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -80.29 114.34 19.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.049 0.452 . . . . 0.0 110.521 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -169.23 -41.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.339 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 25.0 m120 53.23 82.6 0.24 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.765 179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -48.18 -34.62 24.56 Favored 'Trans proline' 0 N--CA 1.496 1.656 0 C-N-CA 122.683 2.255 . . . . 0.0 111.847 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.5 mp -109.19 167.89 9.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.809 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -125.97 -165.5 1.44 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.449 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -57.59 140.39 51.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.11 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.57 151.14 49.28 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.197 0.523 . . . . 0.0 110.696 -179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.574 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.3 m-85 -120.08 110.48 16.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.159 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.401 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 51.6 mt -83.43 108.25 15.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.668 HG22 HG22 ' A' ' 103' ' ' VAL . 69.4 t -113.28 137.19 47.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.17 0.509 . . . . 0.0 110.979 -178.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -99.21 106.9 19.11 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.18 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.614 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -75.87 146.51 39.74 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.893 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.584 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 17.9 m-80 -75.32 88.79 2.57 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.604 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 87.95 156.66 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.435 0 O-C-N 123.945 0.778 . . . . 0.0 110.716 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.689 ' O ' HG22 ' A' ' 147' ' ' VAL . 36.6 Cg_exo -59.74 -24.84 77.2 Favored 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.584 2.189 . . . . 0.0 112.468 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -78.35 -13.62 59.77 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 120.975 -0.29 . . . . 0.0 111.513 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.41 ' OD2' ' O ' ' A' ' 142' ' ' ASN . 82.5 m-20 -97.73 -17.08 19.61 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-O 120.651 0.262 . . . . 0.0 111.309 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.689 HG22 ' O ' ' A' ' 144' ' ' PRO . 4.6 m -61.17 -32.97 54.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 ptmm? -75.83 -34.24 60.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.62 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 86.7 m -70.98 -40.03 72.14 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.42 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.454 HD11 ' HB ' ' A' ' 99' ' ' THR . 33.4 mm -65.69 -41.1 89.73 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.297 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.23 95.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.321 0.581 . . . . 0.0 110.166 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -66.85 -40.48 87.92 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.719 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -72.47 -32.77 66.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.265 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.04 69.87 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.771 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.569 ' HA ' HG11 ' A' ' 160' ' ' VAL . 68.0 mttm -62.2 -18.05 59.94 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.323 179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.64 8.27 45.12 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.73 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 17.6 mm -84.59 117.87 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 C-N-CA 121.184 -0.206 . . . . 0.0 110.682 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 38.49 -115.31 0.15 Allowed 'General case' 0 CA--C 1.538 0.486 0 O-C-N 124.09 0.869 . . . . 0.0 111.519 178.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -120.7 40.57 2.12 Favored Glycine 0 C--N 1.341 0.815 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 155' ' ' LYS . 11.5 p -42.96 146.51 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 81.0 p -92.74 -47.44 7.07 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.222 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -165.39 154.12 11.91 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.819 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.02 140.96 47.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.774 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -143.28 137.36 28.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.718 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -90.2 179.11 5.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.713 179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.661 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 179.808 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 m120 . . . . . 0 N--CA 1.457 -0.094 0 CA-C-O 120.531 0.205 . . . . 0.0 110.651 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.441 HG13 ' N ' ' A' ' 59' ' ' ARG . 0.3 OUTLIER -145.39 173.99 3.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.441 ' N ' HG13 ' A' ' 58' ' ' VAL . 0.3 OUTLIER 71.71 137.06 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 123.643 0.589 . . . . 0.0 110.363 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.496 HG13 ' HB ' ' A' ' 139' ' ' VAL . 0.1 OUTLIER -138.23 141.19 38.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.388 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 93.6 t -116.19 125.04 73.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.46 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.489 HG21 ' HB1' ' A' ' 154' ' ' ALA . 61.0 t -109.16 116.63 52.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 120.881 -0.328 . . . . 0.0 110.182 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -84.35 138.65 32.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.608 ' CG2' HG11 ' A' ' 68' ' ' VAL . 1.5 mt -102.11 153.28 5.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.895 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.122 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 35.5 mmt180 -59.02 149.02 28.69 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.728 0.775 . . . . 0.0 110.831 179.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.79 135.56 54.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.024 -179.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 16.8 t0 69.15 26.07 5.61 Favored 'General case' 0 N--CA 1.457 -0.105 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.902 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.625 HG13 ' H ' ' A' ' 70' ' ' ASP . 9.1 p -73.23 -29.43 28.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.996 0.427 . . . . 0.0 110.451 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 54.66 32.81 17.98 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.932 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.625 ' H ' HG13 ' A' ' 68' ' ' VAL . 12.6 p-10 -59.83 -37.75 80.1 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.015 0.436 . . . . 0.0 110.511 -179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -104.53 22.86 14.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.631 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.425 ' O ' ' CE2' ' A' ' 87' ' ' TYR . 5.3 t -85.97 -139.43 0.08 Allowed 'General case' 0 C--O 1.221 -0.438 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.668 -179.553 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -164.95 -32.35 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -159.33 145.24 16.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.983 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.5 pt -130.41 152.23 37.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 121.244 0.545 . . . . 0.0 110.429 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -99.68 120.89 40.42 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.933 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -145.17 138.13 26.34 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.219 -0.9 . . . . 0.0 111.244 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 57.6 29.27 16.92 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.717 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 71.82 11.88 74.09 Favored Glycine 0 CA--C 1.532 1.11 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -122.9 141.25 52.11 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 -179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 88.9 m -96.48 125.68 41.14 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-O 120.876 0.369 . . . . 0.0 110.147 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.9 m -129.71 155.94 41.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.293 0.568 . . . . 0.0 109.883 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 75.4 p -70.55 147.71 49.0 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.666 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 39.8 t30 -58.67 152.85 17.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.927 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -60.19 102.57 0.17 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.244 -179.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 87' ' ' TYR . 23.8 m-20 45.42 72.18 0.23 Allowed 'General case' 0 CA--C 1.504 -0.823 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.627 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.461 ' C ' ' O ' ' A' ' 86' ' ' ASP . 1.2 t80 -32.44 128.28 0.24 Allowed 'General case' 0 N--CA 1.466 0.339 0 O-C-N 124.48 1.113 . . . . 0.0 109.909 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 63.15 41.78 7.74 Favored 'General case' 0 C--N 1.342 0.278 0 O-C-N 123.245 0.341 . . . . 0.0 110.996 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.0 tttp -71.96 -46.72 56.38 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 121.153 0.502 . . . . 0.0 110.309 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 88.2 t -70.8 -37.52 69.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.441 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -64.48 -43.54 93.86 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.914 -179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -70.34 -37.62 74.68 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.422 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 46.8 t -64.92 -42.13 94.96 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.4 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.1 mt -69.32 -39.77 78.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.834 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -68.82 -24.3 64.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.076 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -90.56 4.53 50.97 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.477 179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.8 mmt -59.83 -23.37 63.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 119.21 -0.424 . . . . 0.0 110.653 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 75.32 -62.22 0.45 Allowed 'General case' 0 C--N 1.349 0.585 0 O-C-N 123.466 0.479 . . . . 0.0 111.196 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.575 ' HB ' HD11 ' A' ' 150' ' ' ILE . 53.7 m -59.39 -17.25 28.67 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.114 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 17.3 m -86.38 149.89 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-O 120.857 0.36 . . . . 0.0 110.773 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -90.83 -42.36 10.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.916 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.5 p -157.57 156.47 32.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.528 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 139' ' ' VAL . 59.7 t -134.84 129.89 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.913 179.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 96.2 m -125.76 131.76 52.45 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.003 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -87.03 116.26 24.97 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.064 0.459 . . . . 0.0 110.379 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 28.4 t -104.74 119.89 40.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.607 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.3 t -62.41 160.4 13.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.254 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 10.3 ptpp? -62.61 -37.12 85.01 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.028 0.442 . . . . 0.0 110.207 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -69.19 -40.46 78.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.926 -179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -70.43 -38.58 74.57 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.493 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.406 HE21 ' HB3' ' A' ' 136' ' ' ALA . 10.9 tp-100 -66.65 -40.5 88.69 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.36 -179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.629 ' O ' HG23 ' A' ' 116' ' ' THR . 16.1 t80 -63.54 -43.92 95.71 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.646 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.78 -39.45 87.82 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.75 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -67.27 -39.75 86.1 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.95 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.771 HD23 HD11 ' A' ' 118' ' ' ILE . 70.7 mt -66.29 -38.09 86.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.893 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 112' ' ' TYR . 76.6 p -69.08 -33.64 73.87 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.183 0.515 . . . . 0.0 110.664 -179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -68.3 -38.63 81.83 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.98 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.771 HD11 HD23 ' A' ' 115' ' ' LEU . 41.5 pt -80.43 -33.07 13.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.568 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.89 8.13 45.09 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.425 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 62.19 -149.21 47.93 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -75.46 150.34 38.28 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.994 -0.282 . . . . 0.0 110.286 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.423 ' HA ' HD13 ' A' ' 125' ' ' ILE . 8.2 t-20 75.18 -150.89 0.03 OUTLIER 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 124.166 0.916 . . . . 0.0 110.048 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 75.93 -29.68 0.18 Allowed 'General case' 0 C--N 1.344 0.329 0 O-C-N 123.562 0.539 . . . . 0.0 110.778 -179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.404 ' H ' ' C ' ' A' ' 122' ' ' ASN . 1.6 mmtm -145.23 -83.09 0.14 Allowed 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.51 HG22 ' O ' ' A' ' 125' ' ' ILE . 1.3 mp 58.58 106.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.189 0.519 . . . . 0.0 110.003 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 2.6 t80 179.51 97.46 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.355 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -149.72 33.71 0.69 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.586 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -99.3 -19.02 22.28 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -130.52 -64.31 0.85 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.847 0.356 . . . . 0.0 110.763 -179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -151.15 165.49 33.74 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.863 -179.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -59.33 132.14 87.89 Favored Pre-proline 0 N--CA 1.449 -0.48 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.134 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -69.02 -25.74 31.73 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 123.115 2.543 . . . . 0.0 112.405 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 58.2 mt -112.5 -176.57 2.94 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.853 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.92 -162.65 1.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.49 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -60.87 154.26 22.59 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.711 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.406 ' HB3' HE21 ' A' ' 111' ' ' GLN . . . -142.46 151.28 41.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.871 -179.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.561 ' CE1' HD11 ' A' ' 64' ' ' ILE . 4.7 m-85 -123.06 112.19 17.47 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.209 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 46.3 mt -86.85 111.24 21.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.762 -0.459 . . . . 0.0 109.762 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 103' ' ' VAL . 78.4 t -114.8 138.27 45.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.366 0.603 . . . . 0.0 110.82 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -104.85 108.31 19.74 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.25 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.568 ' HB2' ' HA ' ' A' ' 147' ' ' VAL . . . -66.58 145.95 55.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.812 0.339 . . . . 0.0 110.947 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -57.45 -39.3 76.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 109.796 -179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -137.39 161.33 61.39 Favored Pre-proline 0 C--O 1.237 0.435 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.813 179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.522 ' O ' HG12 ' A' ' 147' ' ' VAL . 39.0 Cg_exo -59.64 -19.94 55.45 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.848 2.365 . . . . 0.0 112.062 179.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 17.5 p30 -95.16 -4.79 45.41 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.641 179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -97.61 -22.11 16.68 Favored 'General case' 0 C--O 1.224 -0.272 0 CA-C-O 120.762 0.315 . . . . 0.0 110.574 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.568 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 6.6 p -57.8 -35.07 49.8 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 CA-C-O 121.004 0.43 . . . . 0.0 109.961 179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.6 ptmt -71.88 -34.99 69.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.813 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.418 ' O ' ' HG3' ' A' ' 152' ' ' GLU . 59.7 m -73.25 -38.75 65.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.98 179.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.575 HD11 ' HB ' ' A' ' 99' ' ' THR . 33.4 mm -69.06 -40.46 80.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.857 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.42 -40.37 95.63 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.635 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.418 ' HG3' ' O ' ' A' ' 149' ' ' THR . 1.0 OUTLIER -76.87 -24.46 52.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.129 -179.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -85.1 -34.85 22.12 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.253 0.549 . . . . 0.0 110.547 -179.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.489 ' HB1' HG21 ' A' ' 62' ' ' VAL . . . -69.49 -30.02 67.8 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.58 -0.737 . . . . 0.0 110.866 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 14.6 ptmt -67.84 -12.18 60.1 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 120.905 0.383 . . . . 0.0 110.998 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 58.7 mtmt -105.65 9.12 33.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.078 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.501 HG22 ' HG2' ' A' ' 158' ' ' GLU . 7.0 mm -53.78 -78.55 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 120.786 -0.366 . . . . 0.0 110.77 -179.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.501 ' HG2' HG22 ' A' ' 157' ' ' ILE . 81.5 mm-40 -145.44 -80.63 0.16 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.135 -179.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -121.04 62.11 0.52 Allowed Glycine 0 CA--C 1.523 0.554 0 N-CA-C 110.954 -0.859 . . . . 0.0 110.954 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -76.72 156.66 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.884 0.373 . . . . 0.0 110.28 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.4 t -109.81 -42.77 4.17 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.322 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -166.63 153.62 9.14 Favored 'General case' 0 C--O 1.214 -0.783 0 C-N-CA 120.761 -0.375 . . . . 0.0 110.614 -179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.9 t -130.75 135.5 60.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.576 -0.449 . . . . 0.0 110.5 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -137.8 133.56 34.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.755 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 57.4 p-10 -78.23 178.43 7.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.573 -0.285 . . . . 0.0 110.833 179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.627 0 N-CA-C 110.741 -0.944 . . . . 0.0 110.741 -179.829 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 CA--C 1.522 -0.1 0 CA-C-O 120.814 0.34 . . . . 0.0 110.703 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -177.52 -22.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.088 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 14.4 ttm180 -90.53 135.35 33.76 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.091 0.472 . . . . 0.0 110.246 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.4 ' CG2' HG23 ' A' ' 147' ' ' VAL . 95.5 t -125.42 133.43 69.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.646 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.513 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 78.9 t -115.5 122.46 69.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.47 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 66.1 t -106.74 108.71 25.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.108 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.446 ' CD2' ' HB2' ' A' ' 136' ' ' ALA . 82.4 m-85 -81.18 145.61 30.92 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 120.998 0.427 . . . . 0.0 110.026 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.726 HD11 ' CE1' ' A' ' 137' ' ' TYR . 78.3 mt -111.82 157.75 12.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.853 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.458 ' N ' HG22 ' A' ' 64' ' ' ILE . 28.1 mmt85 -50.2 173.73 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.569 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -59.33 -117.07 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.367 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -84.94 55.26 3.4 Favored 'General case' 0 N--CA 1.444 -0.743 0 O-C-N 121.641 -0.662 . . . . 0.0 110.318 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 68' ' ' VAL . 7.1 p -84.81 -11.13 11.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.593 178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 68.21 131.9 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 120.87 0.367 . . . . 0.0 110.222 -179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -149.17 -91.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.291 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -89.37 65.11 7.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 120.845 0.355 . . . . 0.0 110.476 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 15.6 m -128.89 -125.64 0.22 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.796 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 180.0 -39.0 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 82.1 p -140.99 147.89 39.44 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.506 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.8 pt -129.87 148.79 33.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.553 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -97.7 122.7 41.1 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.372 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -144.78 134.88 24.01 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.886 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 55.39 31.48 16.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.425 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 69.87 21.99 76.84 Favored Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.825 -0.91 . . . . 0.0 110.825 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -131.04 137.2 49.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.749 0.309 . . . . 0.0 110.445 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.1 m -93.08 122.44 35.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.491 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.6 m -128.38 155.7 40.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.22 0.533 . . . . 0.0 110.099 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 60.8 p -73.03 153.16 41.0 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.585 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.7 p-10 -82.05 -176.34 6.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -130.24 -34.44 1.64 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.768 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -97.95 56.75 1.26 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.206 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.415 ' O ' ' N ' ' A' ' 89' ' ' LYS . 15.6 t80 -56.08 123.08 13.22 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 118.482 -0.771 . . . . 0.0 109.593 -179.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.487 ' CG ' ' O ' ' A' ' 88' ' ' HIS . 2.0 p80 26.46 43.07 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 O-C-N 125.372 1.67 . . . . 0.0 111.11 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 87' ' ' TYR . 85.7 tttt -66.58 -40.36 88.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.61 -0.682 . . . . 0.0 110.466 -177.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 93.2 t -69.02 -38.99 79.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.121 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -61.01 -41.79 97.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.418 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.6 -36.81 73.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.41 -179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.6 m -67.05 -41.98 85.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.351 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.9 mt -71.71 -39.55 70.08 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.975 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 7.8 mmtt -66.85 -31.56 72.25 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.274 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -82.56 5.23 21.58 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.854 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.402 ' HE3' ' HB2' ' A' ' 153' ' ' ASP . 3.1 mmt -55.81 -24.63 37.31 Favored 'General case' 0 CA--C 1.509 -0.633 0 CA-C-N 116.65 -0.25 . . . . 0.0 110.865 -179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 76.47 -56.18 0.57 Allowed 'General case' 0 C--N 1.343 0.322 0 O-C-N 123.365 0.416 . . . . 0.0 110.469 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 99' ' ' THR . 92.6 m -71.07 -10.95 60.64 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.454 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -84.28 137.93 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 120.891 0.377 . . . . 0.0 110.96 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -86.34 -43.22 13.06 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.494 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 48.4 t -156.35 151.24 26.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.434 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.576 HG22 HG12 ' A' ' 139' ' ' VAL . 95.7 t -130.25 128.79 64.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.983 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.6 m -119.02 130.42 55.64 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 121.047 0.451 . . . . 0.0 110.578 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 54.3 t80 -90.76 113.67 25.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.077 0.465 . . . . 0.0 110.66 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 33.7 t -94.02 107.54 19.45 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.058 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 43.1 t -57.72 142.42 45.34 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.319 0.58 . . . . 0.0 110.862 -179.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -58.35 -32.23 68.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.015 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -63.51 -30.94 71.98 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -71.16 -38.34 72.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.818 179.126 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' A' ' 136' ' ' ALA . 23.0 mm-40 -67.31 -39.29 85.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.275 -178.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.445 ' O ' HG23 ' A' ' 116' ' ' THR . 85.8 t80 -65.12 -40.02 93.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.337 179.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -62.78 -38.11 89.31 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.626 -0.716 . . . . 0.0 109.966 -179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 26.6 mmtp -64.99 -38.76 92.03 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.215 179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.543 HD23 HD11 ' A' ' 118' ' ' ILE . 92.1 mt -64.84 -38.78 92.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.426 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.445 HG23 ' O ' ' A' ' 112' ' ' TYR . 80.7 p -69.46 -30.83 68.82 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.518 0.675 . . . . 0.0 110.51 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -69.91 -36.64 75.55 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.716 179.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.543 HD11 HD23 ' A' ' 115' ' ' LEU . 46.1 pt -87.42 -29.71 5.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.582 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -113.09 22.9 13.89 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.97 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 60.57 -167.44 10.37 Favored Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.2 p30 -104.31 20.18 18.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.894 0.378 . . . . 0.0 110.779 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -101.26 -13.0 18.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.934 -179.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 2.7 p-90 -91.64 0.33 57.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.374 179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -60.29 137.52 58.11 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 120.723 0.297 . . . . 0.0 110.663 -179.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 6.3 tp -148.96 145.61 17.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.338 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 130' ' ' ALA . 5.2 m-85 59.45 77.86 0.29 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.547 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -83.85 12.09 6.61 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.706 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -84.63 32.5 3.39 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 26.3 t0 64.88 17.63 11.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.609 0.242 . . . . 0.0 110.597 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 126' ' ' PHE . . . -62.57 -41.67 99.07 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.358 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 48.12 80.92 0.27 Allowed Pre-proline 0 C--O 1.234 0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.412 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -49.75 -39.0 47.82 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.654 2.236 . . . . 0.0 111.762 -179.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.459 ' HG ' HD11 ' A' ' 115' ' ' LEU . 2.4 mm? -79.09 174.09 11.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.66 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.74 -171.62 2.77 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.693 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.86 149.62 24.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.68 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.513 ' HB1' ' CG1' ' A' ' 61' ' ' VAL . . . -131.4 141.62 49.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.114 0.483 . . . . 0.0 110.711 -179.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.726 ' CE1' HD11 ' A' ' 64' ' ' ILE . 13.7 m-85 -99.04 115.71 29.59 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.816 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 44.7 mt -93.88 111.38 24.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.665 HG21 HG21 ' A' ' 150' ' ' ILE . 4.7 m -115.49 150.83 17.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.054 0.454 . . . . 0.0 110.312 -178.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -108.74 107.7 18.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.42 179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -60.83 139.11 58.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -58.32 -39.15 78.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.371 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.545 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -134.95 162.14 59.49 Favored Pre-proline 0 C--O 1.239 0.533 0 CA-C-O 121.16 0.505 . . . . 0.0 110.711 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.545 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 29.2 Cg_endo -63.42 -15.08 46.2 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.76 2.307 . . . . 0.0 111.385 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -98.73 -5.21 31.87 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.711 0.291 . . . . 0.0 110.301 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -92.38 -25.81 18.34 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-O 120.706 0.289 . . . . 0.0 110.731 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.427 HG12 ' H ' ' A' ' 147' ' ' VAL . 0.1 OUTLIER -49.65 -35.22 9.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.816 179.381 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.54 -33.03 60.66 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.685 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.401 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 84.3 m -72.1 -39.87 68.59 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.406 179.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.665 HG21 HG21 ' A' ' 139' ' ' VAL . 40.1 mm -69.88 -40.51 78.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.513 -179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.91 -41.76 86.56 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.839 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.401 ' HG2' ' O ' ' A' ' 149' ' ' THR . 25.1 pt-20 -73.59 -33.85 64.8 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.558 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.402 ' HB2' ' HE3' ' A' ' 97' ' ' MET . 95.7 m-20 -71.65 -35.76 70.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.559 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.46 -32.07 73.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.345 -179.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 57.3 mmtt -61.13 -20.46 62.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.823 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.01 -3.67 58.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.857 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 96.8 mt -90.62 120.4 39.43 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-O 121.472 0.653 . . . . 0.0 110.477 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 20.6 pt-20 -58.28 147.48 30.61 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.646 179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 91.58 -9.49 76.97 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.956 -0.857 . . . . 0.0 110.956 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 160' ' ' VAL . 10.9 p -66.5 129.73 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 CA-C-O 120.988 0.423 . . . . 0.0 110.266 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 62.1 p -100.65 -42.77 6.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.467 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.7 tt0 -167.81 145.61 4.46 Favored 'General case' 0 C--O 1.217 -0.611 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.876 -179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 47.2 t -127.16 133.92 67.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.441 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -139.62 136.81 34.75 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.391 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 48.3 p-10 -88.82 179.7 6.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.8 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.765 0 N-CA-C 111.085 -0.806 . . . . 0.0 111.085 179.601 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 . . . . . 0 CA--C 1.518 -0.288 0 N-CA-C 110.14 -0.318 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 58' ' ' VAL . 0.5 OUTLIER 72.94 -9.34 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 123.365 0.415 . . . . 0.0 111.162 -179.309 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.7 ttm180 -105.79 129.29 54.01 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 120.921 0.391 . . . . 0.0 110.859 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.565 HG13 ' HB ' ' A' ' 139' ' ' VAL . 0.9 OUTLIER -128.06 139.73 51.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.86 179.373 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.604 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 63.7 t -117.25 122.97 71.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.829 0.347 . . . . 0.0 110.742 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.476 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 91.3 t -103.58 115.67 45.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.118 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.8 m-85 -79.7 132.02 36.1 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 120.996 0.426 . . . . 0.0 110.121 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.843 HD11 ' CD1' ' A' ' 137' ' ' TYR . 64.4 mt -109.82 135.16 49.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.883 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.01 169.78 0.98 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.807 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.7 mtpt -84.75 157.31 21.07 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.15 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER 72.64 -6.46 1.62 Allowed 'General case' 0 N--CA 1.464 0.256 0 O-C-N 123.45 0.469 . . . . 0.0 110.917 -179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.8 t -66.21 -45.11 90.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 CA-C-O 120.841 0.353 . . . . 0.0 110.776 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 48.86 42.91 21.01 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.47 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.631 ' CG ' HD13 ' A' ' 64' ' ' ILE . 5.6 p-10 -56.43 -45.18 80.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.806 -179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -120.34 10.04 11.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.788 179.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 18.8 m -98.45 103.01 14.92 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.444 ' C ' HG23 ' A' ' 74' ' ' THR . 13.1 pt20 -52.67 141.75 20.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.398 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.444 HG23 ' C ' ' A' ' 73' ' ' GLN . 1.3 p 59.12 161.56 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.755 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.622 HD11 HD22 ' A' ' 84' ' ' ASN . 71.3 mt -125.35 135.16 64.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.115 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -103.47 120.15 40.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.474 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 36.3 mmtm -131.88 129.18 40.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.696 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 56.99 -87.47 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.339 0.399 . . . . 0.0 110.707 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -148.69 25.79 1.33 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -134.54 148.05 50.42 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.749 0.309 . . . . 0.0 110.669 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.71 133.8 55.6 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.082 -179.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.8 m -125.46 167.76 19.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.304 0.573 . . . . 0.0 110.128 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 80.2 m -75.01 131.74 40.84 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.188 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.622 HD22 HD11 ' A' ' 75' ' ' ILE . 14.7 t-20 -90.8 101.5 14.25 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.047 0.451 . . . . 0.0 110.54 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 48.8 p-10 -74.61 -4.74 38.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.939 179.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -103.47 12.41 35.21 Favored 'General case' 0 N--CA 1.453 -0.323 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.51 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -57.45 133.75 55.47 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 121.01 0.433 . . . . 0.0 110.382 -179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 62.16 63.36 1.08 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.453 0.644 . . . . 0.0 111.138 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -113.63 -57.86 2.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.637 179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.03 -35.65 75.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.794 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 34.3 t80 -64.6 -40.17 95.04 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.898 -179.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -67.94 -40.18 83.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.704 -179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.646 ' HB3' HD12 ' A' ' 157' ' ' ILE . 65.9 m -67.03 -40.24 87.16 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.476 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.419 ' O ' HG11 ' A' ' 100' ' ' VAL . 75.6 mt -70.96 -37.71 72.79 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 11.0 mmtt -65.99 -30.5 71.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.268 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -87.23 4.25 43.33 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.141 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 2.3 mmt -56.49 -23.61 40.53 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.81 -179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 78.79 -47.45 0.42 Allowed 'General case' 0 N--CA 1.467 0.387 0 O-C-N 123.335 0.397 . . . . 0.0 110.38 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.57 ' HB ' HD11 ' A' ' 150' ' ' ILE . 16.9 m -88.53 18.77 4.31 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 121.278 0.561 . . . . 0.0 110.676 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.613 HG23 HG13 ' A' ' 139' ' ' VAL . 3.3 p -104.04 141.37 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.152 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 65.8 tttp -101.06 -40.87 7.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.228 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 42.5 t -160.27 148.84 16.92 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.453 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 139' ' ' VAL . 58.9 t -127.24 126.71 68.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.548 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.577 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 99.9 m -117.68 126.03 51.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.18 0.514 . . . . 0.0 110.571 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 43.4 t80 -92.59 119.16 31.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.677 ' O ' ' O ' ' A' ' 135' ' ' ASP . 7.4 t -110.94 87.68 2.6 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 119.721 -0.792 . . . . 0.0 111.07 -179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 106' ' ' SER . 30.9 t -39.72 139.52 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.942 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.8 pttt -50.79 -35.52 32.39 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.931 -178.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -68.65 -38.98 80.89 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.288 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.07 -35.68 66.71 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.627 0.727 . . . . 0.0 110.685 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.693 HE22 ' HB2' ' A' ' 136' ' ' ALA . 12.8 tt0 -74.24 -33.61 63.39 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.482 179.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.711 ' O ' HG23 ' A' ' 116' ' ' THR . 42.9 t80 -67.42 -42.04 83.85 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.339 -179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.7 pt-20 -68.98 -35.29 76.54 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.444 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -69.71 -38.17 76.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.66 179.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.418 ' HA ' HG12 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -67.52 -35.86 79.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.581 -179.791 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.711 HG23 ' O ' ' A' ' 112' ' ' TYR . 81.2 p -69.99 -32.69 71.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.1 0.476 . . . . 0.0 110.573 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 51.9 tp10 -68.99 -37.99 79.04 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.853 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.418 HG12 ' HA ' ' A' ' 115' ' ' LEU . 44.3 pt -82.01 -30.49 10.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.505 -178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.36 7.36 38.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.773 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 71.71 -173.82 43.66 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 52.5 p-10 -95.78 29.09 2.79 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.953 0.406 . . . . 0.0 110.585 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 45.8 p-10 -125.71 42.9 3.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.114 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.526 ' HE1' HG22 ' A' ' 116' ' ' THR . 0.3 OUTLIER -141.67 -26.57 0.68 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.637 179.756 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -59.14 138.08 57.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.211 0.529 . . . . 0.0 110.753 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.401 ' C ' ' CG ' ' A' ' 126' ' ' PHE . 5.5 tp -139.82 -23.42 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.348 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . 0.401 ' CG ' ' C ' ' A' ' 125' ' ' ILE . 11.2 p90 34.27 56.3 0.64 Allowed 'General case' 0 N--CA 1.467 0.382 0 O-C-N 123.957 0.786 . . . . 0.0 110.665 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.6 tm-20 -114.8 128.53 56.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.835 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.24 -107.81 3.36 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.976 -0.85 . . . . 0.0 110.976 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.566 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 47.3 t0 -59.89 -27.52 66.78 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 121.217 -0.193 . . . . 0.0 110.585 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 129' ' ' ASP . . . 77.3 -14.24 0.86 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.792 0.683 . . . . 0.0 110.674 -179.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -132.44 71.74 78.86 Favored Pre-proline 0 N--CA 1.45 -0.441 0 CA-C-O 120.736 0.303 . . . . 0.0 110.256 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.37 -31.82 59.04 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.674 2.25 . . . . 0.0 111.637 -179.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.44 HD13 ' HA ' ' A' ' 133' ' ' LEU . 4.5 mm? -100.82 153.58 19.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -116.49 -175.14 2.69 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.034 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.677 ' O ' ' O ' ' A' ' 106' ' ' SER . 96.8 m-20 -58.31 -30.3 66.57 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 121.868 0.842 . . . . 0.0 110.856 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.693 ' HB2' HE22 ' A' ' 111' ' ' GLN . . . 51.98 125.6 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.629 0.728 . . . . 0.0 111.392 179.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.843 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.1 OUTLIER -112.65 103.65 11.7 Favored 'General case' 0 C--N 1.316 -0.861 0 O-C-N 121.628 -0.67 . . . . 0.0 109.588 179.836 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.577 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 1.4 mp -79.27 108.58 12.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.828 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.613 HG13 HG23 ' A' ' 100' ' ' VAL . 99.6 t -111.18 135.49 50.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.407 0.622 . . . . 0.0 111.313 -179.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.3 mp0 -96.34 106.36 18.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.327 179.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.494 ' HB1' ' HB2' ' A' ' 146' ' ' ASP . . . -69.68 147.2 50.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.647 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -52.34 -35.33 50.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.222 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -148.75 164.03 23.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.744 179.64 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.497 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.2 Cg_exo -57.73 -29.4 85.57 Favored 'Trans proline' 0 N--CA 1.496 1.66 0 C-N-CA 122.936 2.424 . . . . 0.0 112.071 179.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 10.2 m120 -83.64 -3.82 58.06 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.71 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.494 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 83.8 m-20 -98.73 -10.69 22.78 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 110.237 -0.283 . . . . 0.0 110.237 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.497 HG22 ' O ' ' A' ' 144' ' ' PRO . 8.6 m -62.44 -29.03 45.85 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.461 ' HG3' HG23 ' A' ' 147' ' ' VAL . 0.2 OUTLIER -80.32 -34.16 36.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.02 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 97.5 m -72.34 -40.0 67.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.172 179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.57 HD11 ' HB ' ' A' ' 99' ' ' THR . 28.9 mm -66.71 -40.86 87.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.287 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.609 ' HA ' HG11 ' A' ' 163' ' ' VAL . . . -64.59 -40.01 94.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.24 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -68.16 -39.11 82.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.708 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -72.3 -34.98 68.54 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.624 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -63.3 -36.07 82.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.735 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.43 -17.88 60.38 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.861 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -93.9 8.07 42.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.127 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.646 HD12 ' HB3' ' A' ' 93' ' ' SER . 18.2 mm -92.32 119.94 40.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 110.238 -0.282 . . . . 0.0 110.238 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 79.1 mm-40 44.58 -98.55 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 O-C-N 123.683 0.615 . . . . 0.0 111.025 179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -159.16 48.77 0.41 Allowed Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.3 m -50.5 143.83 2.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 C-N-CA 121.031 -0.267 . . . . 0.0 110.355 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 45.0 t -61.8 -48.38 80.9 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.942 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -174.39 154.56 2.15 Favored 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.552 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.609 HG11 ' HA ' ' A' ' 151' ' ' ALA . 45.1 t -115.96 131.94 66.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.47 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -127.7 127.14 43.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.741 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -78.1 174.18 11.42 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.575 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.7 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -179.832 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.3 m120 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.508 0.194 . . . . 0.0 110.555 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.403 ' HA ' HG11 ' A' ' 147' ' ' VAL . 0.4 OUTLIER 46.77 35.63 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-O 121.076 0.465 . . . . 0.0 111.016 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 18.1 ttm180 -101.1 133.63 45.33 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.82 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.0 t -124.21 137.04 58.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.989 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.402 HG13 ' HB1' ' A' ' 136' ' ' ALA . 95.7 t -116.82 122.98 71.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.88 -0.328 . . . . 0.0 110.569 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.451 ' CG1' HG23 ' A' ' 160' ' ' VAL . 58.5 t -109.98 117.12 53.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 49.2 m-85 -83.91 139.02 32.87 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.022 0.439 . . . . 0.0 110.282 179.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.692 HD11 ' CE1' ' A' ' 137' ' ' TYR . 32.8 mt -100.78 148.64 6.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.472 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -46.71 154.95 0.28 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.336 0.589 . . . . 0.0 111.017 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -64.93 -36.76 85.4 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.637 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -98.97 70.75 1.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.489 -179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.415 HG13 HG22 ' A' ' 64' ' ' ILE . 1.5 p 176.67 126.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.117 179.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -122.03 89.94 3.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.031 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.12 -87.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.79 -179.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 t30 -93.9 58.14 2.57 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.808 -0.357 . . . . 0.0 111.063 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.8 m -107.97 -30.02 8.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 71.6 95.87 0.07 Allowed 'General case' 0 C--O 1.232 0.17 0 O-C-N 123.859 0.724 . . . . 0.0 110.157 -179.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 71.25 144.94 0.06 Allowed 'General case' 0 C--O 1.232 0.182 0 O-C-N 123.567 0.542 . . . . 0.0 110.334 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 41.6 pt -119.35 151.74 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 CA-C-O 121.247 0.546 . . . . 0.0 109.786 179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -119.35 138.05 53.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.797 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.2 pttt -143.52 135.58 26.75 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.451 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 58.17 -86.25 0.02 OUTLIER 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.684 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -152.92 30.64 0.81 Allowed Glycine 0 CA--C 1.527 0.797 0 N-CA-C 110.564 -1.014 . . . . 0.0 110.564 179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -137.11 148.26 46.58 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.874 0.368 . . . . 0.0 110.869 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 93.9 m -112.39 129.16 56.41 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.094 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.3 t -127.37 135.28 63.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.528 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.7 151.64 20.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.548 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -97.48 172.81 7.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.015 0.436 . . . . 0.0 110.791 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -122.4 -20.2 6.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.016 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 55.8 p-10 -108.35 53.67 0.68 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.044 0.45 . . . . 0.0 110.686 -179.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -60.25 -48.18 82.82 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.867 -178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -126.94 99.21 5.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.531 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -140.21 -64.0 0.48 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.21 179.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 54.2 t -65.17 -36.76 78.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 91.2 t80 -62.09 -40.99 97.7 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.089 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -68.56 -39.88 80.85 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.52 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.6 t -66.99 -42.01 85.79 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.441 0.639 . . . . 0.0 110.316 -179.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.402 HD23 ' HE2' ' A' ' 97' ' ' MET . 78.1 mt -73.51 -39.57 64.7 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.261 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -68.47 -39.56 81.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.572 -179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -92.77 6.35 47.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.427 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.402 ' HE2' HD23 ' A' ' 94' ' ' LEU . 2.4 ttm -61.62 -17.46 55.35 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.739 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 75.53 157.38 0.19 Allowed 'General case' 0 CA--C 1.511 -0.553 0 O-C-N 123.879 0.737 . . . . 0.0 109.457 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 99' ' ' THR . 22.0 m 70.5 5.31 5.32 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.895 0.747 . . . . 0.0 110.896 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.464 ' O ' HG23 ' A' ' 100' ' ' VAL . 32.7 m -112.79 124.86 69.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-O 121.163 0.506 . . . . 0.0 110.488 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -66.82 -44.21 81.75 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.159 179.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 83.8 p -163.28 162.37 25.17 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.303 0.573 . . . . 0.0 110.355 -179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 139' ' ' VAL . 42.5 t -132.7 129.19 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.69 179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.402 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 98.3 m -119.65 128.93 54.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.929 0.395 . . . . 0.0 110.072 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -87.31 120.69 28.86 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.295 0.569 . . . . 0.0 110.634 -179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 42.4 t -105.3 116.94 32.79 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.452 179.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 46.5 t -65.43 146.95 54.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.758 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -65.61 -34.62 78.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.283 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -65.87 -40.25 91.45 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.942 -179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 13.6 tm-20 -69.86 -37.75 76.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.056 -179.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -65.66 -40.27 92.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.097 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . . . . . . . . . 36.0 t80 -68.8 -38.66 80.1 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.673 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -63.26 -37.1 85.92 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.148 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.421 ' O ' HG12 ' A' ' 118' ' ' ILE . 70.0 mmtt -70.5 -39.25 74.26 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.086 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.456 HD23 HD11 ' A' ' 118' ' ' ILE . 14.8 mt -65.78 -39.67 91.21 Favored 'General case' 0 CA--C 1.516 -0.361 0 O-C-N 123.471 0.482 . . . . 0.0 111.667 -179.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 5.9 t -71.66 -33.91 69.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.635 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -69.32 -39.05 78.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.052 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.456 HD11 HD23 ' A' ' 115' ' ' LEU . 39.1 pt -80.76 -33.15 13.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.738 -0.665 . . . . 0.0 111.362 -179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 21.7 mmt -80.87 -20.75 41.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.213 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.94 102.97 1.4 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 61.55 -173.39 0.14 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -70.05 77.91 0.5 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.916 0.389 . . . . 0.0 110.324 179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 9.7 p-90 -62.05 -32.38 72.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.986 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -102.88 147.25 27.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.656 -179.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 18.4 mm -101.5 116.31 44.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.215 0.531 . . . . 0.0 110.658 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -165.22 26.45 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.9 pm0 -53.95 118.02 3.67 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.219 0.533 . . . . 0.0 110.792 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 154.09 -157.23 27.34 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -89.33 4.48 48.73 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.037 -0.265 . . . . 0.0 110.695 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -111.4 149.74 30.79 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -121.58 152.63 58.71 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.582 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -68.18 -27.9 34.71 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.91 2.406 . . . . 0.0 112.297 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 89.7 mt -125.91 177.56 6.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.915 -179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -129.98 -169.9 2.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.555 -179.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.412 ' CB ' HD12 ' A' ' 64' ' ' ILE . 98.0 m-20 -60.89 147.33 43.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.912 0.387 . . . . 0.0 110.47 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.402 ' HB1' HG13 ' A' ' 61' ' ' VAL . . . -130.92 145.22 51.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.409 -179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.692 ' CE1' HD11 ' A' ' 64' ' ' ILE . 3.5 m-85 -115.59 114.07 24.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.127 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.402 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 49.8 mt -89.01 106.53 16.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.588 HG22 HG22 ' A' ' 103' ' ' VAL . 71.8 t -110.74 136.91 45.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.97 0.414 . . . . 0.0 110.751 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -98.72 106.87 19.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.063 -0.517 . . . . 0.0 109.696 179.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 147' ' ' VAL . . . -74.83 150.83 39.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.855 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.589 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 34.0 t-20 -80.91 91.23 5.97 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.849 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.589 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 92.76 149.74 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.246 0 O-C-N 124.564 1.165 . . . . 0.0 110.47 179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.615 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.7 Cg_exo -60.15 -19.84 58.68 Favored 'Trans proline' 0 N--CA 1.493 1.453 0 C-N-CA 122.862 2.375 . . . . 0.0 112.58 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 24.1 m-80 -86.72 -5.34 59.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.63 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -101.19 -17.85 16.44 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.815 -0.175 . . . . 0.0 110.784 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.615 HG22 ' O ' ' A' ' 144' ' ' PRO . 18.9 m -58.94 -33.51 50.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 121.091 0.472 . . . . 0.0 109.756 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -38.36 65.91 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.15 179.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 93.3 m -68.76 -39.18 80.38 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.524 -179.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 27.0 mm -66.43 -40.3 86.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.403 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.66 -40.43 95.42 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.472 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -67.52 -39.39 85.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.723 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -73.3 -35.02 66.05 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.622 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.435 ' HA ' HG12 ' A' ' 157' ' ' ILE . . . -63.52 -34.86 78.73 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.517 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.525 ' HA ' HG11 ' A' ' 160' ' ' VAL . 68.3 mttm -64.82 -15.14 61.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.023 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 29.3 mtmt -101.39 8.74 42.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 179.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 154' ' ' ALA . 8.6 mm -59.45 -69.6 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 C-N-CA 121.058 -0.257 . . . . 0.0 111.18 -178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 171.87 -77.6 0.0 OUTLIER 'General case' 0 N--CA 1.457 -0.11 0 O-C-N 123.73 0.643 . . . . 0.0 110.833 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -93.23 31.03 6.6 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 111.34 -0.704 . . . . 0.0 111.34 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.525 HG11 ' HA ' ' A' ' 155' ' ' LYS . 14.4 p -82.43 131.84 32.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.215 -0.291 . . . . 0.0 110.215 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 27.0 t -96.34 -53.97 3.43 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.929 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -152.93 153.77 33.67 Favored 'General case' 0 C--O 1.217 -0.62 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.62 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 98.3 t -122.78 134.22 66.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.005 0.431 . . . . 0.0 110.831 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -118.52 115.57 24.86 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.472 179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.32 114.06 21.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.956 179.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.545 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.737 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.462 ' C ' HG23 ' A' ' 58' ' ' VAL . 6.9 m120 . . . . . 0 C--O 1.234 0.269 0 N-CA-C 110.548 -0.167 . . . . 0.0 110.548 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.497 HG12 ' H ' ' A' ' 59' ' ' ARG . 0.7 OUTLIER 56.38 176.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 -179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.497 ' H ' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER 71.57 144.42 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.307 0.575 . . . . 0.0 111.17 179.425 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 95.9 t -148.52 147.3 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.403 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.544 ' CG1' ' HB1' ' A' ' 136' ' ' ALA . 59.2 t -121.7 126.01 74.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.208 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.65 115.35 49.6 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.265 0 CA-C-O 120.946 0.403 . . . . 0.0 110.041 179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -85.67 141.13 29.98 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-O 121.286 0.565 . . . . 0.0 109.92 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.742 HD11 ' CD1' ' A' ' 137' ' ' TYR . 80.7 mt -115.45 144.7 22.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.931 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.496 ' O ' ' C ' ' A' ' 66' ' ' LYS . 1.6 mpt_? -44.98 139.17 3.26 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-O 118.824 -0.608 . . . . 0.0 109.374 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.496 ' C ' ' O ' ' A' ' 65' ' ' ARG . 17.5 mttm -5.48 -90.21 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.873 0 O-C-N 125.326 1.641 . . . . 0.0 111.466 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 30.8 p30 -140.14 50.59 1.71 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.469 HG13 ' N ' ' A' ' 69' ' ' GLU . 5.9 p -49.77 -51.71 15.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.547 -178.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.469 ' N ' HG13 ' A' ' 68' ' ' VAL . 21.8 pt-20 174.64 25.22 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.167 0.292 . . . . 0.0 110.239 178.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.421 ' HB3' HG21 ' A' ' 64' ' ' ILE . 32.6 p-10 -62.68 -150.69 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.449 -178.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -78.4 60.82 2.68 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.287 0.565 . . . . 0.0 110.089 -179.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 32.2 t -129.87 92.54 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.547 179.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -56.84 120.24 7.57 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.2 m 61.4 122.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.277 0.56 . . . . 0.0 111.041 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 46.5 pt -124.1 155.51 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.273 0.559 . . . . 0.0 110.126 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -87.23 111.69 21.26 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.999 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 78' ' ' GLU . 2.5 mttt -144.18 148.97 35.7 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.219 -178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 77' ' ' LYS . 0.7 OUTLIER -27.1 102.91 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.803 1.314 . . . . 0.0 111.076 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 121.17 22.4 2.9 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 -178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 78.12 -159.86 0.03 OUTLIER 'General case' 0 C--N 1.345 0.396 0 O-C-N 123.827 0.369 . . . . 0.0 110.442 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 82.3 p -70.44 120.4 16.04 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.088 0.47 . . . . 0.0 109.938 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.2 t -118.82 132.17 69.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.153 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 66.9 p -66.75 151.02 48.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.552 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 1.2 p-10 -92.42 174.57 7.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.957 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -124.37 -4.4 7.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.233 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -128.89 54.63 1.78 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.955 0.407 . . . . 0.0 109.922 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -57.68 -49.42 76.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.841 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.1 m170 -122.95 26.73 8.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.721 0.296 . . . . 0.0 110.673 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.7 tmtt? -69.55 -45.77 67.97 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.106 0.479 . . . . 0.0 110.915 -179.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.494 HG12 HD12 ' A' ' 94' ' ' LEU . 86.3 t -69.77 -39.29 77.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.69 -0.687 . . . . 0.0 110.032 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -62.55 -43.96 97.52 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.181 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -63.98 -40.87 97.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.599 -179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 70.3 m -67.98 -41.69 81.95 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.256 -179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.494 HD12 HG12 ' A' ' 90' ' ' VAL . 73.3 mt -70.73 -25.69 63.05 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.654 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.07 -28.7 25.47 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.042 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -103.51 3.71 35.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.339 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 12.8 ptm -60.75 -17.21 47.43 Favored 'General case' 0 C--O 1.232 0.172 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.953 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 77.31 152.03 0.13 Allowed 'General case' 0 C--N 1.341 0.231 0 O-C-N 123.869 0.731 . . . . 0.0 109.542 -178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . . . . . . . . . 4.1 m 73.59 5.91 4.97 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 123.841 0.713 . . . . 0.0 110.7 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.8 p -108.05 133.1 53.96 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.126 0 CA-C-O 121.201 0.524 . . . . 0.0 110.795 179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 33.0 ttpt -85.87 -51.75 6.19 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.975 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.1 m -149.04 155.02 40.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.338 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.606 HG22 HG12 ' A' ' 139' ' ' VAL . 98.3 t -133.56 128.7 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.237 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 98.8 m -124.98 132.38 53.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.584 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -90.92 116.98 29.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.24 0.543 . . . . 0.0 109.978 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 47.7 t -108.11 128.25 54.52 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.087 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 82.9 p -66.02 159.49 25.78 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.126 0.489 . . . . 0.0 110.86 -179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -63.98 -33.31 75.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.287 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 14.5 tm-20 -63.47 -36.72 84.68 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.131 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -67.86 -38.64 83.37 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.643 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -66.85 -40.9 88.05 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.647 -179.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.708 ' O ' HG23 ' A' ' 116' ' ' THR . 61.5 t80 -64.71 -43.41 93.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.721 179.355 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -64.12 -40.44 96.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.275 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.4 mmtm -64.35 -41.75 96.6 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.933 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.546 HD23 HD11 ' A' ' 118' ' ' ILE . 81.7 mt -68.4 -38.72 81.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.895 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.708 HG23 ' O ' ' A' ' 112' ' ' TYR . 81.2 p -71.38 -32.73 68.8 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.369 -178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -67.25 -40.44 86.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.929 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.546 HD11 HD23 ' A' ' 115' ' ' LEU . 37.8 pt -79.17 -36.1 17.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.992 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 22.3 mmt -76.28 -37.43 57.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.849 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 109.11 -137.96 14.49 Favored Glycine 0 CA--C 1.529 0.942 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -96.12 17.7 15.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.666 0.269 . . . . 0.0 110.621 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -123.18 -160.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 65.81 148.6 0.04 OUTLIER 'General case' 0 CA--C 1.517 -0.311 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.573 ' HE2' ' HB3' ' A' ' 130' ' ' ALA . 0.0 OUTLIER 76.36 -70.64 0.13 Allowed 'General case' 0 N--CA 1.456 -0.127 0 O-C-N 124.013 0.821 . . . . 0.0 110.589 -179.346 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.503 HG22 ' O ' ' A' ' 125' ' ' ILE . 1.0 OUTLIER 56.12 103.55 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.165 0.507 . . . . 0.0 110.691 -179.817 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -164.3 -61.15 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.742 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -173.6 -29.97 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.645 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 108.51 -25.0 20.97 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 56.6 p-10 -102.22 9.85 39.74 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.733 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.573 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . . . -83.33 158.27 22.25 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 120.853 0.358 . . . . 0.0 110.7 179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -129.03 70.64 81.73 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.592 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -65.32 -27.65 55.45 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.842 2.361 . . . . 0.0 112.186 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.21 173.79 7.22 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.286 -179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -128.21 -165.99 1.56 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.059 0.457 . . . . 0.0 110.718 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -66.01 147.96 52.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.589 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.544 ' HB1' ' CG1' ' A' ' 61' ' ' VAL . . . -130.01 146.5 51.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.702 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.742 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.8 OUTLIER -113.34 108.98 17.97 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 178.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.448 HG23 HH11 ' A' ' 59' ' ' ARG . 40.2 mt -86.5 111.32 21.25 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.652 HG21 HG21 ' A' ' 150' ' ' ILE . 6.4 m -119.4 149.8 21.93 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.6 0 CA-C-O 121.115 0.483 . . . . 0.0 109.904 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -105.76 107.52 18.55 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.909 178.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -73.09 149.3 43.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.53 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.519 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 47.7 t-20 -79.61 87.86 5.15 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.326 -0.55 . . . . 0.0 109.95 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 95.96 153.36 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.475 0 O-C-N 125.104 1.502 . . . . 0.0 109.662 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.608 ' O ' HG22 ' A' ' 147' ' ' VAL . 31.4 Cg_endo -63.76 -15.45 48.95 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.135 1.89 . . . . 0.0 112.206 -179.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -88.33 -10.21 50.21 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.304 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -96.16 -15.48 22.07 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.338 0.113 . . . . 0.0 111.012 179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 144' ' ' PRO . 34.3 m -56.92 -31.96 37.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.78 -35.47 62.53 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.229 -0.896 . . . . 0.0 110.246 179.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 91.7 m -69.95 -40.15 75.61 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.194 0.521 . . . . 0.0 110.357 -179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . 0.652 HG21 HG21 ' A' ' 139' ' ' VAL . 21.5 mm -66.07 -41.33 89.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.255 -179.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.483 ' CB ' HG21 ' A' ' 163' ' ' VAL . . . -65.86 -40.89 92.09 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.401 -0.519 . . . . 0.0 110.521 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -67.13 -40.54 86.79 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.585 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 60.3 t0 -70.06 -39.97 75.35 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.426 179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -64.24 -32.99 74.8 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.734 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -62.13 -20.29 63.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.797 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 21.1 mttm -86.64 -2.77 58.79 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.883 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 21.7 mm -83.46 129.88 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 CA-C-O 120.917 0.389 . . . . 0.0 110.119 -179.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -62.54 140.03 58.62 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.163 -179.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 91.48 -6.99 80.52 Favored Glycine 0 CA--C 1.531 1.056 0 N-CA-C 111.498 -0.641 . . . . 0.0 111.498 -179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 160' ' ' VAL . 14.2 p -66.26 131.57 31.97 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.12 0 CA-C-N 117.295 0.548 . . . . 0.0 110.131 179.456 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 33.7 t -105.62 -48.75 3.58 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.475 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -161.66 147.49 13.74 Favored 'General case' 0 C--O 1.215 -0.723 0 C-N-CA 120.834 -0.347 . . . . 0.0 110.725 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.483 HG21 ' CB ' ' A' ' 151' ' ' ALA . 0.8 OUTLIER -131.06 141.71 45.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.196 0.522 . . . . 0.0 111.207 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -138.49 135.88 35.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.55 179.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 55.0 p-10 -90.28 156.32 18.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.909 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.586 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 179.774 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.8 p30 . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.705 0.288 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.421 ' O ' ' CB ' ' A' ' 59' ' ' ARG . 61.1 t -57.33 130.5 20.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.421 ' CB ' ' O ' ' A' ' 58' ' ' VAL . 10.6 tpt180 158.98 115.27 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.526 0 O-C-N 124.638 1.211 . . . . 0.0 110.413 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 64.9 t -129.39 134.42 63.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.812 0.339 . . . . 0.0 110.424 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.9 t -120.36 122.58 68.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 44.4 t -110.93 116.42 52.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -86.98 137.54 32.27 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.794 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.669 HD11 ' CE1' ' A' ' 137' ' ' TYR . 24.6 mt -105.37 146.53 12.26 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.495 -179.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . 0.535 ' O ' ' C ' ' A' ' 66' ' ' LYS . 13.2 mmt180 -46.3 138.22 5.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.823 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.535 ' C ' ' O ' ' A' ' 65' ' ' ARG . 18.4 mmtm 8.69 -99.2 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 O-C-N 124.684 1.24 . . . . 0.0 111.452 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -138.82 69.05 1.37 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.489 HG21 ' HB2' ' A' ' 65' ' ' ARG . 3.3 t -79.02 53.03 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.705 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 65.8 -74.38 0.06 Allowed 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.599 0.562 . . . . 0.0 110.591 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.408 ' CG ' HG21 ' A' ' 64' ' ' ILE . 12.1 m-20 51.16 -139.96 0.91 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.647 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -87.37 38.01 0.8 Allowed 'General case' 0 N--CA 1.456 -0.136 0 CA-C-O 120.764 0.316 . . . . 0.0 110.617 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.9 m -96.97 -147.61 0.31 Allowed 'General case' 0 C--O 1.221 -0.415 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.406 ' C ' HG23 ' A' ' 74' ' ' THR . 9.8 pt20 -170.59 137.59 1.37 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.406 HG23 ' C ' ' A' ' 73' ' ' GLN . 1.5 p 59.83 116.93 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.143 0.497 . . . . 0.0 110.262 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.4 mm -113.09 137.29 46.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 0.0 110.402 -178.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 15.0 tm-20 -85.48 122.59 29.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.037 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -132.62 152.42 51.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.135 -0.938 . . . . 0.0 110.44 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 26.0 pt-20 -43.58 -29.49 0.49 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.601 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.45 45.05 2.4 Favored Glycine 0 CA--C 1.53 1.018 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 71.12 -168.44 0.15 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.921 0.391 . . . . 0.0 110.39 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 98.0 m -73.01 130.64 40.8 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.017 0.437 . . . . 0.0 109.834 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.09 137.87 55.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.297 -179.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.2 p -49.42 137.13 15.19 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.736 -179.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 18.4 p-10 -78.46 -178.38 5.76 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.878 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -150.17 179.04 8.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.056 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.475 ' CG ' ' O ' ' A' ' 86' ' ' ASP . 0.0 OUTLIER 47.15 24.85 0.45 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.305 0.574 . . . . 0.0 110.967 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -45.29 -41.08 8.32 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.199 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -124.2 60.49 1.13 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.139 0.495 . . . . 0.0 110.646 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -114.37 -55.06 2.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.153 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 66.7 t -66.82 -36.47 77.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.418 0.628 . . . . 0.0 109.401 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -65.61 -41.05 93.19 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.431 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -63.55 -40.77 97.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.523 -179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.0 p -65.66 -36.28 83.21 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.509 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.423 ' O ' HG21 ' A' ' 103' ' ' VAL . 73.9 mt -80.34 -16.85 53.62 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.712 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.18 -33.28 14.77 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.912 0.386 . . . . 0.0 111.567 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 -93.91 6.55 48.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.866 -179.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.69 -19.43 2.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.439 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 80.04 -50.64 0.36 Allowed 'General case' 0 N--CA 1.462 0.175 0 O-C-N 123.322 0.389 . . . . 0.0 110.935 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 99' ' ' THR . 14.2 m -83.81 22.46 1.12 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 120.936 0.398 . . . . 0.0 111.348 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.7 m -118.99 150.23 21.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.082 0.467 . . . . 0.0 111.077 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -106.5 -32.77 7.93 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.492 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.0 t -164.2 148.53 9.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.882 -179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.682 HG22 HG22 ' A' ' 139' ' ' VAL . 98.2 t -132.61 128.13 57.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.386 179.481 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . . . . . . . . . 99.7 m -120.89 124.38 44.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.92 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -85.07 115.6 22.97 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.949 0.404 . . . . 0.0 109.933 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . . . . . . . . . 43.4 t -101.28 113.12 25.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.587 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 85.7 p -66.86 160.87 25.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.88 0.372 . . . . 0.0 110.491 -179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.96 -31.45 72.64 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.305 -179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.5 tm-20 -65.95 -38.94 89.91 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.627 179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.1 tp10 -67.52 -41.02 85.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.5 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.481 ' NE2' ' HB2' ' A' ' 136' ' ' ALA . 21.8 mt-30 -66.96 -38.35 85.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.749 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.685 ' O ' HG23 ' A' ' 116' ' ' THR . 0.6 OUTLIER -67.44 -37.05 82.39 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.874 -179.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -62.92 -39.18 93.79 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.085 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -65.93 -39.3 90.39 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.479 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.72 -37.36 82.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.659 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.685 HG23 ' O ' ' A' ' 112' ' ' TYR . 82.8 p -69.64 -33.36 72.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.427 -179.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -68.25 -38.33 81.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.305 179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.407 HG13 ' HG2' ' A' ' 119' ' ' MET . 38.7 pt -84.7 -29.95 6.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.191 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . 0.407 ' HG2' HG13 ' A' ' 118' ' ' ILE . 37.4 mmt -94.44 -67.71 0.84 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.945 0.402 . . . . 0.0 110.137 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 178.49 166.5 34.81 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 179.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -89.28 8.06 32.38 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.654 0.264 . . . . 0.0 110.599 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -142.02 32.15 1.57 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.443 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . . . . . . . . . 1.6 p-90 -103.24 -11.36 18.04 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 116.521 -0.309 . . . . 0.0 110.432 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.415 ' O ' HG23 ' A' ' 125' ' ' ILE . 15.7 ptmt -87.75 141.37 28.65 Favored 'General case' 0 C--O 1.231 0.113 0 CA-C-O 120.853 0.358 . . . . 0.0 110.788 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.415 HG23 ' O ' ' A' ' 124' ' ' LYS . 0.5 OUTLIER -157.68 134.39 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.005 -179.877 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 179.23 26.81 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.939 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 64.68 -80.85 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 O-C-N 123.159 0.287 . . . . 0.0 110.681 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -123.48 -93.49 1.09 Allowed Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 45.0 p-10 -89.0 -164.8 1.2 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 110.211 -0.292 . . . . 0.0 110.211 179.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.495 ' HB3' ' O ' ' A' ' 129' ' ' ASP . . . 72.01 131.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.729 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -160.95 154.88 18.93 Favored Pre-proline 0 N--CA 1.448 -0.569 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.8 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.28 -13.59 38.17 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.904 2.403 . . . . 0.0 112.312 179.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -103.37 153.03 20.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.966 0.412 . . . . 0.0 110.768 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -133.45 -170.62 2.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.318 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.92 143.76 57.37 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.775 179.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.481 ' HB2' ' NE2' ' A' ' 111' ' ' GLN . . . -129.93 148.11 51.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.132 0.491 . . . . 0.0 110.309 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.669 ' CE1' HD11 ' A' ' 64' ' ' ILE . 1.1 m-85 -121.24 111.87 17.92 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.418 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.61 109.96 21.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.682 HG22 HG22 ' A' ' 103' ' ' VAL . 98.4 t -115.68 139.73 40.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.94 0.4 . . . . 0.0 111.008 -178.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -100.3 105.7 17.26 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.805 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -74.91 151.61 38.9 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.915 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.571 ' O ' ' HB3' ' A' ' 143' ' ' ALA . 53.6 t-20 -78.52 89.83 4.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.142 179.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 142' ' ' ASN . . . 93.44 152.18 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.265 0 O-C-N 124.613 1.196 . . . . 0.0 110.176 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.67 ' O ' HG22 ' A' ' 147' ' ' VAL . 33.2 Cg_exo -60.59 -19.95 62.41 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.43 2.087 . . . . 0.0 112.356 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -86.01 -6.9 58.96 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.512 -178.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -101.19 -15.66 17.27 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.748 -0.206 . . . . 0.0 110.959 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.67 HG22 ' O ' ' A' ' 144' ' ' PRO . 24.3 m -57.96 -35.28 51.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.135 0.493 . . . . 0.0 110.073 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 13.2 ptmm? -74.66 -32.61 62.3 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.995 179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 85.2 m -71.46 -39.52 70.9 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.551 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 36.8 mm -65.04 -41.35 91.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.4 -179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.36 -41.13 98.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.232 0.539 . . . . 0.0 110.282 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.9 -38.46 79.64 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 45.5 t0 -69.77 -37.45 76.4 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.608 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -61.93 -36.14 80.49 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.607 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -62.85 -18.05 62.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.709 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -101.67 7.46 42.03 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.357 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 32.9 mt -79.23 -64.78 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.151 0 CA-C-O 120.749 0.309 . . . . 0.0 111.46 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -143.07 -89.33 0.13 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.934 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -141.11 78.5 0.29 Allowed Glycine 0 C--N 1.333 0.4 0 N-CA-C 110.827 -0.909 . . . . 0.0 110.827 -179.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.511 HG11 HG13 ' A' ' 163' ' ' VAL . 89.2 t -81.39 109.32 15.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.12 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 93.2 p -65.19 -39.9 93.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.771 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -150.76 155.96 40.31 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.563 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.511 HG13 HG11 ' A' ' 160' ' ' VAL . 0.1 OUTLIER -140.67 123.72 16.39 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.994 179.592 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.43 127.92 49.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.656 -179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.99 102.92 12.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.453 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.743 0 N-CA-C 110.77 -0.932 . . . . 0.0 110.77 179.877 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 . . . . . 0 CA--C 1.523 -0.082 0 CA-C-O 120.795 0.331 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 32.2 m -131.25 160.63 42.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.961 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 169.12 96.23 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.053 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 58.6 t -120.46 126.33 75.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 75.3 t -114.02 119.96 62.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.205 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.458 ' HB ' ' HB2' ' A' ' 137' ' ' TYR . 59.4 t -108.95 113.53 44.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -86.18 134.17 33.81 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.498 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.665 HD11 ' CD1' ' A' ' 137' ' ' TYR . 93.9 mt -110.16 140.82 27.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.751 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ARG . . . . . . . . . . . . . 1.5 mtp180 -47.12 163.55 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.199 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.9 -12.6 33.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.198 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -83.98 7.56 18.0 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.638 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 12.4 p -138.56 135.02 43.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 120.737 0.303 . . . . 0.0 110.358 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -112.14 91.58 3.71 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.613 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -62.22 -69.45 0.25 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.778 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -97.34 67.51 2.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.918 0.39 . . . . 0.0 111.093 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.61 -38.98 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.422 179.439 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 63.11 145.62 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.539 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.89 126.36 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.261 0.553 . . . . 0.0 110.687 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 91.1 mt -124.87 140.38 48.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.37 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -85.94 113.31 21.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.292 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 29.0 mmtp -132.76 137.33 46.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.112 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 57.38 28.09 14.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.482 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 73.66 16.74 79.06 Favored Glycine 0 CA--C 1.529 0.955 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -129.53 140.27 51.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.874 0.369 . . . . 0.0 110.583 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.5 m -87.21 120.77 28.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.194 0.521 . . . . 0.0 110.449 -179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 26.8 m -133.07 158.43 43.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.185 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 41.7 p -59.5 147.78 35.51 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.667 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.7 p-10 -83.02 -37.24 24.21 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.616 -179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 68.31 3.03 3.52 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.899 -178.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 25.0 m-20 -140.2 72.9 1.41 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -90.04 -67.89 0.82 Allowed 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -110.71 87.02 2.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.767 0.318 . . . . 0.0 111.552 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.436 ' HG3' ' H ' ' A' ' 90' ' ' VAL . 14.4 ptmt -122.26 -49.41 2.05 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.277 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.436 ' H ' ' HG3' ' A' ' 89' ' ' LYS . 99.1 t -71.48 -37.77 65.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.489 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.413 ' CE2' ' HG3' ' A' ' 95' ' ' LYS . 37.0 t80 -64.95 -40.01 94.36 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.869 -179.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -66.04 -41.25 91.14 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.432 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.5 m -66.79 -42.2 86.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.336 0.588 . . . . 0.0 110.217 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.527 ' O ' HG11 ' A' ' 100' ' ' VAL . 98.5 mt -69.36 -22.68 63.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.457 -179.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.413 ' HG3' ' CE2' ' A' ' 91' ' ' TYR . 27.4 mmtt -86.79 -31.31 20.96 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.934 0.397 . . . . 0.0 111.525 179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -88.89 -5.14 58.21 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.999 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . . . . . . . . . 1.3 ttm -50.71 -19.88 1.07 Allowed 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 78.57 -49.45 0.46 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 122.671 0.388 . . . . 0.0 111.127 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' THR . . . . . 0.509 HG22 ' O ' ' A' ' 99' ' ' THR . 17.6 m -82.18 12.22 4.52 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.951 0.405 . . . . 0.0 111.214 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.527 HG11 ' O ' ' A' ' 94' ' ' LEU . 3.5 p -97.7 141.43 15.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.349 0.595 . . . . 0.0 111.294 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -103.92 -40.02 6.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.579 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 47.3 t -161.18 148.26 15.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.523 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 139' ' ' VAL . 65.9 t -127.77 126.23 66.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.131 179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 138' ' ' ILE . 85.1 m -116.28 131.17 57.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.103 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PHE . . . . . 0.405 ' CE1' ' HB3' ' A' ' 135' ' ' ASP . 39.1 t80 -89.02 124.69 34.52 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' SER . . . . . 0.726 ' HB3' ' HB3' ' A' ' 136' ' ' ALA . 0.1 OUTLIER -113.81 90.42 3.34 Favored 'General case' 0 C--N 1.323 -0.567 0 C-N-CA 120.579 -0.448 . . . . 0.0 110.316 -179.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 31.1 t -47.8 142.49 4.73 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 120.874 0.369 . . . . 0.0 110.766 -179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.3 pttp -60.66 -39.01 86.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.655 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.08 -41.8 81.36 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.944 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -69.6 -37.88 77.06 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.329 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . 0.499 ' HG2' HD12 ' A' ' 133' ' ' LEU . 11.8 tp-100 -65.3 -39.55 92.65 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.086 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.662 ' O ' HG23 ' A' ' 116' ' ' THR . 49.2 t80 -62.67 -42.09 99.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.767 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -64.52 -39.94 94.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.143 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.1 mmtm -65.53 -39.24 91.55 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.794 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.949 HD13 HD11 ' A' ' 118' ' ' ILE . 2.2 mm? -67.11 -36.45 81.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.67 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.662 HG23 ' O ' ' A' ' 112' ' ' TYR . 70.3 p -69.95 -34.32 73.27 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.675 -179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.2 -39.55 82.4 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.926 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.949 HD11 HD13 ' A' ' 115' ' ' LEU . 44.7 pt -77.91 -27.18 14.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.065 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -94.94 -72.65 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.265 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 166.85 -170.49 41.33 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -76.45 126.67 31.4 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.685 0.279 . . . . 0.0 110.745 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 30.7 m120 55.76 57.75 5.0 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.021 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' TRP . . . . . 0.52 ' CD1' HG22 ' A' ' 116' ' ' THR . 12.1 p-90 -91.28 -17.27 26.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.714 179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -133.48 -176.84 4.29 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.707 -179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 19.0 tt -132.87 158.17 43.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.14 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.47 63.42 0.8 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.953 -179.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -76.38 -18.12 59.03 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.641 179.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -77.14 -156.3 7.46 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 110.964 -0.855 . . . . 0.0 110.964 -179.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -60.49 -39.89 89.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.708 0.289 . . . . 0.0 110.682 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -168.61 -73.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.882 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -111.05 132.74 21.53 Favored Pre-proline 0 N--CA 1.451 -0.386 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -70.39 -24.31 26.91 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.775 2.317 . . . . 0.0 112.086 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.499 HD12 ' HG2' ' A' ' 111' ' ' GLN . 3.5 mm? -78.72 168.16 20.15 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.74 -179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -123.38 -174.03 2.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.831 -179.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . 0.565 ' O ' ' O ' ' A' ' 136' ' ' ALA . 89.9 m-20 -55.09 -23.34 20.03 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.181 -178.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . 0.726 ' HB3' ' HB3' ' A' ' 106' ' ' SER . . . 42.02 124.67 0.0 OUTLIER 'General case' 0 C--O 1.216 -0.699 0 O-C-N 124.795 1.309 . . . . 0.0 112.357 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.665 ' CD1' HD11 ' A' ' 64' ' ' ILE . 0.3 OUTLIER -120.27 106.94 12.39 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.66 -0.65 . . . . 0.0 109.7 179.548 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.502 ' HB ' ' HB ' ' A' ' 104' ' ' THR . 32.0 mt -86.89 108.07 17.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.726 HG22 HG22 ' A' ' 103' ' ' VAL . 77.4 t -105.8 139.06 28.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.991 0.424 . . . . 0.0 110.666 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 23.3 mp0 -103.05 110.61 22.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.057 179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.454 ' HB1' ' HB2' ' A' ' 146' ' ' ASP . . . -68.28 148.69 50.42 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.171 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -57.69 -40.09 78.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.04 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.45 ' HB1' ' HD2' ' A' ' 144' ' ' PRO . . . -132.52 158.18 76.35 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.884 179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.45 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 33.2 Cg_endo -63.09 -12.17 28.57 Favored 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.721 2.281 . . . . 0.0 112.043 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -99.5 -3.97 32.33 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.975 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.454 ' HB2' ' HB1' ' A' ' 141' ' ' ALA . 96.6 m-20 -96.68 -15.69 21.33 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 122.513 0.325 . . . . 0.0 111.11 -179.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.446 ' H ' HG12 ' A' ' 147' ' ' VAL . 0.1 OUTLIER -52.56 -34.76 19.69 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.752 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -71.88 -34.71 69.41 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.746 179.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 64.9 m -73.56 -38.76 65.09 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.572 0.701 . . . . 0.0 110.557 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 46.0 mm -67.04 -41.64 87.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.452 -179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.94 -39.56 93.69 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.771 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -70.75 -30.12 66.55 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.476 -178.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -74.87 -38.68 61.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.756 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -69.09 -26.28 64.84 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.906 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 6.1 mttm -62.63 -23.06 66.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.585 179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -105.83 7.21 32.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.603 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -83.2 132.9 30.31 Favored 'Isoleucine or valine' 0 C--O 1.232 0.153 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.707 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 33.69 -129.43 0.06 Allowed 'General case' 0 CA--C 1.543 0.703 0 O-C-N 124.218 0.949 . . . . 0.0 111.463 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . -113.14 41.6 2.17 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 12.3 p -43.13 135.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 CA-C-O 120.986 0.422 . . . . 0.0 110.77 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 41.1 t -77.11 -45.96 25.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.977 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLU . . . . . . . . . . . . . 59.2 tt0 -168.39 148.44 4.65 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.035 -179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 64.1 t -120.41 128.88 76.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 121.143 0.497 . . . . 0.0 110.698 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -116.27 119.23 35.06 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.38 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -97.64 155.64 16.89 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.918 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 -179.918 . . . . . . . . 0 0 . 1 stop_ save_